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Summary
Muscle differentiation is a complex process involving the transition from 
undifferentiated mesoderm to a final functional musculature. Mef2 is an essential 
positive regulator central to the co-ordination of this process. It targets a plethora of 
key genes both early and late in the differentiation program and its activity must be 
tightly controlled (Pothoff and Olson, 2007).
The aim of my research was to investigate the role of Mef2 in orchestrating 
Drosophila muscle differentiation. I did this by analysing the formation of the larval 
somatic musculature under conditions that either increased or decreased Mef2 activity 
using gain and loss-of -function of either; Mef2 itself, Him, a repressor of Mef2 
activity (Liotta et al, 2007) or of Zfhl, a potential regulator of Mef2 expression 
(Postigo et al, 1999). Part of this investigation involved the generation and 
characterisation of Mef2 dominant negative proteins and isolation of a Him mutant. 
Detailed analysis revealed a distinct subset of somatic muscles that are missing when 
Mef2 activity is reduced and another subset of muscles that are duplicated when Mef2 
activity is increased. This suggests a role for Mef2 in patterning of the musculature 
that has not been established previously. In addition, I identified a role for Mef2 in the 
regulation of Him expression, revealing a mechanism whereby Mef2 could be 
involved in its own repression.
I also investigated the role of mesol8E in muscle differentiation; a previously 
uncharacterised novel gene identified as an early target of Mef2 (Taylor, 2000). I 
found this to be a Myb-like domain containing protein that is a direct target of Mef2. 
Over-expression caused a severe disruption to the somatic musculature, revealing a 
potential role for mesol8E in muscle guidance. Generation of mesol8E mutant alleles 
by FRT element mediated recombination showed the gene to be essential for 
development.
Chapter 1 : Introduction
Introduction
1.1 Drosophila as a model organism.
I have used genetics and molecular biology techniques to study muscle development in the 
fruit fly, Drosophila melanogaster.
Drosophila was first used as a model organism for scientific research 100 years ago 
(Morgan, 1910), and during this period its use led to many of the key principles of classical 
genetics being first established (Ashbumer et al, 2004).
Drosophila is a small, yet fascinatingly complex organism, which is fecund, fertile all year 
round, cheap to maintain and has a temperature dependent life cycle of around twelve days. 
The life cycle is shown in FIG 1.1. Male and female adult flies are clearly distinguishable 
and after mating the females lays the fertilised embryos externally. The embryo then 
undergoes embryogenesis; the development of all the structures required for larval life. As 
the embryo is external to the female parent each of the stages of embryogenesis can be 
easily studied as development occurs. At the final stage of embryogenesis the newly 
formed larva is ready to hatch and after doing so undergoes three growth cycles; passing 
through three larval instar stages. During these instar stages the larva undergoes 
considerable growth and a build up of energy stores until it is ready to undergo pupation, 
where it will metamorphose and finally eclose, emerging as an adult fly.
These aspects of Drosophila biology make it attractive for use as a laboratory organism, 
but it is the genetics, the genetic manipulability and the number of techniques established 
over these last 100 years that truly makes Drosophila a super model organism for scientific 
research.
D. melanogaster has a relatively small genome of around 180Mb, consisting of approx 
13,600 genes which are divided among four chromosomes; the X chromosome, two main
1
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FIG 1.1 The life cycle of D
Image taken from flymove (Weighmann et al, 2003)
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autosomes (II and III) and an additional small autosome (IV) (Adams et al, 2000; 
Greenspan, 1997). Through the use of well-established collections of visible markers and 
balancer chromosomes, which prevent recombination from occurring, the inheritance of 
these chromosomes can be traced from parent to progeny in each generation and so 
particular genes of interest can be traced (Ashbumer et al, 2004).
Along with other Drosophila species, the euchromatic genome of Drosophila melanogaster 
has been completely sequenced and made publicly available (Adams et al, 2000) and this 
marked a huge step forward in the way that investigations into the biology of Drosophila 
were approached (Ashbumer and Bergman, 2005). This sequence information has been 
annotated and collected onto the Flybase database (www.flybase.org), which is the key 
resource for any Drosophilist, as it aims to contain the essential data on all the genes in the 
Drosophila genome (Ashbumer and Drysdale, 1994; Drysdale, 2008).
Despite the obvious differences between flies and man, we actually share considerable 
similarity with regard to the key biological processes; 60% of Drosophila genes have 
orthologs in humans (Rubin, 2001) and 77% of genes identified as being responsible for 
disease in humans are also found in Drosophila (Reiter et al, 2001). As research progresses 
in a variety of different organisms the evolutional conservation of molecular components, 
signalling pathways, protein interaction and gene regulation becomes increasingly 
apparent.
Drosophila is an organism of great genetic manipulability. As an invertebrate it generally 
has only one copy of each gene in its genome and thus it has proven relatively straight 
forward in achieving large numbers of gene deletion mutants, be this through large scale 
screens for a particular phenotype, where random mutagenesis is achieved through the use 
of chemical or ionising damage or through the action of transposable elements, or through
2
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the direct targeted deletion of a known gene of interest. The generation of gene deletions in 
vertebrate models, which not only is more difficult than gene deletion in Drosophila is also 
repeatedly problematic due to the fact that often a gene has multiple copies, with degrees of 
functional redundancy between them.
1.2 Techniques in Drosophila research.
Throughout its period of study a number of key techniques for investigating the function, 
significance, interaction and regulation of a gene have been developed. Outlined below are 
key experimental techniques that have been essential to my PhD.
1.2.1 Gene Over-expression / Gain-of-Function :
Of particular note is the Gal4 UAS expression system (Brand and Perrimon, 1993), which 
allows the ectopic expression of a transgene construct in any specific pattern in the 
organism to investigate the role of a gene. FIG 1.2 shows a schematic of how the Gal4 
UAS system works. It enables the researcher to ectopically express any gene with both 
spatial and temporal control and also control of the levels of the protein being over­
expressed and the significance of this technique cannot be stressed enough. For a review of 
Gal4 UAS applications see Duffy, 2002.
1.2.2 Gene Expression pattern visualisation:
The localisation of either the RNA transcript of a particular gene or the protein product of a 
gene can be traced and visualised through the use of RNA in-situ hybridisation (Lehmann 
and Tautz, 1994) or protein immuno-histochemistry using specific antibodies (Lang et al,
3
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By using the Gal4 UAS system, gene expression can be targeted to specific regions at any place or time within the flies’ development.
The system makes use of two yeast (S.cerevisiae) specific components that are introduced into the fly transgenically; the transcription 
factor Gal4 and the sites that the Gal4 transcription factor binds to -  the Upstream Activation Sequence (UAS). Through these factors 
any gene of interest can be expressed in any pattern of interest.
The system works through two indivdual trangenic lines that must be brought together in a genetic cross to activate. One line, the Gal4 
driver line, contains the promoter of gene interest which will drive the Gal4 transcription factor in the promoter's specific pattern. The 
other line, the UAS over-expression line, contains the gene of interest to be over-expressed. The gene of interest contains a series of 
Gal4 binding sites upstream of it and will only be expressed in the presence of the Gal4 protein. Consequently the gene of interest is 
only expressed in the pattern of the promoter of interest.
The Gal4 UAS system is temperature sensitive, with more Gal4 protein being expressed at higher temperatures and consequently the 
level of expression of the gene of interest can be controlled.
(Figure adapted from Brand and Perrimon, 1993 and Duffy, 2002)
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1980). Through RNA in-situ hybridisation the expression pattern of a gene can be traced 
and there exists databases that aim to not only provide the appropriate cDNA to allow the 
expression pattern of every gene in the genome to be traced in this way (www.fruitfly.org, 
Stapleton et al, 2002), but also databases that aim to provide images for the expression 
pattern of all these genes (www.flyexpress.org Kumar, 2009).
1.2.3 Gene Expression Regulation:
Through the use of reporter constructs, the expression regulation of a gene can be 
investigated. This involves the use of transgenic constructs which place a region of 
regulatory DNA from the predicted promoter of a gene upstream of a reporter gene such as 
GFP (Green Fluorescent Protein) or LacZ\ the promoter sequence then drives expression 
of the reporter and this can then be visualised by either immuno-histochemistry or in the 
case of GFP direct visualisation with fluorescence (Ashbumer et al, 2004). Through 
analysis of transcription sites within the regulatory region and manipulation through 
techniques such as site directed mutagenesis, the key transcription factors involved in the 
expression of a gene can be elucidated. A further aspect of the study of gene expression 
regulation is the use of in-silico transcription factor binding site searches within areas of 
phylogenetic conservation to form the basis of this reporter constmct design (see Zhang 
and Gerstein, 2003 review). Phylogenetic footprinting to identify sequence conservation 
makes use of the complete genomic sequences established for a number of distantly-related 
Drosophila species and through alignment and comparison of equivalent DNA regions 
across these species regions can be identified that are evolutionarily conserved (Grad et al, 
2004). The evolutionary distance between even the most closely related Drosophila species 
sequenced to D.melanogaster (D.simulans) is around 3 million years (Russo et al, 1995), 
whereas the most distantly related species to D .melanogaster sequenced (D. mojavensis) is
4
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around 50 million years or (Russo et al, 1995), or the equivalent evolutionary distance 
between mouse and man (Hartl and Lozoskaya, 1994) and as a result of this any 
conservation in non-coding DNA sequence (where there is a greater degree of tolerated 
mutation and sequence variation than coding DNA), suggests that this site may be of 
particular importance, and as such is often indicative of the sites of key transcription factor 
binding sites involved in the regulation of the gene. The Vista tools website is a key 
program for phylogenetic footprinting in Drosophila (Frazer et al, 2004).
1.2.4 Gene Loss-of-Function :
In genetics, the classical way of understanding the function of a gene is through the 
isolation and characterisation of a mutant. Traditionally this was achieved through the 
random mutagenesis of the whole genome using either ionising radiation, chemicals or the 
mobilisation of transposable elements, followed by the subsequent screening of all the 
mutant lines for an effect upon a particular process (see St.Johnson, 2002 for review). 
Though such techniques have identified a large number of key developmental genes (for 
example, Nusslein-Volhard and Wieschaus, 1980) and provided huge advances in the 
understanding of developmental biology, these forward genetics screens are laborious and 
as time goes on the same mutants are repeatedly isolated instead of novel genes of interest 
being hit.
Consequently with the advent of both the annotated genome sequence (Adams et al, 2000; 
Drysdale, 2008) and recent advances in molecular recombination techniques such as FRT 
element mediated recombination (Parks et al, 2004; Ryder et al 2005) and homologous 
recombination (Rong and Golic, 2000) a gene that is already known to be of interest (for 
example due to its expression pattern or a phenotype associated with its over-expression) 
can be specifically targeted for deletion. Such targeted deletion, or reverse genetics, marks
5
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a significant step forward for the relatively straight forward generation of specific mutants 
(Adams and Sekelsky, 2002; Venken and Bellen, 2005).
In addition to this, the technique of RNAi (RNA interference), that was first discovered in 
C.elegans (Fire et al, 1998), can be used in Drosophila (Reichhart et al, 2002; Kavi et al, 
2008) to knock down the RNA transcripts of a specific targeted gene, and consequently 
reduce that genes RNA and subsequent protein levels. This technique can be used as part of 
the Gal4 UAS system (Brand and Perrimon, 1993), such that a gene can have its expression 
levels reduced in a spatial and temporal manner as well as increased in this way through 
use of a regular UAS construct (Duffy, 2002). Recently, large scale projects have been 
undertaken which aim to provide stocks containing RNAi transgenic lines corresponding to 
every gene in the genome (Dietzl et al, 2007 and NIG-FLY, Japan).
As part of my PhD thesis I generated and characterised mutations in specific genes of 
interest using P-element mediated recombination and characterised other mutant lines that 
were generated by homologous recombination in collaboration with another lab.
These two techniques are outlined below.
1.3 Transposable Elements
Transposable elements are autonomous mobile units that mediate their transposition 
through the enzyme transposase. They are parasites of DNA which can cause mutation and 
genome change and are capable of both vertical (from parent to offspring) and horizontal 
(from one organism to another, sometimes one species to another) transmission (Engels, 
1983; Kidwell, 1983; Kidwell, 1985).
6
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P elements are a Type II Transposon family which only invaded Drosophila around 200yrs 
ago but has now eventually spread through all populations (entering Drosophila 
melanogaster only around lOOyrs ago). Because the invasion has been relatively recent, 
there exist original laboratory strains of Drosophila melanogaster (M strain) which contain 
no P-elements (Kidwell 1983; Engels, 1992).
The isolation and manipulation of P-elements have allowed them to be developed as a 
geneticist’s tool for generating gene mutation. By combining an immobile transposase 
enzyme with a mobile non-autonomous element, one single element put into an M strain fly 
can be allowed to make one jump to a region at random within the genome. In doing so this 
element may land in a gene and disrupt its function. That element can then be mapped to 
determine its new position in the genome (Spradling et al, 1995; Castro and Carareto, 
2004). This has been the basis for a number of forward genetics screens using P elements 
and other types of transposable element to generate new mutants (for review see Bellen et 
al, 2004).
The transposition of an element in the genome is not entirely random; there is an apparent 
preference for particular regions of DNA, and certainly an avoidance of heterochromatin, 
which may reflect the accessibility of the DNA (Berg and Spradling, 1991). To try to 
maximise the number of different insertions a large number of transposition events have 
been performed using different types of element starting from a number of various initial 
positions to transpose from (Bellen et al, 2004).
Recently a number of key efforts have been made to generate transposable element stocks 
that will achieve an insertion in every gene in the genome. The three main insertion 
projects are The Berkeley Drosophila Genome Project (Bellen et al, 2004), the European 
DrosDel project kept at Cambridge and Szeged (Ryder et al, 2004), and the Exelixis 
collection kept at Harvard Medical School (Thibault et al, 2004) .With a screen specific to
7
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the X chromosome (Beinert et al, 2004) and the Drosophila Genetic Resource Center 
(Kyoto Japan) also making contributions.
It was initially observed that it is possible to achieve transposition between the 5’ end of 
one element and the 3’ end of another which was adjacent to it. Such Hybrid Element 
Insertion (HEI) allows for the transposition of the endogenous DNA between the elements 
(Grey et al, 1996).
The subsequent development of a technique that used the basis of this observation to allow 
for a combination of elements on different copies of a chromosome, trans -  heterozygous 
P-element deletion (Gubb et al, 1997) opened up the potential for achieving deletion of a 
gene region between two elements, by simply crossing two lines together, instead of the 
previous complicated process of acquiring the elements on the same chromosome first for 
HEI (Ryder and Russell, 2003 review).
A significant development involving the DrosDel and Exelixis collections is that the 
element they used were designed in a way that allows for detectable trans- recombination 
between two different elements (Golic and Golic, 1996; Thibault et al, 2004). This achieves 
a deletion of the DNA between two elements mediated by recombination through 
appropriately orientated FRT sites within the element (Ryder and Russell, 2003). 
Consequently through the combination of two different pre-established single insertion 
lines, a vast number of deletions become possible (Ryder et al, 2004; Parks et al, 2004). 
These can generate anything from a partial deletion of a gene to the removal of large 
portions of a chromosome, causing the deletion of hundreds of genes at one time. The main 
limiting factor is that the FRT sites in the elements must be in the same orientation to be 
compatible for a recombination event between them. This is not always the case, as when 
an element jumps it can land in either orientation in the genome.
8
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1.4 Homologous Recombination.
For the maintenance and viability of a genome it is essential that the DNA repair and 
recombination machinery of a cell acts to repair any double strand breaks it detects in the 
DNA. It achieves this in part through using the intact homologous DNA on the other 
chromosome as a template. The occurrence of this defence process can be exploited to 
achieve targeted gene deletion, duplication or disruption through the introduction of open 
ended DNA containing regions of homology to the gene of interest.
Such gene targeting through homologous recombination has been welcomed in the field of 
genetics, as it allows for the specific deletion of a gene already established to be of interest 
(reverse genetics), when previously a mutant could only be achieved through laborious 
screens using chemicals, radiation or transposable elements (forward genetics) (reviews 
Adams and Sekelsky, 2002; Venken and Bellen, 2005).
This technique had been well established in a number of model systems such as mouse and 
yeast (Orr-Weaver et al, 1981; Jasin and Berg, 1988) but proved more difficult in 
Drosophila. Only recently has it been successfully achieved (Rong and Golic, 2000), after 
finding difficulties in efficiency when using the male germline (Bellaiche et al, 1999). It 
has subsequently been developed in different ways as a means of generating gene deletion, 
duplication or point mutation (Rong and Golic, 2001; Rong et al, 2002; Gong and Golic, 
2003; Xie and Golic, 2004) and shown to be capable of generating targeted deletions as 
large as 47Kb (Gong and Golic, 2004).
There are two established approaches for homologous recombination; Ends In and Ends 
Out. Ends In results in a gene duplication, which can subsequently be reduced to a single 
copy through Crel activity (Xie and Golic, 2004). Ends Out achieves gene deletion through
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replacement with a marker gene (Gong and Golic, 2003). The nomenclature refers to the 
direction the arms of the construct point when the recombination event occurs (FIG 1.4.1). 
Briefly, the Ends Out gene replacement technique (FIG 1.4.2) involves the use of an 
introduced construct which contains FRT sites (for mobilising the injected construct once 
in the genome), an I-Scel cut site (for generating a double strand break in the mobilised 
construct), and a w+ marker gene flanked by two arms of homology. These arms are 
homologous to the regions of endogenous DNA flanking the gene you want to delete. The 
FRT site and I-Scel site are specific to the yeast, Saccharomyces cerevisiae and are 
activated or cut through the Flp recombinase (Flippase) and I-Scel enzymes respectively; 
both of which are heat-shock inducible and introduced into the genome by appropriate 
crossing (see Materials and Methods). When a successful recombination event occurs the 
endogenous gene is deleted, being replaced with a w+ marker gene from the construct (see 
FIG 1.4.2). The event is traced by following the effect of the w+ marker on eye colour and 
then confirmed by PCR or Southern blot hybridisation to the gene region.
It is these techniques for gene deletion and those outlined above for gene functional and 
transcriptional analysis that I will use to investigate the roles of two novel genes involved 
in muscle differentiation in Drosophila.
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1.5 Muscle Development in Drosophila.
For my PhD I investigated the process of somatic muscle differentiation; asking how 
undifferentiated mesoderm undergoes the complex transition to form a final functional 
musculature. This process of myogenesis involves the differentiation of specific muscle 
precursors and their fusion with surrounding myoblasts to form the multinucleate myotubes 
that form part of a regular repeating pattern of interacting muscles (reviews Baylies et al, 
1998; Ruiz-Gomez, 1998; Frasch, 1999).
1.5.1 Overview
Muscle forms from the germ band layer of mesoderm in the embryo. There are four main 
steps to this process, and as is always the case in developmental biology this involves the 
sequential build up of complexity necessary for pattern formation. Initially cells in the 
embryo must adopt a mesodermal fate. The developing mesoderm then undergoes 
processes of subdivision and following this subdivision there is a commitment of the 
different muscle types (somatic, visceral, pharyngeal and cardiac). Finally, there is the 
process of muscle differentiation itself, which will result in a complete functional structure 
of interacting musculature (Taylor, 1995; Paululat et al, 1999).
1.5.2 Specification of the Mesoderm
The mesodermal germ layer forms from the most ventral cells of the blastoderm due to the 
action of the zygotic transcription factors Twist and Snail (Jiang et al, 1991; Ip et al, 1992). 
These are expressed in response to high concentrations of the maternal transcription factor 
Dorsal, which forms a nuclear localisation gradient from a ventral position in the embryo
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(Jiang et al, 1991; Pan et al, 1991). Both Twist and Snail are essential for the formation of 
the mesoderm (Leptin, 1992) and Twist is expressed in all the cells of the mesoderm and its 
derivatives (Thisse et al, 1988). During gastrulation these Twist expressing cells invaginate 
along the ventral midline then migrate dorsally forming a monolayer just beneath the 
overlying ectoderm (Leptin and Grunewald, 1990).
Initially the mesoderm at this stage is uniform, with all cells expressing the bHLH 
transcription factor Twist at the same level (Thisse et al, 1987) and also as a result 
expression of the direct Twist targets; the muscle specific transcription factors Mef2 and 
Tinman which are now activated is also uniform (Lilly et al, 1995; Taylor et al, 1995; 
Azpiazu and Frasch, 1993). Subsequently there is a subdivision to the mesoderm that 
causes the levels of Twist expression in the mesoderm to become modulated, which has a 
crucial effect on the assignment of cells in adopting different muscle types (Baylies and 
Bate, 1996; Taylor, 1996 review).
1.5.3 Subdivision of the mesoderm.
The subdivision of the mesoderm results from a combination of regulatory factors which 
are extrinsic and intrinsic to the mesoderm (Baylies and Bate, 1996). This subdivision 
occurs along both the dorsal-ventral axis and the anterior-posterior axis. The ectoderm 
overlying the dorsally-located mesodermal monolayer secretes a series of extrinsic signals 
which effect cell fate and pattern the mesoderm, Decapentaplegic (Dpp), Wingless (Wg) 
and Hedgehog (hh) signalling molecules are all secreted in this way and these factors are 
conserved in both their form and function in mesoderm specification in vertebrates and 
invertebrates (review Baylies et al, 1998). Dpp in this manner plays a role in subdivision of
12
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the dorsal-ventral axis through maintenance of Tinman expression dorsally (Frasch, 1995; 
Maqbool and Jagla, 2007 review).
Additionally, a subdivision of the mesoderm occurs along the anterior posterior axis 
through the action of the pair rule genes Even-skipped (Eve) and Sloppy Paired (Sip) which 
are both intrinsic to the mesoderm. Eve is required for the formation of the anterior 
mesodermal derivatives; visceral muscle and fat body - Eve mutants fail to form these 
structures (Azpiazu et al, 1996) and Sip is required for the formation of the posterior 
mesodermal structures; the somatic and heart muscle -  which Sip mutants fail to form 
(Riechmann et al, 1997). The action of these factors is associated with a modulation of 
Twist expression; high levels of Twist are maintained in the Sip domain and low levels of 
Twist occur in the Eve domain (Dunin-Borkowski et al, 1995).
As mentioned above, extrinsic Dpp signalling maintains Tinman signalling dorsally 
(Frasch, 1995) in addition Hh signalling acts upon the anterior region of the embryo 
maintaining Bagpipe (Bap), a gene required for visceral muscle formation (Azpiazu et al,
1996) and Wg reinforces the difference between the Eve and Sip domains through 
maintaining high levels of Twist in the Sip domain (Reichmann et al, 1997).
It is this combination of D/V and A/P mesodermal subdivision that allows the specification 
of the three different muscle types; somatic, visceral, and cardiac and also the fat body 
according to the four domains in a segment. Cells which are in the Sip domain express high 
levels of Twist and if they are also positioned dorsally and receive sufficient Tinman 
signals from the overlying ectoderm, they will adopt a cardiac fate. Cells in the Sip domain 
that are positioned more ventrally and do not receive the Tinman signal adopt a somatic 
muscle fate. Similarly cells in the Eve domain are divided by their dorsal and ventral 
position; dorsally positioned cells in this domain will become visceral muscle, whereas 
those located ventrally will become fat body (Reviewed Maqbool and Jagla, 2007).
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1.5.4 Somatic muscle development
It is from this point of D/V and A/P mesodermal subdivision that the somatic muscle 
begins to be specified. The larval somatic musculature consists of a regular, repeating 
pattern of thirty interacting individual muscles in each abdominal hemi-segment (Bate, 
1990). These muscles are multinucleate myotubes which are attached to the cuticular 
exoskeleton at points specific to each individual muscle (Bate, 1990; Frasch 1999 review). 
Though each individual somatic muscle is similar with respect to physiological and 
structural characteristics (Bate and Rushton, 1993) there are distinct morphological 
differences between each individual muscle in terms of shape and size, position and 
orientation within the abdomen, attachment sites and motomeuron innervation (Bate, 1993; 
Ruiz-Gomez, 1998; Frasch, 1999). It is through analysis of these characteristics that an 
assessment of correct somatic muscle differentiation can be made. FIG 1.5.1 and FIG 1.5.2 
shows the somatic musculature with a figure from Bate, 1993 showing each of the 30 
individual somatic muscles.
The formation of an individual somatic muscle from the specified somatic mesoderm can 
be divided into a number of key stages;
specification of a muscle progenitor cell from a uniform population of cells within 
the “somatic muscle domain” by lateral inhibition
asymmetric division of the progenitor to form at least one muscle founder cell 
- the recruitment of fusion competent myoblasts (FCMs) to a single founder cell, 
their fusion to the founder cell and the subsequent development of a multinucleate 
myotube
extension of this developing myotube towards tendon cell attachment sites in the 
epidermis
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A) Stage 17 embryo B) Abdominal hemi-segment
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FIG 1.5.1 Somatic musculature of the St17 embryo
A) Stage 17 wild type embryo stained with anti-(B3 tubulin antibody to visualise the somatic musculature. Embryo is 
viewed laterally and muscles focussed in an external plane. The embryo is divided into thoracic and abdominal 
hemi-segments. Abdominal hemi-segments A2-A7 contain the same pattern of 30 individual muscles, a 
schematic of which are shown in B)
B) Schematic of the 30 individual muscles of an abdominal hemisegment (A2-A7) showing an internally focussed 
and an externally focussed view of the muscles. Each muscle has a unique shape, size, position, attachment and 
innervation characteristics which are specific to that muscle type (Image from Bate, 1993).
A B
FIG 1.5.2 Wild-type somatic muscle pattern in
A flattened view of an A2-7 abdominal hemisegment. (A) Internal view. (B) External view. 
Abbreviations: DA: dorsal acute; DO; dorsal oblique; DT; dorsal transverse; LL: lateral 
longitudinal; LO: lateral oblique; LT: lateral transverse; VA: ventral acute; VL: ventral 
longitudinal; VO: ventral oblique; VT: ventral transverse; ISN: intersegmental nerve; SN: 
segmental nerve; TN: transverse nerve. This figure is from Bate, 1993.
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These steps define the position (within the hemisegment and relative to other muscles), the 
size, shape and attachment points of each individual muscle.
1.5.5 Progenitor Specification
The muscle progenitors form from a field of uniform cells that all express lethal o f scute 
1(1)sc and have the potential to form a progenitor. However, through Notch and Delta 
mediated lateral inhibition single cells in the field become progenitor cells (whereas the 
other surrounding cells undergo their own program of differentiation and become the 
FCMs) (Carmena et al, 1995).
1.5.6 Founder Cell formation
The muscle progenitors divide once to form key cells in the developing muscle program. 
The asymmetric determinant Numb has been shown to play a key role in the specification 
of the fate of these cells (Ruiz-Gomez and Bate, 1997; Carmena et al, 1998; Park et al,
1998); the cell that acquires Numb in the division adapts one fate, whereas the sibling cell 
that does not acquire Numb adopts another fate. What the actual fate of these siblings is can 
vary depending upon the original progenitor itself. For example, though one of the siblings 
always forms a founder cell which will go on to form an individual muscle, the other 
sibling can be an adult muscle precursor (AMP) (Bate, 1990), a heart pericardial cell 
(Carmena et al, 1998) or another founder cell which will become a different adjacent 
individual muscle (Ruiz-Gomez and Bate, 1997). However, there is no variation in the fate 
of the cells that each individual progenitor will produce; for example the progenitor that 
forms the DAI muscle founder always also gives a daughter that forms a pericardial cell
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(Su et al, 1999) and the progenitor that forms the VA1 muscle founder always also gives a 
daughter that forms the VA2 muscle founder (Ruiz-Gomez et al, 1997).
When there are errors in the distribution of Numb at this stage of division the fate of the 
sibling cells can be affected. For example there is a progenitor that gives rise to the VA3 
muscle founder and an AMP, and the sibling cell of the pair that acquires Numb will 
always adopt the VA3 fate whereas the sibling cell that does not acquire Numb will adopt 
the AMP fate. However when Numb is over-expressed so that it is acquired by both of the 
daughter cells on division of the progenitor, both of the siblings adopt the VA3 fate. 
Alternatively, in a Numb mutant, neither of the daughter cells can acquire Numb on 
division of the progenitor, and consequently both adopt an AMP fate (Ruiz-Gomez and 
Bate, 1997).
This would manifest itself in the Stl 7 embryo as a duplication of the VA3 muscle (and loss 
of AMP) in the UAS-Numb condition and loss of the VA3 muscle (with duplication of the 
AMP) in the Numb mutant condition. In a similar manner, if a particular progenitor 
normally gives rise to two muscle founders rather than a muscle founder and an AMP (as is 
the case with the VA1 and VA2 muscles), then this would show itself in the Stl 7 embryo 
as a transformation of muscle fate between the two. (Ruiz-Gomez and Bate, 1997).
Each individual muscle is derived from a single founder cell and these founder cells form 
in a stereotypic pattern within the hemi-segment (Bate, 1990; Bate, 1993) and then remain 
in a fixed position relative to each other during development until the final muscle pattern 
is formed (Beckett and Baylies, 2007).
Each founder cell expresses a combination of transcription factors which define it and the 
subsequent individual muscle that will form from it, and consequently these transcription 
factors are sometimes known as muscle identity genes (Baylies et al, 1998; Frasch, 1999 
reviews). Examples of genes expressed in specific progenitors are Kruppel (Ruiz-Gomez et
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al, 1997), apterous (Bourgouin et al, 1992), S59/slouch (Dohrmann et al, 1990; Knirr et al,
1999), even-skipped (Frasch et al, 1987) muscle segment homeobox (msh) (Nose et al, 
1998), nautilus (Keller et al, 1997), ladybird (Jagla et al, 1998), vestigial (vg) (Williams et 
al, 1991), collier (Crozatier and Vincent, 1999; Dubois et al, 2007), toll (Halfon et al, 
1995) and connectin (Nose et al, 1992) (Baylies et al, 1998; Ruiz-Gomez, 1998; Frasch, 
1999; Maqbool and Jagla, 2007 reviews) and some of these transcription factors are 
necessary and sufficient for the formation of a specific individual muscle type. FIG 1.5.2 is 
a schematic taken from Baylies et al 1998 which shows some of these identity gene 
expression patterns in the individual muscles of the final somatic musculature.
In a similar manner to the Numb experiments, altering the acquisition of certain identity 
genes also causes a change in fate, for example in apterous mutants a loss of the LT 
muscles is seen, whereas when apterous is over-expressed LT muscle duplication occurs 
(Bourgouin et al, 1992), which is indicative of the way that Numb is required for the 
maintenance of identity gene expression in certain situations (Ruiz-Gomez and Bate, 1997; 
Park et al, 1997; Carmena et al, 1998).
1.5.7 Founder cell and Fusion Competent Myoblast fusion
Once a founder cell has formed it must begin the process of myoblast fusion in order to 
grow into the multinucleate myotube that forms an individual muscle. As mentioned 
above, the founder cells and FCMs derive from the same initial population of cells, but due 
to lateral inhibition the founder cells adopt a different fate. The founder cell and FCMs 
surrounding it express a distinct combination of proteins which mean that fusion is always 
asymmetric; it can only be between a founder and a FCM not between two founders or two 
FCMs (Reviewed in Taylor, 2000; Taylor, 2002; Dworak and Sink 2002; Taylor, 2003).
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FIG 1.5.3 Expression pattern of identity genes in somatic muscle
Figure taken directly from (Baylies et al, 1998) shows how identity genes are expressed in the somatic 
muscles of the embryo.
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Some factors are common to both types of cell but there are others that are specific to just 
one type. Dumbfounded (Duf) and sticks and stones (sns) are two such cell-type specific 
proteins. D uf is expressed specifically in the founder cells and is a myoblast attractant 
essential for fusion (Ruiz-Gomez et al, 2000). Whereas sns is specifically expressed on the 
surface of the FCMs and is attracted to Duf (Bour et al, 2000). After the initial recognition 
of the founder and FCM through Duf and Sns the rest of the fusion process can occur. This 
involves a number of other proteins which are essential for the process, including Roughest 
(Striinkelnberg et al., 2001), Myoblast city (Rushton et al, 1997), Rolling pebbles (Rols) / 
Antisocial (Ants) (Menon and Chia, 2001; Rau et al, 2001; Chen and Olson, 2001), Hibris 
(Artero et al, 2001), Loner and Arf (Chen et al, 2003).
As a fusion competent myoblast fuses it adopts the fate of the founder cell / developing 
myotube and thus its nucleus also expresses the specific muscle identity genes of the 
original founder cell. There are two temporal phases to myoblast fusion (Beckett and 
Baylies, 2007) and though the fusion appears to occur at similar times for each developing 
muscle (such that it doesn’t appear that one muscle forms before another) (Beckett and 
Baylies, 2007) there is variation in the number of fusion events for each individual muscle 
which is reflected in the variation its final size of a final and is seen by the number of 
nuclei it contains (Bate, 1990).
1.5.8 Myotube guidance and attachment
As the myotube develops it also must be guided to its appropriate attachment sites in the 
epidermis so that the final muscle will be positioned correctly within the embryo so that it 
can function as a unit as part of the working musculature (Volk, 1999; Schnorrer and 
Dickson, 2004). This is achieved through cross talk between the extending myotube and the
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tendon cell attachment sites. And as fusion events are still occurring between FCMs and 
this extending and growing myotube, this means that there are two intercellular 
communication events occurring simultaneously during this time (Schnorrer and Dickson,
2004).
The myotube projects filipodia in the direction of nearby tendon cells and on reaching the 
destination they stop extending and form a stable connection through adhesion molecules 
such as integrin (Schnorrer and Dickson, 2004). This adhesion allows the muscle to 
contract from this position; flies that are null for integrin form their muscles properly and 
have them reach the attachment sites appropriately but the muscle does not cope with 
contraction, and the muscle consequently balls up due to not being able to maintain its 
attachment (Brown et al, 2000).
The tendon cells are positioned at stereotypic positions within the epidermis and their 
initial formation occurs independently of muscle formation; tendon cells form normally 
even in Twist mutants which have no mesoderm (Becker et al, 1997). The Zinc finger 
transcription factor Stripe is an early marker of the tendon cells (Volk and VijayRaghavan, 
1994), and is essential for their correct function. In Stripe mutants muscles fail to reach 
their attachment sites (Frommer et al, 1996), whereas over-expression of stripe at ectopic 
sites in the epidermis causes the formation of ectopic tendon cells in these positions to 
which the myotubes migrate to, consequently disturbing the final musculature pattern 
(Vorbruggen and Jackie, 1997). Despite tendon cells being able to form independently of 
the mesoderm initially, they subsequently require muscle; the EGF receptor on the surface 
of the tendon cell requires a signal in the form of the ligand Vein to be secreted from the 
extending myotube in order for the tendon cell to correctly differentiate (Yamitzky et al,
1997).
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1.5.9 Mef2 and Orchestration of the Muscle Differentiation 
process
Mef2 (Myocyte enhancer factor2) is a key promoting factor in the orchestration of muscle 
differentiation in invertebrates and vertebrates (Taylor, 1995; Pothoff and Olson, 2007). It 
is a MADS box (MCM1, Agamous, Defeciens and SRF) containing transcription factor 
(Shore and Sharrocks, 1995; Molkentin et al, 1996) which is essential for somatic muscle 
development.
Due to the occurrence of two genome duplications there are four copies of Mef2 in 
vertebrates, A,B,C and D (Yu et al, 1992; Edmondson et al, 1994) and as a result, studying 
the role of Mef2 in vertebrate differentiation proves difficult due to a degree of redundancy 
between the different copies (Black and Olson, 1998). However, Drosophila has only one 
copy of M efl (Lilly et al, 1994; Nguyen et al, 1994; Taylor et al, 1995), and so it is has 
been possible to generate null and hypomorphic mutant lines for this gene (Bour et al, 
1995; Lilly et al, 1995; Ranganayakulu et al, 1995) which have revealed a great deal about 
its significance in muscle development. A M efl null mutant embryo forms no somatic 
muscle, showing that is necessary for the formation of the somatic muscle in invertebrates 
(Bour et al, 1995; Lilly et al, 1995). The M efl hypomorphic mutants show a series of 
varying degrees of severity on the formation of muscle; from the vast majority of somatic
J / 9
muscles being missing in M efl mutants, to only a few muscles being affected in the 
weak hypomorph mutant M efl65. M efl424 shows an intermediate phenotype to these 
(Ranganayakulu et al, 1995). The different hypomorphic mutants produce different 
amounts of Mef2 and have been used to show that Mef2 levels have various effects on the 
timing and occurrence of gene activation to influence muscle differentiation in 
embryogenesis (Gunthorpe et al, 1999; Elgar et al, 2007). M efl is expressed throughout all
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the muscle types (somatic, visceral, pharyngeal and the contractile cardiac) and is present 
from early mesoderm going from the uniform field of high expression Twist cells in the 
mesoderm to the complex structure of the final regular repeating musculature at the end of 
embryogenesis (Nguyen et al, 1994; Lilly et al, 1994; Taylor et al, 1995). As mentioned 
previously, Twist is responsible for this early Mef2 expression (Taylor et al, 1995), acting 
directly upon its regulatory sequence (Cripps et al, 1998).
Mef2 has been shown to bind to the consensus regulatory sequence YTAWWWWTAR 
(Andres et al, 1995) and a number of key genes associated with muscle structure have been 
identified as direct Mef2 targets; for example, Tropomyosin (Lin et al, 1996), p3-tubulin 
(Damm et al, 1998) and Paramyosin (Arrendondo et al, 2000). In addition, more recently a 
number of key large-scale studies have shown that Me£2 binds to the regulatory region of a 
large number of genes essential for many aspects of muscle differentiation and plays a role 
in their expression either directly or indirectly (Junion et al, 2005; Sandmann et al, 2006; 
Elgar et al, 2008).
A number of mechanisms exist to ensure that the regulation of Mef2 itself is correct and its 
activity is restrained until the appropriate times during development. The co-repressor, 
Him (Holes in Muscle) was recently shown to repress Mef2 activity in embryogenesis 
acting through the conserved repressor Groucho (Liotta et al, 2007; Liotta PhD thesis,
2005) and also in the adult musculature (Soler and Taylor, 2009). Over-expression of Him 
causes a severe inhibition of somatic muscle differentiation in a manner that mimics the 
Mef2 loss-of-function alleles (Liotta et al, 2007).
In addition the conserved repressor Zfhl (Zinc finger homeodomain 1) (Lai et al, 1993) 
shows evidence of Mef2 repression (Postigo et al, 1997) and like Him, its over-expression
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also causes an inhibition to somatic muscle differentiation (Postigo et al, 1997; Postigo et 
al, 1999).
Another means of regulation is the tight control of Mef2 activity throughout development 
as Mef2 levels have a direct effect upon muscle differentiation (Gunthorpe et al, 1999). 
There are genes that have a low requirement of Mef2 activity in order to be expressed and 
other genes that have a high requirement of Mef2 activity in order to be expressed. Such 
low requirement genes are expressed earlier in embryogenesis, whereas the high 
requirement genes are expressed later (Elgar et al, 2008) and this observation reveals a 
general way in which Mef2 can act upon a number of transcriptional targets over time.
In addition to this Mef2 can bind to the DNA as a homodimeric or heterodimeric protein 
(Black and Olson, 1998; Pothoff and Olson 2007) and a range of bHLH proteins can act as 
the binding partner in this Mef2 heterodimer (Black and Olson, 1998). Variation in the 
Mef2 binding partner also provides another possible means of Mef2 regulation in activating 
targets. In addition, Mef2 has been shown to be capable of auto-regulation (Cripps et al, 
2004) and thus can provide a way of rapidly upregulating its activity at the appropriate 
time.
All of these mechanisms provide a means of Mef2 activity to be tightly regulated over time 
such that its plethora of targets can be activated in the appropriate place and the appropriate 
time to ensure the correct differentiation of the musculature. However, though it is known 
that Mef2 is expressed in the majority of key cells throughout muscle development and that 
Mef2 is essential for somatic muscle differentiation itself, the exact involvement of Mef2 in 
these different stages is poorly understood.
At the early stages of the muscle differentiation program Mef2 is expressed but its role is 
not understood. For example, at the stage of progenitor formation, Mef2 is expressed in the 
muscle progenitor and subsequently maintained in the founder cell but lost in the
22
Chapter 1 : Introduction
pericardial cell (Su et al, 1999). And at the fusion stage, Mef2 is expressed in both the 
fusion cell and the FCMs (Taylor, 2003 review), targets many of the genes involved in the 
fusion process (Sandmann et al, 2006), but must oversee the differential expression 
programs that distinguish the founder cell and the FCM in some way.
Initially it was thought that Mef2 acted later in somatic muscle differentiation, as the 
majority of its established targets were structural genes expressed towards the end of 
myogenesis (Lin et al, 1996; Damm et al, 1998; Arrendondo et al, 2000). However, when it 
was shown that it played a part in the regulation of the novel mesodermal gene mesol8E, 
Mef2 was established to have a role early in development as well (Taylor, 2000). 
Subsequent evidence that Mef2 regulated another early gene, Actin57B (Kelly et al, 2002), 
combined with the recent data from global analyses of Mef2 action (Junion et al, 2005; 
Sandmann et al, 2006; Elgar et al, 2008) which reveal a number of genes involved in the 
early differentiation stages to be potential Mef2 targets, means that Mef2 plays an active 
role throughout the stages of myogenesis. What the specific roles are for Mef2 in these 
stages of myogenesis is an important question for understanding the process of muscle 
differentiation.
Though the Mef2 hypomorphic alleles have provided insight into the importance of Mef2 
they are limited in their use for studying the different stages of muscle differentiation. In
yy  y ialleles that cause a large decrease in Mef2 activity (such as in the Mef2 ' null mutant or 
the Mef2113 hypomorph) the detrimental effect of an event early in myogenesis may mask a 
role that Mef2 plays later in embryogenesis. Conversely with alleles that cause a milder 
decrease in Mef2 activity, (such as the Mef265 allele) the embryo may be able to pass 
through such earlier developmental stages but as a result the drop in Mef2 activity is not 
significant enough to determine an effect in other stages. Consequently, alternative 
approaches for investigating Mef2 function in myogenesis are required.
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1.6 Main Aims for my PhD
The main aims of my PhD are to investigate the roles of Mef2 and genes that are involved 
in regulation of its activity during the muscle differentiation programme.
I have done this in the following main ways;
- Generation and characterisation of a Mef2 dominant negative construct that can be used 
with the Gal4 UAS system to allow the controlled reduction of Mef2 activity in a spatial 
and temporal manner during the different stages of muscle differentiation.
- Investigation into the expression regulation of the Him gene.
- Generation and characterisation of mutant alleles in Him to further assess the role of this 
gene in muscle differentiation and Me£2 repression
- Characterisation and comparison of the gain-of-function and loss-of-function phenotypes 
associated with the Zfhl and Him genes.
- Investigation of the early Mef2 target and potential Mef2 effector meso!8E, through 
bioinformatics, transcriptional regulation studies and gain-of-function experiments and the 
generation of loss-of-function alleles.
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Materials and Methods
2.1 Molecular Biology
2.1.1 Agarose gel Electrophoresis
DNA fragments were separated by size using electrophoresis on agarose gels.
1% (w/v) agarose with lx TBE (90mM Tris-Borate, 2mM EDTA) gels used with lul per 
10ml molten gel of ethidium bromide solution (lOmg/ml) added. DNA loaded on the gel 
and intercalated with ethiduim bromide was visualized with a UV transilluminator.
Lambda Hindlll DNA and 1Kb Plus (Invitrogen) ladder were used as molecular weight 
markers.
2.1.2 DNA gel extraction
DNA fragments were purified by running on an agarose gel, extracting the fragment with a 
clean scalpel whilst visualising it under a low frequency UV light source and using a gel 
extraction kit (Qiagen) in accordance to the manufacturers’ instructions.
2.1.3 DNA Precipitation with ethanol.
DNA was precipitated by the addition of 2 volumes of ice cold ethanol after the salt 
concentration was adjusted with 1/10 volume of 3M sodium acetate. The mixture was 
incubated for 20-30 minutes at -80°C (or o/n at -20°C) and the DNA was recovered by 
centrifugation at 13.000 rpm in a microfuge for 20 minutes. The pellet was washed with 
70% ethanol, air dried and resuspended in a suitable volume of double distilled H2O.
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2.1.4 Phenol chloroform extraction
DNA was purified of proteins and salts using phenol chloroform and washing with ethanol 
as follows. dH20 was added to take the volume up to lOOul and then lOOul of phenol 
chloroform (Sigma) was added. This mixture was vortexed at centrifuged at r.t at 
13000rpm for lOmins. The upper, DNA-containing phase, was collected and DNA 
precipitation performed to concentrate it.
2.1.5 Restriction digests
All restriction digests were performed in a total volume of 50ul and the incubation 
performed at 37°C for 2hrs. Buffers and enzymes used were NEB. Double digests were 
either performed simultaneously or sequentially in accordance with enzyme buffer 
compatibility. Where appropriate enzyme activity was stopped by heat inactivation (65°C, 
20mins), phenol chloroform purification or DNA gel extraction (Qiagen).
2.1.6 Blunt ends
If blunt ends were required after a restriction enzyme cut, the DNA was purified then the 
ends were filled in with T4 DNA polymerase (NEB), supplemented with dNTPs (lOOuM) 
and BSA in an appropriate buffer (NEB). The reaction was carried out at 37°C for 35mins, 
then the T4 DNA pol was heat inactivated at 75°C for 20mins.
2.1.7 Vector dephosphorylation
To prevent unwanted recircularisation of prepared vectors the ends were dephosphorylated 
using Calf Intestinal Phosphatase (CIP) (NEB). Vector purified by phenol chloroform
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extraction and DNA precipitation was resuspended in diH20 and dephosphorylated in a 
total volume reaction of 30ul at 37°C for 20mins. The vector would then be purifed by gel 
extraction (Qiagen).
2.1.8 Ligation
Ligation was performed in a lOul total volume reaction, using T4 DNA Ligase (NEB) and 
the prepared insert with appropriately cut and dephosphorylated vector in a ratio of 3:1. 
Ligations were performed either at room temperature for lhr followed by lhr on ice, or at 
16°C overnight (12°C o/n if the ligation involves an EcoRI site).
Ligations using pGEM-T (Promega) were performed using the provided kit in accordance 
to manufacturers instructions.
2.1.9 Genomic DNA Extraction
Approx. 15-20 flies were collected, anaesthetised, kept on ice and homogenised in a 1.5ml 
Eppendorf using rapid strokes with a DNase-free plastic grinding pestle and lOOul of 
Buffer A (lOOmM TrisHCl pH7.7, lOOmM EDTA, lOOmM NaCl, 0.5% SDS). An 
additional 200ul of Buffer A is added along with 3ul Proteinase K (15.6mg/ml) and 
incubated in 65°C water bath for lhr. 2ul of RNAse A (lOmg/ml, Qiagen) is added and 
incubated at 37°C for 20mins. lOOul of 5M KOAc is added and the mixture voretexed and 
incubated on ice for 5mins before centrifuging using a microfuge at 13000rpm for 25mins. 
The supernatant is transferred to a fresh tube, mixed with 450ul of ice cold isopropanol and 
centrifuged at 13000rpm for 5mins. The recovered DNA pellet is washed in 70% ethanol, 
air dried and resuspended in an appropriate volume of dH20 (Sigma).
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2.1.10 PCR -  Polymerase Chain Reaction
Standard PCR reactions were carried out for the generation of the various constructs using 
the DyNAzyme EXT high fidelity DNA Polymerase (Finnzymes). Reactions were carried 
out in a 50pl volume, containing 5pi of optimised DyNAzyme EXT buffer (containing 
1.5mM MgCh), lp l of lOmM dNTPs (Promega), lpl of 25pM forward oligonucleotide 
primer (MWG), lp l of 25pM reverse oligonucleotide primer (MWG), 5pl of lOOng/pl 
template DNA (plasmid or genomic) and 1 pi of DNA polymerase. The volume was then 
adjusted with distilled H2O (Sigma). The DNA templates were amplified using 20-30 
cycles in a Peltier thermal cycler (MJ Research) equipped with a heated lid.
In general the following program was used:
Initial denaturation: 95°C, 5 minutes 
Denaturation: 95°C, 1 minute 
- Annealing: 55-65°C, 1 minute
Extension: 72°C, 1 minute/Kb of template sequence 
Final extension: 72°C, 5-10 minutes
2.1.11 Site Directed Mutagenesis
Site Directed Mutagenesis of circular DNA was performed according to the Quik Change 
Site Directed Mutagenesis Protocol (Stratagene). Mutagenesis primers were designed using 
the Stratagene website tool.
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2.1.12 Bacterial Cultures and agar plates
Bacteria were grown either in liquid culture in Luria-Bertani (LB) medium (per Litre: 1 Og 
Bacto-tryptone, 5g yeast extract, 5g NaCl, pH 7.0) at 37°C with continuous shaking at 
300rpm, or on LB-agar (LB plus 15g/L Bacto-Agar) plates at 37°C. Ampicillin, at a final 
concentration of lOOpg/ml was used as a selector where appropriate.
2.1.13 Transformation of Competent Cells
5-10ul of ligation mixture is incubated on ice for 15mins with 50ul of E.coli DH5a 
competent cells (Invitrogen) and then heat shocked in a 42°C bath for 45 seconds for the 
cells to take up the DNA. The cells are given 2mins on ice to recover then given 450ul of 
prewarmed SOC medium (2% Tryptone, 0.5% Yeast Extract, lOmM NaCl, lOmM KC1, 
lOmM MgCb, lOmM MgSC>4, 20mM Glucose) and incubated at 37°C for 45min with 
shaking.
Cells that took up the DNA are selected by plating out lOOul / 250ul of the mixture onto 
LB Agar / Antibiotic plates and incubated at 37°C o/n. For all the plasmids I have used the 
selective antibiotic has been ampicillin.
2.1.14 Plasmid Preparation from bacterial culture.
1.5ml of o/n bacterial culture was centrifuged at 13000rpm for 5 mins to pellet cells. The 
supernatant was removed and an additional 1.5ml centrifuged. The plasmid Spin Mini Prep 
protocol (Qiagen) was then performed according to the manufacturers instructions. For 
larger plasmid preparations 50ml of o/n bacterial culture was used with the Midi prep kit 
(Qiagen).
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2.1.15 Preparation of Digoxigenin-labelled RNA probe for RNA 
in-situ hybridisation
Prior to transcription, DNA templates were linearised with appropriate restriction enzymes 
and were then purified by gel extraction.
Transcription reactions were carried out in 50pl containing approximately 500ng of 
linearised template DNA, lpl of 10X transcription buffer (Roche), lpl of DIGNTP mix 
(Roche), 0.5pl of RNAse inhibitor (Roche) and lpl of T7 RNA polymerase (Roche). The 
volume was then adjusted to lOpl with RNAse free H2O (Sigma). Reactions were 
incubated at 37°C for 2 hours. After transcription, the DNA template was removed by the 
addition of lpl of DNAsel buffer, 6pl of H20 and 3pl of DNAsel RNase free (lOU/pl; 
Roche). This was incubated at 37°C for 15 minutes. The RNA probes were then 
fragmented with 80 j l l 1 of 125mM sodium carbonate (pH 10.2) at 60°C for 15minutes. The 
alkaline hydrolysis of the probes was stopped by adding of 50pl 7.5M ammonium acetate. 
RNA was precipitated with isopropanol, washed with 70% ethanol, air dried and 
resuspended in TEiformamide (1:1).
The yield of DIG-labelled RNA was estimated in a spot test using a DIG-labelled control 
(Roche). The test was performed following the manufacturer’s instructions. Briefly, 
dilutions of both the control and the probes (all in RNase free double distilled H2O) to be 
tested were spotted and cross-linked to a positively-charged nylon membrane (Roche). The 
spots were then colorimetrically detected and the comparison of the intensities of the spot 
allowed an estimation of labelling yield. Probes were diluted with TE:formamide (1:1) to 
25ng/pl and 5pi was used for in situ hybridisation
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2.2 Cell Biology
2.2.1 Immunohistochemistry
Fixed embryos (See 2.3.3 for embryo fixation method) stored in methanol were stained 
with a single antibody as follows.
Embryos were washed in lx PBS-TX (PBS buffer with 0.3% Triton X-100) and then 
blocked in PBS-TX BSA (PBS-TX with 0.5% bovine serum albumin (Sigma)) at room 
temp for 3xl0mins. Preabsorbed primary antibody was diluted in PBS-TX, added to the 
embryos and incubated overnight at 4°C with gentle shaking. Primary antibody is removed 
and embryos washed in PBS-TX before adding biotinylated secondary antibody to 
whichever animal the antibody was raised in (here anti-mouse or anti-rabbit (Vector 
Laboratories)) and incubating at room temp for lhr. After removal of antibody and washing 
with PBS-TX the signal is amplified using Vectastain Elite ABC Kit (Vector Laboratories) 
The stain was then developed with 0.5mg/ml diaminobenzadine (DAB) (Sigma) and 0.02% 
hydrogen peroxide. Embryos were mounted either in 80% glycerol or in an acetone: 
araldite mixture (1 :1 ratio) after a serial dehydration in ethanol. Mounting in glycerol 
allowed rotation of the embryos with gently pressure on the cover slip, enabling 
observation of all the musclulature and this method was generally preferred.
Embryos were viewed on a Zeiss Axioskop microscope in bright field or nomarski settings 
and photographed using the axiovision software and Axiocam digital camera
2.2.2 Antibody double labelling
Double antibody stainings were performed essentially as described in 2.2.1 with the main 
difference being the addition of Nickel salts on visualisation of one antibody to ensure a 
black colouring develops, as opposed to the usual brown.
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When primary antibodies were raised in different species, both were added at the same time 
and developed sequentially. After the overnight incubation, embryos were washed, the first 
secondary antibody was added and the stain developed using nickel salts (which gives a 
black colour). Embryos were then washed and blocked with 0.5% BSA and incubated for 
one hour at room temperature with the second secondary antibody. This was developed 
without nickel salts to give a light brown precipitate.
When primary antibodies were raised in the same animal, embryos were incubated 
overnight at 4°C with gentle shaking with the first antibody and developed using nickel 
salts. Embryos were then washed, blocked with 0.5% BSA and incubated overnight at 4°C 
with gentle shaking with the second primary antibody. This was developed the next day 
without nickel salts.
2.2.3 RNA in-situ hybridisation
In situ hybridisations were carried out essentially as described by Kopczynski et al, 
1998 with the use of Digoxigenin-labelled RNA probes. Fixed embryos were rehydrated in 
MeOH: 4% paraformaldehyde/PBS before fixing for a further 10 minutes in 4% 
paraformaldehyde/PBS. After 3 washes in IX PBS containing 0.1% tween-20 (PBT), 
embryos were prehybridised at 55°C for 1 hour in hybridisation buffer (50% formamide 
(Fluka), 4X SSC (Sigma), IX Denhardf s solution (Sigma), 250pg/ml yeast tRNA (BRL), 
250pg/ml salmon testis DNA (Sigma), 50pg/ml heparin (Sigma), 0.1% Tween-20). 
Embryos were then hybridised overnight at 55°C with 0.125pg of DIG-labelled RNA probe 
in 0.5ml hybridisation buffer. The next morning, embryos were washed with 4 changes of 
washing solution at 55°C (50% formamide, 2X SSC, 0.1% tween-20) during the day, the 
last wash was overnight .For the detection, embryos were incubated for 90 minutes at room 
temperature with anti-DIG antibody (Roche) in PBT (1:2000). The stain was developed in
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the dark at room temperature by incubation in colour solution: 9 p 1/ml NBT and 7pl/ml 
BCIP (both Roche) in 0.3ml detection buffer (lOOmM Tris pH 9.5, lOOmM NaCl, 50mM 
MgCb, 0.1% Tween-20). Embryos were mounted in 80% glycerol and analysed using an 
image grabbing system and processing set up (Axiocam digital camera + Axiovision 
software) linked to a Zeiss Axioskop microscope.
2.2.4 Somatic muscle scoring analysis
For muscle phenotype assessment, the somatic muscles of Stl 7 embryos were analysed by 
scoring each of the 30 muscles (Bate, 1993) for muscle loss, duplication, shape defects and 
attachment defects in abdominal hemi-segments A2-A4 (a total therefore of 90 muscles 
per embryo). Unless stated otherwise, 20 separate embryos were scored for this analysis. 
Embryos were generally stained with anti-(33 tubulin antibody for muscle visualisation.
2.2.5 Hatching and Survival tests
In general females homozygous for different GAL4 drivers were crossed with males 
homozygous for each UAS construct (the main exception to this being Mef2-En (X) in 
which case, females of the UAS line were used) and laying pots kept at the appropriate 
experimental temperature (usually, 18°C, 21°C, 25°C or 29°C) from an appropriately timed 
lay, fertilised embryos of around St 14 were selected on the basis of gut autoflorescence 
under a florescence microscope (and also absence of any GFP balancer if the cross required 
it e.g Mef2 mutants). These were then transferred to the dry half of an apple juice plate 
containing a thin layer of fresh yeast on the other half. These plates were then returned to 
the experimental incubating temperature and embryos allowed to hatch overnight. 
Percentage of hatching was scored and 2nd instar larva were transferred to tubes as they
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emerged over the next few days. The percentage of transferred larvae that survived to white 
pupae, black pupae and adult stages were then scored. A minimum of 200 embryos were 
aligned for each experiment and a limit of 100 embryos per apple juice plate and 35 larvae 
per tube was imposed when transferring the animals.
2.2.5 Adult muscle DLM dissection
For analysis of the direct longitudinal muscles (DLMs) in adult flies, black pupae were 
selected, carefully removed from their pupal case and fixed in 17.4% parafomaldehyde 
(diluted in PBS from 37% stock) for a minimum of overnight. Fixed flies were then washed 
in PBS quickly then again, with shaking for 20mins, then dissected by pinning the head and 
lower abdomen, removing wings and legs and making a transverse cut section between the 
second and third pairs of legs. Two further transverse cuts were made, one beneath the head 
and one a the lower half of the abdomen which results in two transverse sections of the 
thorax which were stained in hematoxylin solution for 5 mins, washed twice in PBS for 
2mins min each and then once in 80% glycerol / PBS for 2mins. Hemi-thoraces were then 
mounted in glycerol, coverslips sealed with nail polish and then imaged using the Zeiss 
Axioskop microscope.
2.3 Fly and embryo work:
2.3.1 Fly Husbandry
Fly stocks were maintained on a medium containing 6.77% commeal, 7.26% dextrose, 
1.45% yeast, 0.68% agar, 2.26% nipagin and 0.32% propanoic acid. The majority of the
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stocks were kept at 18°C and changed every four weeks. When making stocks, crosses 
were kept at 25°C.
When collecting virgins for UAS/GAL4 experiments or crosses, the stocks were amplified 
and kept at 25°C during the day and 18°C during the night to optimise virgin females 
collection, which was usually performed first thing in the morning and twice again during 
the day as needed.
New stocks received from the Drosophila stock centre (Bloomington), Exelixis (Harvard 
Medical School) or DrosDel (Szeged University, Hungary) or other researchrers were kept 
in quarantine for at least three generations and inspected for mite infection before being 
brought into the laboratory’s fly room.
2.3.2 Fly Stocks
The following stocks have been used for my PhD :
Oregon R (OR) flies were used as a standard wild-type stock.
Transgene constructs were initially injected into yw flies and subsequently balanced using 
FM7 (y,ct/ FM7, ftz lacZ) X chromosome balancer or If / Cyo ; TM3 / TM6b or 3703 
CyO/Sco; MKRS/TM6B autosomal balancer lines.
2057 Sequencing strain flies (Bloomington) were used to extract genomic DNA for 
Dmesol8E and Him reporter construct generation.
yw  flies were used to generate genomic DNA for the homologous recombination construct 
arms.
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Mutant Stocks Table 2.3.1 
Gal4 Lines Table 2 .3.2 
UAS Lines Table 2 .3.2
UAS Mef2 Dominant Negative Lines Table 2.3.4 
Reporter constructs and GFP fusion stocks Table 2.3.5 
Transposable Element lines used in mutant generation Table 2.3.6
2.3.4 Generation of new stocks
Table 2.3.7 shows the new experimental stocks I generated through crossing previously 
established stocks appropriately.
The general crossing schemes I used for the combination of either a homozygous viable 
line on the second and third chromosomes, X and second chromosomes and X and third 
chromosomes are shown in FIG. 2.3.1, 2.3.2 and 2.3.4.
The combinations that contain a lethal allele, such as the Zjhl mutant, require more care in 
the cross due to the necessity of marked balancer chromosomes. FIG 2.3.5 shows the 
scheme that was used to generate the Him D e l; Zfhl / TM3 ftz LacZ double mutant.
36
Stock Chromosome Comment Origin Reference
Him52; + ; + X P-element deficieny D.Hancock -
Him74; + ;  + X Homologous recombination Z.Han -
Himl95; + ; + X Homologous recombination Z.Han -
mesol8E Del-6 /  FM7; + ; + X P-element deletion D.Hancock -
mesol8E Del-8 /  FM7; + ; + X P-element deletion D.Hancock -
meso!8E Dup-11 /  FM7; + ; + X P-element duplication D.Hancock -
+ ; Mef26i/CyO ; + III EMS induced R. Schulz Ranganayakulu et al, 1995
+ ; Mef24*4/  CyO; + III EMS induced R. Schulz Ranganayakulu et al, 1995
+ ;  Mef2U i/CyO; + III EMS induced R.Schulz Ranganayakulu et al, 1995
+ ; Mef2n  n/  CyO; + III EMS induced B.Bour Bour et al, 1995
+ ; + ; Zjhl2/  TM3 III EMS induced M.Bate Lai et al, 1993
Table 2.3.1 Mutant Lines used.
Stock Chromosome Comment Origin Reference
Twist; Twist Gal4 X ; II Bay lies and Bate, 1996
Mef2 Gal4 III Ranganayakulu et al, 1996
24B Gal4 II Brand and Perrimon, 1993
69B Gal4 III Brand and Perrimon, 1993
rP298 Gal4 X Founder cell driver Menon and Chia, 2001
1151 Gal4 X Adult muscle driver Anant et al, 1998
UAS Dicer; Mef2 Gal4 II ; III Mef2 Gal4 with UAS Dicer to enhance the effects of 
RNAi
Ranganayakulu et al, 1996 
Schnorrer et al, 2004
Table 2.3.2 Gal4 Lines used.
Stock Chromosome Comment Origin Reference
UAS Him II Homozygous viable. M. Taylor Liotta et al, 2007
UAS Zfhl III Homozygous viable.
UAS Mef2 High III Homozygous viable. Strong expression line. 
Also called UAS Me£2 “Nguyen” in lab.
B.Bour Bour et al, 1995
UAS Mef2 Low III Homozygous viable. Weaker expression line. Also 
called UAS Mef2 10T4A.
K. Beatty Gunthorpe et al, 1999
UAS mesol8E 29T1 II Homozygous viable. Weaker expression line. M.Taylor -
UAS mesol8E 29T24 II Homozygous viable. Weaker expression line. M.Taylor -
UAS mesol8E 20T2 III Homozygous viable. Strong expression line. M.Taylor -
UAS mesol8E 1-125 II N terminal truncation o f meso 18E D.Hancock -
Table 2.3.3 UAS Lines used (for UAS Mef2 dominant negatives see Table 2.3.4).
Stock Chromosome Comment Origin Reference
Mef2-En L10-1 X Homozygous viable. Stronger line. Used in this study. D.Hancock -
Mef2-En L2-1 II Homozygous viable. Strong line. Used in this study 
and Blanchard et al.
D.Hancock Blanchard et al, 2009
Mef2-En L5-1 II Homozygous lethal. Over CyO. Weak stock. D.Hancock Blanchard et al, 2009
Mef2-En L6-1 II Homozygous lethal. Over CyO. Weak stock. D.Hancock -
Mef2-En L3-1 III Homozygous lethal. Used in Blanchard et al. D.Hancock -
Mef2-Stop L2-1 X Homozygous viable. D.Hancock -
Mef2-Stop L6-1 II Homozygous viable. D.Hancock -
Me£2-Stop Ll-1 III Homozygous lethal. Over TM6B. Weak stock D.Hancock -
Mef2-Stop L4-1 III Homozygous viable. D.Hancock -
Mef2-Stop L6-1 ; L4-1 I I ; III Homozygous viable. Used in this study D.Hancock -
Table 2.3.4 UAS Mef2 Dominant Negative Lines generated
Stock Comment Origin Reference
Him Eco/Xba 3.8KB GFP fusion “Mini-gene” fusion construct. The 3.8KB Him regulatory 
region driving the Him gene fused to GFP at its C terminus
D. Liotta Liotta et al, 2007
Him Eco/Xba 3.8KB GFP pStinger The Him 3.8Kb region in a GFP reporter. D. Hancock -
Him Eco/Xho 2.8Kb GFP pH Stinger Also called p43 in the lab S. McConnell -
Him Xho/ Xba 1Kb T GFP pStinger 1Kb region upstream of gene, including TATA box D. Hancock -
Him Xho/ Xba 1Kb NT GFP pHStinger 1Kb region upstream of gene, excluding TATA box D. Hancock -
Him Posakony 3.6Kb GFP pStinger J. Posakony Rebeiz et al, 2002
Him Posakony 2.2Kb GFP pStinger J. Posakony Rebeiz et al, 2002
Him 1KB NT Mef2 SDM pHStinger Deletes Me£2 site in 1Kb NT GFP D.Hancock -
Him 3.8KB Twi OL SDM pStinger Deletes overlapping Twist sites in 3.8Kb GFP D.Hancock -
Mesol8E C GFP pStinger 1Kb region upstream of gene in a GFP reporter D.Hancock -
Mesol8E D GFP pStinger Region in first intron in a GFP reporter D.Hancock -
Mesol8E C Mef2 SDM GFP pStinger Deletes Mef2 site in mesol8E C GFP D.Hancock -
Table 2.3.5 Reporter constructs and GFP fusion stocks
Stock Chromosome Comment Origin Reference
pBacWH f04435 X pBacWH FRT element just downstream of 
Upd2. Used for Him52 deficiency.
Harvard Medical School 
(Exelixis)
Thibault et al, 2004
pBacWH fD6349 X pBacWH FRT element just upstream of aril 
Used for Him52 deficiency.
Harvard Medical School 
(Exelixis)
Thibault et al, 2004
pBacWH e02398 X pRB (RazorBac FRT element) in the third intron 
of mesol8E. Used for mesol8E deletion / 
duplication.
Harvard Medical School 
(Exelixis)
Thibault et al, 2004
pRS-UM-8195-3 pRS3 X pRS element just upstream (54bp) from the start 
of mesol8E. Used for pRS-UM-8195-3 pRS3r 
generation. W+
DrosDel, Cambridge Ryder et al, 2004
pRS-UM-8195-3 pRS3r X The “flipped out” version of the above element. 
Used for meso!8E deletion / duplication. IT-
DrosDel,Cambridge / 
D.Hancock
wlll8iso ;2iso ;3iso - White insertion line 
DSK001
DrosDel, Cambridge Ryder et al, 2004
w1U8iso ;Sco/SM6B,70FLP ;3iso II Heat-shock Flippase on 2nd Chrmosome 
DSK001
DrosDel, Cambridge Ryder et al, 2004
FM7h/P {RS3 } 1( 1 )CB-6411 -3 [ 1 ]; 2iso; 
3 .
^ 1 S 0
X X Balancer 
DSK014
DrosDel, Cambridge Ryder et al, 2004
P { w[+mC]=XP} 1( 1 )XPG-L[ 1 ], 
w [1118]/FM 7c
X Exelixis Balancer D Stock 
7756
Harvard Medical School 
(Exelixis)
Parks et al, 2004
Table 2.3.6 P-Element lines used in mutant generation.
Stock Chromosomes
Mef2-En Rescue
Mef2-En (X ); UAS Me£2 Low X ; III
Mef2-En (X) ; UAS Mef2 High X ; III
Me£2-En (II); UAS Mef2 Low II ; III
Mef2-En (II); UAS Me£2 High II ; III
Him mutant Combinations
Him 52 ; Zfhl-2 / TM3 ftz LacZ X ; III
Him 52 ; Him GFP fusion X ; III
Him 52; GroBX22 X ; III
Him 74 ; Zfhl-2 / TM3 ftz LacZ X ; III
Him 74 ; Him GFP fusion X ; III
Him 74 ; Me£2 Gal4 X ; III
Him 195 ; Zfhl-2 / TM3 ftz LacZ X ; III
Him 195 ; UAS Mef2 Low X ; III
Him 195 ; Me£2 Gal4 X ; III
Mesol8E functional analysis
UAS mesol8E 29T24 ; UAS Mef2 Low II ; III
UAS mesol8E 29T24 ; UAS Me£2 High II ; III
UAS mesol8E 29T1 ; UAS Me£2 Low II ; III
UAS mesol8E 29T1 ; UAS Me£2 High II ; III
UAS Him ; UAS mesol8E 20T2 II ; III
Table 2.3.7 Generation of new stocks.
Him Del (X ): Zfhl Del (IIP double
1A) ?  FM6 / N ; TM2 / MKRS x x / Y ; Zfhl-2 / TM6B dfd YFP Sb 3
I
Colled 9 F M 6/x ;Z fh l-2 /T M 2
IB) 9 Him D el;+  x x / Y ; Zfhl-2 / TM3 ftz LacZ 3
-I
Colled 8  Him Del / Y ; TM3 ftz LacZ / +
2) 9 F M 6 /x ; Zfhl-2 / TM2 x Him D el/ Y ; TM3 ftz LacZ/ + 8
i
Colled 9  FM6 / Him Del; Zfhl-2/TM 3 ftz LacZ (TM2 / TM3 ftz LacZ is ubx pheno)
and 3  FM6 / Y ; Zfhl -2 / TM3 ftz LacZ
3) 9 FM6 / Him Del; Zfhl-2/TM 3 ftz LacZ x FM6 / Y ; Zfhl-2 / TM3 ftz LacZ 3
i
Colled 9 FM6 / Him D el; Zfhl -2 / TM3 ftz LacZ 
3 Him Del / Y ; Zfhl -2 / TM3 ftz LacZ
4) 9 FM6 / Him D el; Zfhl -2 / TM3 ftz LacZ x Him Del / Y ; Zfhl -2 / TM3 ftz LacZ 3
i
Collect $ Him Del / Him D el; Zfhl-2 / TM3 ftz LacZ
$  Him Del / Y ; Zfhl -2 / TM3 ftz LacZ and cross for STOCK
FIG 2.3.5 Crossing Scheme for Him Del and ZfhI2 / TM3 ftz LacZ double mutant.
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2.3.3 Embryo Collection and Fixation
Embryos were collected on apple juice-agar plates supplemented with fresh yeast. 
Collections were made according to the stage at which the embryos were required and the 
temperature at which the flies were kept.
For fixation, embryos were transferred from the apple juice-agar plate to a basket with a 
wire mesh base, washed with water and placed in 50% bleach until the chorion membrane 
was removed (approximately 2 minutes). Dechorionation was monitored under a dissecting 
microscope. Dechorionated embryos were rinsed, dried and transferred into a 2ml tube 
containing 1ml heptane. They were then fixed for 20 minutes in heptane: 4% 
paraformaldehyde/PBS (1:1), and the vitelline membrane removed by vortexing in a mix of 
heptane and methanol (1/1). The embryos were then washed and stored in methanol at 
-20°C until required.
2.3.4 Transgenic construct injection
The injection mix was prepared in IX Spradling buffer (ImM Sodium Phosphate buffer 
pH6.8, 0.5mM KC1) with the DNA to be injected at a final concentration of lpg/pl and the 
helper DNA (which is a source of transposase that will promote the mobilisation of the 
constructs from the plasmid into the genome) at a final concentration of 0.25pg/pl. The 
mix was spun for 10 minutes at full speed and 0.5-1 pi was loaded into the injection needles 
prepared by pulling capillaries (1.0mm x 0.78mm, Harvard Apparatus) with a needle puller 
(KOPF Instruments).
Embryos for injection were obtained from young yellow-white females. The yw stock was 
expanded to obtain as many young flies as possible. A minimum of 150 young females and 
approximately 50 males were placed into laying pots and allowed to lay eggs onto apple
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juice-agar plates for few days until they reached their “laying peak” (usually 3-4 days). On 
the day of injection, plates were changed 3-4 times before the injection and then every 30 
minutes during injection.
Embryos from the 30 minutes lays were collected into a mesh basket and dechorionated in 
50% sodium hypochlorite (Sigma). They were then aligned onto a coverslip, covered with 
glue (prepared by placing double side Scotch TM tape in 50-100ml of heptane), posterior 
end at the edge. Aligned embryos were dessicated for approximately 10 minutes, by 
placing them in a pot containing Silica-gel 6-16 mesh self-indicating (Fisher), and then 
covered with halocarbon oil (Voltalef, HI OS). They were injected using a 
micromanipulator connected to a pump (Narishige) and a Nikon microscope.
Coverslips with injected embryos were placed into a humidified chamber (apple juice-agar 
plate supplemented with fresh yeast and fixed with damp Whatman paper) at 18°C. 
Embryos were allowed 48 to 50 hours to recover and hatch. Each single newly hatched first 
instar larva was then collected and transferred into a vial containing fly medium. Vials 
were placed at 25°C until Fo adults emerged.
Fo males were individually mated with three virgin yw females. The Fi generation was then 
screened for transformants by looking for the emergence of red eye colour. (Fo females 
were only crossed to male yw flies if there were insufficient Fo males that emerge).
Red eyed FI offspring indicate the successful emergence of a transformant line which was 
then balanced with FM7 (if on X) or #3703 (if an autosomal insertion) to generate balanced 
homozygous stock.
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2.4 Construct generation:
2.4.1 Mef2 Dominant Negative
The aim of this was to generate a construct that retains the DNA binding domain (MADS) 
and Mef2 dimerisation domain, but excludes the transactivation domain of the Mef2 
protein. This would then act as a dominant negative protein, capable of binding to sites on 
the DNA but not activating the genes it would normally once bound.
The MADS and Mef2 domains of Mef2 are conserved among vertebrates and invertebrates 
and found at the N terminus of the protein. The C terminus contains the transactivation 
domain. In Drosophila Mef2 the MADS and Mef2 domain are situated at amino acids 1-86 
of the protein (Taylor et al, 1995). The sizes of previous successful dominant negative 
proteins that removed the C terminus in vertebrates are shown below :
Mef2A, amino acids 1-131: Omatsky et al, 1997 (from a study by Yu, 1996)
Mef2C, amino acids 1-109: Krainc et al, 1998 
Me£2C, amino acids 1-105 : Okamoto et al, 2000
Mef2D, amino acids 1-153: Shin et al, 1999 (from a study by Molkentin, 1996)
Based on this information I selected a size of 128 amino acids for the Mef2 dominant 
negative truncation, this ensured the MADS and Mef2 domain was included, was in the 
same size range and previous constructs and fit conveniently with primer design.
I made two Dominant Negative constructs; one, named Mef2-Stop, which was just a 
truncation of the Dmef2 protein, consisting of the first 1-128 amino acids and removing the 
C terminus. The other, named Mef2-En consisted of this truncation fused to the Engrailed
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repressor domain. Such Engrailed fusions had been used previously for a number of 
successful dominant negative proteins (e.g Tinman and Pannier in Drosophila Han and 
Olson 2002; Klinedinst and Bodmer, 2003).
I used DMef2 Isoform III cDNA (clonelO CsCl purified from MVT 31/03/94), as template 
for generating PCR fragments with appropriate restriction sites for the Mef2 region. (For 
the purposes of this construct though it does not matter which Dmef2 isoform was used 
though, as our fragment is amino acids 1-128. The first splice event occurs at amino acid 
186). I used the engrailed repressor region in pLit28 (a gift from Cyrille Alexander, NIMR) 
as template for the Engrailed 2-298 fusion.
Nomenclature:
1. Mef2-Stop:
Describes the truncated protein alone; Mef2 1-128 with a Stop introduced.
2. Mef2-En:
Describes truncation plus engrailed repressor fusion; Mef2 1-128, (no stop), Bglll linker, 
EnR 2-298, (stop).
Mef2-Stop
The Mef2-Stop construct is simply these 128 amino acids with an additional Stop codon at 
the end.
Primers:
Dmef2 fwd EcoRI -  GAA TTC ATG GGC CGC AAA AAA ATT CAA ATA TC 
Dmef2 rev STOP Bglll -  AGA TCT H  A GCG CTG CAT CAT GTT CTG G
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Underlined shows restriction site. Red highlights introduced stop codon.
The PCR fragment was amplified using Dynazyme EXT (Finnzymes) using Mef2 cDNA as 
template, ligated into pGEMT (Promega), sequenced (Lark) and cloned into pUAST 
(Brand and Perrimon 1993) using EcoRI and Bglll (NEB).
Mef2-En
The Mef2-En construct is these 128 amino acids without the additional Stop codon, but 
instead a Bglll linker and amino acids 2-298 of the Engrailed repressor domain. A Stop 
codon was introduced at the end of the repressor domain.
Primers:
Dmef2 fwd EcoRI -  GAA TTC ATG GGC CGC AAA AAA ATT CAA ATA TC
Dmef2 rev GO Bglll - AGA TCT GCG CTG CAT CAT GTT CTG G
EnR fwd Bglll -  AGA TCT GCC CTG GAG GAT CGC TG
EnR rev Xhol - CTC GAG TTA GGA TCC CAG AGC AGA TTT CTC
Underlined shows restriction site. Red highlights introduced stop codon.
The Dmef2 1-128 fragment was amplified by PCR using Mef2 cDNA as template, ligated 
into pGEMT and sequenced. The EnR 2-298 domain was also amplified by PCR, using 
EnR in pLit28 as template (a gift from Cyrille Alexandre, NIMR)., This fragment was then 
ligated into pGEMT and sequenced.
The Mef2 1-128 fragment was then cloned into pUAST using EcoRI and Bglll. This 
construct was subsequently reopened with Bglll and Xhol and the PCR generated EnR 
domain ligated in after excision of that fragment from pGEMT .
The introduction of a two amino acid linker to the final protein has been used previously in 
other EnR fusion dominant negative proteins. (E.g Tinman and Pannier in Drosophila Han 
and Olson 2002, Klinedinst and Bodmer 2003).
Constructs injected to generate transgenic lines as described above.
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2.4.2 Him reporter constructs and Him Gal4.
Him 3.8Kb pStinger GFP
The Him EcoRI / Xbal 3.8Kb pStinger construct was generated from an EcoRI / Xbal 
3.8Kb fragment in pBS ks II vector which was generated previously in the lab by D.Liotta. 
This fragment was used in the generation of the Him 3.8Kb GFP fusion mini gene that was 
used in a previous publication (Liotta et al, 2007). The EcoRI site in this fragment is 
endogenous to the Him non-coding sequence but the Xbal site was introduced artificially 
by PCR.
Briefly, this Him 3.8Kb GFP fusion mini gene fragment was made by D.Liotta in the 
following three-step process;
1. Generation of an EcoRI-BamHI 2.7Kb fragment from a simple restriction digest of a 
Him X clone in pBluescript utilising internal restriction sites endogenous to the Him non­
coding region and cloning of this fragment into pBSKSII+ vector.
2. Generation of a BamHI-Xbal 1.1Kb fragment by PCR using the following primers 
Fwd (5’-3’) : CCG ATT GGA TCC CAT CTT GCG GCA C (BamHIunderlined) 
Rev : (5’-3’) : TGA CGC CCA TCT AGA TTG GTG GCT CTG (Xbal underlined)
(The BamHI site is endogenous to the Him region but the Xbal site is generated artificially 
by PCR at the end of the fragment).
3. Ligation of this 1.1Kb fragment into the EcoRI-BamHI 2.7Kb pBSKSII+ construct to 
generate an EcoRI-Xbal 3.8Kb pBSKS+ construct.
From this EcoRI / Xbal 3.8Kb pBSks II construct, I cut out the Him 3.8Kb EcoRI / Xbal 
fragment and cloned into the pStinger GFP vector (Barolo et al, 2000) as follows:
The 3.8Kb pBS ks II construct was first cut with EcoRI, the ends were blunted, and then a 
cut with Xbal was made. This fragment was then carefully separated from the 3.0Kb pBS
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ks II vector by running on a gel, extracting the band and gel purification (Qiagen). In 
parallel, the pStinger vector was cut with Bglll, blunted, and then cut again with Xbal. The 
opened vector was dephosphorylated by CIP and gel purified in preparation for ligation 
with the 3.8Kb fragment. This was subsequently transformed into bacteria and clones 
containing the insert taken, confirmed by restriction analysis and PCR to the Him region 
and prepared for injection.
Him 3.8Kb pTGAL
In addition, in parallel to this I made a Him 3.8Kb Gal4 construct using the same DNA 
fragment but this time cloning into pPTGAL (Brand and Perrimon, 1993) instead of 
pStinger. The pPTGAL vector was cut with StuI, blunted and then cut with Xbal and the 
construct generated in the same way as with pStinger above.
Him 1Kb T pStinger GFP
As the 1Kb T construct contains the Him TATAA box, this region was cloned into the 
pStinger GFP vector (a gift from J.Posakony, (from Barolo et al, 2000) which itself 
contains no TATAA box.
The template for this was a previously generated Him 1.1Kb T pGEM-T Easy construct 
generated in the lab by D.Liotta. This fragment (originally called 1C6 1Kb PCR3), was 
generated using the following primers :
Fwd (5’-3’) : CCG ATT GGA TCC CAT CTT GCG GCA C (BamHIunderlined) 
Rev : (5’-3’) : TGA CGC CCA TCT AGA TTG GTG GCT CTG (Xbal underlined)
The BamHI site is endogenous to the Him region but the Xbal site is generated artificially 
by PCR at the end of the fragment. There is also an endogenous Xhol site within this 
fragment approximately lOObp upstream of the BamHI site.
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To clone the Xhol-Xbal fragment into pStinger to generate Him 1Kb T pStinger I did the 
following :
Digested Him 1.1Kb pGEMT with Xhol, blunted the ends and then cut with Xbal to 
generate a Him 1Kb Xhol-Xbal fragment and purified this fragment by gel extraction 
(Qiagen). I prepared the pStinger vector by digesting with Bglll, blunting the ends and 
then digesting with Xbal. The cut vector was then dephoshorylated using CIP enzyme and 
purified by gel extraction ready for ligation with the Xhol-Xbal fragment. This was 
subsequently transformed into bacteria and clones containing the insert taken and prepared 
for injection (Qiagen spin mini/midi and DNA precipitation to concentrate DNA).
Him 1Kb NT pHStinger
This region contains no TATAA box and so was inserted into the pHStinger GFP vector 
(Barolo et al, 2000)), which does.
I designed the following primers for Dynazyme EXT PCR to generate the fragment.
Fwd: G AG ATCTCTCG AGT AGTTTTT AG AT GC AG 
Rev: G A ATT CT GT GCTCT CT GCGGGTTT G
These generate a fragment of 870bps which was originally cloned into pGEM-T and 
sequenced. Bglll and EcoRI sites introduced in the Fwd and Rev primers respectively were 
used to generate the fragment from pGEM-T, which was purified and cloned into prepared 
pHStinger GFP vector and injected into flies.
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2.4.3 Him site directed mutagenesis reporter constructs
Analysis of the Him 1Kb sequence identified a number of Twist sites and a Mef2 site 
within the sequence region (Him chapter section). As a result of this I designed a number 
of primers to delete the consensus Mef2 site and the proximal and overlapping Twist sites 
in the region according to the mutagenesis criteria outlined by Stratagene.
Him 1Kb NT AMef2 SDM pHStinger 
Primers
Mef2-I SDM : TTATTTTTAA to TTCCiGCGCiTAA (SacII site introduced)
Him dMef2 1 fwd cag ta a  cac  atg ggc cca cga gtt atg ttt ccq egg taa  tcc cac  aaa  gag teg ate  tec aaa  ac 
Him dMef2 1 rev gtt ttg gag ate  gac tct ttg tgg gat tac  ege gga a ac  ata act cgt ggg ccc atg tgt tac  tg
Template Him 1Kb NT pGEMT (see section 2.4.2). Stratagene Quikchange protocol. Bglll 
/ EcoRI digest to confirm clone insert. SacII digest to check SDM site change. Sequencing 
of whole region to confirm SDM and check for other mutations. Subcloning of fragment 
into pH Stinger using Bglll / EcoRI and prep of construct and injection in usual way.
Him 3.8Kb ATwist OL pStinger GFP 
Primers
Twi OL SDM : CACATGTG to CGGCCGTG
Him Twi-OvLAP fw geg geg ctg gtg ctg ccq gee qtg ttc tgt gtt ggg ct
Him Twi-OvLAP rv age  cca aca  cag aac  acg gcc ggc age acc  age gcc gc
Template Him 1Kb T pGEMT (BamHI-Xbal fragment in pGEMT - see section 2.4.2; 
strictly the BamHI-Xbal fragment is 1.1Kb not 1Kb). Stratagene Quikchange protocol. 
Bglll / EcoRI digest to confirm clone insert. Sequencing of whole region to confirm SDM 
and check for other mutations.
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To generate the Him 3.8Kb ATwist OL pStinger GFP construct I removed a BamHI-Xbal 
1.1Kb fragment from Him 3.8Kb pStinger GFP and replaced it with a BamHI-Xbal 1.1Kb 
fragment taken from this Him “1Kb” T ATwist OL pGEMT fragment containing the 
desired Twist mutation. Digests for both were simple double digests with subsequent vector 
dephosphorylation, gel purification, preparation and injection in the usual way.
I was unsuccessful in generating a Him 1Kb T ATwist OL pStinger GFP construct. For this 
the following preparation is necessary :
Digestion of Him 1Kb T ATwist OL pGEMT with (Xhol (Blunt) / Xbal) to generate 
fragment for insertion into pH Stinger (Bglll (Blunt) / Xbal) prepared vector.
2.4.4 mesol8E Reporter constructs
Primers: Underlined shows restriction site.
Construct A -  1848bp :
18E-A fwd:SphI GCATGCCAAGAATAAGAATCCACC Tm = 61.0°C 
18E-A rev :BglII AG AT CTTCG ACT GG AT A A AATCGGT C Tm = 61.6°C
Construct B - 1759bp :
18E-B fwd: Bglll AG AT CT G AAAG ATT G AA AG AT AC AAGC AG 
Tm = 61.0°C
18E-B rev:EcoRI GG AATTCGT ATT AAC A A AGT A AT ATCC A AGG 
Tm = 61.0°C
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Construct C -  1155bp :
Fwd (EcoRI) - GAATTCATTATACCCGCCTGTTGG Tm 61.1 °C
Rev (BamHI) - GGATCCCGTTGCCGATACTAAC Tm = 62.1°C
Construct D -  771 bp :
Fwd (Bglll) -  AGATCTCAGGACGGCGGACTAC Tm = 63.9°C 
Rev (BamHI) - GG AT CCTTT GT G AC ACTT AACGTCT AG Tm = 63.5°C
Constructs were amplified from 2057 genomic DNA with 20-30 cycles of PCR using the 
high fidelity DNA polymerase, Dynazyme EXT (Finnzymes). The fragment was extracted 
and purified using a Qiagen gel extraction kit, ligated into pGEM-T vector (Promega) and 
subsequent Spin-mini preps (Qiagen) containing the insert were sequenced (Lark 
Sequencing or Cardiff University sequencing service). The fragment was then extracted 
from pGEM-T and ligated into pHStingerGFP (construct D) or pStingerGFP (construct C) 
using the appropriate restriction enzymes. A Midi-prep of the construct was performed 
(Qiagen) and after DNA precipitation to obtain a DNA concentration of at least lOOng/ul 
was ready for injection into embryos.
(mesol8E A and mesol8E B were not made : PCR fragments were generated of the 
appropriate sizes but were not successfully ligated into pGEMT due to time restraints. 
Primers work well, give clean single products and are included here for future reference).
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2.4.5 mesol8E Site directed mutagenesis reporter constructs
Mef2 binding site consensus sequence YTAWWWWTAR (Andres et al, 1995)
Primers were designed to destroy the Mef2 site by site directed mutagenesis using the 
Stratagene Quikchange II kit guidelines.
One set used a 6bp change introducing a SacII site into the sequence
CTATTTTTAG Mef2 site
CCCGCGGTAG SacII site introduced by SDM
Fwd : 18E C Mef2-SDM SacII
5’ 3’
CTGC AC A AC AT ACT CGT AT CCCGCGGTAGGCT ACG ACTTTTCCC ATTT GGC
Rev : 18E C Mef2-SDM SacII
5’ 3’
GCC A AAT GGG AAA AGTCGT AGCCT ACCGCGGG AT ACGAGT AT GTT GT GC AG
Tm = 7 8 . 2  n = 51
This strategy is similar to that used by Cripps et al in the Mef2 autoregulation paper 
(Cripps et al, 2004). The new sequence in the context of the full mesol8E C region was 
checked for the potential of introducing new binding site to the region using Patch (gene- 
regulation.com) and none were found.
There is a potential hair pin in the oligo at 55deg (Generunner) but this appears 
unavoidable. In addition, primers were designed to completely destroy the mef2 site by 
introducing a Notl site (in a similar manner to the Kelly et al Act57B Mef2 paper -  but 
without the introduction of an extra base! Kelly et al, 2002) This requires an 8bp change.
CTATTTTTAG
CGCGGCCGCG
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Fwd : 18E C Mef2-SDM Notl
5’ CCATACTGCACAACATACTCGTATCGCGGCCGCGGCTACGACTTTTCCCATTTGGCC 
Rev : 18E C Mef2-SDM Notl
5’ GGCCAAATGGGAAAAGTCGTAGCCGCGGCCGCGATACGAGTATGTTGTGCAGTATGG 
Tm = 78.6
This oligo has the potential for forming hairpin loops at 55, dimers at 55 and bulge loops at 
58 -  hence the concern for designing the other primer.
The SacII site SDM primers were used to generate the construct.
Construct generation :
Genomic DNA prepped from 2057 sequencing strain embryos. SacII Mef2 SDM primers 
used to generate change in the 18E C fragment in pGEM-T (the intermediate construct 
from generation of the 18E C pStinger construct above) -  pGEMT construct used as 
considerably smaller than pStinger (3Kb plasmid rather than 10Kb) thus more convenient 
for SDM PCR. Protocol as Stratagene Quikchange II manual (Stratagene). 3.5ml LB amp 
cultures from colonies grown O/N and plasmids extracted using Qiagen Spin Mini Prep kits 
according to protocol.
Clones were selected for using EcoRI / BamHI (NEB) restriction digest, to check that the 
correct 1155bp C reporter region, and if so a separate digest using SacII (NEB) was 
performed to check for introduction of the SDM at the Mef2 site. Positive clones were then 
sequenced to confirm appropriate SDM change (and no other mutations within the region) 
and cloned into pStinger using EcoRI / BamHI to make the final mesol8E C AMef2 SacII 
SDM pStinger construct.
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2.4.6 UAS 18E 1-125 and UAS 18E 1-197 truncations
UAS 18E 1-125 construct.
Amino acids 1-125. Contains the myb-like region (18-86), the putative NLS (86-102) and 
then continues to include some weak conservation homology on blasted sequence.
Fwd uses a conveniently situated native EcoRI site and rev introduces a Stop site and an 
Xbal site for cloning into pUAST.
Fwd: 18E 1-125 EcoRI
5’ 3’
CACCACAGAATTCCCAAATGGATACGAAG
Tm = 65.3 EcoRI site within mesol8E underlined. ATG initiation codon in bold.
Rev : 18E 1-125 Xbal
5’ 3’
TCTAGACTAGCCATTCGATCCCCAGC
Tm = 66.4 Stop codon in bold. Introduced Xbal site for construct underlined.
Rev as read (GCTGGGGATCGAATGGCTAGTCTAGA
Primer Tm equation 18 > = 69.3 + [ ( 0.41 x  % GC ) -  ( 650 / length ) ]
UAS 18E 1-125 construct generation.
Mesol8E cDNA in pNB40 vector (Nick Brown library) from MVT [7F9.5A] (Taylor, 
2000) used as template for the PCR. Phusion DNA pol (NEB) used for PCR fragment 
generation gave appropriately sized 375bp product. PCR fragment gel purified (Qiagen) 
and ligated into pGEM-T and appropriate colony screened by restriction digest (EcoRI /
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Xbal) and sequenced in house (Cardiff University). Fragment subcloned into pUAST and 
prepped for injection in usual way.
UAS 18E 1-197 construct.
Mesol8E truncation to include the myb-like domain, NLS and the Serine rich region (165- 
191).
Fwd: 18E 1-197 EcoRI
5’ 3’
C ACC AC AGA ATTCCC AAAT GG AT ACGAAG 
Tm = 65.3
(This is just the same primer for the 1-125 construct)
RevA : 18E 1-197 Xbal
5’ 3’
T GT AG ATT AC AGGA AGCGGTCC AGCTT G 
Tm = 66.5
(But gives potential primer dimer at 58.5 degrees)
RevB : 18E 1-197 Xbal 
T GT AGACT AC AGGAAGCGGTCC AGC 
Tm = 66.2
But has less matching residues to anneal to the region.
Mesol8E 1-197 was not generated. Primers included for reference.
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Mesol8E 1-125 truncation amino acid sequence :
MDTKNPPPVTSSYHHQRAPRTPESYFNVPESVALLNIVKSERIQSAFQSN 
RKNHASVWEMVAEVLNRFSARKRTAKQCCNRYENLKKIYTQLKKNPERHV 
RRNWPYMFLFKEIEEQRGECWGSNG s t o p
Mesol8E 1-197 truncation amino acid sequence :
MDTKNPPPVTSSYHHQRAPRTPESYFNVPESVALLNIVKSERIQSAFQSN 
RKNHASVWEMVAEVLNRFSARKRTAKQCCNRYENLK K I YTQLKKNPERHV 
RRNWPYMFLFKEIEEQRGECWGSNGKRLALITKNHNELSYYQRRRQAAEL 
GVLLNKDNLTPHQ H SLLQSLSQSQ SQSH SHAHSTDSSQSGSKLDRFL s t o p
Mesol8E 1-553full length amino acid sequence :
M DTKNPPPVTSSYHHQRAPRTPESYFNVPESVALLNIVKSERIQSAFQSN 
RKNHASVWEMVAEVLNRFSARKRTAKQCCNRYENLKKI YTQLKKNPERHV 
RRNWPYMFLFKEIEEQRGECWGSNGKRLALITKNHNELSYYQRRRQAAEL 
GVLLNKDNLTPHQ HSLLQSLSQSQSQSHSHAHSTDSSQSGSKLDRFLPNH 
FVEAQLSEVAGPVGGSASGVSGMSAGGFDENPLQMQMVQAAAAAAAVAAH 
KRHELQMASVGGVQMTPEDDDEDEPQRPAFKNHLHVLGHGHGLGLGHAPM 
DDSGEAPDFEKDCNGALNMHHQNNNHNENHISMKSEPLSEGEFNPDDIQL 
MQTNYNGAQNYYSPGMDANILHPDVIVDTDILSDCSSSTTLKKKRKMSTS 
TDGDSTNYELIEYLKRREKRDEELLKRMDAREDRLMNLLERTWAIETLA 
VKRALTFPVNPTKENA PA TA RPLSPPPPEAQ FA APPA TQ EQPTSPERN GI 
ATGRSGTIPVANQDAAIEVPDDGDSGDDVQVKDKLAKLTPKAGGDERTDG 
R Q T
2.4.7 UAS 18E Amyb-like SDM construct
Site directed mutagenesis to the myb-like region of mesol8E, specifically targeting the 
conserved residues of the 3rd (DNA interacting) helix. Changing to prolines or glycines. 
Ideally with only a one base change to achieve this. Change 6 residues using 8bp changes. 
RTAKQCCNRYENLKKIYTQL to RTAKPGCNGPEGPKKIYTQL 
RTAKQCCNRYENLKKIYTQL MADF conserved residues in the 3rd helix 
RTAKQCCNRYENLKKIYTQL Myb-like conserved residues in the 3rd helix 
RTAKQCCNRYENLKKIYTQL BLAST identified residues in the 3rd helix
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Primers designed according to Stratagene SDM Quikchange kit specifications 
(Tm = 81.5 +0.41(%GC)- 675/N - % mismatch)
N = 63 Tm = 79.3°C 
Fwd : 18E myb SDM
5’CGGAAGCGAACGGCCAAGCCGGGCTGCAATGGGCCCGAGGGCCCCAAGAAG
ATCTACACGCAG
Rev : 18E myb SDM
5’CTGCGTGTAGATCTTCTTGGGGCCCTCGGGCCCATTGCAGCCCGGCTTGGCCG
TTCGCTTCCG
mesol8E wild type sequence and translation :
R K R T A K Q C C N R Y E N  L K K  
CGG AAG CGA ACG GCC AAG CAG TGC TGC AAT CGG TAG GAG AAC CTC AAG AAG
I  Y T Q 
ATC TAC ACG CAG
meso!8E Site Directed Mutagenesis sequence and translation :
R K R T A K P G C N G P E G  P K K  
CGG AAG CGA ACG GCC AAG CCG GGC TGC AAT GGG CCC GAG GGC CCC AAG AAG
I Y T Q 
ATC TAC ACG CAG
Construct generation was attempted according to Stratagene Quikchange manual using 
UAS 18E full length 1-553 pUAST (MVT -  [UAS 7F9.5A] )as template for PCR. A small 
number of clones (two - after a previous unsuccessful SDM attempt with no colonies) were
generated after plating out, but these were negative for the appropriate change on
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sequencing. Would recommend subcloning the 1-553 fragment into pGEMT for a smaller 
template for SDM in order to generate the construct successfully.
2.5 Gene Deletions :
2.5.1 FRT element mediated deletion of the Him gene region
As outlined in the Him chapter, the deletion occurs between the f06349 pBacWH element 
and the f04435 pBacWH element.
A recombination event between these results in a deletion of approx 98Kb that removes 
Him and five other genes; Frql, Andorra, Frq2, Her and CG33639. (FIG 6.4.1)
The crossing scheme for the recombination event is shown in FIG 2.5.1
2.5.2 FRT element mediated deletion of mesol8E
As outlined in the mesol8E chapter, the deletion occurs between the DrosDel RS3 element 
UM-8195-3 and the Exelixis element pRB e02398. The scheme required two steps; the 
initial conversion of the pRS3 w+ UM-8195-3 element into an element pRS3r w- so that it 
was ready for recombination and the second step required the trans-recombination between 
this pRS3 w- element and the pRB e02398 w+ element.
The crossing schemes are outlined in FIG 2.5.2A and 2.5.2B respectively.
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FIG 2.5.2 meso!8E transposable element Deletion
2.5.2A) DrosDel element UM8195-3 pRS3 w+ converted to UM8195-3r pRS3r w-
1. c? w1118 / Y ; TM6B/ MKRS.hsFLP 86E x $v w1118iso, p{ FRT, w+}RS3 ; 2iso; 3iso
Heat shock progeny J ,
Collect <5 wl,ls iso, p{FRT, tv+ }RS3 /  Y;MKRS,ksFLP 86E /  3iso
2 . 3  w1118 iso, p{FRT, w+ }RS3 / Y ;MKRS,hsFLP 86E / 3iso x ? v FM7h iso ;2iso;3iso
I
Collect ? v  FM 7h/ w,ns iso p{FRT, w-}RS3r
3. $ FM7h/ wlll8iso p{FRT, w-}RS3r x 3  FM 7hiso/ Y ; 2iso ; 3iso
I
Collect 3  w " lsiso p{FRT, w-}RS3r/Y  
and $ v  FM7h / w, , ,s iso p f FRT, w-}RS3r
4. S  wln8iso p{FRT, w-}RS3r x ?v  FM7h / w 1118iso p{ FRT, w-JRS3r
i
Collect 3  w '" 8isop{FRT, w-}RS3r /  Y
and ? v  FM7h /  w,I,s isop{FRT, w-}RS3r
5. d1 w1118 iso p{FRT, w-}RS3r / Y x $v FM7h / w " 18 iso p{ FRT, w-}RS3r
J .
Collect 3 w ‘" 8isop{FRT,w-}RS3r / Y  and $v w " ls iso p{F RT, w-)RS3r
And cross for STOCK.
FIG 2.5.2cont. meso!8E transposable element Deletion
FIG 2.5.2B)
Trans-recombination between UM8195-3r pRS3r w- element and Exelixis e02398 pRB w+ 
element
1. S  w1118 ; TM6B/ MKRS,hsFLP 86E x ?v  w " 18 iso, p{FRT, w+ }RB ; 2iso ; 3iso
Collect o w '" 8 iso, p{FRT, w+ }RB /  Y ; MKRS.hsFLP 86E
2. c?'wlll8iso, p{FRT, w+ }RB / Y; MKRS.hsFLP 86E x $v wlll8iso p{FRT, w-}RS3r
(from 2.5.1 A stock)
Collect ?v w " ,s iso pfFRT, w -}RS3r/w",s iso, p{FRT, w+ }R B ; MKRS.hsFLP 86E
3. $v w1118 iso p{FRT, w-}RS3r/ w1118iso, p{FRT, w+ }RB ; MKRS,hsFLP 86E
x S  FM7h iso ;2iso ;3iso
Collect ?  v w1118 iso p{FRT, w-}RS3r —  p{FRT, w+ }RB / FM7h iso
4. ?v  w1118 iso p{FRT, w-}RS3r —  p{FRT, w+ }RB / FM7h iso
x S  FM7h iso ;2iso ;3iso
Heat shock progeny  ^  
Screen progeny for emergence o f  w+ c?’s.
Two possibilities...
I f  none, suggests recombination is lethal...
5.1 Stock: w1118 iso p{FRT, w-}RS3r —  p{FRT, w+ }RB / FM7h iso
Ifw+ S  can occur, suggests recombination is viable
5.2 Stock: w1118 iso p{FRT, w-}RS3r —  p{FRT, w+ }RB
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2.5.3 Screen / Confirmation of transposable element mutant 
lines.
For the Him deletion, PCR had to be used to screen the lines. It was subsequently used to 
confirm the lines. For mesol8E, eye colour suggested a deletion (w+) or a duplication (w-) 
event, but PCR was needed to distinguish these from un-recombined elements.
2.5.4 Genomic DNA Extraction from individual flies.
As large number of single flies needed to be prepped for genomic DNA for the screening I 
used an alternative quicker (and cruder) method for obtaining DNA than outlined in 2.1.8 
for construct preparation. Emerging females from the progeny to be screened were allowed 
to mate (crossed with FM7h males) and once a number of eggs were seen to be laid to 
ensure genes were passed on she was prepped for DNA to test the line as follows.
Genomic DNA Extraction from individual flies.
Engels quick prep genomic DNA extraction.
1. 1 anaesthetised fly in 50ul Squishing Buffer pipetted up and down 10 times.
2. 30mins at 37deg C.
3. 5mins at 85deg C to inactivate Proteinase K.
Crude DNA prep stored at 4deg and used that day or next in PCR reaction.
Squishing Buffer:
lOmM Tris-HCl pH 8.8 
ImM EDTA 
25mM NaCl 
200ug/ul Proteinase K
PCR Reaction :
1.5ul ThermoPol Buffer NEB
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0.5ul Fwd primer (25pmol/ul)
0.5ul Rev primer (25pmol/ul)
0.5ul lOmM dNTP’s NEB
2.0ul quick prep DNA
lO.lul diH20 RNAse free SIGMA
0.2.l Taq DNA pol NEB 
20ul Total Volume
PCR Program :
1. 5min @ 95°C
2. 30sec @ 95°C
3. lmin @ Annealing temp
4. lmin @ 72°C
5. Go to step 2. x35 times
6. 5min @ 72°C
7. Forever @ 4°C
Annealing temp was specified as 2°C lower than lowest Tm of primer pair used.
2.5.5 Primers used in screen 
Him primers
Him P Element deletion confirmation primers (A,B,C,D pairs)
Primers specific to a P-element and adjacent genomic DNA 
For element pWH f06349
A Fwd gen : GCGTGGCAAGAAGACGGAAATG 62.11 
A Rev pWH : TCCAAGCGGCGACTGAGATG 61.4 
Fragment size will be 448bps
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B Fwd pWH : CCTCG AT AT AC AG ACCG AT AAAAC 59.3 
B Rev gen : ACTAGCAAATAATTCCCCAAAGCC 59.3 
Fragment size will be 286bps
For element pWH f04435
C Fwd gen : GGG A A ATTT CAT CT AGGT GGCG 60.25 
C Rev pWH : TCCAAGCGGCGACTGAGATG 61.4 
Fragment size 506bps
D Fwd pWH : CCTCG AT AT AC AG ACCG AT AAAAC 59.3 
D Rev gen : ATT AC AGT C ATT GCGGCTT ACG 58.39 
Fragment size will be 386bps
Because of the number of flies involved with the Him screen, I just initially screened using 
the primer pairs A and D. A positive result for both of these for a line suggests a deletion, a 
result for just A suggests unrecombined pBacWH f06349 , a result for just D suggests 
unrecombined pBacWH f04435 and a result for neither suggests a duplication. If a A and D 
positive result was obtained for a line, the test was repeated using A,B,C and D pairs with 
controls using these primer pairs against P-element stocks. The line was further tested 
using primers specific to the region outside of the deletion area at either side and inside of 
the deletion area. These primers are described below.
Primers specific to genes upstream (Aril), downstream (Upd2) and within (Him) the 
deleted region:
Aril primers 
5’ end of gene
FWD1 : GCCTGGAGCCACCTTCTAG TM = 60.95
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REV1 : C AGTC AC AAGGCT C AG A AGC TM = 59.35 
Product size = 356 bp’s 
3’ end of gene
FWD2 : CACAAAGGCACAGTCGAAAAGC TM = 60.25 
REV2 : GC ACCC ATCG AT AAGC AG AT G TM = 59.82 
Product size = 387 bp’s
Upd2 primers
5’ end of gene
FWD1 : CTC GCT AT AAT ACT GG AAGGGC TM = 60.25 
REV1 : GAGCGTCTCAACTTTCACACG TM = 59.82 
Product length 
3’ end of gene
FWD2 : GCT GAG ACT CAT AT C ACT GT CG TM = 60.25
REV2 : GC AGC AAGCG ATT GT GAT AGTT G TM = 60.64 
Product length = 544 bp’s
Him region primers
5’ end
FWD1 : CGATCTCCAAAACAAACCCGC TM = 59.82
REVla : CAGTATCTTGTAGATGACGCCC TM = 60.25
Product size = 190bps
REV 1 b : CTAGAAATCTGCACAGCTGCTG TM = 60.25
Product size = 428
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3’ end
FWD2 : GCTGCTCTTCCATTTTCCCAC TM = 59.82 
REV2 : CCGGAAATCAGAACAGGCATC TM = 59.82 
Product size =356
Mesol8E  deletion primers
Dmesol8E P element deletion
Primers specific to a P-element and adjacent genomic DNA 
For element pRB e02398
A Fwd gen : GATGTCGTCCGGATTGAACTCG 62.18 
A Rev pRB : TCCAAGCGGCGACTGAGATG 61.4 
Fragment size will be 434bps
B Fwd pRB : CCTCGATATACAGACCGATAAAAC 59.3 
B Rev gen : ACCCGACTTCGAAAAGGACTG 59.82 
Fragment size will be 444bps
For element pRS UM8195-3 
C Fwd gen : ATCCCGTTGCCGATACTAAC 57.3 
C Rev pRS : CACAACCTTTCCTCTCAACAA 56.98 
Fragment size will be 308bps
D Fwd pRS : C AAT CAT ATCGCT GT CT C ACTC 58.39 
D Rev gen : GTT GG AAT CAT GCTT GCTCT G 57.87 
Fragment size will be 360bp
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Mef2 Dominant Negative 
3.1 Introduction
As outlined previously there are limitations to using the Mef2 hypomorph or null alleles to 
investigate the roles of Mef2 in the orchestration of muscle differentiation (Section 1.5.9), 
and as a result of this I designed and generated two Mef2 Dominant Negative proteins that 
could be over-expressed using the Gal4 UAS system (Brand and Perrimon, 1993) and reduce 
Mef2 activity in a spatially and temporally controlled manner through the use of appropriate 
Gal4 lines and driving temperatures.
Normal Mef2 protein consists of three key domains that provide distinct aspects essential for 
its function. At the N terminus there is a MADS box domain, which is a 57 amino acid region 
that allows the Mef2 protein to bind to DNA at its specific binding sites (Yu et al, 1992; 
Andres et al, 1995; Molkentin et al, 1996). The MADS box is highly conserved and is named 
after a number of proteins from across the animal and plant kingdom that the domain was 
first identified in (MCM1, Agamous, Deficiens and SRF) (Shore and Sharrocks, 1995). The 
MADS box also enables Mef2 to homodimerise with other Mef2 molecules (Black and Olson, 
1998). Adjacent to the MADS box is a Mef2 domain, a region of 29 amino acids which 
allows the Mef2 protein to dimerise with a different protein (heterodimerisation), such as a 
bHLH transcription factor (Molkentin et al, 1996; Black and Olson, 1998). At the C terminal 
end of the Mef2 protein is a transactivation domain that is essential for activation of Mef2 
gene targets once the protein has bound to the DNA (Yu 1996; Black and Olson 1998). These 
three regions axe highly conserved among all Mef2 proteins with respect to their relative 
position in the protein and with respect to sequence for the MADS and Mef2 domains -  the 
transactivation domain varies between organisms and even Mef2 isoforms in the same
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organism (Pothoff and Olson, 2007). However, all three domains are essential for the correct 
function of the Mef2 protein (Black and Olson, 1998; Nguyen et al, 2002).
The MADS domain of Drosophila Mef2 is situated at amino acids 1-57 and the Mef2 domain 
is at amino acids 58-86 (Taylor et al, 1995). I designed my dominant negative constructs so 
that the protein should retain DNA binding and protein dimerisation capability (the MADS 
and Mef2 domains), but due to a truncation of the C terminal end, lack the transcriptional 
activation capability of wild type Mef2 protein. This introduced protein should then compete 
with the wild type Mef2 protein present and reduce the transcriptional activation of Mef2 
dependent genes. Such Mef2 dominant negative constructs have been successfully used 
previously for the different vertebrate Mef2 copies in cell culture, (Omatsky et al, 1997; 
Krainc et al, 1998; Shin et al, 1999; Kolodziejczyk et al, 1999; Okamoto et al, 2000), and the 
rationale behind the design of these dominant negative constructs was based upon studies 
analysing the requirement of the different Mef2 regions through various degrees of truncation 
(Molkentin et al, 1996; Yu, 1996).
I have generated two different versions of the Mef2 dominant negative; one is just a 
truncation alone, the other is the truncation with the engrailed repressor domain fused to it 
(Han and Manley, 1993; Smith and Jaynes, 1996). Such engrailed repressor fusions have 
been used previously in a number of other successful dominant negative proteins, such as 
Tinman and Pannier in Drosophila and Nkx2.5 in Xenopus (Han et al, 2002; Klinedinst and 
Bodmer, 2003; Fu at al, 1998) and more recently for successful Mef2 dominant negative 
proteins in vertebrate systems; Mef2C in mice (Arnold et al, 2007) and Mef2C in mice and 
P I9 cells (Karamboulas et al, 2006a; Karamboulas et al, 2006b). Fusion to the engrailed 
repressor domain has been shown in previous constructs in other systems to increase the
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strength of phenotype achieved by the dominant negative when compared to the phenotype 
associated with the truncation alone (Karamboulas et al, 2006b).
The two Mef2 dominant negative constructs were designed as follows ;
The Mef2 dominant negative fused to the Engrailed repressor domain consists of the first 128 
amino acids of the Drosophila Mef2 protein which is fused in frame to the repressor domain 
of engrailed (amino acids 2-298 of engrailed) (Han and Manley, 1993; Smith and Jaynes, 
1996). The size of the Mef2 truncation was chosen to include the MADS and Mef2 domains 
(amino acids 1-86) but be of an appropriate length to abolish transactivation properties based 
upon previous analysis of Mef2 proteins (Taylor et al, 1995; Molkentin et al, 1996; Yu 1996). 
I also considered the lengths of previous successful Mef2 dominant negatives in vertebrate 
systems generated through truncation and used these as a guide for a suitable size for a 
Drosophila Mef2 dominant negative. The lengths of previous successful vertebrate Mef2 
truncations are as follows :
Mef2A, amino acids 1-131: Omatsky et al, 1997 (from a study by Yu, 1996)
Mef2C, amino acids 1-109: Krainc et al, 1998 
Mef2C, amino acids 1-105 : Okamoto et al, 2000
Mef2D, amino acids 1-153: Shin et al, 1999 (from a study by Molkentin et al, 1996)
Considering the lengths of these previous proteins and the established location of the MADS 
and Mef2 domains a length of around 110-140 amino acids seemed suitable for a truncation 
of Drosophila Mef2. A length of 128 amino acids was chosen based on the criteria outlined 
and that it fell conveniently with primer design.
I called this Mef2 dominant negative truncation fused to the engrailed repressor, Mef2-En. 
The second dominant negative is a Mef2 truncation alone. It consists of the first 128 amino 
acids of Mef2 followed by an introduced Stop codon. I called this Mef2 dominant negative
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protein Mef2-Stop. Both of the Mef2 dominant negatives were made as UAS constructs for 
use with the Gal4 UAS system (Brand and Perrimon, 1993). A schematic of the Mef2-En, 
Mef2-Stop and Wild Type Mef2 is shown in FIG 3.1.1 See Materials and Methods 2.4.1 for 
Primer sequence and cloning protocol for generation of the constructs.
After generating the Mef2-En and Mef2-Stop constructs, I first confirmed them by 
sequencing and they were injected in-house (J.Han) to establish multiple transgenic lines. I 
chose to concentrate my investigations on homozygous viable insertion lines in order to try to 
minimise any potential phenotypes arising from effects caused by construct insertion and to 
make analysis more straight forward on crossing with Gal4 flies (avoiding the need to select 
against balancer chromosome markers of heterozygous insertion lines in the experimental 
progeny). After initial testing of a number of insertion lines (See Table 2.3.4 Materials and 
Methods), I chose to use the following homozygous lines for characterisation; Mef2-En L10- 
1 (X) and Mef2-En L2-1 (II) and Mef2-Stop L6-1 (II); Mef2-Stop L4-1 (III).
Initially I wanted to test if any muscle phenotype at all could be generated through the use of 
the constructs, and if so, to characterise this phenotype in detail and establish the nature of it; 
asking if it occurs through a reduction in Mef2 activity, as one would expect if the constructs 
were functioning correctly as dominant negative proteins.
3.2 Mef2 dominant negative lines disrupt somatic myogenesis
To test if the Mef2 dominant negative constructs gave any phenotype I over-expressed them 
in the embryo using Mef2 Gal4.1 chose this driver because it would allow for the most direct 
competition with endogenous Mef2 protein (being expressed in all the same places) and 
because Mef2 Gal4 is a particularly strong mesodermal driver (Ranganayakulu et al, 1996).
63
N C
MADS Mef2 Mef2 wild type protein
1-128 129-501
MADS Mef2 EnR Mef2-En Dominant Negative
1-128 2-298
MADS Mef2 Mef2-Stop Dominant Negative
1-128
FIG 3.1.1 The structure of wild type Mef2 and the Mef2-En and Mef2-Stop Dominant 
Negative proteins.
Schematic showing the structure of normal Mef2 protein in Drosophila and the two types of Mef2 dominant negative 
designed for this study.; Mef2-En and Mef2-Stop.
Wild type Mef2 contains the MADS domain and the Mef2 domain at its N terminal end. The MADS domain confers DNA 
binding ability and Mef2 homodimerisation ability and the Mef2 domain provides heterodimerisation ability; allowing Mef2 to 
bind other proteins. The C terminus contains the transactivation domain which is responsible for Mef2 activating genes once 
bound to Mef2 binding sites within their regulatory DNA region.
*The size of the Mef2 protein is between 501 and 540 amino acids depending upon splice variant (A,B,C,D or F) of the 
gene; however the first splice event occurs at amino acid 186, so amino acids 1-128 are present within all Drosophila Mef2 
isoforms (Taylor et al, 1995 and Gunthorpe et al, 1999, Flybase).
The Mef2-En dominant negative contains the MADS and Mef2 binding domains, but at amino acid 128, is fused in frame to 
the repressor domain of the engrailed protein. This domain is covered by amino acids 2-298 of the engrailed protein. The 
length of Mef2-En is 427 amino acids, including an introduction of 2 amino acids at the restriction site linker that joins the two 
sections and a stop codon at the end of the engrailed repressor domain.
Mef2-Stop consists of the N terminus of Mef2 alone, and is just amino acids 1-128 with an additional stop codon at the end.
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For analysis of the terminal phenotype of somatic musculature I stained St 17 embryos with 
p3-tubulin antibody and scored the presence, absence, shape defects and attachment defects 
of each of the individual somatic muscles in hemi-segments A2-A4. As each abdominal 
hemi-segment is made up of a regular, repeating pattern of 30 individual muscles (Bate, 1993) 
and see FIG 1.5.1 and FIG 1.5.2), this meant I scored a total of 90 muscles per embryo, with 
each individual muscle type being scored three times per embryo (e.g muscle DTI is scored 
in A2, A3, and A4 per embryo). A total of 20 different embryos were scored for each 
analysis and so I scored a total of 1800 muscles per experiment, with each individual muscle 
type being scored 60 different times.
The following crosses were used as part of this analysis :
Mef2-En (X) x Mef2 Gal4 at 29°C 
Mef2-En (II) x Mef2 Gal4 at 29°C 
Mef2-Stop ( I I ; III) x Mef2 Gal4 at 29°C 
Mef2-En (X) x Mef2 Gal4 at 25°C 
Mef2-En (II) x Mef2 Gal4 at 18°C
Table 3.2.1, Table 3.2.2 and FIG 3.2.1 and FIG 3.2.2 show the results from this.
A number of conclusions can be made from this data and they are summarised as follows: 
Firstly, both the Mef2-En and the Mef2-Stop constructs do give a phenotype when over­
expressed in muscle and this phenotype is associated with a decrease in the number of 
muscles (Table 3.2.1 and Table 3.2.2).
The Mef2-Stop construct shows a weaker phenotype than the Mef2-En construct, but this is a 
subset of the Mef2-En phenotype as opposed to a completely distinct phenotype. This effect
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of Mef2-En being stronger than the Mef2-Stop is perhaps not surprising from previous work 
which compares a Mef2 truncation with a Mef2 truncation fused to the Engrailed repressor 
(Karamboulas et al, 2006a).
The Mef2-En (X) line is stronger than the Mef2-En (II) line; more muscles are lost with 
Mef2-En (X) than with the Mef2-En (II) line when driven at the same temperature (Table 
3.2.1, Table 3.2.2 and FIG 3.2.1 compare analysis when driven at 29°C for these two lines).
However, the phenotype of the Mef2-En (II) line driven at 29°C gives a subset of muscle 
missing that are lost in the Mef2-En (X) line driven at 29°C (Compare Table 3.2.2 row 1 with 
row 2) and lowering the driving temperature of the Mef2-En (X) line to 25 °C makes the 
phenotype more similar to that produced by the Mef2-En (II) line at 29°C (Compare data for 
these lines in Table 2.3.1 and in Table 2.3.2); This suggests that the difference in phenotype 
is due to one line expressing more Mef2-En protein than the other, rather than the effects of 
an additional gene associated with the position of the Mef2-En (X) insertion in the genome.
The strength of the phenotype can be varied using either choice of line (Mef2-En (X), Mef2- 
En (II) or Mef2-Stop ( I I ; III) and choice of driving temperature and each of these phenotypes 
give a clear range of effects.
From this range of effects conclusions can be made about which individual muscles are more 
susceptible to effects from the constructs; i.e which muscles are more easily lost and which 
are more readily retained in the embryo (Table 3.2.2).
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Muscle Phenotype
Mef2-En (X)
x Mef2 Gal4 
(29°C)
Mef2-En (X)
x Me£2 Gal4 
(25°C)
Mef2-En (II)
x Mef2 Gal4 
(29°C)
Mef2-En (II)
x Mef2 Gal4 
(18°C)
Mef2-Stop ( I I ; III)
x Mef2 Gal4 
(29°C)
Wild Type
(Oregon R) 
(29°C)
% Embryos with 
Muscle missing
100% 100% 100 % 75% 37.5 % 0%
Average No. Muscles 
Missing per embryo
34.2 22.3 25.9 2.5 1.5 0
Range of Muscles 
Missing per embryo
2 6 - 4 5 9 - 4 6 2 0 -3 4
VOio 0 - 3 0
Table 3.2.1 The Mef2 Dominant Negative lines cause a loss of muscle with a range of effects according 
to line and driving temperature.
The two different types of Mef2 Dominant Negative ; Mef2-En and Mef2-Stop, were tested by driving throughout the musculature with Mef2 
Gal4 at various temperatures. Two homozygous lines for the Mef2-En construct were tested (Mef2-En (X) and Mef2-En (II)) and a single stock 
of the Mef2-Stop construct was tested. This stock, Mef2-Stop (II;III), has a homozygous insertion for the Mef2-Stop construct on the second and 
third chromosomes.
Fixed embryos were stained with p3-tubulin antibody to visualise the musculature and the individual somatic muscles of Stl 7 embryos were 
scored. Scoring was performed for each of the 30 muscles in an abdominal hemi-segment for hemi-segments A2-A4 (a total of 90 muscles) and 
this was done for 20 separate embryos for each experimental condition tested. An individual embryo only needs to have one muscle missing 
(A2-A4) to be scored as having muscles missing. The average number of muscles missing per embryo corresponds to A2-A4 only, therefore the 
maximum number of muscles that can be missing in an embryo is 90 (30 x 3 hemisegments) for any one embryo. The range of muscles missing 
corresponds to the variation in the total number of muscles missing (A2-A4) for each of the embryos scored for that experiment.
Twenty wild type (Oregon R) embryos were scored for this experiment and found to have no muscles missing.
Muscles Missing in 
> 50 % Embryos
Muscles Missing in 
25 -49 % Embryos
Muscles Missing in 
10 -24 % Embryos
Mef2-En (X)
x Mef2 Gal4 
(29°C)
DAI, DA2, D03, D04 
DA3, LT4, LOl, SBM, 
VL1, VIA, VA1, VA3, 
VOl, V02, V03, V04, 
V05, V 06
D02, D05, LL1 LT1, 
LT3, VT1 VL2, VL3
DOl, DTI, LT2 
VA2
Mef2-En (II)
x Mef2 Gal4 
(29°C)
DA2, D03, D04, DA3, 
D05, VOl, V02, V04  
V06, VIA, VA1, V05
DAI, LL1, VL1, VL2 D02, LT3, SBM
Mefi-En (X)
x Mef2 Gal4 
(25°C)
DA2, D03, D04, DA3, 
D05, LL1, SBM, VA3, 
V03, V04, V05, V06
D02, LT1, LT4, LOl, 
VT1, VL1, VL2, VL3, 
VIA, VA1, VOl, VO,
DOl, DAI, LT2, 
LT3
Mef2-En (II)
x Mef2 Gal4 
(18°C)
DA2, V04, V06 D03, V05
Mef2-Stop (II);
m
x Mef2 Gal4 
(29°C)
DA2, D03, V04
TABLE 3.2.2 Phenotype analysis of muscles missing in Mef2 
dominant negative experiments.
Individual somatic muscles missing in various experimental conditions using either the 
Mef2-En and Mef2-Stop Dominant Negative lines. Two lines were tested for the Mef2-En 
Dominant Negative; Mef2-En (X) and Mef2-En (II).
To be scored as missing in an embryo for this table, one or more copies of the individual 
muscle must be lost within hemi-segments A2-A4. The data presented then corresponds 
to the total percentage of embryos that show this muscle loss out of all the embryos 
scored in the analysis.
Highlighted in bold are the individual muscles that are more susceptible to the action of 
the constructs; they are lost at the highest frequency within each experimental condition.
Embryos were stained with p3-tubulin antibody to allow visualisation of the St17 muscles 
for analysis.
A) Mef2-En (X) x Mef2 Gal4 (29°C)
B) Mef2-En (II) x Mef2 Gal4 (29°C)
C) Mef2-Stop (II ; III) x Mef2 Gal4 (29°C)
D) Wild Type (29°C)
FIG 3.2.1 The Mef2-En and Mef2-Stop constructs give a somatic 
muscle phenotype
The Mef2-En (X), Mef2-En (II) and Mef2-Stop constructs were driven by Mef2 Gal4 at 29°C, 
stained with p3-tubulin to visualise musculature and representative St17 embryos shown (A, 
B, C). A  comparison to wild type (D) can be made.
FIG 3.2.2 Graphs to show muscle phenotype for Mef2 Dominant 
Negative lines at different temperatures
Different Mef2-En and Mef2-Stop dominant negative lines were driven at various temperatures 
and the individual muscles of hemi-segments A2-A4 for 20 embryos of each experimental 
condition were scored. The percentage of embryos that show at least one individual muscles 
to be missing (Blue) or duplicated (Red) are shown in the graphs. Only one copy of a 
particular muscle type needs to be missing from A2-A4 for that embryo to be scored.
Muscles labelled in graph in following order left to right; D O l, DA1, D01, DA2, D03, D04, 
D05, DT1, LL1, LT1, LT2, LT3, LT4, SBM, LO l, VT1, VL1, VL2, VL3, VL4, VA1, VA2, VA3, 
V O l, V 02, V 03 , V 04 , V 05.
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FIG 3.2.2 Graphs to show muscTe°phenotype for Mef2 Dominant 
Negative lines at different temperatures
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3.2.1 Mef2-En and Mef2-Stop constructs give a muscle phenotype
Table 3.2.1 shows how each of the lines causes a reduction in the number of muscles that 
form; with the Mef2-En (X) driven at 29°C having muscles missing in 100% of embryos 
scored and giving a phenotype that has an average number of muscle missing (A2-A4) of
34.2 and the Mef2-En (II) driven at 29°C also having muscles missing in 100% of embryos 
but with an average number of muscle missing (A2-A4) of 25.9.
The Mef2-Stop line, which is considerably weaker than the Mef2-En lines at this same 
driving temperature, has muscles missing in 37.5% of embryos with an average number of 
muscles missing A2-A4 of only 1.5 per embryo, though this is still a distinct phenotype in 
comparison to wild type embryos (Table 3.2.1).
FIG 3.2.1 shows representative embryos for these analyses.
3.2.2 Mef2-Stop gives a weak version of the same phenotype as 
Mef2-En
As mentioned above the Mef2-Stop phenotype is considerably weaker than that of the Mef2- 
En driven at the same temperature (Table 3.2.1 and FIG 3.2.1). However, the phenotype is a 
definite subset of the Mef2-En phenotype rather than a distinct, separate phenotype. Table
3.2.2 shows how the only muscles recorded as missing at least once (A2-A4) in 10-24% of 
embryos scored in the Mef2-Stop experiment are DA2, D03 and V04. Driving the weaker 
Mef2-En line (II) at a low temperature of 18°C means that less Mef2-En protein is produced 
due to the temperature sensitive nature of the Gal4 UAS system (Brand and Perrimon, 1993) 
and as a result a milder phenotype is induced. In this experiment (Mef2-En (II) x Mef2 Gal4 
at 18°C) there are only five muscles lost at any notable frequency and these are DA2, V04
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and V06 missing at least once (A2-A4) in 25-50% of embryos scored and D03 and V05 
missing at least once (A2-A4) in 10-24% of embryos scored (Table 3.2.2). This result is very 
encouraging in that it shows that the Mef2-Stop gives a subset effect of the Mef2-En 
phenotype but also gives indication as to which muscles are more easily lost or gained in an 
experiment using these constructs. In FIG 3.2.2 this comparison can be seen in a graph 
representing all muscles that were either missing or duplicated for each experiment. 
Comparing Mef2-En (II) x Mef2 Gal4 at 18°C here (FIG 3.2.2, D) with Mef2-Stop ( I I ; III) x 
Mef2 Gal4 at 29°C (FIG 3.2.2 , E), shows very clearly the similarity of phenotypes, and from 
this we can also see that the V06 muscle is lost in 5% of embryos in the Mef2-Stop 
experiment (not included in Table 3.2.2 data) suggesting the importance of this muscle in the 
phenotype also.
3.2.3 Mef2-En (X) is stronger than Mef2-En (II), but both give 
similar phenotypes on temperature variation.
As discussed in section 3.2.1, Mef2-En (X) gives a stronger phenotype in terms of the 
average number of muscles missing than Mef2-En (II) when driven at 29°C. This is also true 
for the range of muscles missing (26-45 for Mef2-En (X) and 20-34 for Mef2-En (II) (Table 
3.2.1). The analysis of the individual muscles missing (Table 3.2.2) also shows that Mef2-En 
(X) gives a stronger phenotype than Mef2-En (II); more muscles are missing at a greater 
frequency. In Table 3.2.2b, I have shown this data again but highlighted the similarities 
between the muscles affected; in red are muscles that are lost at the same frequency range in 
Mef2-En (II) as Mef2-En (X) at 29°C and in underlined are muscles that are missing in the 
adjacent frequency range. This shows very strikingly that the same subset of muscles are lost
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Muscles Missing in 
> 50 % Embryos
Muscles Missing in 
25 -50 % Embryos
Muscles Missing in 
10 -24 % Embryos
Mef2-En (X)
x Mef2 Gal4 
(29°C)
DAI, DA2, D03, D04 
DA3, LT4, LOl, SBM, 
VL1, VL4, VA1, VA3, 
VOl, V02, V03, V04, 
V05, V06
D02. D05. LL1 LT1. 
LT3, VT1 VL2, VL3
DOl, DTI, LT2 
VA2
Me£2-En (II)
x Mef2 Gal4 
(29°C)
DA2, D03, D04, DA3, 
D05, VIA VA1, VOl, 
V02, V04, V05, V06
DAI. LL1. VL1. VL2 D02. LT3. SBM
TABLE 3.2.2b Comparison of the muscle phenotypes of Mef2-En 
(X) and Mef2-En (II) driven by Mef2 Gal4 at 29°C.
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for the two lines, with nearly all the muscles lost in Mef2-En (II) being lost at the same or 
similar frequencies in Mef2-En (X) at this temperature. FIG 3.2.2 shows this information in 
the form of a graph (compare A with C). Dropping the driving temperature of Mef2-En (X) 
to 25°C brings the muscle phenotype to one that is more similar to that of Mef2-En (II) at 
29°C, as seen in FIG 3.2.2 B and C and the average number of muscles missing (A2-A4) and 
the range of muscles missing for these experiments (Table 3.2.1).
3.2.4 The strength of phenotype can be varied by changing the 
UAS line or the driving temperature.
As has been shown in this section (3.2.1-3.2.4) the different UAS lines (Mef2-En (X) or (II) 
and the different constructs (Mef2-En or Mef2-Stop) can be placed in order for the strength 
of phenotype associated with them; Mef2-En (X) > Me£2-En (II) > Mef2-Stop ( I I ; III) and 
as one would expect with the Gal4 UAS system, the driving temperature can also vary this 
phenotype due to increased or decreased amounts of protein production with higher or lower 
temperature respectively (Brand and Perrimon, 1993). Consequently this shows that the three 
lines can be used accordingly to give a range of phenotypes as desired.
3.2.5 There are subsets of muscles that appear more readily lost.
As alluded to in the Mef2-Stop section (section 3.2.2), there are muscles that seem to be most 
easily lost -  DA2, D03, V04 and V06 and these are missing in all experimental conditions; 
In mild phenotype associated with Mef2-Stop they are the only muscles missing and this loss 
is at a low frequency (at least once A2-A4 in 5-24% of embryos). When driving the weaker 
Mef2-En at a low temperature (Mef2-En (II) at 18°C) they represent the majority of the
68
Chapter 3 : Mef2 Dominant Negative
muscles missing (4 out of 5, the other being V05) with this loss occurring at a higher 
frequency (at least once (A2-A4) in 25-50% of embryos for DA2, V04 and V06 and at least 
once (A2-A4) in 10-24% of embryos for D03) and when the Mef2-En lines (II) or (X) are 
driven at a higher temperatures they are the consistently the most frequently lost individual 
muscle types (FIG 3.2.2) of a subset of a large number of muscles missing (Table 3.2.2).
3.2.6 There are subsets of muscles that appear more readily 
retained.
Conversely, from this there are individual muscles that remain present in the embryo even in 
the conditions where there is substantial muscle loss with a severe phenotype (e.g Mef2-En 
(X) or Mef2-En (II) at higher driving temperatures of 29°C or 25°C. Here we can see that the 
individual muscles DOl, DTI, LT2 and VA2 appear to be frequently present in all conditions. 
This suggests that the development of these muscles is less susceptible to the Mef2-En and 
Stop constructs.
FIG 3.2.3 shows a summary of the muscles most frequently missing and present with the 
constructs.
3.2.7 Characterisation of the Mef2-En construct
After establishing that the Mef2-En can give a strong muscle phenotype and the severity of 
the phenotype is dependent upon the strength of the Gal4 driver used and the temperature the 
experiment is performed at, I wanted to further investigate the nature of this phenotype for 
both of the homozygous lines investigated. At this point, due to the weak nature of the Mef2-
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Muscles most frequently missing Muscles most frequently present
DA1, D03, V04, V06 D01, DT1, LT2, VA2
FIG 3.2.3 Muscles most frequently missing and present in the somatic muscle 
phenotypes associated with Mef2-En and Mef2-Stop constructs.
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Stop phenotype (and that it appeared to be a weaker version of the Mef2-En dominant 
negative), I decided to predominantly concentrate on characterisation of the Mef2-En 
construct lines.
To make any further progress on the significance of the observations made with the 
constructs I needed to characterise them to determine if they were functioning as Mef2 
dominant negatives as they were designed and the phenotypes could be attributed to a loss of 
Mef2 activity. This characterisation is described below.
3.3 The Mef2 Dominant Negative can mimic Mef2 hypomorph 
alleles.
The previous studies of Mef2 hypomorphs (Ranganayakulu et al, 1995; Gunthorpe et al,1999) 
went into limited detail regarding somatic muscle defects, only reporting muscles that were 
missing at a high frequency (in more than 50% of the embryos). For an accurate comparison 
of the dominant negative phenotype to the alleles I repeated this analysis, scoring the 
frequency of muscle loss, duplication, and shape and attachment defects for all of the 30 
somatic muscles in a hemi-segment.
3.3.1 Mef2 Dominant negative mimics the Mef265 allele.
The Mef265 mutant is a weak hypomorph, which has some muscle deletions and defects due 
to a decrease in Mef2 activity. In the Ranganayakulu study it is reported that the LOl and 
SBM muscles are consistenty missing, and in the Gunthorpe study it is reported that LOl, 
VA3, V03 and LT4 are missing in over 50% of embryos scored (10 embryos were scored for 
the Gunthorpe analysis and SBM was never observed as missing) (Ranganayakulu et al, 1995;
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Muscles Missing in 
> 50% Embryos
Muscles Missing in 
25 -49% Embryos
Muscles Missing in 
10 -24% Embryos
Shape Defects in >75% 
of embryos
Mef265 VA3, V04 LT4, LOl, V05, 
V06
DA2, D03, SBM, 
VL2, VL3, V03
D03, D04, DA3, LT1 
VT1, VA1, VA2, VA3 
V04, V05, V06
Mef2-En (II) x Mef2 
Gal4 @ 18°C
- DA2, V04, V06 D03, V05 VA3
Mef265
(Ranganayakuku 1995)
LOl, SBM
Mef265
(Gunthorpe 1999)
LOl, VA3, V03, 
LT4
Table 3.3.1 The same subsets of muscles are missing and affected in the Afef265 
hypomorph as the Mef2 Dominant Negative.
The Mef265 mutant is a weak Mef2 hypomorph which has some muscle deletions and defects due to a decrease in Mef2 
activity. (Ranganayakulu et al 1995, Gunthorpe et al 1999). When Mef2 activity is reduced mildly, by using the Mef2 
Dominant Negative at a low temperature, the mild Mef265 hypomorph can be mimicked. All of the individual somatic 
muscles missing when the Mef2 Dominant Negative is driven at 18°C are missing in the Mef265 mutant (Highlighted as 
Bold in Table).
The data for the Mef265 phenotype from the Ranganayakulu et al, 1995 and the Gunthorpe et al, 1999 studies are 
included in the table for comparison to the detailed data for the Mef265 phenotype obtained for this study.
Mef2-EnWild Type
FIG 3.3.1 The Mef2 Dominant Negative can mimic the 
muscle phenotype of the Mef2mutant.
Driving the Mef2-En (II) Dominant Negative in the Mef2 pattern at 18°C can 
mimic the phenotype of the weak Mef265 hypomorph mutant. For example in 
the ventral muscles V 06  is missing (arrow in B and C), VA3 is either missing ( *  
in B and C) or misshapen ( * ’ in B and C) and VA2 is misshapen, projecting 
further ventrally than wild type (compare arrow head in B and C to wild type, A).
A schematic of these muscles affected muscles is shown in D.
Dominant negative line used is Mef2-En (II), crossed with Mef2 Gal4 at 18°c. 
The Mef265 mutants were first selected against GFP to ensure embryos were 
homozygous mutants. All embryos were stained with anti p3-tubulin antibody 
and viewed laterally, with ventral muscles of hemi-segments A2-A4 shown in 
figure. Muscle Schematic
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Gunthorpe et al, 1999). Here I present data showing muscle loss over a range of frequencies 
and shape defects seen in individual muscles in over 75 % of embryos scored (20 embryos 
scored for each experimental condition) (Table 3.3.1).
When the Mef2-En (II) dominant negative was driven by Mef2 Gal4 at a temperature of 
18°C, a mild muscle phenotype was seen. This phenotype is similar to that seen with the 
Mef265 allele; all of the muscles that were missing in the Mef2 DN were missing at a similar 
frequency in the Mef265 mutant (Table 3.3.1 -  muscles highlighted in bold). In addition, 
muscle defects that are seen in the Mef265 mutant, such as VA2 projecting further ventrally 
and VA3 being misshapen compared to wild type, are also seen in the Mef2 dominant 
negative (FIG 3.3.1).
The similarity of phenotype between the Mef2-En driven by Mef2 Gal4 at the relatively low 
temperature of 18°C and the phenotype of the weak Mef265 mutant allele suggests that the 
Mef2-En muscle phenotype may occur as a result of a mild reduction in Mef2 activity. In 
addition this similarity of phenotype from a reduction in Mef2 activity by two completely 
different ways may indicate the individual muscles that are more readily lost when Mef2 
activity is reduced and that perhaps have a higher Mef2 requirement for their correct 
development than other individual somatic muscles.
3.3.2 Mef2 Dominant negative mimics the Me/2424 allele.
As previously established in the Ranganyakulu and Gunthorpe studies the Mef2424 
hypomorph has a much more severe phenotype than Mef265\ the weak M efl65 allele causes a 
phenotype where fewer muscles are missing than the stronger Mef2424 intermediate 
hypomorph, though these muscles lost are a subset of those missing in the Mef2424 phenotype 
(Ranganayakulu et al, 1995; Gunthorpe et al, 1999).
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Experiment Muscles Missing in 
> 50% Embryos
Muscles Missing in 
25 -49% Embryos
Muscles Missing in 
10 -24% Embryos
Me/2424
DAI, DA2, DA3, LT4, 
SBM, LOl, VL2, V04, 
D03, D04, D05, V02, 
V06
DOl, D02, LT3, VL3, 
VL4, VA3, VOl, V03, 
V05
DTI, VT1
Mef265 VA3, V04 LT4, LOl, V05, V06 DA2, D03, SBM, 
VL2, VL3, V03
Me/2424 
(Ranganayakulu 1995)
D03, DA3, LOl. SBM. 
VL2, VL3, VL4, V05
Mef265 
(Ranganayakulu 1995)
LOl. SBM
Mef2424 
(Gunthorpe 1999)
D03, DA3, V03, VA3, 
LO l, ((V04, V05, V06))
Mef265 
(Gunthorpe 1999)
LOl, VA3, V03, LT4
Table 3.3.2 Comparison of muscles missing in Mef2*24 and Mef265 hypomorph mutants
Table to show how individual muscles are lost in Mef2424 and Mef265 hypomorph mutants in the three studies carried out 
on them (this study, Ranganayakulu et al, 1995 and Gunthorpe et al, 1999). For each study, the muscles lost in the 
Mef265 hypomorph are a subset of those lost in the Mef2424 hypomorph mutant (highlighted as bold for this study, 
underlined for Ranganyakulu study and italicised for Gunthorpe study).
Brackets surrounding V04,V05,and V 06  in Mef2424 analysis of Gunthorpe study mean that two out of these three muscles 
are lost in 50% of embryos scored.
Embryos were stained with p3-tubulin to visualise musculature and muscles were scored in hemi-segments A2-A4 for 20 
embryos. Only one individual muscle out of the three scored (A2-A4) need be missing for an embryo to be scored as 
having that muscle type missing.
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The analysis required for this study, went into greater depth, showing that not only are all the 
muscles missing in Mef265 mutants also missing in Mef2424 mutants, but also that these 
muscles are often missing at a higher frequency in Mef2424 mutants (Table 3.3.2) -  for 
example LT4 and LOl were missing in 25-49% of Mef265embryos but over 50% of Mef2424 
embryos. Similarly, VL3 and V03 were missing in 10-24% of Mef265embryos but in 25-49% 
of M efl424 embryos. Muscles, such as DTI and VT1, that were only occasionally lost in 
Mef2424 mutants were never observed as lost in any of the Mef265 mutants scored. All of this 
shows that not only does Mef265give muscles missing that are a subset of Mef2424 but also 
that this phenotype is a milder version of the same effect -  suggesting that each of the 
individual somatic muscles can be ordered into their requirement of Mef2 activity to 
correctly form. Muscles such as V04 and LOl, are the most easily lost and so we can 
conclude that these require the most Mef2 activity to form, whereas muscles such as DTI and 
VT1 often remain present even in conditions associated with a significant decrease in Mef2 
activity and thus require only a low amount of Mef2 activity to correctly form (Table 3.3.2). 
In addition I found that both the average number of muscles missing per embryo scored, and 
the range of muscles missing in an embryo are considerably higher in the Mef2424 mutant 
compared to the Mef265 mutant (Table 3.2.3) This stronger muscle phenotype consequently 
results in a lower embryo survival rate, when hatching and survival experiments are 
performed (Table 3.3.3).
By driving the Mef2 Dominant Negative with Mef2 Gal4 at a higher temperature (29°C 
instead of 18°C) a more severe muscle phenotype was induced. This is because the Gal4 
UAS system is temperature dependent; an increase in temperature causes a greater 
production of Gal4 protein which consequently leads to expression of more UAS protein 
(Brand and Perrimon, 1993). So, in theory this would mean that there is more Mef2 
dominant negative protein available to compete with endogenous Mef2.
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Mef2 424 Mef2 65
Muscle phenotype (25°c) (25°c)
% embryos with 100% 100%
muscle missing
Average No. muscles 
missing per embryo 25.1 4.5
Range of muscles 
missing per embryo 14-34 1 -9
Survival assay
Hatching 7.8 % 79.9 %
Survival 0% 0%
Table 3.3.3 Comparison of severity of Mef2 424 and M ef265 hypomorphs.
Table showing how the severity of the Me/2424 mutant varies compared to the Me/265 mutant.
Individual somatic muscles were visualised with anti p3 tubulin antibody and muscles in abdominal hemisegments A2-A4 of 
20 St17 embryos were scored after homozygous mutant embryos were taken after selection against GFP. Stocks used 
Me/2424 / CyO wg GFP and Me/265 / CyO wg GFP (Ranganayakulu et al, 1999)
For Hatching and Survival assay 200 homozygous fertilised embryos were selected by absence of GFP marker gene and 
gut auto-fluorescence respectively and then their progress through the life cycle (FIG 1.1) was charted from hatching of 1st 
instar larva at the end of embryogenesis to eclosion of adult flies after pupation. 20 Wild type embryos scored showed no 
muscles missing and gave a hatching rate of 99% and survival rate of 98%.
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This severe muscle phenotype is strikingly similar to the muscle phenotype of Mef2424 
mutants. Analysis of the somatic musculature (abdominal hemi-segments A2-A4) of St 17 
embryos revealed that the severity of the Mef2 dominant negative and Mef2424 phenotypes 
are the same; both in terms of the average number of muscles missing per embryo (25.1 / 90 
missing in A2-A4 of Mef2424 embryos, compared to 25.9 / 90 missing in A2-A4 of embryos 
over-expressing the Mef2 dominant negative) and in terms of the range of muscles missing 
per embryo (between 14 and 34 muscles missing (A2-A4) in Mef2424 embryos compared to 
between 20 and 34 muscles missing (A2-A4) in Mef2 dominant negative embryos) (Table 
3.3.4). More importantly, it is the same individual muscles that are missing in the two 
experimental conditions that are generating these phenotypes; the same muscles are lost at 
the same or similar frequencies in the Mef2424 mutant and the Mef2 dominant negative. For 
example, DA2, D03, D04, DA3, V04 and V06 are all missing in over 50% of embryos in 
both Mef2424 and the Mef2 dominant negative driven by Mef2 Gal4 at 29°C (underlined and 
bold, Table 3.2.5). In addition, not only are other muscles lost at similar frequencies, but the 
same muscles frequently remain present (e.g LT1, LT2 and VA2 were never scored as 
missing in either experimental condition) (Table 3.3.5).
The appearance of the phenotype can be seen to mimic Mef2424 in St 17 embryos stained with 
anti p3-tubulin antibody (FIG 3.3.2).
In addition, although the stronger Mef2 dominant negative line (Mef2-En (X)) gave a 
phenotype when it was driven by Mef2 Gal4 at 29°C that was generally more severe in terms 
of number of muscles affected than the Mef2424 allele (an average number of muscles 
missing of 34.2 (A2-A4) with a range of 26-45 for Mef2-En (X) driven by Mef2 Gal4 at 
29°C (Table 3.2.1) as opposed to an average of 25.1 muscles missing (A2-A4) and a range of
47413-34 for the Mef2 mutant (Table 3.3.3)) , it could still show individual embryos within
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Muscle phenotype
Mef2 424
(25°c)
Mef2-En x Mef2 Gal4
(29°c)
% embryos with 
muscle missing
100% 100%
Average No. muscles 
missing per embryo 25.1 25.9
Range of muscles 
missing per embryo 14-34 20-34
Survival assay
Hatching 7.8 % 52%
Survival 0% 0%
Table 3.3.4 Mef2 Dominant Negative can mimic the Mef2 424 hypomorph.
When driven at a higher temperature the Mef2-En (II) Dominant negative can cause a greater reduction in Mef2 activity, 
mimicking the intermediate Mef2 hypomorph mutant allele Mef2424. Both the severity of the muscle phenotype (this table) 
and the individual muscles missing (Table 3.2.5) are comparable. Images of representative embryos show the similarity of 
the phenotype (FIG 1.2.1).
For the muscle phenotype experiment 90 muscles were scored (hemisegments A2-A4) per embryo, with a total of 20 
embryos scored for each cross. Only 1/90 muscles need be missing for an embryo to be scored as having muscles 
missing. 20 Wild type embryos scored showed no muscles missing and gave a hatching rate of 99% and survival rate of 
98%.
Lines used : Mef2-En (II) for Mef2 Dominant Negative and Mef2424 (Ranganayakulu et al, 1999), Oregon R for wild type . 
Embryos stained with anti b3-tubulin (guinea pig).
Muscles Missing in 
> 50% Embryos
Muscles Missing in 
25 -49% Embryos
Muscles Missing in 
10 -24% Embryos
Mef2424 DAI, DA2, DA3, LT4, 
SBM, LOl, VL2, V04, 
D03, D04, D05, V02, 
V06
DOl, D02, LT3, VL3, 
VL4, VA3, VOl, V03, 
V05
DTI, LL1, VT1
Mef2-En (II) x 
Mef2 Gal4 
(29°C)
DA2, D03, D04. DA3. 
D05, VOl, V02, V04, 
V06, VL4, VA1, V05
DAI, LL1, VL1, VL2 D02, LT3, SBM
Mef2424
(Ranganayakulu 1995)
D03, DA3, LOl, SBM, 
VL2, VL3, VL4, V05
Mefl424
(Gunthorpe 1999)
D03, DA3, V03, VA3, 
LOl, ((V04, V05, V06))*
Table 3.3.5 - The same subsets of muscles are missing and affected in the Mef2*24 
hypomorph as the Mef2 Dominant Negative
The Mef2424 mutant is an intermediate Mef2 hypomorph which has many muscle deletions and defects due to a 
decrease in Mef2 activity. (Ranganayakulu et al,1995; Gunthorpe et al, 1999,this study). The UAS Gal4 system is 
temperature sensitive and can be driven harder, producing more protein, at higher temperatures, consequently inducing 
a stronger phenotype (Brand and Perrimon, 1993). By driving the Mef2-En (II) Dominant Negative at 29°C instead of 
18°C a stronger muscle phenotype can be induced, altering the phenotype from one that mimics the weaker Me/265 
hypomorph to one that mimics the intermediate Mef2424 hypomorph.
*ln the Gunthorpe study one or more of either V04, V 05 or V 06 muscles are missing. They are not scored individually.
The vast majority of muscles missing when the Mef2 Dominant Negative is driven by Mef2 Gal4 at 29 °C are also 
missing in the Mef2424 hypomorph (bold in table).
Wild Type
A
Mef2-En (II)
/Wef2424
FIG 3.3.2 Mef2-En dominant negative 
can mimic the Mef242hypomorph
A wild type embryo at 29 °c shows the regular muscle 
pattern (A) whereas an embryo over-expressing the 
Mef2-En (II) Dominant Negative at 29°c in the Mef2 
Gal4 pattern (B) shows a phenotype that resembles 
that seen in the Mef2424 hypomorph mutant (C). 
Dorso-lateral muscles such as D03, D04 and DA3 
are frequently missing or misshapen.
Embryos are St17, stained with anti p3-tubulin 
antibody to visualise musculature and orientated 
dorso-laterally. Mef2 424 mutants were first selected 
against GFP with antibody staining to ensure 
homozygosity of the mutant.
Mef2424
FIG 3.3.3- Mef2-En (X) Dominant Negative can also mimic the hypomorph allele
Representative St17 embryos stained with b3-tubulin show that the Mef2 Dominant Negative driven at 29°c with Mef2 Gal4 
(A) is capable of mimicking the Mef2 424 hypomorph (B). DA1 and DA2 are missing (compare arrows in A and B to wild type 
C), D 03 is missing (compare arrowhead in A and B to wild type C), DA3 is missing or missattached (compare asterisk in A 
and B to wild type C) and D01 and D 02 muscles are thinner than wild type (bracket in A and B versus C). In addition to the 
same individual somatic muscles being affected in the Mef2 DN at this temperature and the Mef2 424 mutant (this fig and 
Table 1.2.2), the embryos have the same severity of muscle phenotype, with the similar average numbers of muscles 
missing per embryo and the same range of muscles missing per embryo (Table 1.2.1).
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the phenotype range that were close mimics of the Mef2424 muscle phenotype (FIG 3.3.3). 
This shows that the mimicry of the Mef2-En (II) dominant negative to the Mef2424 
hypomorph does not occur as a result of a chance phenotype caused due to position effects 
upon insertion of the line, but is due to the genuine action of the Mef2-En dominant negative 
protein.
The fact that driving the Mef2 dominant negative at a higher temperature gives a mimic of 
the phenotype associated with the Mef2424 allele again suggests that the dominant negative 
phenotype occurs as a result of a reduction in Mef2 activity. However, importantly, it also 
suggests that through control of the driving temperature of the Mef2 dominant negative, the 
degree of Me£2 activity level reduction can be regulated. Driving the Mef2 dominant 
negative at a low temperature, results in a mild reduction in Mef2 activity, giving a 
phenotype similar to the Mef265 allele, whereas driving the dominant negative at a high 
temperature results in a greater reduction of Mef2 activity, giving a phenotype that mimics 
the Mef2424 mutant. One significance of this in the embryo is that it means phenotypes 
intermediate to those produced by the alleles can be generated when driving with Mef2 Gal4 
at various temperatures, but most importantly by using different Gal4 lines it means Mef2 
activity level can be reduced by controlled amounts in more specific places and times in 
development.
3.4 The Mef2 Dominant negative gives a distinct phenotype to 
UAS Mef2.
Despite the fact that the Mef2 dominant negative can mimic the Mef2 alleles, it is important 
to show that over-expression of this truncated form of Mef2 protein is not functioning in any 
way as full-length Mef2. This is especially important as it is well established that over-
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expression of full length Mef2 gives a muscle phenotype which shows a significant 
disruption to muscle pattern (Bour et al, 1995; Gunthorpe et al, 1999). To address this I 
analysed the phenotype of UAS Mef2 and compared it to the dominant negative phenotype.
3.4.1 Mef2 Dominant negative gives a distinct terminal somatic 
musculature phenotype when compared to UAS Mef2.
In her study D.Gunthorpe reports that in embryos over-expressing Mef2 “Aberrations in 
every muscle were seen at least once after scoring 15 hemi-segments for defects.” and that 
“These included deletions and duplications of muscles, as well as muscles found in the 
wrong position and muscles with shapes that did not resemble wild-type”, but that there “did 
not appear to be a reproducible pattern to this disruption as the precise defects varied from 
segment to segment and from embryo to embryo” (Gunthorpe et al, 1999).
In this study, I analysed the somatic muscles in abdominal hemi-segments A2-A4 of 20 
embryos (60 hemi-segments) and found that although the muscle phenotype gives a range of 
affects, with muscles being missing, duplicated, missattached or misshapen there is a pattern 
to the phenotype, with certain muscles being more easily lost than others (e.g, DTI, LT4 and 
VA1 are missing in over 50% of embryos scored) and other individual muscles remain 
present more than others (e.g, D03, DA4, VA3, VOl, V02 which were either never missing 
or missing in only 5% of embryos) (FIG 3.4.1, A). What is most striking about this result is 
how this phenotype, which arises through an increase in Mef2 activity, differs from the 
phenotype associated with the Mef2 dominant negative. Although both over-expression of 
full length Mef2 and over-expression of the Mef2 dominant negative cause a disruption to the 
muscle pattern (See FIG 3.4.2), the way in which the pattern is disrupted is distinct under 
each condition, in fact in many respects the disruption to pattern is the inverse of the other;
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A) UAS Mef2 High x Mef2 Muscle Phenotype
□ Missing
□  Duplicated
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FIG 3.4.1 Graphs to show variation in muscle phenotype 
between over expression of full length Mef2 and the Mef2 
dominant negative.
Full length Mef2 or Mef2-En dominant negative were driven with Mef2 Gal4 at 29°C and the 
individual muscles of hemi-segments A2-A4 for 20 embryos of each experimental condition 
were scored. The percentage o f embryos that show at least one individual muscles to be 
missing (Blue) or duplicated (Red) are shown in the graphs. Only one copy of a particular 
muscle type needs to be missing from A2-A4 for that embryo to be scored. UAS Mef2 and 
Mef2-En show different individual muscles to be affected.
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FIG 3.4.2 Over-expression of full length Mef2 gives a different 
phenotype to over-expression of the Mef2 Dominant Negative
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FIG 3.4.2 Over-expression of full length Mef2 gives a different phenotype to over­
expression of the Mef2 Dominant Negative
Over-expression of full length Mef2 gives a muscle phenotype that is different to over-expression of the Mef2-En Dominant 
Negative. Although an increase in Mef2 activity (UAS Mef2) and a decrease in Mef2 activity (Mef2-En) both cause a 
disruption to the muscle pattern (compare A and B with wild type C), the way the pattern is disrupted and the individual 
muscles affected are very different. In UAS Mef2 embryos the DT1 muscle is often missing (arrow in A), whereas in Mef2 
DN embryos (and in other situations with decreased Mef2 activity such as Me/2 hypomorphs -  see other tables) the DT1 
muscle remains present (arrow in B). In fact in embryos with decreased Mef2 activity, DT1 is one of the few muscles that 
remains present and its shape relatively unaffected - even in embryos with a severe muscle phenotype affecting the 
majority of muscles. Conversely DA3 and the D03 and D04 muscles are frequently missing when Mef2 activity is reduced, 
seen here with the Mef2 DN (arrowhead (DA3) and asterisks in B), whereas in UAS Mef2 these muscles often remain 
present (arrowhead and asterisks in A).
G shows a schematic of the wild type muscles highlighted in this phenotype comparison.
Mef2-En line shown here is Mef2-En (X) and UAS Mef2 line is UAS Mef2 High (Bour et al, 1995). Both were driven at 29°C 
with the Mef2 Gal4 driver. Wild type embryos are Oregon R. Muscles stained using anti p3-tubulin antibody.
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with
muscles
MISSING
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MISSING
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embryo
Range
Muscles
frequently
MISSING
%
Embryos 
with muscle 
DUPLICATED
Average 
DUPLICATED 
muscle per 
embryo
Range
Muscles
DUPLICATED
UAS Mef2 
(High)
X
M ef2  G al4  
(25°C )
100% 8.95 3-18 DTI 60% 1.5 0-2
DOl, D05, 
LT1, LT3, 
LT4, VA3, 
V04
Mef2-En
(X)
X
M ef2  G al4  
(29°C )
100 % 34.2 26-45
DA2, D03, 
D04, DA3, 
D05, VO l, 
V02, V04, 
V06
15% 1.33 0-2 VA1, VA2
Table 3.4.1 -  UAS Mef2 gives a different muscle phenotype to Mef2 Dominant Negative
Increase of Mef2 activity through over-expression of full length Mef2 gives a distinct muscle phenotype which is different to the 
phenotype associated with over-expression of the Mef2 Dominant negative, which causes a decrease in Mef2 activity. With 
UAS Mef2, fewer muscles are missing, and the individual muscles missing are different to the Mef2 dominant negative. In 
addition a much greater frequency of muscles are duplicated in the UAS Mef2 embryos, and the individual muscles duplicated 
are different compared to those duplicated in the Mef2 Dominant negative embryos.
Lines used are Mef2-En (X) for the dominant negative and UAS Mef2 High (Bour et al, 1995).
Muscles Missing
in >75% 
Embryos
Muscles Missing
in 50 - 74% 
Embryos
Muscles Missing
in 25-49% 
Embryos
Muscles Missing
in 15-24% 
Embryos
UAS Mef2
X
Mef2  G 
(25°c)
DT1 LT4, VA1 DA1, D02, DA2, 
LL1, LT1, LT2, 
LT3, L 01 , VL4, 
V04, V 06
DA3, VL1, VL3
Mef2-En
X
Mef2  G 
(29°c)
DA2, D03, D 04  
DA3, SBM, VL1 
VL4, VA3, V01 
V02, V04, V 05  
V 06
DA1, LT4, L01, 
VA1, V 03
D02, D05, LL1 
LT1, LT3, VT1 
VL2, VL3
D01, DT1, LT2 
VA2
Table 3.4.2 - Mef2 over-expression affects individual muscles differently than Mef2 DN.
The muscles frequently missing in Mef2-En Dominant Negative embryos are frequently present in embryos where Mef2 is over­
expressed (Blue in table). There are also muscles that are frequently present in Mef2 DN embryos which are often missing in 
UAS Mef2 embryos (Red in table). This data shows that although the muscle pattern is disrupted in response to either a 
decrease (Mef2 DN) or an increase in Mef2 activity (UAS Mef2) the way the pattern is disrupted is distinctly different and it 
highlights the way different individual somatic muscles respond to Mef2 levels, possibly due to their relative requirement for 
Mef2 during development. Mef2-En (X) fo rM e f2  Dominant negative and, UAS Mef2 (High) (III).
Chapter 3 : Mef2 Dominant Negative
with individual muscles that are frequently missing in the Mef2 dominant negative, 
remaining frequently present in embryos over-expressing full length Mef2, and muscles that 
are often unaffected in Mef2 dominant negative frequently being missing or misshapen in 
UAS Mef2 embryos (FIG 3.4.1). For example, in embryos over-expressing the Mef2 
dominant negative in the Mef2 pattern the dorsal muscles D03, D04 and DA3 are missing in 
95%, 85% and 80% of embryos scored respectively, whereas in embryos over-expressing full 
length Mef2 protein in the Mef2 pattern D03, D04 and DA3 are present in 100%, 95% and 
85% of embryos respectively. Other examples in this vein also occur; the lateral muscle, 
SBM, is missing in 85% of dominant negative embryos but missing in only 10% of UAS 
Mef2 embryos, and the ventral muscles VA3, VOl, and V02 are missing in 95%, 80% and 
80% of Mef2 dominant negative embryos respectively but remain present in 95%, 100% and 
100% of UAS Mef2 embryos respectively (FIG 3.4.1). The opposite situation also occurs, 
with the DTI muscle being the most severely affected in embryos which over-express full 
length Mef2 (missing in 75% of embryos), whereas this muscle is one of the few to remain 
unaffected in embryos which undergo a reduction in Mef2 activity, remaining present even in 
severe phenotypes where a large number of muscles are missing, such as in the Mef2424 
hypomorphic allele (Table 3.3.2) or, in this case, in the Mef2 dominant negative, where it 
remains present in 95% of embryos. (FIG 3.4.1, Table 3.4.1, Table 3.4.2).
The observation that particular muscles are missing, whereas other muscles remain present, 
in response to the same levels of Mef2 activity show that groups of muscles respond 
differently to Mef2. However, the fact that when the opposite Mef2 condition is imposed on 
the system (i.e there is a gain rather than a loss of Mef2 activity) these same muscles respond 
in the opposite manner to previously (under a loss of Mef2 activity) suggests a potential role 
for Mef2 in patterning. The observation is less easy to explain as a simple observation of
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some muscles requiring highMef2 and others requiring low Mef2 and could suggest more of 
a role at the level of founder cell patterning for Mef2.
In addition, over-expression of full length Mef2 causes a number of muscle duplications, 
with at least one duplication occurring in 60% of the embryos scored (Table 3.4.1). These 
duplications predominantly occur in the dorsal muscle DOl, the lateral muscles LT1-LT4 
and the ventral muscle VA3 (FIG 3.4.1 and FIG 3.4.3) and seem to be the individual somatic 
muscles that are repeatedly duplicated in conditions which involve an increase in Mef2 
activity (see later chapters). In the Mef2 dominant negative there are rarely examples of a 
muscle being duplicated; only four cases of a muscle duplication occurs, (within 3 embryos -  
15% of embryos scored) and these duplications are in muscles VA1 and VA2 (the total 
number of duplications in the UAS Mef2 experiment was 18) (FIG 3.4.1). So, not only are 
there significantly more duplications that occur in embryos that over-express full length 
Mef2 as opposed to the Mef2 dominant negative, but also these duplications are in a different 
subset of muscles, again highlighting a difference in the phenotypes of the two conditions. 
These considerable differences in phenotype between UAS Mef2 and the Mef2 dominant 
negative strongly suggest that the two constructs are working in different ways, that the 
muscle phenotype associated with the Mef2 dominant negative does not occur as a result of 
an increase in Mef2 activity, and that the truncated version of the Mef2 protein does not 
retain any of the wild type function. Additionally this experiment also further highlights the 
response of different individual somatic muscles to Mef2 activity levels. It suggests that not 
only are particular muscles reliably/reproducibly lost with a reduction in Mef2 activity (in the 
Mef2 dominant negative and the Mef2 alleles) -  suggesting a high requirement for Mef2 
activity for these particular muscles, but also how muscles that have a low requirement for 
Mef2 activity to form correctly (frequently present in the Mef2 dominant negative and Mef2
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FIG 3.4.3 Examples of duplications seen in UAS Mef2 embryos
Unlike the Mef2-En lines over-expression of full length Mef2 causes a large number of 
muscle duplications. Duplications can occur ventrally (e.g in muscle VA3 - arrowhead in 
A), laterally (e.g in LT1 -  arrow in B) and dorsally (e.g in D01 -  asterisk in C). A 
schematic showing these three muscles in the wild type musculature is shown in D.
However, duplications are not the only aspect of the phenotype, there is considerable 
disruption to the muscle pattern when Mef2 is over-expressed, with muscles missing, 
misshapen, missattached, heart defects and a considerable number of unfused myoblasts 
present throughout the body wall of the embryo (See FIG 3.4.2).
UAS Mef2 (High) used, driven by Mef2 Gal4 at 25°C. Muscles stained with (33-tubulin 
antibody. M uscle  S chem atic
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alleles) are also the most susceptible to large increases in Mef2 activity, being lost the most 
readily in UAS Mef2 embryos. This again suggests a possible role for Mef2 in patterning of 
the somatic musculature.
3.4.2 The Mef2 Dominant Negative reduces P3-tubulin expression 
in the early embryo whereas UAS Mef2 increases it.
In addition to comparing the muscle phenotype of the Mef2 dominant negative with full 
length Mef2 at St 17, I also compared the effects of over-expression at earlier stages in 
development by looking at the protein levels of p3-tubulin. p3-tubulin is expressed in the 
somatic mesoderm, where it is a Mef2 target, and in the developing visceral mesoderm,
77 7 /where it is not (Damm et al, 1998). Mef2 embryos, which are null mutants for Mef2 
(Bour et al, 1995), lose all somatic J33~tubulin expression, but the visceral muscle is 
unaffected (Damm et al, 1998). When the Mef2 dominant negative was over expressed in 
the Mef2 Gal4 pattern it caused a reduction in p3-tubulin levels in the somatic muscle 
compared to wild type (FIG 3.4.4, A). In contrast, over-expression of full length Mef2 
caused an increase in p3-tubulin levels in the somatic muscle compared to wild type (FIG 
3.4.4, B). In the visceral muscle levels of p3-tubulin were unaffected in both the Mef2 
dominant negative and UAS Mef2 embryos. For this experiment, embryos were fixed and 
stained in parallel and fifteen individual embryos for each stage for each experimental 
condition were imaged and the representative one shown. This experiment shows that the 
Mef2 dominant negative definitely reduces Mef2 activity and that it works in an opposite 
manner to full length Mef2, giving a phenotype that sends p3-tubulin levels in the opposite 
direction.
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FIG 3.4.4 Levels of (33-tubulin are reduced by the Mef2 DN compared to wild type and 
UAS Mef2
Over-expression of a dominant negative form of Mef2 reduces the amount of the muscle protein |33-tubulin in the developing 
somatic mesoderm (arrow, A) when compared to wild type (arrow, B) this is seen throughout the developmental stages.
When full-length Mef2 protein is over-expressed in the same way somatic (33-tubulin increases (arrow, C) compared to wild 
type at the corresponding stages (arrow, B).
In the visceral mesoderm, where (33-tubulin is not a Mef2 target, over-expression of the dominant negative does not reduce 
expression (arrowhead, A), and over-expression of full length Mef2 does not increase expression (arrowhead, C) in 
comparison to wild type (arrowhead, B).
Embryos shown are from St11-St12l, stained with anti-(33-tubulin antibody and viewed laterally. All experiments were 
performed at 29°c and fixed and stained under the same conditions. Mef2 DN line used was Mef2-En (II), UAS Mef2 line was 
Nguyen. UAS proteins were driven by Mef2 Gal4. Wild type are Oregon R. Each embryo shown is representative and one of 
fifteen others recorded of the same type at the same stage.
Mef2 DN Wild Type UAS Mef2
St11
B c
*■ .
St12e • * r  -
St12
St12l
Mef2 DN Wild Type
^ P H r
UAS Mef2
FIG 3.4.4 Levels of ^3-tubulin are reduced by the Mef2 DN compared to wild type and 
UAS Mef2
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3.5 The Mef2-En construct acts as a Dominant Negative protein; 
its phenotype can be rescued with co-expression of full length 
Mef2.
If the Me£2 dominant negative construct is acting upon Mef2 targets and reducing Mef2 
activity through competition with endogenous Mef2 protein then co-expression of full length 
Mef2 should rescue the muscle phenotype that the dominant negative induces.
To test this, I generated stocks which contained a copy of the Mef2 dominant negative 
construct and a copy of the UAS Mef2 construct. For the experiment outlined below I used 
stocks containing Mef2-En (II) and UAS Mef2 low (III) (Gunthorpe et al ,1999), but I have 
generated stocks containing either Mef2-En (II) or Mef2-En (X) and UAS Mef2 High (III) or 
UAS Mef2 low (III) (See materials and methods).
3.5.1 Co-expression full length Mef2 rescues the Stl7 phenotype 
associated with the Mef2 Dominant Negative.
Over-expression of the Mef2 dominant negative (Mef2-En (II)) with the mesodermal driver 
24B Gal4 (Brand and Perrimon, 1993) at 29°C gave a strong muscle phenotype; 95% of all 
embryos scored have muscles missing, with an average of 20.5 muscles missing (A2-A4) per 
embryo and the range of muscles missing in an embryo being between 0 and 45 (Table 3.5.1). 
When UAS Mef2 low is co-expressed with the Mef2 dominant negative under the same 
experimental conditions the severity of the muscle phenotype is considerably reduced. Only 
66% of embryos scored have muscles missing, with an average of 2.2 muscles missing (A2- 
A4) per embryo, and the range of muscles missing in an embryo being between 0 and 9 
(Table 3.5.1). Detailed analysis of the individual somatic muscles that are affected in these
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Muscle phenotype
Mef2-En x 24B Gal4
(29°C)
Mef-En ;UAS Mef2 x 24BGal4
(29°C)
% embryos with 
muscle missing
95% 66%
Average missing 
per embryo
20.5 2.2
Range 0 - 4 5 0 - 9
Survival assay
Hatching 52% 62%
Survival 0% 0%
Table 3.5.1 Over-expression of full length Mef2 can rescue the phenotype of the Mef2 
Dominant Negative.
For the muscle phenotype experiment 90 muscles were scored (hemisegments A2-A4) per embryo, with a total of 20 
embryos scored for each cross. Only 1/90 muscles need be missing for an embryo to be scored as having muscles 
missing. 20 Wild type embryos scored had no muscles missing.
For hatching and survival 200-300 fertilised embryos were aligned and allowed to hatch on apple juice plates at 29 degrees. 
Wild type embryos gave a hatching rate of 99% and a survival rate of 98%.
Lines used: Mef2-En (II) for Mef2 DN and UAS Mef2 low (III) . Embryos stained with anti b3-tubulin (guinea pig)
Muscles Missing 
in 50- 75% Embryos
Muscles Missing
In 25 -49% 
Embryos
Muscles Missing
in 10-25%  
Embryos
Mef2-En 
x 24B Gal4
(29°C)
DA2, D03, D04, 
D05, LT4, VT1, 
VL4, VA1, VA3, 
V01, V02, V03, 
V04, V05, V06
DA1, DA3, LL1, 
LT3, SBM, L01, 
VL1, VL2, VL3, 
VA2
D02, DT1, LT1 
LT2
Mef2-En ; UAS Mef2 
x 24B Gal4
(29°C)
V04 D03, D04, L01, 
V05
Table 3.5.2 Over-expression of full length Mef2 can rescue the individual muscle 
phenotype of the Mef2 Dominant Negative.
When UAS Mef2 is co-expressed with the Mef2 DN the severity of the muscle phenotype is reduced, with considerably 
fewer muscles in terms of both muscle type and frequency being lost. However all the muscles that are lost in the Mef2 
dominant negative and UAS Mef2 co-expression embryos are also lost in the Mef2 dominant negative embryos (but at a 
higher frequency) (highlighted as bold in table), showing that the muscles lost in the rescue embryos are a subset of those 
lost in the Mef2 dominant negative embryos.
For the muscle phenotype experiment 90 muscles were scored (hemisegments A2-A4) per embryo, with a total of 20 
embryos scored for each cross. Only 1/3 of each muscle type need be missing for an embryo to be scored as having that 
muscle missing.
Lines used: Mef2-En (II) for Mef2 DN and UAS Mef2 10T4A (low) (III) . Embryos stained with anti b3-tubulin (guinea pig)
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two phenotypes reveals that the muscles missing in embryos co-expressing the Me£2 
dominant negative and UAS Me£2 are a subset of the muscles missing in the embryos over­
expressing the dominant negative alone, and that these muscles are lost at a reduced 
frequency (Table 3.5.2). For example, the V04 muscle is the most frequently lost in the 
Mef2 dominant negative embryos, missing in 65% of embryos scored at an average rate of 
2.2 muscles absent per A2-A4 hemisegment. (Table 3.5.2), whereas in the Mef2 dominant 
negative and UAS Mef2 co-expression embryos V04 is still the most frequently lost muscle, 
but here it is missing in 30% of embryos scored at an average rate of 1.8 muscles absent per 
A2-A4 hemisegment (Table 3.5.2). A similar pattern exists for all of the muscles missing in 
the co-expression embryos (Table 3.5.2).
This change is similar to the reduction in phenotype seen in going from a Mef2 424 to a Mef265 
hypomorph mutant (Table 3.3.3), reflecting a similar change in Mef2 activity levels.
In fact, reassuringly the muscles lost in the Mef2 dominant negative and UAS Mef2 co­
expression embryos are the same as those lost in a Mef2 65 mutant and so, from this one can 
gauge the level of Mef2 activity in each of the conditions; over-expression of the Mef2 
dominant negative alone gives a phenotype with Mef2 activity levels similar to those of a 
Mef2 424 mutant (Table 3.5.3), whereas co-expression of UAS Mef2 with the Mef2 dominant 
negative reduces the Mef2 activity levels to give a phenotype that is similar to, but weaker 
than, a Mef2 65 mutant (the same muscles are missing in the co-expression embryos as those 
in the Mef2 65 mutant, but at a lower frequency) (Table 3.5.3).
This shows an additional level of control for varying Mef2 activity levels; one could use 
either the weaker or stronger Mef2-En dominant negative line, or one of these with UAS 
Mef2 being co-expressed, as well as varying the temperature. For example, if the Mef2 
activity levels with the Mef2-En (II) weaker dominant negative line were too high in an
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experiment at 18°C, the Mef2-En could be co-expressed with UAS Mef2 to achieve the 
desired level rather than lowering the temperature further.
3.5.2 Ectopic expression of a Mef2 target gene is lost when the 
Mef2 dominant negative is co-expressed with UAS Mef2.
Ectopic over-expression of Mef2 is sufficient to induce the expression of its target genes (Lin 
et al, 1997; Gunthorpe et al, 1999). However this is on the proviso that the levels of ectopic 
Mef2 are sufficiently high as to meet the threshold of Mef2 activity required for that 
particular gene (Elgar et al, 2008). For example, a Mef2 target gene that has a low 
requirement for Mef2 activity, such as Act57B can be induced by low levels of Mef2 over­
expression whereas a gene with a high requirement for Mef2 activity, such as Myosin Heavy 
Chain, cannot (Elgar et al, 2008 and observations from this study). (But MHC can be induced 
with sufficiently high levels of Mef2 over-expression). With this in mind, I wanted to see if a 
gene that could be ectopically expressed in response to low levels of Mef2 over-expression 
could no longer be expressed if the Mef2 levels were sufficiently reduced when UAS Mef2 
had the Mef2 dominant negative co-expressed with it. Mind Bomb 2 (CGI 7492) is a gene 
that requires low levels of Mef2 activity for its expression (Elgar et al, 2008), and its 
expression can be induced ectopically in the ectoderm by both UAS Mef2 High (Elgar et al, 
2008) and UAS Mef2 low (this study) when driven by the ectodermal driver 69B Gal4 
(Brand and Perrimon, 1993). As revealed by in-situ hybridisation, ectopic expression of 
Mind Bomb 2 is seen in the ventral midline of embryos which over-express UAS Mef2 low 
ectopically in the 69B Gal4 pattern (FIG 3.5.4, A). However, when the Mef2 dominant 
negative (Mef2-En (X)) is co-expressed with UAS Mef2 low under the same experimental 
conditions the ectopic expression of Mind Bomb 2 is reduced to barely detectable levels
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Muscles Missing 
in 50- 75% Embryos
Muscles Missing 
In 25 -49% Embryos
Muscles Missing 
in 10 -24% Embryos
Mef2-En x 
24B Gal4 (29°C)
DA2, D03. D04, 
D05, LT4, VT1. 
VL4, VA1, VA3, 
V01, V02, V03, 
V04, V05, V06
DA1, DA3, LL1, 
LT3, SBM, L01, 
VL1, VL2, VL3, 
VA2
D02, DT1, LT1 
LT2
Mef2 En; UAS Mef2 x 
24B Gal4 (29°C)
- V04 D03, D04. L01. 
V05
Mef2424
DA1, DA2, DA3, 
D03. D04. D05. 
LT4, SBM, L01, 
VL2, V02, V04, 
V 06
D01, D02, LT3, 
VL3, VL4, VA3, 
V01, V03, V05
DT1, VT1
Mef265 VA3, V04 LT4. L01. V05, 
V 06
DA2, D03, SBM, 
VL2, VL3, V03
Table 3.5.3 The rescue of the dominant negative phenotype by co-expression of UAS 
Mef2 causes a similar reduction in muscle phenotype as going from a Mef2424 to a 
Mef265 hypomorph mutant.
Table 3.5.3 The rescue of the dominant negative phenotype by co-expression of UAS 
Mef2 causes a similar reduction in muscle phenotype as going from a Mef2*24 to a 
Mef265 hypomorph mutant.
The muscles that are missing in the Mef2 dominant negative over-expression embryos are similar to those that are lost in 
the /We/2424 hypomorph mutant (underlined in table). In addition the muscles that are missing in embryos that co-express 
the Mef2 dominant negative and UAS Mef2 are similar to those lost in /We/265 embryos (underlined in table). From this we 
can gauge that the rescue of the Mef2 dominant negative muscle phenotype by UAS Mef2 is similar in going from a Mef2 
activity level of the /We/2424 hypomorph to a level associated with the /We/265 hypomorph.
Lines used : Mef2-En (II) for Mef2 DN and UAS Mef2 10T4A (low) (III) . 24B Gal4 for driving line. Embryos stained with 
anti b3-tubulin (guinea pig)
UAS Mef2 x
A
X• * ,-fc X
Mef2-En x 
C . i  '
Mef2-En ; UAS Mef2 x 698 
B *  * , *  . * *
Wild Type
D fl u
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FIG 3.5.4 Mef2 DN can compete with full length Mef2 to rescue ectopic expression of a 
Mef2 target gene
UAS Mef2 driven by 69B Gal4 at 25°C is capable of inducing ectopic expression of the Mef2 target gene CG17492 (arrow in 
A). Co-expression of Mef2 DN rescues this expression with considerably reduced expression of the Mef2 target gene (arrow 
in B). The Mef2 DN alone does not induce any expression of CG17492 (C), giving an expression pattern identical to wild 
type (D). Embryos are St 13 shown ventrally. Experiments were incubated, fixed and stained in parallel. Images of 15 St13 
embryos for each experiment were captured and representative ones are shown. Mef2 Dominant Negative line is Mef2-En 
L10-1 (X). UAS Mef2 is 10T4A (III). 69B Gal4 (II). Wild type is Oregon R.
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(FIG 3.5.4, B). When the Mef2 dominant negative alone is driven by 69B Gal4 it produces 
no ectopic Mind Bomb 2 transcript as one would expect, with the Mind Bomb 2 expression 
pattern in these experimental embryos looking like wild type. (FIG 3.5.4, C and D). This 
experiment again shows how the Mef2 dominant negative and full length Mef2 can compete 
with each other and that more of one (the dominant negative) causes a reduction in Mef2 
activity, whereas more of the other (UAS Mef2) causes an increase in Mef2 activity.
3.6 Using the Mef2 dominant negative to investigate the role of 
Mef2
After characterising the Mef2 dominant negative and establishing it as a useful tool for 
reducing Mef2 activity, the next step is to begin investigating its use with specific Gal4 lines 
in order to reduce Mef2 activity level with temporal and spatial control. With variation in 
experimental temperature driving the Gal4 line, the strength of the Mef2 dominant negative 
insertion line and (as outlined in 3.5.1) the possibility of combining the Mef2 dominant 
negative line with UAS Mef2, there exists a number of ways of controlling the generated 
level of Mef2 activity reduction in time and space in the fly. Consequently the Mef2-En 
dominant negative is a useful tool for investigation into the many roles of Mef2 in the 
orchestration of differentiation.
3.6.1 Reducing Mef2 activity specifically in the founder cells.
By driving the Mef2 dominant negative with rP298 Gal4 (Menon and Chia, 2001) Mef2 
activity can be reduced specifically in the founder cells of the developing embryo.
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rP298 was initially identified as an enhancer trap line which drove expression specifically in 
the founder cells (Nose et al, 1992; Nose et al, 1998). Subsequent analysis revealed this 
expression to correspond to that of Dumbfounded (Duf), the founder cell specific FCM 
(fusion competent myoblast) attractant (Ruiz-Gomez at al, 2000).
As outlined in my introduction (section 1.5.7 and 1.5.9) Mef2 is expressed in both the 
founder cells and the surrounding FCMs (Taylor, 2003) and though both of these cells 
express a different set of proteins essential for the fusion process, Mef2 may play a role in 
activating both sets (Sandmann et al, 2006).
Over-expression of the Mef2 dominant negative specifically in the founder cells results in a 
complex disruption to muscle pattern, with loss, duplication and shape and attachment 
defects in individual muscles (Table 3.6.1 and FIG 1.6.1).
The predominant phenotype was shape defects (100% of embryos) and muscle loss (66.6% 
of embryos), though a large percentage of muscles are also duplicated (41.7%) (Table 3.6.1). 
The individual muscles most frequently missing when Mef2-En is over-expressed in the 
founders are the same as those most often missing when the Mef2 dominant negative is 
driven throughout the developing muscle by Mef2 Gal4 (Table 3.6.2). Interestingly though, 
the individual muscles that are duplicated when the Mef2 dominant negative is over­
expressed using rP298 Gal4 are more like the set of individual muscles duplicated when an 
increase in Mef2 activity occurs, for example in the UAS Mef2 embryos seen in Table 3.4.1/ 
FIG 3.4.1. This could again suggest a role for Mef2 in patterning at the level of the founder 
cells as previously alluded to in section 3.4.1. If this was the case one might expect to see an 
opposite phenotype to the one described here with over-expression of full length Mef2 driven 
in these cells.
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%
Embryos
with
muscles
MISSING
Average
MISSING
per
embryo
Range
%
Embryos 
with muscle 
DUPLICATED
Average 
DUPLICATED 
Muscle 
per embryo
Range
%
Embryos
with
SHAPE
DEFECTS
Average
SHAPE
DEFECTS
per
embryo
Range
Mef2-En (X)
X
rp298 Gal4 
(29°c)
66.6 % 5.1 2 -9 41.7% 2.4 1-3 100 % 18.7 4-41
Table 3.6.1 -  Muscle phenotype when Mef2 activity is reduced in founder cells by Mef2 DN
A reduction of Mef2 activity specifically in the founder cells was achieved using the Mef2 DN and the Gal4 UAS system. This 
gives a complex disruption to muscle pattern, with muscle loss, duplication and shape defects highlighted here.
Somatic muscles were visualised by staining against (33-tubulin antibody. Muscles in abdominal hemi-segments A2-A4 were 
scored in 10 individual embryos for this analysis.
Mef2 dominant negative line used is Mef2-En (X), and driven by rP298 Gal4 at 29°C.
Mef2-En in founder cells
Mef2-En in founder cells
Wild Type
D Wild Type
FIG 3.6.1 -  Reducing Mef2 activity in founder cells disrupts muscle pattern
Over-expression of the Mef2 DN specifically in the founder cells at 29 °C results in a complex disruption to muscle pattern with 
loss, duplication and shape and attachment defects in individual muscles. In some embryos both loss and gain of muscles 
were observed -  in the example shown in hemi-segment A2, D01 is duplicated (asterisks, A) and DA2 is missing (arrow) and 
in hemisegment A3, D01 is duplicated and DA1 is missing (arrowhead). Compare with wild type, B. In others, individual 
muscles did not find their attachment points and balled up (e.g V 01, compare arrow in C to wild type, D), or had other shape 
defects, such as being narrower and shorter than wild type (e.g V05, compare arrowhead in C to wild type D).
Mef2 Dominant negative line used is Mef2-En (X) and driving Gal4 for founder cells is rP298 Gal4 (Menon and Chia, 2002). 
Wild tvoe is Oreaon R. Embrvos St17 and muscles stained with B3-tubulin antibodv.
Muscles 
MISSING 
in > 50 % 
Embryos
Muscles 
MISSING 
in 2 5 - 4 9 %  
Embryos
Muscles 
MISSING 
in 8 -24% 
Embryos
Muscle
DUPLICATED 
in 8 -24%  
Embryos
Mef2-En (X)
X
rp298 Gal4 
(29°c)
DA2 DA1, D03, 
DA3
D05, L01, 
VL2, V01, 
V04, V05
D01, D03, 
LT1, LT2, 
V04
Mef2-En (X)
X
Me/2 Gal4 
(29°c)
DA2 D03
D04 DA3 
SBM VL1 
VL4 VA3 
VOI V02 
V04 V05 
V06 DA1 
LT4 L01
VA1 V03
D02, D05, 
LL1, LT1, 
LT3, VT1 
VL2, VL3
D01, DT1, 
LT2 VA2,
VA1, VA2
Table 3.6.2 Muscles affected when Mef2 activity is reduced in founder cells by Mef2-En
A reduction of Mef2 activity specifically in the founder cells was achieved using the Mef2 DN and the Gal4 UAS system. The
same individual muscles are most readily lost when driven in founder cells as when driven in the Mef2 Ga4 pattern (highlighted
as bold in the table).
Somatic muscles were visualised by staining against p3-tubulin antibody. Muscles in abdominal hemi-segments A2-A4 were 
scored in 10 individual embryos for the rP298 Gal4 analysis and 20 for the Mef2 Gal4 analysis.
Mef2 dominant negative line used is Mef2-En (X), and driven by rP298 Gal4 or Mef2 Gal4 at 29°C.
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3.6.2 Reducing Mef2 activity in the adult muscles
As well as providing a means for investigating the role of Mef2 in muscle development in the 
embryo, this Mef2-En dominant negative can also be used to study Mef2 in the adult 
musculature. The adult muscles in Drosophila, are an interesting model for studying muscle 
differentiation, as their physiology, attachment and interaction with neurones, closely 
resembles vertebrate musculature (Bernstein et al, 1993; Vigoreaux, 2001). Unlike the 
muscles of the embryo or larvae they are made up of muscle fibres (Miller, 1950), which 
means they have a closer resemblance to the skeletal muscle in vertebrates. The Mef2 null 
and hypomorphic mutants, that have provided insight into the importance of Mef2 in muscle 
differentiation in the embryo, cannot be used in the conventional way to study Mef2 in the 
adult musculature because they are embryonic lethal. (Lilly et al, 1995; Bour et al, 1995; 
Ranganyakulu et al, 1995).
Because of this, a study of the role of Mef2 in these muscles using Mef2 mutants has had to 
be previously performed using heteroallelic combinations of Mef2 alleles that are weak 
enough to pass through embryogenesis and larval life (Ranganyakulu et al, 1995) or through 
use of a temperature sensitive Mef2 hypomorph (Goldstein et al, 2001 and Baker et al, 2005). 
However, the use of both of these techniques is quite limited for an investigation of Mef2’s 
role at this stage because they still retain a relatively high level of Mef2 activity.
As I have shown, my Mef2 dominant negative protein is capable of achieving a reduction in 
Mef2 activity that is comparable to the Mef2424 hypomorphic allele. Consequently this means 
that a reduction of Mef2 activity levels in the adult musculature can now be achieved that is 
of comparable strength to the strong Mef2 hypomorphic alleles.
By using the Mef2 dominant negative with adult muscle Gal4 driver lines, such as 1151 Gal4 
(Anant et al, 1998), a considerable reduction in Mef2 activity could be achieved for the first
84
Chapter 3 : Mef2 Dominant Negative
time to investigate the role of Mef2 in adult muscle development without any reduction of 
Mef2 activity in embryogenesis.
I drove the Mef2 dominant negative lines in the developing adult musculature using 1151 
Gal4 and investigated the effect of reducing Mef2 activity on the formation of the Dorsal 
Longitudinal Muscles (DLMs). The DLMs are large multifibre muscles involved in powering 
the wings for flight in the adult fly. They exist as two sets of six muscles, one set of six each 
side of the thorax of the fly (Vigoreaux, 2001) (See FIG 3.7.1, A for wild type DLM pattern). 
Reduction of Mef2 activity using either of the Mef2-En dominant negative lines results in the 
formation of these muscles being inhibited (FIG 3.7.1) Analysis of DLM’s after dissection of 
black pupae revealed that frequently 0 DLM’s form instead of the wild type number of six 
when the Mef2 dominant negative is over-expressed using 1151 Gal4. And also, that the 
Mef2-En (X) line gives a stronger muscle phenotype than the Mef2-En (II) line, as was 
previously observed in embryonic muscle analysis when driving the dominant negative lines 
with Mef2 Gal4. With Mef2-En (X) 82% of hemi-thoraces scored had lost all of the DLMs 
(18 / 24), whereas with Mef2-En (II) 55% of hemi-thoraces scored had lost all of the DLMs 
(12 / 22) (Table 3.7.1). Other thoraces in both lines that did not have all DLMs missing, had 
between one and two DLM muscles present (Mef2-En (X)) or between one and four DLMs 
present (Mef2-En (II)) (Table 3.7.1). There was one fly which over-expressed the Mef2-En 
(II) dominant negative and showed a phenotype of four DLMs in one hemithorax and three 
DLMs in the other hemithorax. The formation of three DLMs is associated with a failure of 
the developing DLMs to split and form the final six muscles (Baker et al, 2005), however in 
this example the muscle are also very strangely positioned, being aligned laterally as opposed 
to along a dorso-ventral axis as seen in the splitting phenotype. More flies need to be 
dissected and examples observed to further investigate this aspect of the Mef2 dominant 
negative phenotype before any conclusions can be drawn from it. In using the adult system I
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Wild Type Mef2-En (II) Mef2-En (II)
Mef2-Stop_________
FIG 3.7.1 : A reduction in Mef2 activity in the adult causes a decrease in DLM fibre number
When Mef2 activity is reduced in the adult by either the Mef2-En DN (B,C,D) there is a severe disruption to DLM fibre formation. 
Wild type flies develop 6 DLMs per hemi-thorax (A), whereas the stronger Mef2-En DN line (D) tend to develop 0 DLMs. The less 
strong Mef2-En DN often shows 0 DLMs developing (see Table 3.7.1) but also frequently 1 DLM (B). There was one example with 
this line which showed the formation of 4 DLMs (C - left side) and 3 DLM’s (C - right side), suggesting a phenotype more like the 
ts Mef2 alleles. The weak Mef2-Stop line showed wild type like numbers of DLM formation (E). (All experiments at 25°C, adult 
muscle expression driven with 1151 Gal4, wild type flies were 1151 Gal4 alone.)
Number DLM’s per hemi-thorax
Cross 0 1 2 3 4 5 6 Total
Wild Type 
{Ml 151 Gal4)
- - - - - 2 22 24
Mef2-Stop (II; 
III)
x M l 151 Gal4
2 22 24
Mef2-En DN 
(II)
x M l 151 Gal4
12 7 1 1 1 22
Mef2-En DN 
(X)
x M l 151 Gal4
18 4 2 24
Table 3.7.1 -  Adult muscle DLM analysis for Mef2 Dominant Negative
DLM fibre number was scored in dissected 96hr APF black pupae. Mef2 DN driven by 1151 Gal4. All experiments 
performed at 25°C. Wild type controls were 1151 Gal4 alone.
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decided to again test the use of the Mef2 Stop truncation dominant negative construct. This 
gave a phenotype at a driving temperature of 25°C that was identical to wild type in terms of 
number of DLM missing and so, as with the work done in the embryo, shows that the Mef2 
Stop dominant negative is very weak.
3.6.3 Reducing Mefi activity in other systems.
Mef2 is also a key regulator in other aspects of biology (Pothoff and Olson, 2004), including 
the differentiation of neurons (for review see Shalizi and Bonni, 2002). Recent work from the 
lab of Justin Blau at New York University has explored a role for Mef2 in the adult 
Drosophila brain. For this study, we sent the group lines of the Mef2-En dominant negative, 
which they used in their system to reduce the activity of Mef2. The Mef2-En dominant 
negative gave an opposite phenotype to Mef2 gain-of-function (Blanchard et al, 2010 in 
press). Their work highlights that the use of the Mef2-En construct is transferrable to other 
developmental systems and makes an important contribution to the tools available for 
investigating the role of Mef2 in various aspects of Drosophila development, not just Mef2’s 
role in the differentiation of muscles.
3.7 The Mef2 Dominant Negative can also mimic a Me£2 RNAi 
line
Recently efforts have been made to provide a means of being able to reduce every gene in the 
genome through the generation of large scale RNAi stocks (Dietzl et al, 2005). An RNAi line 
for Mef2 was generated in this effort and consequently I ordered it to analyse in comparison 
to the Mef2 Dominant Negative protein.
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Initially I confirmed that the Mef2 RNAi stock was acting upon Mef2 by showing that over­
expression of the RNAi line resulted in a reduction of Mef2 transcript. FIG 3.7.1 shows the 
result from this. Mef2 RNAi x Mef2 Gal4 causes a reduction in Mef2 expression relative to 
Mef2 Gal4 controls (C and D). Also, it has been shown that overexpression of Dicer2, a 
component of the cells RNA processing machinery can enhance this phenotype. 
Consequently, UAS Dicer ; Mef2 Gal4 stocks were made in the lab (J.Han) and I also tested 
this line at driving over-expression of Mef2 RNAi in comparison to UAS Dicer ; Mef2 Gal4 
controls. These embryos show an even greater reduction of Mef2 transcript levels, suggesting 
that co-expression of Dicer would give a stronger phenotype in this case.
I analysed the terminal somatic musculature of embryos driving Mef2 RNAi with UAS 
Dicer ; Mef2 Gal4 at 29°C in the usual way (20 embryos, A2-A4). They show a strong 
muscle phenotype with striking similarity to Mef2-En (X) x Mef2 Gal4 at 29°C. Table 3.7.1 
shows how the two conditions give very similar severities of muscle phenotype in terms of 
average number of muscles missing and range of muscles missing (34.2 and 26-45 for Mef2- 
En, 36.2 and 24-58 for Mef2 RNAi). The conditions are lethal at the embryonic stage as 
shown by hatching and survival tests .Table 3.7.2 shows this similarity in terms of individual 
muscles missing, there is striking similarity between the type of individual muscle lost and 
the frequency the loss occurs at. Representative embryos show this very clearly in FIG 3.7.2. 
In addition, analysis also revealed that like the Mef2 Dominant Negative, Mef2 RNAi was 
able to mimic the Mef265 hypomorph (Mef2 RNAi x Mef2 Gal4 at 29°C.) and the Mef2424 
hypomorph (Mef2 RNAi x UAS Dicer ; Mef2 Gal4 at 29°C.).
This further highlights another proof that the Mef2 Dominant Negative is acting to reduce 
Mef2 activity and by use in side by side comparison adds strength to any observation attained 
using the Gal4 UAS system to reduce Mef2 activity; if a phenotype is the same from over-
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A) Mef2 RNAi x 
Dicer; M
B) Dicer; M *n i
C) Mef2 RNAi x 
Mef2
D) Mef2
FIG 3.7.1 Mef2 RNAi reduces Mef2 RNA transcript levels
Mef2 RNAi targets Mef2. In-situ hybridisation to detect Mef2 RNA transcript shows almost complete loss of Mef2 RNA 
when Mef2 RNAi is driven by Mef2 Gal4 in the presence of additional Dicer (A).
Whereas Dicer; Mef2 Gal4 control embryos without Mef2 RNAi show wild type levels of Mef2 transcript (B).
When Mef2 RNAi is driven by Mef2 Gal4 without additional Dicer in the cross, Mef2 RNA levels are still reduced (compare 
C to wild type D) but to a lesser extent (compare C to A). This milder reduction in Mef2 transcript levels correlates with the 
weaker muscle phenotype observed when Mef2 RNAi is expressed without Dicer.
Mef2 RNAi line used #15550 (III) (VDRC), UAS Dicer (II) (VDRC).Experiments performed at 29°C.
Mef2-En and Mef2 RNAi give similar muscle 
phenotypes
Muscle phenotype
Mef2-En x Mef2 Gal4
(29°c)
Mef2 RNAi x Dicer; Mef2 Gal4
(29°c)
% embryos with 
muscle missing
100% 100%
Average No. muscles 
missing per embryo 34.2 36.2
Range of muscles 
missing per embryo 26-45 24-58
Survival assay
Hatching 0% 0%
Survival 0% 0%
Table 3.7.1. Mef2 Dominant Negative and Mef2 RNAi give similar muscle phenotypes.
For the muscle phenotype experiment 90 muscles were scored (hemisegments A2-A4) per embryo, with a total of 20 
embryos scored for each cross. Only 1/90 muscles need be missing for an embryo to be scored as having muscles 
missing. Wild type embryos have no muscles missing over 20 embryos scored and gave a hatching rate of 99% and a 
survival rate of 98%.
Lines used: Mef2-En (X) for Mef2 DN and Mef2 RNAi #15550 (VDRC) (III) . Embryos stained with anti b3-tubulin (guinea 
PigI
Muscles Missing 
in >75% Embryos
Muscles Missing 
in 50 - 75% Embryos
Muscles Missing 
in 15-50% Embryos
Muscles Missing 
in 0-15% Embryos
Mef2 DN x
M ef2 G 
(29°C)
DA2 D03 D 04  
DA3 SBM VL1 
VL4 VA3 V01
V02 V 04 V 05  
V 06
DA1 LT4 L01 VA1
V 03
D02 D 05 LL1 LT1
LT3 VT1 VL2 VL3
D01 DT1 LT2 
VA2
Mef2 RNAi
X
Dicer;
Gal4
(29°C)
DA1 DA2 D03
DA3 LT3 LT4 
SBM L01 VL4 
VA3 V01 V02
V 03
D04 D 05 LT2 VL3
VA1 V 04 V 06
D02 LT1 VL2
V 05 VL1
D01 LL1 VT1 
DT1 VA2
Table 3.7.2 Mef2 Dominant Negative and Mef2 RNAi give similar muscle phenotypes.
Analysis of muscle type missing in Mef2 Dominant Negative and Mef2 RNAi lines driven by Mef2 Gal4 at 29 °C.
For two very different ways of reducing Mef2 activity the phenotypes are strikingly similar, with the same muscles generally 
being affected in the same way. For example, DA2, D03, DA3, SBM, VL4, VA3, V01 and V 02  are missing in over 75% of 
embryos in both experiments and D01, DT1 and VA2 are frequently present (in 85-100% of embryos). A similar subset of 
muscles are affected in the Mef2424 hypomorph (see Table 3.3.5) indicating a reproducible requirement of Mef2 activity for 
different muscle types. Bold black indicates muscle type missing with similar frequency in both lines. Blue indicates muscles 
missing in over 50% of Mef2 RNAi embryos and 75% of Mef2 DN, suggesting a similar but stronger effect in the DN. Red 
indicates muscles missing in over 50% of Mef2 DN embryos and 75% of Mef2 RNAi, suggesting a similar but stronger effect in 
the RNAi for these muscles. Lines u s e d : Mef2-En (X) for Mef2 DN and Mef2 RNAi #15550 (VDRC) (III) . Embryos stained with 
anti b3-tubulin (guinea pig)
Mef2 DN Mef2 RNAi Wild Type
FIG 3.7.2 Mef2 Dominant Negative and Mef2 RNAi give similar muscle phenotypes.
Representative St17 embryos for Mef2 DN (A) and Mef2 RNAi (B) driven by Mef2 Gal4 at 29°C, with wild type for comparison (C). 
Both Mef2 embryos show striking similarity, with similar muscles being missing (e.g DA3/D04/D03, L01 and LT4 -  shown by 
asterisk, arrow and arrowhead in A ’ and B’, with wild type muscles in C’) and similar muscles remaining present (DT1 arrow in A 
and B, VA2 arrowhead in A and B). Those that are present but show defects are affected in similar ways, e.g LT1 and LT2 being 
thinner in the middle and mishapen at the ends (Bracket in A ’ and B’).
Lines u se d : Mef2-En (X) for Mef2 DN, Mef2 RNAi #15550 VDRC. Mef2 RNAi also had UAS Dicer in the cross
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expression of Mef2 Dominant Negative and from over-expression of RNAi then that 
phenotype would be very reliable as it would have been achieved through two very distinct 
mechanisms.
3.8 Discussion
The Mef2 Dominant negative proteins can reduce Mef2 activity in a spatial and temporal 
manner. Though the Mef2-En dominant negative proteins give a stronger phenotype than the 
Mef2-Stop truncation, both affect the same subset of individual somatic muscles, suggesting 
that they decrease Mef2 activity in a similar way. Detailed characterisation of two Mef2-En 
lines reveal that the dominant negative protein functions by competition with wild type Mef2 
protein; co-expression of full length Mef2 reduces the severity of the Mef2-En phenotype 
and similarly the ectopic expression of a known Mef2 target gene seen on over-expression of 
wild type Mef2 protein is lost when Mef2-En is co-expressed.
Once it was established that the Mef2 dominant negative could reduce Mef2 activity, detailed 
analysis of the terminal somatic musculature after over-expression of the dominant negative 
in the Mef2 pattern revealed that the Mef2-En lines could reliably reproduce the phenotype 
of the Mef2 hypomorphic alleles. In addition, by varying the type of dominant negative used 
(Mef2-En fusion or Mef2-Stop), the line used (Mef2-En (II) or the stronger Mef2-En (II)) or 
the driving temperature, phenotypes that were milder, intermediate or stronger than the 
Mef265 and Mef2424 alleles could be achieved. This means that a convenient method of 
reducing Mef2 activity to specific levels can be achieved in a spatial and temporal manner.
Following the characterisation of the Mef2 dominant negative lines and the Mef265 and 
Mef2424 mutant alleles a distinct pattern emerged regarding which muscles were affected
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under different conditions of decreased Mef2 activity. A subset of muscles were more easily 
lost than others; DA2, D03, V04, V06 were either the only muscles missing in conditions 
associated with a mild reduction of Mef2 activity or the most frequently missing muscles in 
conditions associated with a severe reduction in Mef2 activity. Conversely, there was a 
different subset of muscles that frequently remained present, even under conditions of 
severe reduced Mef2 activity that cause the majority of somatic muscles to be missing. The 
DOl, DTI, LT2, VA2 muscles belong in this category. Consequently, one can conclude that 
the individual somatic muscles have different requirements for Mef2 activity, with muscles 
that are lost most easily having a high requirement for Mef2 and the muscles that frequently 
remain present having a low requirement for Mef2. Observations that the levels of Mef2 
activity are essential for correct muscle differentiation have been previously well established 
(Gunthorpe et al, 1999) and a whole genome analysis of Mef2 mutants by Elgar et al 
revealed specific high Mef2 requirement and low Mef2 requirement genes in development 
(Elgar et al, 2008). One could imagine that such high and low Mef2 requirement genes would 
be a means of instigating the formation of a high or low Mef2 requirement muscle. 
Over-expression of the Dominant Negative in specific patterns using various Gal4 lines 
highlights the real strength of the constructs as a tool for investigating Mef2 function
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H i m  Expression Regulation
4.1 Introduction
As previously established through over expression and RNAi studies (Liotta et al, 2007), 
Him is a repressor of muscle differentiation which acts to inhibit the activity of Mef2 
protein.
In my thesis I further characterised the role of Him in muscle development. I did this in a 
number of ways as outlined below ;
Investigation of Hims ’ expression regulation using GFP reporter constructs. 
Detailed analysis of the muscle phenotype associated with over-expression 
phenotype of Him in the mesoderm.
Generation and characterisation of Him loss of function alleles.
Together these different means of investigation allowed for further insight into the function 
of Him.
4.2 Him expression.
The Him expression pattern is tightly regulated and goes through a number of specific 
changes throughout embryogenesis. Him is initially expressed in a broad mesodermal 
pattern during development, but prior to the onset of muscle differentiation expression 
rapidly declines, only remaining on in the undifferentiated cells of mesodermal origin; the 
adult muscle precursors (A.M.Ps) and the pericardial cells of the heart. It is expressed in 
undifferentiated cells of the developing mesoderm. Such strict maintenance of expression 
in undifferentiated cells, but rapid decline of expression in cells at the point of 
differentiation is characteristic of a repressor and the tight regulation of Him in this manner
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is essential for correct muscle development; as seen when Him expression is maintained 
ectopically in the developing somatic musculature in over-expression studies (See Chapter 
5).
The expression pattern of Him in wild type Oregon R embryos is shown in FIG 4.2.1 by in- 
situ hybridisation. Expression begins around St9 in the developing mesoderm, and around 
Stl 1 follows the pattern of mesodermal segmentation. It is around this stage that expression 
in the somatic muscle precursors, heart precursors and pharyngeal muscle precursors 
begins. At late Stl2, around the time of onset of somatic muscle differentiation, Him 
rapidly declines in the somatic muscle cells, but is maintained strongly in the A.M.Ps, heart 
pericardial cells and also the pharyngeal muscle. By late Stl 3, by the time the somatic 
muscle has completed differentiation, all somatic muscle Him expression has been 
completely lost, and from this point, remains solely in the A.M.Ps, pericardial cells and 
pharyngeal muscle until the end of embryogenesis at Stl 7. From around St 15 the level of 
expression decreases in these cells until it is barely detectable at Stl 7.
This distinctive expression pattern of Him poses a number of questions which could 
provide insight into the role of Him and to gene regulation in general. Specifically these are 
“Which factors are responsible for Huns’ expression?”, “How is Hims’ expression 
rapidly down-regulated?” and “What makes Him persist in the A.M.Ps?”
4.3 Him Reporter construct analysis
A previous study looking for potential Suppressor of Hairless Su(H) target genes (Rebeiz et 
al, 2002) identified the region upstream of Him playing a part in the expression of Him. 
They identified in this region a cluster of four Su(H) binding sites and seven Twist sites. 
Subsequently analysis by myself identified two Mef2 sites, according to the consensus 
YTAWWWWTAR (Andres et al, 1995) (FIG 4.3.1). This region was divided up and GFP
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FIG 4.2.1 Him expression pattern - RNA in-situ hybridisation
Him expression declines as muscle differentiates. Expression begins at St9 where it is expressed in the developing mesoderm. 
At St12 it is also expressed in the somatic muscle precursors and heart precursors. Around the onset of somatic muscle 
differentiation, at late St12, Him expression begins to rapidly decline in the developing somatic muscle, whilst remaining in the 
adult muscle precursors and heart pericardial cells. By St13, when the somatic muscle has differentiated, Him expression is lost 
completely in the somatic muscle, but still expressed strongly in the AMP’s and heart. By the end of embryogenesis, at St17, Him 
expression in the AMP’s and pericardial cells weakens considerably, until it is barely detectable.
St9 and St10 embryos are shown laterally only. St11, St12e, St12l, St13, St15 and St17 embryos are shown laterally (upper 
image) and dorsally (lower image). Embryos were wild-type, Oregon R.
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reporter constructs to analyse the area (FIG 4.3.1). The Him Xho/Xba 1Kb T pStinger and 
the Him 1Kb NT pHStinger constructs were designed and generated by me (See FIG 4.3.8 
and Materials and Methods), the Him Posakony pStinger constructs are from the Rebeiz et 
al study, the Him 3.8Kb GFP fusion construct is from Liotta et al, 2007 Him study and the 
Him Xho/Xba 2.8Kb pStinger constructs and Him Setl-3 constructs were generated by 
Stuart McConnell, a previous post-doc in the lab. Binding sites for Su(H), Twist and Mef2 
were searched using the following established consensus sequences; Su(H) -  
YGTGDGAA (Rebeiz et al, 2002), Twist -  CACATG (Cripps et al, 1998), Mef2 
YTAWWWWTAR (Andres et al, 1995).
4.3.2 Him Eco/Xba 3.8Kb GFP fusion
This covers the region upstream of the Him gene. The expression of the Him Eco/Xba 
3.8Kb GFP fusion construct comes on early, at St9, in the same way as Him expression and 
follows the same basic expression pattern as Him up to the end of embryogenesis at Stl 7. 
There are differences in how the somatic muscle expression persists, for example compare 
the GFP fusion embryo at St 13 with the Him in-situ embryo at St 13 in FIG 4.3.2b and also 
at St 17 especially it is noticeable how the pericardial and ring gland expression is stronger 
than in the Him in-situ at the corresponding stage.
4.3.3 Him Eco/Xho 2.8Kb GFP reporter
This covers the region upstream of Him, without the inclusion of the 1Kb region 
immediately adjacent to the start site. The early mesodermal expression of the Him 
Eco/Xho 2.8Kb reporter is weaker than the Him in-situ at stages 10 and 11 and lacks the 
initial anterior expression in the head region at these stages. At the later stages, St 16 and
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FIG 4.3.1 GFP Reporter construct map of the Him regulatory region
The region between the Her and Him genes was previously shown to be the potential regulatory region for Him (Rebeiz et 
al 2002). Two GFP reporter constructs were generated from this Rebeiz et al study; one named “Posakony 3.6Kb”, which 
covers a large region upstream of the Him transcription start site up to and including the cluster of Su(H) sites and another 
named “Posakony 2.2Kb” which does not include the Su(H) sites.
To investigate the Him regulatory region in detail, me and previous members of the lab made GFP reporter constructs to 
cover the whole region, in order to establish the key regions and transcription factor binding sites for the correct expression 
of the Him gene.
FIG 4.3.2-4.3.7 GFP Fusion and GFP Reporter construct expression patterns
The following figures show the expression pattern of either a Him GFP fusion construct (FIG 4.3.2) or various Him GFP 
reporter constructs (4.3.3-4.3.7) as visualised by anti-GFP antibody - which stains brown in the figures. Each stage 
shown is of a representative embryo for that stage and each type of construct had at least three independent lins tested 
to confirm the pattern was not due to insertional effects.
For comparison to the normal Him expression pattern the Him RNA in-situ hybridisation is shown for wild type embryos 
at corresponding stages (blue staining in figures).
FIG 4.3.2 -  Him 3.8Kb GFP fusion construct expression pattern (Eco/Xba)
FIG 4.3.3 -  Him 2.8Kb (p43) GFP reporter construct expression pattern (Eco/Xho) 
FIG 4.3.4 -  Him 1Kb T GFP reporter construct expression pattern (Xho / Xba)
FIG 4.3.5 -  Him 3.6Kb Posakony GFP reporter construct expression pattern 
FIG 4.3.6 -  Him 2.2Kb Posakony GFP reporter construct expression pattern 
FIG 4.3.7 -  Him 1Kb NT GFP reporter construct expression pattern
Him Eco/Xba 3.8 Kb GFP fusion(3776)
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FIG 4.3.2 Him Eco/Xba 3.8Kb GFP fusion construct expression
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FIG 4.3.3 Him Eco/Xho 2.8Kb GFP reporter construct expression
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FIG 4.3.4 Him Xho iXba 1Kb T GFP reporter construct expression
Him 3.6 Kb Posakony pStinger (3574)
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FIG 4.3.5 Him Posakony 3.6Kb GFP reporter construct expression
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FIG 4.3.6 Him Posakony 2.2Kb GFP reporter construct expression
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FIG 4.3.7 Him 1KB NT GFP reporter construct expression
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Stl 7, expression in the pharyngeal muscle is not detectable in the Him Eco/Xho 2.8Kb 
reporter, whereas it is still detectable in the Him in-situ at the corresponding stages. By 
comparison the pericardial expression of the heart is just as strong at Stl 6, and stronger at 
S tl7 in the reporter compared to the Him in-situ. (See FIG 4.3.3b). Other than this the 
expression closely resembles that of the Him in-situ, with loss of the somatic expression 
occurring in the same way as the Him in-situ at Stl 3 and appropriate A.M.P, pericardial 
cell and early pharyngeal expression.
4.3.4 Him Xho/ Xba 1Kb GFP reporter
The 1Kb region immediately upstream of the Him start site, containing the TATA box. The 
early expression pattern is similar to Him expression in the Him in-situ, with the 
appropriate onset and level of expression in the developing mesoderm. The expression in 
the anterior region is also induced appropriately. However as the mesoderm begins to 
specialise at St 12 it is apparent that this reporter shows striking differences, there is no 
expression in the cardiac precursors, but there is expression in the visceral precursors. 
Somatic muscle expression does not get turned off at all and instead persists until the end 
of Stl 7, being expressed in the fully differentiated musculature. Visceral muscle expression 
and head muscle expression also occurs from St 12 through to the end of Stl 7 and the 
cardiac expression, which begins around St 14 is weak and occurs in the cardioblasts. 
Pharyngeal muscle expression remains strong until Stl 7.
93
Chapter 4 : Him Expression Regulation
4.3.5 Him Posakony 3.6Kb GFP reporter
This covers the same region as the Him Eco/Xho 3.8Kb GFP fusion construct short of 
200bp farthest upstream from the Him gene. The expression pattern is similar to the Him 
Eco/Xho 3.8Kb GFP fusion construct although, perhaps the somatic muscle expression 
persists for longer
4.3.6 Him Posakony 2.2Kb GFP reporter
This construct covers the 2.2Kb immediately upstream of the Him gene. It is the same 
region as the Him Posakony 3.6Kb construct but with the region containing the cluster of 
Su(H) sites and one Twist site removed.
The expression pattern is the same as the Him Posakony 3.6Kb construct, but the 
expression is weaker in intensity in the developing mesoderm and especially so in the heart 
precursors around S tl2.
4.2.7 Him 1Kb NT GFP reporter
This construct is shorter than the Him 1Kb Xho/Xbal construct. It contains the same Mef2 
and Twist binding sites, but has the TATA box excluded. The expression pattern is the 
same as the Him 1Kb Xho/Xbal construct.
4.2.8 Him 1Kb NT delMef2 SDM (SacII) GFP reporter
I analysed the lkb region in detail (FIG 4.2.8) and I designed primers to delete the Mef2 
site within this region and also to Twist sites in the region to investigate their function. I 
generated a deletion construct to the 1Kb NT region (FIG 4.3.8 and Materials and
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FIG 4.3.8 Analysis of the Him 1Kb region
CrCG 4G TAGTTTTTAGATGCAGTATTATTAAGTAGAAAATTGTAACCG 
T AT A AT ATT CC ATTATATTAAATATTTTTATAGCACTAAAGAAATAAAAGC 
CC ATTTT AT AATTT AT ATT AC A AAA AT ACTT AACC AT AG A AACTT AT GAT A 
TGAT ACC AAT ATTTAAGTTCC AAAA AATGTAGAACATTTTTAAGT AT AT AC 
TCGAAAAT ATT AATTTTCAAAATTGAT ATTC AAG AG AT ATT AT AAAAAGA 
TCCCC ATTCT AA AT ATCT A AC AT CAT GCC AT GCTTT CT AAT G AGT AT AGT A 
TACCCCT GCT ACCCT GT C A AT CCGC AA AAC AGGCGCC G AAAC AT GCGGTT 
T CTCGC AGC AG ACT GCC ACGGG AA AAATTCGGTTCG AG ATTT GGG AAT GG 
ATGT AT G ACGG AGC AG AAGG AGC AGG ACCCGG ATTT CGG ATTT CGGAATG
g a t a t g g a a a t g a a g a t g g a a a t g g g a c t t t g a c t g c g c g a c g g c H I ^ H
jCGCCGCTGGCGATGCCGCTGGATGTTGl^BGCAGCGGTCGGTGCAG
c a g c g a a a g t g t t g B ^ M t a t g a g a g g g t c t a t t t t t g g g g c g a t t g t
GCGGCGCTGGTGCTGCKTATGiaTTCTGTGTTGGGCTGCTAAAAGGCA
ITGTAATGAGAGC AGAAAATAGAATTGACTf^ ^ M A GCAATGTCCC 
ATAAAGCGGGAGTTTCGAGTTTGGCGCGCAATGTGCCGCACCAGCAA 
ACGAACAAAAGAAAAAAAAA AAA AAAA AACACAGCCAGTAA||Hm||G 
GCCCACGAGTTATGTTTTATTTTTAATCCCACAAAGAGTCGATCTCCAAA 
AC AAACCCGC AG A GAG C  A C A TAT AAAG AG ACTCGGT GG ACG AGT GGT 
TCGAAACAGTCTTCCGCCGCAGCTCGACGCGCTCGCATATCGGGAATATA 
TAGATCGGAGATATCGCAGGACCCACAGCAGAGCAGAGCCG iG AC XX 
A ( '( CCTCGATG
■ ■ ■  = General E Box motif (Murre et al, 1989)
B B B I  = Twist E Box (Cripps et al, 1998)
YTAWWWWTAR = Mef2 site motif (Andres et al, 1995)
TTATTTTTAA = Mef2 site to consensus (Mef2-I)
CTATTTTTGG = Mef2 site one away from consensus (Mef2-0)
CAGAAA AT AG = Mef2 site 2 away from consensus -  not bothering with. 
Bg g c c c  = Apal site -  can be used to split construct into two.
TTATTTTTAA Mef2 site is similar to the Mef2 site shown to be functional in 
microRNA-1 (DmiR-1) TTAATTTTAG (Sokol and Ambros, 2005)
CACATGl is the exact same overlapping Twist Ebox shown to be functional in 
Mef2 regulation (Cripps et al, 1998)
CTCGAGJ  AGTTTTTAG ATGCAG Marks the fwd primer of the 1Kb T and 
1KB NT constructs. Note the Endogenous Xhol site.
C A AACCCGCAGAGACCACA Marks the rev primer of the 1Kb NT construct.
I (> \ (* ( ( ?' A A Marks the rev primer of the 1Kb NT construct. An ectopic
Xba I site is introduced at the end.
FIG 4.3.8 Analysis of the Him 1Kb region cont.
From this Site Directed Mutagenesis primers aiming to mutate the following sites 
were designed
Mef2 site to consensus (Called “Mef2-I”) : TTATTTTTAA
Mef2 site one away from consensus (Called “Mef2-0”) : CTATTTTTGG
Twist site most proximal to the Him gene start site (Called “Twi Prox”) : H H H
Over-lapping Twist sites (Called “Twi OL”) : U M i —
Primers:
Primers designed according to Stratagene requirements 
Mef2-I SDM : TTATTTTTAA to TTCGGCGGTAA (SacII site introduced)
Him dMef2 1 fwd cag taa  cac atg ggc cca cga gtt atg ttt ccq egg taa  tcc cac  aaa  gag teg ate tec aaa  ac 
Him dMef2 1 rev gtt ttg gag ate  gac  tct ttg tgg gat tac  ege gga aac  ata  act cgt ggg ccc atg tgt tac  tg
Mef2-0 SDM : CTATTTTTGG to CCCGCGGTGG
Him dMef2 0 fwd gtt gca get gta tga gag ggt ccc qcq a tg ggg cga ttg tgc ggc get gg
Him dMef2 0 rev cca geg ccg cac  aa t ege ccc acc  geg gga ccc tct cat aca  get gca ac
Twi Prx SDM : CAC ATG to TGC AT A
Him Twi-Prox fwd gaa  caa  aag a a a  aaa  a a a  a a a  a a a  a a a  cac  age cag taa  tgc ata  ggc cca cga gtt atg ttt ta 
Him Twi-Prox rev ta a  aac  ata  act cgt ggg cct atg ca t tac  tgg ctg tgt ttt ttt ttt ttt ttt ttc ttt tgt tc
Twi OL SDM : CACATGTG to CGGCCGTG
Him Twi-OvLAP fw geg geg ctg gtg ctg ccq qcc qtq ttc tgt gtt ggg ct
Him Twi-OvLAP rv age cca aca  cag aac  acg gcc ggc age acc age  gcc gc
The Twist OL site is exactly the same as that shown to be functional as the Key Twist 
E Box in Mef2 regulation. I mutated the sequence in exactly the same way as they did 
which lost expression of a reporter construct (Cripps et al, 1998).
I successfully generated the following SDM constructs which were sequenced and 
found to be correct (Strategy using Stratagene Quikchange II SDM Kit).
Him 1Kb NT AMef2-I SDM pGEMT 
Him 1Kb T ATwi OL SDM pGEMT 
Him 1Kb T ATwi Prox SDM pGEMT
From these constructs I subcloned the fragments to get the following reporter 
constructs
: Him 1Kb NT AMef2-I SDM pH Stinger 
: Him 3.8Kb T ATwi OL SDM pStinger
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Methods) and the subsequent injection, generation of multiple transgenic lines and their 
analysis was done by J.Han in the lab. She found that in all of the lines there was no 
expression of GFP (J.Han pers.comm), showing that the Mef2 site is responsible for the 
expression of the 1Kb region and therefore that there is a functional Mef2 site that 
contributes to the expression of Him.
The contribution of this Mef2 site to Him expression may occur early in the development; 
comparison of the Him 3.8Kb GFP fusion construct with the Him 2.8Kb (p43) GFP 
construct, shows a distinct difference early on; compare the S tll embryos, where 
expression of the Him 3.8Kb construct is more like wild type Him expression (FIG 4.2.1) 
than the Him 2.8Kb expression (FIG 4.2.2). However, there are also distinct differences in 
the late expression of the two constructs that suggest Him 2.8Kb is more like the wild type 
Him pattern than Him 3.8Kb.
Further analysis of this and site directed mutagenesis to the 1Kb region in the context of the 
3.8Kb GFP reporter would be most informative for the specific action of Me£2 upon Him 
regulation.
4.4 Discussion
The identification of Mef2 as a direct activator of Him is a particularly interesting result in 
that, not only does it identify a mechanism for the regulation of Him that has not been 
established previously, but also, as Him is a repressor of Mef2 protein, it means that Mef2 
is indirectly instigating its own regulation. This action of “activating its repressor”, is a 
novel role for Mef2.
It is well known that the regulation of Mef2 must be tightly controlled throughout 
differentiation, but especially so early on in muscle development where the positive action
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of Mef2 must be restrained until the appropriate time for differentiation to occur. Liotta et 
al provide a model for this whereby the repressive action of Him upon Mef2 means that the 
Mef2 protein is present in the cell and poised ready for activation at the appropriate time 
until the restraining mechanisms can be removed.
This observation would then sit nicely alongside the previous result that Mef2 is capable of 
auto-regulation; increasing its activity later in development by acting upon its own 
enhancer (Cripps and Olson, 2004). If, as suggested above, the Mef2 site in the 1Kb region 
has a contribution to Him expression early in development (before Stl 3 and the onset of 
differentiation) this allows for a model of Mef2 auto regulation (indirect -  then direct) 
which reinforces its repression early on (mediated by Him) when it must be restrained and 
then at the point of muscle differentiation a switch would occur enabling the reinforcement 
of Mef2 activation (mediated by Mef2 directly upon itself). Though an equally likely 
mechanism is that early on, both the indirect and direct Mef2 auto-regulation occurs and 
this ensures a tuning of Mef2 levels in the context of other factors laying down the central 
expression of Mef2 and of Him. This would fit with the rapid down-regulation of Him.
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Him Gain-of-Function
5.1 Introduction
As outlined in Chapter 4, Him expression rapidly declines in the somatic mesoderm and has 
disappeared completely from this lineage by the time the somatic muscle has fully 
differentiated at Stl 3. If Him expression is maintained ectopically in the somatic muscle 
past this stage through the use of the Gal4 UAS system, muscle differentiation is severely 
inhibited. This inhibition is through the repressive action of Him on Mef2 (Liotta et al, 
2007).
For the Liotta et al study, the phenotype of Him over-expression was shown to mimic the
phenotype associated with Mef2 loss of function; over-expression of Him throughout the
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mesoderm with 24B Gal4 at 25°C could give a phenotype like the Mef2 hypomorph in 
terms of general severity and muscle morphology (Liotta et al, 2007). As part of my thesis, 
I wanted to investigate the Him gain-of-function in greater detail; specifically I wanted to 
look at which individual somatic muscles were affected when Him was over-expressed and 
whether certain muscles were more easily affected than others. Not only does this 
information provide a more comprehensive analysis of the Him over-expression somatic 
muscle phenotype and provide greater insight into the action of Him in muscle 
differentiation, it also allows a direct comparison with the somatic muscle phenotypes 
associated with other experimental conditions.
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5.2 Over-expression of Him inhibits somatic muscle 
differentiation
For my analysis of Him gain-of-function, I over-expressed Him in the Mef2 pattern, using 
Mef2 Gal4 (Ranganayakulu et al, 1996). Mef2 Gal4 is a strong mesodermal driver, and by 
driving in the Mef2 pattern, it meant that the expression of Him would continue in the 
somatic musculature until St 17 rather than decline at St 12. In addition the mesodermal 
expression levels of Him would be increased at St9-12 due to this over-expression.
I drove UAS Him with Mef2 Gal4 at 29°C and 21°C and visualised muscles with p3- 
tubulin antibody. The phenotype gave a dramatic reduction in muscle formation at both 
temperatures, with a similar degree of muscle loss at both 29°C and 21 °C (Table 5.2.1) The 
average number of muscles missing per hemi-segment was 67 for Him driven at 29°C and 
68 for Him driven at 21°C -  meaning that around three quarters of the somatic muscles 
completely fail to form under both conditions. For this analysis I scored the presence or 
absence of the 30 individual muscles for the abdominal hemi-segments A2, A3 and A4. 
Those muscles that were present were scored for shape or attachment defects.
Despite the severity of the phenotype the identity of the muscles could still be determined 
as they generally still retained their position attachments and though the shape was often 
disrupted to some extent, the way it was disrupted was characteristic of that muscle type 
observed in milder examples of the phenotype observed in the range of results for that 
experiment.
As one would expect the individual muscles that are lost at both temperatures are generally 
the same (Underlined in Table 5.2.2).There are certain muscles which are lost almost all of 
the time in each of the hemi-segments scored in all embryos under both experimental 
conditions; for example, D05, LOl, VA3, V03, V04, V05 and V06 are missing at an
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Muscle phenotype
UAS Him x Mef2 Gal4
(29°C)
UAS Him x Mef2 Gal4
(21 °C)
% embryos with 
muscle missing
100% 100%
Average No. muscles 
missing per embryo 67.1 68.0
Range of muscles 
missing per embryo 59-72 65-77
Survival assay
Hatching 0% 0%
Survival 0% 0%
Table 5.2.1 -  Muscle phenotypes in embryos over-expressing Him at different 
temperatures.
Over expression of Him gives a severe muscle phenotype, with the majority of somatic muscles being lost. The severity of 
the phenotype is similar when driven by Mef2 Gal4 at 29°C and 21 °C.
Muscles scored A2-A4 for 20 embryos.
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average of at least 2.8 / 3 times in hemi-segments A2-A4 in 100% of embryos scored 
(Table 5.2.2) This shows that these individual muscles are more readily lost than others 
under Him over-expression conditions. Conversely there are muscles that appear to be 
more resistant to a decrease in Mef2 activity due to Him over-expression; for example DTI 
is more frequently present than it is missing -  it is missing only in one hemi-segment of the 
three scored in 50% of embryos at 21°C (Table 5.2.2) and was always present in the 
experiment driving Him at 29°C. Similarly VT1 and VA2 are lost less frequently in both 
the experiments (Table 5.2.2).
The severity of the Him over-expression phenotype can be seen in the representative 
embryo in FIG 5.2.1. This embryo, which had UAS Him driven at 29°C, shows a severe 
disruption to the muscle pattern, with large gaps and holes in the somatic musculature due 
to the large number of muscles missing. The few muscles that are present in the embryo 
have either severe shape defects or attachment defects or both. There are no muscles that 
are wild type in appearance. For example in this embryo, DA2 is considerably thinner than 
wild type, DAI stretches from a dorsal to ventral position instead of an anterior to posterior 
one, and DTI is misshapen, being of varying degrees of thickness as opposed to a uniform 
thickness as in the wild type condition. Other muscles, such as the VL muscles frequently 
form but fail to find both their anterior and posterior attachment points and consequently 
ball up. The identity of specific muscles that have lost their attachment (for example DAI 
in this embryo) can be determined based upon their other characteristics that are retained 
such as position within the embryo and general shape, and also, more importantly the 
observation that the same muscle may often be affected in a similar way with less severity 
elsewhere, and from this is indicative of the same effect but caused slightly more severely. 
A comparison of embryos showing the over-expression of Him at either 29°C or 21°C is 
shown in FIG 5.2.2. Though the phenotypes look very similar, the number of muscles
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Cross Muscles 
Missing in
100%
Embryos
Muscles 
Missing in
90-99 % 
Embryos
Muscles 
Missing in
80-89%
Embryos
Muscles 
Missing in
60 - 79% 
Embryos
Muscles 
Missing in
50-59%
Embryos
Muscles 
Present in
7 0 -8 9 %
Embryos
Muscles 
Present in
90 -  100%
Embryos
UAS Him
X
Mef2 Gal4 
(29°C)
D02, D03, D05, 
LL1, LTi, L l i  
LT3, LT4, LOl, 
V IA  VA3, V02, 
V03, V04, V05, 
V06
DA2, DA3, SBM, 
VL3, VA1, VOl,
D04, VL2, DAI, VT1 
VA2, DOl
VL1 DTI
UAS Him
X
Mef2 Gal4 
(21°C)
DAI, DA2, D03, 
D05, LT2, LT3, 
LT4, LOl, VL2, 
VA1, VA3, VOl, 
V02, V03, V04, 
V05, V06
D04, DA3, SBM, 
VL3, VL4
DOl, LTI, 
VL1
D02, LL1 DTI, VA2 VT1
Table 5.2.2 -  Muscles missing in embryos over-expressing Him at different 
temperatures.
Muscle scoring analysis for UAS Him driven by Mef2 Gal4 at 29°C and 21 °C. The 30 individual somatic muscles of abdominal 
hemi-segments A2, A3 and A4 (a total of 90 muscles) were scored per embryo. 20 embryos were scored for UAS Him at 29 
and 10 embryos were scored for UAS Him at 21 °C.
Only one individual muscle from any of the three hemi-segments scored needs to be missing for an embryo to be scored as 
having that individual muscle type missing. A muscle that is coloured blue is missing in that percentage of embryos at an 
average frequency of 2.8 or greater per embryo scored -  i.e that individual muscle was missing almost every time in each of 
the three hemi-segments scored per embryo. Muscles that are underlined are lost in a similar percentage of embryos at both 
temperatures.
Wild Type UAS Him
*
r
FIG 5.2.1 Over-expression of Him inhibits formation of somatic muscle in the embryo
FIG 5.2.1 Over-expression of Him inhibits formation of somatic muscle in the embryo
Over-expression of Him in the somatic muscle causes a severe disruption to muscle pattern due to inhibition Mef2 activity. The 
majority of somatic muscles are missing (see Table 5.2.2 for details), however the heart appears relatively unaffected in comparison 
to wild type (compare B to wild type A -  this figure, and FIG 5.2.3)
In the dorso-laterally aligned embryo (D) the dorsal muscles D01 and DA1 are missing (arrowhead and asterisk), and the few 
muscles that are present have either severe shape defects, such as DA2 being considerably thinner than wild type (compare arrow 
in D to arrow in C), or have attachment defects, such as in DA1 stretching from dorsal to ventral instead of anterior to posterior 
(compare attachment points marked by blue arrowheads in D to those of wild type in C).
In the laterally aligned embryo (F) the majority of lateral muscles are missing, with only one misshapen SBM muscle (arrow) and one 
misshapen LT muscle (arrowhead) forming out of the three hemi-segments shown. DT1 is present more frequently (asterisks), 
although still has shape defects.
The majority of ventral muscles are also missing or severely misshapen. VA2 is often distinguishable (arrow) and frequently one or 
two, but not all, of the VL muscles form in a hemi-segment, but do not attach properly and ball up (arrowhead)
Experimental embryos are UAS Him J7 driven at 29°Cby Mef2 Gal4. Wild type are Oregon R. All embryos are St17 and stained with 
anti j33-tubulin antibody.
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missing is similar (Table 5.2.1) and the types of individual somatic muscles missing is 
similar (Table 5.2.2) there is some difference in the frequency that an individual muscle is 
lost in an embryo. For example the LT muscles are missing at a greater frequency per 
embryo A2-A4 when Him is driven at 29°C than when driven at 21°C (Table 5.2.3), though 
the percentage of embryos that have at least one of the individual LT muscles missing is 
the same at both temperatures (Table 5.2.2).
These data can be seen in FIG 5.2.2, where there are a greater number of LT muscles 
present in the embryo over-expressing Him at 21°C than compared to the embryo over­
expressing Him at 29°C. In addition, the shape defects in the LT muscles that remain 
present in the embryos over-expressing Him at 29°C, appear to be more pronounced than 
the shape defects affecting those present in the embryos over-expressing Him at 21°C; the 
dorsal attachment points do not seem to be reached in the LT muscles as often in the 
embryos over-expressing Him at 29°C and they can show a greater degree of balling up.
Though the majority of somatic muscles are missing in Him gain-of-function embryos, p3- 
tubulin expression in the heart appears relatively unaffected in comparison to wild type. In 
wild type embryos, p3-tubulin is expressed in four of the six cardioblasts that make a hemi- 
segment of the linear heart tube (Damm et al, 1998; FIG 5.2.3). Mef2 is expressed in all six 
of the cardioblasts (Bour et al, 1994; Lilly et al, 1994; Taylor et al, 1995), and consequently 
the Mef2 Gal4 driver would cause ectopic Him expression in these cells. With Him over­
expression here there is little effect upon the heart; it generally appears wild type apart 
from the occasional loss or gain of p3-tubulin positive cardioblasts or kinking in the heart 
tube (FIG 5.2.3).
Previous work in the lab found that this to be in contrast to Myosin Heavy Chain (MHC) 
expression in the heart of embryos that used Mef2 Gal4 to drive over-expression of Him in
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FIG 5.2.2 Over-expression of Him at a higher temperature shows an increased frequency 
of individual muscle loss.
FIG 5.2.2 Over-expression of Him at a higher temperature shows an increased frequency 
of individual muscle loss.
Over-expression of Him driven by Mef2 Gal4 at 21°C and 29°C both give severe muscle phenotypes with the majority of 
individual somatic muscles being missing at least once in each embryo of the three hemi-segments (A2-A4) scored (Table
2.3.2). The main difference between the two phenotypes is that the frequency of certain muscles being missing can be higher 
in an embryo when Him is driven at the higher temperature. For example with the lateral muscles LT1.LT2, LT3 and LT4 the 
average number of muscles present is higher at 21 °C than at 29°C and those that are present at the higher temperature show 
a more severe degree of shape defects (5 LT muscles present here at 21 °C, A. 2 LT muscles present at 29°C, B and the full
set of 12 LT muscles for the three hemi-segments in a wild type embryo, C -  all shown by asterisks). Other muscles, such as
the VL’s show similar phenotypes at both temperatures -  being missing or balled up with incorrect attachment when the 
muscle is present (arrow).
Embryos are St17, shown laterally and stained with anti /33-tubulin antibody. Representative embryos are shown. Wild type 
embryo is Oregon R and was at 29 V .
The average number of LT muscles missing per hemi-segment in each embryo scored is as follows 
: UAS Him @ 21 : LT1 = 1.63, LT2 = 2.2, LT3 = 2.5, LT4 = 2.8 
: UAS Him @ 29 : LT1 = 2.95f LT2 = 2.82, LT3 = 2.95, LT4 = 3
Average Number of LT muscles lost (A2-A4) per embryo
Cross LTI LT2 LT3 LT4
UAS Him
X
Mef2 Gal4 
(29°C)
2.95 2.82 2.95 3
UAS Him
X
Mef2 Gal4 
(21°C)
1.63 2.2 2.5 2.8
Table 5.2.3 Average number of LT muscles missing A2-A4 per embryo for UAS Him at 
29°C and 21 °C.
Table to show the variation in the average number of LT muscles missing in abdominal hemi-segments A2, A3 and A4 for 
embryos over-expressing Him when driven by Mef2 Gal4 at either 29°C or 21 °C. In the cases of all of these individual LT 
muscles they are missing at least once in every embryo scored (Table 5.2.2). As each individual muscle occurs once in an 
hemi-segment in wild type embryos the maximum number of muscles that can be missing in hemi-segments A2-A4 is 3. So, for 
example, LT4 in UAS Him at 29°C is missing in every hemi-segment scored in every embryo scored.
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UAS Him UAS Him
FIG 5.2.3 Over expression of Him has mild effects on p3-tubulin expression in the 
heart.
In wild type embryos, the St17 heart is a linear tube of two rows of cardioblasts surrounded by pericardial cells. p3-tubulin 
is expressed in a repeating pattern of four out of six cardioblasts per heart hemi-segment (wild type A). When Him is over­
expressed in the embryo using Mef2 Gal4, only mild defects are seen in the heart when visualised using anti-p3-tubulin 
antibody. Generally the heart appears wild type, though occasionally the heart tube may show a kink in its structure 
(arrow, B), a p3-tubulin positive cardioblast may not form (arrow, C) or a number of additional cardioblast-like cells form 
outside of the vessel (arrow, D).
Heart images are from St17 embryos viewed dorsally and stained with anti j33-tubulin antibody. Wild type is Oregon R and 
UAS Him J7 was driven by Mef2 Gal4. All embryos were at 29 °C.
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the cardioblasts. These embryos show a severe disruption to MHC expression in the 
cardioblasts although the cells themselves were present (Liotta, PhD thesis 2006). These 
results are consistent with the phenotype associated with Mef2 mutants, where the 
cardioblasts of the heart are able to form and can express P3-tubulin, but do not express 
MHC (Ranganayakulu et al, 1995; Damm et al, 1998).
There are a number o f points of interest from these results; it should be remembered that 
wild type expression o f Him occurs in the pericardial cells not the cardioblasts of the heart, 
and so any over-expression of Him in the cardioblasts is ectopic. Mef2 however is 
expressed in the cardioblasts (and not the pericardial cells) so with respect to p3-tubulin 
expression in the cardioblasts either Him has no effect upon Mef2 when driven in these 
cells or more likely, Mef2 itself has no effect upon p3-tubulin expression in the 
cardioblasts. The fact that P3-tubulin expression occurs in the cardioblasts of Me£2 mutants 
makes this first scenario unlikely.
5.3 Discussion
My analysis of UAS Him over-expression with Mef2 Gal4 involved a thorough 
investigation of the formation of the somatic muscles and from this I was able to reveal a 
distinct subset of muscles more readily affected than others; again showing that certain 
muscles have specific requirements for Mef2 and that, as described in the dominant 
negative chapter, these can be High or Low Mef2 requirement muscles. As this is the same 
subset as those seen with the Mef2 Dominant negative and the Mef2 alleles it suggests that 
the phenotype associated with UAS Him is due to the action of Him solely upon Mef2 and 
as such means that the UAS Him line can be can be considered another component of the 
Drosophilist’s tool kit for reducing Mef2 activity in a spatial and temporal manner.
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H i m  Loss of Function
6.1 Introduction
The classical way of understanding a process in developmental genetics is through the 
generation and characterisation of mutants. This can either be through isolation of a gene 
through a random mutagenic screen of the genome searching for the generation of a 
particular affect, or more recently, though the targeted deletion of a known gene of interest. 
As part of my thesis I wanted to generate mutants which were null for Him as a means of 
investigating its role in muscle differentiation. There are two main approaches available for 
achieving the generation of a mutant through this targeted deletion; either FRT-containing 
transposable element mediated trans-recombination or Homologous recombination. Both of 
these techniques involve the directed removal of a region of DNA that the gene of interest 
occupies.
For this study, I generated a null mutation of Him using FRT mediated trans-recombination 
using transposable elements.
6.2 Generation of a Him mutant by transposable element 
mediated recombination.
FIG 6.2.1 shows a transposable element insertion map for the Him and Her gene region. The 
shortest region between two compatible FRT containing transposable elements that could 
fully delete the Him gene was that between two Exelxis pWH elements; pBacWH f06349, 
upstream of A ril and pBacWH f04435, downstream of Upd2. The result of recombination 
between these two elements is the generation of either a deletion or a duplication of DNA 
approximately 98Kb long in the 17A position on the X chromosome. This region contains 
Him and five other genes, Frql, Andorra, Frq2, Her, and CG33639.
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FIG 6.2.1 Transposable element mediated deficiency to gene region
GBrowse map (Flybase) of the Him gene region, showing the transposable element stocks available in the region. The 
area is a relatively “cold” spot transposable element insertion and consequently the smallest genomic fragment that can 
be deleted that results in a complete loss of the Him gene and its regulatory sequence is shown between the two purple 
arrows on the diagram. This corresponds to the region between the pBac WHf06349 and pBac WHf04435 elements and 
results in the loss of a region of DNA approximately 98Kb long which contains Him and five other genes; Frq1, Andorra, 
Frq2, Her and CG33639.
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EEW+ Him  gene region
pWH f06349
FLP FRT recombinase
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I
pWH f0
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B
Primer pair give product?
Event A B C D
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2) pWH 2 no rec no no yes yes
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4) Duplication no* yes yes no*
Him  gene region
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The DNA sequence for the two P elements is 
identical -  they are both WH type. Different colour 
is to show recombination event.
*The primers for both A pair and D pair can bind 
but would each produce a product o f > 100Kb
FIG 6.2.2 Transposable element mediated deficiency to gene region
6.2.3 Him region transposable element deletion
Trans-recombination between Exelixis pWH w+ fl)6349 element and Exelixis pWH w+ 
fl)4435 element.
In following scheme pW H  w+J06349 = pW H l and pW H  w+f04435 = pWH2
1.(?w n " ; TM6B/ MKRS,hsFLP 86E x ? v  w lll8iso, p{FRT, w+ }WH1 ; 2iso ; 3iso
4
Collect S  w " ,s iso, p{FRT, w+ }W H 1 ; MKRS.hsFLP 86E
2. S  w1118iso, p{FRT, w+ }WH1 ; MKRS.hsFLP 86E x ? v  wul8iso p{FRT, w+}WH2
Heat shock progeny J ,
Collect ?v  w " 18isop{FRT, w + }W H l/w '" s iso, p{FRT, »>+ }W H 2 ; MKRS.hsFLP86E
3. ?v  w1118 iso p{FRT, w+}W Hl / w 1118 iso, p{FRT, w+ }WH2 ; MKRS,hsFLP 86E
x S  FM7h iso ;2iso ;3iso
4
Collect $v w " 18isop{FRT, w + }W H l— p{FRT, w+ }W H 2/ FM7h iso
4. $v  w '1,8iso p{FRT, w+}W Hl —  p{FRT, w+ }WH2 / FM7h iso
x S  FM7h iso ;2iso ;3iso
Screen for lethality (no S  w 1118 iso p{FRT, w+}W Hl —  p{FRT, w+ }WH2 red eyed males) 
and either keep over FM7h if  lethality detected or cross to homoygosity of the pWH 
chromosome. Due to fact both the elements were w+ originally, eye colour cannot be used to 
detect a recombination event, i.e red w+ eyes would occur in a duplication, a deletion or an 
unrecombined element for both the elements. So each individual fly must be screened by PCR.
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The compatibility o f the two elements for recombination is dictated by the presence and 
orientation of FRT sites within them. These sites are what the Flipase enzyme acts upon to 
mediate a trans-recombination event between the two elements (Thibault et al, 2004).
FIG 6.2.2 shows a schematic of the two possible outcomes of a successful recombination 
event, with either a deletion or a duplication of the region between the two elements being 
possible. Both of the elements are identical (pWH) and were w+ originally and because of 
this, eye colour cannot be used to detect a recombination event. As red w+ eyes would occur 
in a duplication, a deletion or an unrecombined element for both the elements (see FIG
6.2 .2).
The crossing scheme to perform this recombination event is shown in FIG 6.3.2, and is taken 
from the original scheme as described in Parks et al, 2004. I performed the appropriate 
crossing scheme to induce the recombination event under heat shocked control as outlined. 
Because there is no associated change in eye colour with this particular recombination event, 
I screened for successful recombination solely by PCR; different PCR products are obtained 
with the same sets of primer pairs depending upon the genomic condition as shown in FIG 
6.2.2. The primer sequence for these pairs is shown in the materials and methods, they 
consist of a primer specific to the p-element that has already been established (Thibault et al, 
2004) and a genomic primer specific to the region around the element I designed to pair with 
this. Primers are shown in materials and methods as are primers specific to the Him region 
and the regions outside o f the deletion area.
One line, Him 52, gave products for A and D but not B and C, showing that a successful 
recombination event had occurred. PCR product was obtained for the regions outside of 
the deletion area, specific to Ari 1 and Upd2 but not for the Him region and an in-situ against 
Him was negative showing that the gene had been deleted FIG 6.2.4
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Him mutant alleles by Homologous recombination (Zhe Han)
At the same time as this the lab of Prof.Zhe Han at the University of Michigan were 
generating null mutants targeting Him specifically using ends-out Homologous 
recombination, and these unpublished lines were sent to us as part of an ongoing 
collaboration. These lines were designed to target the Him gene specifically. Two lines were 
successfully generated that were mutants for Him; Him 74 and Him 195.
I confirmed that these stocks were indeed mutant for Him by performing an in-situ against 
Him; if the gene region was deleted there will be no Him DNA to transcribe and hence no 
RNA present in the organism. This indeed was the case, as shown for the two homologous 
recombination lines and the transposable element mediated recombination line, where the in- 
situ is negative for Him in each of these stocks as shown in FIG 6.2.4.
6.3 Him mutant phenotype analysis
The first thing I tested with the three Him mutant lines was the hatching and survival rates to 
check for any lethality. Each of the lines were homozygous viable and fertile and on general 
observation the adult flies appeared healthy, normally sized and active. I aligned 200 
fertilised embryos for each line on apple juice agar plates and charted their progress through 
development from embryo to adult as outlined in the Materials and Methods. Each of the 
lines show partial lethality, giving a reduced survival rate to adult flies. The lethality appears 
to occur mainly at the pupal stage, where the flies either die as black pupae or fail to get 
completely out o f their pupal case, although there is some reduction in the hatching and 
survival rates compared to wild type for the mutant lines passing through embryogenesis and 
the larval stages. For example, with the Him 52 line the hatching rate is reduced from 99 /o to
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Wild Type Him-52 Him-74 Him-195
FIG 6.2.4 Him mutant embryos do not produce RNA transcript
In the Him mutant line generated by transposable element mediated recombination and the mutant lines
generated by homologous recombination (Him-74and Himthe gene was removed. The lines show no 
detectable Him RNA transcript, confirming successful deletion of the gene. Wild Type and mutant embryos were fixed
and RNA in-situ hybridisation against Him performed in parallel. Representative St13 and S till embryos shown.
RNA not detected in mutant lines at any stage.
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95% in comparison to wild type and survival to the 3rd instar larval stage is reduced by a 
further 4% to 91%, whereas for wild type there is no reduction in survival to this stage (Table 
6.3.5).
6.4 The embryonic phenotype of Him mutants.
Although the hatching and survival rates o f the three Him mutant lines suggested that there 
may not be a severe phenotype in embryogenesis I still wanted to test the effect of Him loss 
of function on muscle differentiation.
I wanted to investigate any embryonic muscle phenotype through analysis of the final 
embryonic somatic musculature at St 17, and as with the Him gain o f function experiments 
described previously (Chapter 4), I did this by staining the muscles with anti 03-tubulin 
antibody and scoring for presence, absence, shape or attachment defects in each of the 30 
individual somatic muscles of hemi-segments A2, A3 and A4 of 20 embryos. This means that 
a total of 1800 muscles were scored for each line and that for each individual somatic muscle 
60 different examples of it were scored as part of the analysis.
On initial observation o f the general somatic musculature, the Him mutants appear quite 
similar to Wild Type embryos, there is no massive disruption to the muscle pattern, unlike 
the phenotype associated with Him gain-of-function when the majority of somatic muscles 
are missing when Him is over-expressed in the Mef2 pattern (Compare the St 17 musculature 
of the UAS Him and Him 52 mutants with Wild Type in FIG 6.4.1). However, detailed 
investigation of the St 17 musculature reveals a distinct phenotype associated with Him loss 
of function. Table 6.4.2 shows the data for the somatic muscle phenotype of the Him 
mutants; Him 52, Him 74 and Him 195 in comparison to Wild type (Oregon R) embryos.
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Experiment Embryo
Hatching
Survival to 
3rd Instar
Larvae
Survival to 
black pupae
Survival to 
adult fly
Wild Type 99% 99% 98% 98%
Him 95% 91 % 85% 65%
Him 95% 93% 88% 81 %
Him 98% 95% 87% 75%
Table 6.3.5 Him mutants show partial lethality
Hatching and Survival analysis for Wild Type and Him mutant lines. 200 fertilised embryos were selected by gut auto­
florescence, aligned on apple juice agar plates and allowed to develop at 25°C. Hatching rates were recorded and any 
larvae that reached the 2nd instar stage were transferred to vials at 25 °C and allowed to develop until adulthood.
The Him mutants show a reduced survival rate compared to wild type, and the lethality ^  ^
occurs to the greatest extent at the pupal stage. A large proportion of these, especially in 
the Him 52 line fail to escape the pupal case as black pupae.
The stages of the flies life cycle are shown here in the inset FIG 2.4.5
smbryo
✓
1st instar larva
2nd  instar larva
FIG 2.4.5 Life cycle of Dro 3rd instar larva
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There are a number o f defects in the final somatic muscle pattern of Him mutants; with 
embryos showing individual muscle gain or loss and shape and attachment defects in 
particular individual muscles. In Him 52 mutant embryos the predominant aspect to the 
phenotype is the apparent duplication o f muscles; at least one muscle duplication occurs in 
nearly all of the embryos scored in this line (19 / 20 - 95%)(Table 6.4.2). The nature and 
potential means of occurrence o f these extra muscles is addressed later in this chapter, but 
initially I am describing these as duplications based solely on their appearance. They present 
as a second copy o f an individual somatic muscle, which generally appears to have the wild 
type characteristics of that individual muscle type in terms of shape, position within the 
hemi-segment and general attachment (The attachment can only be generally wild type as 
there are two copies o f the same muscle type in the same region and they do not attach to the 
exact same points). In the vast majority o f cases there is no loss o f other individual muscles 
in the region. FIG 6.4.3 shows examples of such duplications in Him 52 mutant embryos. 
Embryo B in this figure shows a duplication in the dorsal muscle, DO l, the two copies 
appear very similar in terms of shape and position and a distinct division between them can 
be seen, suggesting they are two separate muscles rather than one large DOl muscle. Embryo 
D shows two distinct duplications in the dorsal muscle DAI, one in hemi-segment A2 and 
another in hemi-segment A4. Embryo F shows distinct duplications in the lateral LT muscles, 
there is an additional LTI and LT2 muscle in hemi-segment A2, meaning that there are five 
LT muscles in this hemi-segment instead of the usual three (LTI,2,3) that would be found in 
a wild type embryo. Focussing up and down with the microscope at the time of capturing this 
image revealed these extra LT muscles to be complete individual muscles that are separate 
from one another, rather than single muscles with split ends at the point of attachment that 
could also give the appearance o f additional muscles in an image.
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Him  MutantWild Type
FIG 6.4.1 Him gain-of-function and Him loss-of-function give different phenotypes
Overexpression of Him causes a severe reduction in muscle formation (compare A to wild type, B), whereas Him mutant 
embryos show an opposite phenotype with a gain of muscle. In the Him mutant, (C) a duplication has occurred resulting in two 
copies of the D01 muscle (asterisks). There are two distinct D01 muscles rather than one thick muscle as gap between the 
two can clearly be seen (arrow in C). Compare this to Wild type (B).
The Wild Type embryos in this experiment were Oregon R and the Him mutant was Him52. UAS Him was driven by Mef Gal4 
at 29°C
Him No. Em bryo with 
muscles 
M ISSING
No. Em bryo 
with muscles 
DUPLICATED
No. Embryo 
with muscle 
mis-
ATTACHM ENT
No. Embryo 
with muscle 
SHAPE 
DEFECTS
No. Embryo Affected 11 19 5 20
%  Embryo 55% 95% 25% 100%
Muscle total 14 44 6 228
Avg No. Muscle / 
Em bryo Affected
1.3 2.3 1.2 11.4
Range of muscles 
affected
1 -3 1 - 7 1 -2 3 -2 2
Him No. Em bryo with 
muscles 
M ISSING
No. Em bryo 
with muscles 
DU PLICATED
No. Embryo 
with muscle 
mis-
ATTACHM ENT
No. Embryo 
with muscle 
SHAPE 
DEFECTS
No. Embryo Affected 6 6 0 19
%  Embryo 30% 30% 0 % 95%
Muscle total 33 6 - 99
Avg No. M uscle/ 
Embryo Affected
5.5 1 - 5.2
Range of muscles 
affected
1 - 1 4 1 -2 - 1- 11
Him No. Em bryo with 
muscles 
M ISSING
No. Em bryo 
with muscles 
DU PLICATED
No. Em bryo 
with muscle 
mis-
ATTACHM EN T
No. Embryo 
with muscle 
SHAPE 
DEFECTS
No. Embryo Affected 8 6 4 20
%  Embryo 4 0 % 30% 20% 100%
Muscle total 16 8 18 305
Avg No. Muscle / 
Embryo Affected
2 1.33 4.5 15.25
Range of muscles 
affected
1 - 8 1 - 2 1 - 15 6 - 4 4
Wild Type No. Em bryo with 
muscles 
M ISSING
No. Em bryo 
with muscles 
DU PLICATED
No. Em bryo 
with muscle 
mis-
ATTACHM ENT
No. Embryo 
with muscle 
SHAPE 
DEFECTS
No. Embryo Affected 0 1 0 15
%  Embryo 0% 5 % 0 % 75%
Muscle total 0 1 0 41
Avg No. Muscle / 
Embryo Affected
- 1 - 2.7
Range of muscles 
affected
- 1 - 1 - 7
Table 6.4.2 Somatic muscle phenotype in mutants
FIG 6.4.3 Examples of som atic m uscle duplication in Him 52 mutants
St17 embryos stained with anti (33-tubulin antibody to visualise the muscles reveals 
frequent duplication in certain individual somatic muscles.
The dorsal muscles D O l and DA1 and the lateral LT muscles are frequently duplicated 
(FIG 6.4.4), representative examples of which are shown in this FIG.
The Him 52 embryo in image B shows a duplication in the D O l muscle (indiciated by 
asterisks) in the A2 hemi-segment. Note how there is a definite division between the two 
D01 muscles (arrow) and how the thickness of the two D O l muscles is similar to each 
other and also the single D O l muscles in A3 and A4 of this mutant embryo. Compare the 
embryo with a representative Wild Type embryo (A) which only has one D O l muscle per 
hemi-segment.
In D the Him 52 embryo shows a duplication in the DA1 muscle in hemi-segment A2 and 
hemi-segment A4 (arrows). Each of the duplicated DA1 muscles is distinctly
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FIG 6.4.4 gives a breakdown in the form of a graph of which individual somatic muscles are 
duplicated or missing in the Him mutant embryos and the frequency of occurrence of these 
defects in the embryos scored. The raw data for this table is shown in Tables 6.4.3-6.4.6. 
There is a distinct trend as to which muscles are duplicated, this is most noticeable in the Him 
52 mutant line where the D O l, DAI, LT1 and LT2 muscles are duplicated in between 20 and 
45% of the embryos. DOl is the most frequently duplicated muscle and FIG 6.4.5 shows a 
breakdown of the most frequently duplicated muscles in the Him 52 mutant. The same 
muscles are also duplicated in the Him 74 and Him 195 lines as shown in FIG 2.4.8, with 
DOl again being the most frequently duplicated. Examples of some of the duplications seen 
in Him 74 and Him 195 embryos are shown in FIG 6.4.6.
The muscles that are missing in Him mutants seem to be quite varied and show less of an 
obvious trend than the duplicated muscles. However as can be seen in FIG 6.4.4, DAI, LT4, 
V05 and V 06 are missing in all of the Him mutant lines. And V 06 is the most frequently 
lost muscle in the phenotypes associated with Him 52, Him 195 and also Him 74 ( LT4 is lost 
at the same frequency as V 06 in the Him 74 line). Of the 20 embryos scored for Him 52, 19 
contain at least one muscle duplication and there is a range of duplications within an embryo 
(A2-A4) of 1-7 (Tables 6.4.3 and Table 6.4.6.). 55% of the embryos contain a duplication 
and also have muscles missing. However, in these embryos most of the time there are more 
muscles duplicated than there are missing and there seems to be no pattern between type of 
muscle duplicated and type of muscle missing. For example, though DOl is the most 
frequently missing, there is no pattern with loss of other muscles when a duplication occurs.
This is a recurring observation for duplication of the DOl, DAI and LT muscles; their 
duplication is not at the expense of the formation of another muscle. This can be seen in the
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FIG 6.4.4 Somatic muscle phenotype of Him mutants -  Muscle duplication and Muscle Loss
The thirty somatic muscles of abdominal hemi-segments A2, A3 and A4 were scored for 20 St17 embryos for each Him mutant 
line and Wild Type embryos at 25°C and the percentage of embryos that show either a duplication (red) or absence (blue) of 
an individual muscle is shown here. Only one individual muscle in an embryo (i.e one in hemi-segments A2, A3 or A4) need to 
be duplicated or missing for that embryo to be scored as having that defect in an individual muscle.
The Wild Type embryos in this experiment were Oregon R. In the 20 wild type embryos scored, only one embryo showed a 
muscle duplication and there were no examples of muscles being missing.
TABLE 6.43 : Muscles Duplicated and Mining Him 52*t25°C
I 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Total InX Embryo Average(A2-4)
DOl 1 1 1 1 1 1 1 t 1 9 9 1
DAI 2 It > 2 1 2 2 12 1 7 1 1.71 1
D02
DA2
D03 1 1 1 1
D04 1 1
DA3 I 1 1 1
D05 1 1 1 1
DTI
LL1
LT1 1 1 1 1 1 1 2 8 7 1.14
LT2 1 1 1 2 $ 4 1.25
LT3 1 2 2 3 2 2 1 1.5 2
LT4 t 1 1 1
SBM
LOI 1 1 1 1
VT1 1 1 1 1
VL1
VL2
VL3
VL4
VAI 1 1 1 1
VA2
VA3 2 2 1 2
VOI
V02
V03
V04 2 1 2 1 1 1 J  1
V05 1 1 1 1
V06 1 2 1 4 3 133
DIT 1 3 3 I S 3 3 1 1 2 2 1 2 I 3 2 7 1 44 19 232
MISS - 1 1 1 * - I - 2 1 > - 3 1 - - 14 11 1.27
TABLE 6.4.4 : Muscles Duplicated and Missing Him 74 at 25°C
DOl
DAI
la 1b lc Id
1
le If 2a 2b 2c 3a 3b 3c
1
3d 4a 4b 4c 4d
1
5a
1
Sb 5c Total
2 
1 j
InX Embryo
2 
1 f
Average(A2^)
D02
DA2
1
2
1
2
I I 
1 
1
--------
D03 2 2 1
D04 1 1 1
DA3 1 1 1
D05 .
DTI . --------
LL1 .
LT1 1 1 1
LT2 1 1 1
LT3 1 1 2 2
LT4 2 I 3 6 3
SBM 3 2 5 2
LOI 1 1 1
VT1 .
VL1 _
VL2 1 1 1
VL3 1 1 1
VL4 .
VAI .
VA2 .
VA3 2 2 1
VOI .
V02 1 1 1
V03 .
V04 1 1 2 3 2
VOS 1 1 1
V06 1 1 1 3 3
Dl P 1 1 1 2 1 1 7 6 1.2
MISS » 1 1 H 1 - - - 33 6 5.5
TABLE 6.4.5 : Muscles Duplicated tnd M using H im  195  St 25°C
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Total In X-Embryo Average(A2-4)
DOl 1 1 2 2 I
DAI 1 2 2 I 1 1 2 1
D02
DA2 2 1 3 2 1.5
D03
D04
DA3
D05
DTI
LL1
LT1 1 1 1 1
LT2 I i 1 1
LT3
LT4 1 1 1 1
SBM
LOI
VT1 2 1 1 2 1 1 1 2
VL1
VL2
VL3
VL4
VAI
VA2 1 1 1 1
VA3 1 1 1 1
VOI
V02
V03
V04 1 1 1 1 1 1 1 1
V05 1 2 3 2 2
V06 1 1 1 2 2 1
D IT 1 1 . - 2 1 2 8 6 1.33
.MISS 2 1 1 I 7 1 1 - 16 8 2
TABLE 6.4.6
H i m  5 2 No. Emb with 
Missing
No.Embryo 
with Dup
No. Emb Miss 
ONLY
No. Emb Dup
ONLY
No. Emb 
Miss AND 
Dup
No. Emb
Shape
only
Total
No.
Embryo
No.Emb 11 19 0 8 11 1 20
% Kmb 55% 95% •  % 40% 55% 5%
Muscle total 14 44
Avg No. 
Muscle / Emb
121 2-32
Range 1-2 1-7
H i m  7 4 No. Emb with 
Missing
No.Embryo 
with Dup
No. Emb Miss
ONLY
No. Emb Dup
ONLY
No. Emb 
Miss AND 
Dup
No. Emb 
Shape 
. only _
Total
No.
Embrvo
No Emb 6 6 4 4 10 20
, % Emb 30% 30% 20% 20% 10% 50%
n ...............
Muscle total 33 7
Avg No. 
Muscle / Emb
M 1 2
Range 1 -15 1 -2
H i m  1 9 5 No. Emb with 
Missing
No.Embryo 
with Dup
No. Emb Miss 
ONLY
No. Emb Dup
ONLY
No. Emb 
Miss AND 
Dup
No. Emb
Shape
onlv
Total
i No. 
Embryo
No.Emb 8 6 6 4 2 20
% Emb 40% 30% 30% 20% 10% 40%
■
Muscle total 16 8
Avg No. 
Muscle / Emb
2 1J3
1-8 1-2
ONLY means that there isn't a duplication AND a missing muscle in the same embryo, there could be other defects such as shape, attachment etc.
Embryos described as Shape only have no muscles duplicated or missing but may have attachment and shape defects in individual muscles
All scoring refers to abdominal hemi-segments A2-A4, so the maximum number of muscles missing for an individual muscle type m a single embryo is 3
Wild Type Him Him
/
Wild Type Him Him
LT1, LT2
FIG 6.4.6 Examples of muscle duplications in 74 and mutants
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40% of embryos (8/20) that contain a duplication and have no muscles missing, meaning the 
total number of muscles for that hemi-segment is greater than 30 (with one recorded embryo 
containing 37 muscles in a hemi-segment!). This result is significant in considering the 
potential origins of the duplications.
Though similar, the phenotype for Him 195 and Him 74 appears less severe than that 
associated with Him 52 (FIG 6.4.4 and Table 6.4.6). For Him 195, in 20 scored embryos 30% 
contained duplication and 30% had muscles missing. Only one third of each of these (i.e 2 
embryos) contained both duplications and muscles missing. 20% of embryos had muscles 
missing without duplications and another 20% of embryos had duplications without muscles 
missing. Although the numbers are lower, there is a tendency for duplications to 
predominantly occur in DOl DAI and the LT’s for Him 195. V04-6 muscles are also 
missing in Him 195 and various others including, unlike Him 52, DA2. (Table 6.4.5 and 
6.4.6)
With Him 74, in the 20 embryos scored 30% contained duplications and 40% had muscles 
missing. As with Him 195, one third of the embryos containing duplications also have 
muscles missing (10% of total embryos). 20% of the total embryos contain duplications 
without muscles being missing and 30% of the total embryos have muscles missing without 
duplications also occurring (Table 6.4.6). Like Him 195, though the frequency of duplication 
is lower than Him 52, the main duplication occurs in the Dorsal (DOl) and lateral (LT1,2) 
muscles (FIG 6.4.4). The individual muscles that are missing are also similar to Him 195 (e.g 
V04-6), though there does tend to be generally a higher frequency of cases of muscles 
missing in Him 74 than in the other Him mutants, this is especially so around the lateral 
region; LT3, LT4, SBM and LOI (FIG 6.4.4). Inspection of the breakdown of the muscles
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Duplicated
Muscle
Him-52Mutant 
(% of total duplicated 
muscles)
D01 20.5 %
DA1 27.3 %
LT1 18.2%
LT2 11.4%
LT3 6.8%
Other
muscles
D03, DA3, VA1, VA3, 
V04
Total
Duplications
44 D01, DA1, LT1/2/3
FIG 6.4.5 Frequent somatic muscle duplications in the mutant
FIG 6.4.6 Examples of muscle duplications in Him 74 and Him 195 mutants
Distinct duplications can be seen in individual somatic muscles of Him mutants. Shown here are representative examples of 
duplications in the dorsal D01 muscle and the lateral LT1 and LT2 muscles for Him 195 and Him 74.
The asterisks in B and C show duplications in the D01 muscle of Him195 and Him74 respectively. Compare these to wild type 
(A ) and the schematic highlighting the muscle in this figure.
Similarly the brackets in E and F show duplications in the LT muscles for Him195 and Him74 respectively compared to Wild 
type (F) and schematic.
The Wild Type embryos in this experiment were Oregon R. Muscles were stained with anti |33-tubulin antibody.
No. of Embryos 
showing 
SHAPE defects
(and % of Total 
scored)
Avg. No. of 
Muscles with 
SHAPE 
defects per 
Embryo (A2- 
A4)
Muscles with 
SHAPE defects in 
75 -100% of
Embryos
Muscles with 
SHAPE defects in 
55 -  75 % of 
Embryos
Muscles with 
SHAPE defects 
in 30 -  50 % of 
Embryos
Muscles with 
SHAPE defects 
in 20- 25 % of 
Embryos
Wild T y p e 15(75% ) 2.7 - - VA3, V04 LT1, LT2, VT1
Him 5 20( 100%) 11.4 VA3 DOl, LT1, VAI, 
VA2, V04, V05
D03, D04, VT1, 
V06
-
Him 7 19(95% ) 5.5 - LT1 LT4, VA3, 
V04, V06
D04, VT1,V05
Him 1 20 (100 % ) 15.5 VAI, VA2, VA3, 
V04
DOl, LT1, VT1, 
V06
DAI, LT4, V05 D03, LT2, LT3
Table 6.4.7 Analysis of shape defects in the somatic muscles of mutant embryos
Muscles shape 
defects seen in % of 
embryos scored
|  Shape 75 -  100% 
[ j ]  Shape 55 - 75% 
F I  Shape 30 -  50%
| Shape 20 -  25%
FIG 6.4.7 
Schematic of 
shape defect 
frequencies in 
Him mutants
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missing and in each individual embryo scored (Table 6.4.4) reveals that this greater 
frequency is due to a small number of embryos (2 / 20) which have a relatively* high number 
of muscles missing (embryo 3d, 15 missing and embryo 5a, 14 missing). (* relatively high 
number of muscles missing with respect to the other embryos of the Him 74 phenotype, not 
for example a high number of muscles missing in comparison to severe phenotypes such as 
those seen with Him over-expression or Mef2 loss of function.) Him 195 only has one 
embryo with a large number of muscles missing for the phenotype (embryo 6 - 7  missing ; 
Table 6.4.5) and Him 52 shows no such embryos in the 20 scored (Table 6.4.4).
The majority of embryos in Him mutants show minor shape defects in multiple muscles 
(Table 6.4.2) and a breakdown of which muscles are affected is shown in Table 6.4.7 and in 
the corresponding schematic on the same page in FIG 6.4.7. In all the Him mutant embryos, 
the VO(4-6) muscles are frequently misshapen.
6.5 Thickness Measurements of Dorsal muscles in Him 
mutants
As well as the observation that a number of muscles were duplicated, missing or misshapen a 
large proportion of muscles in the Him mutants appeared to have a variation in thickness 
compared to wild type. This was especially apparent in the dorsal muscles, DOl, D02 and 
DAI, DA2. FIG 6.5.1 shows some examples of this variation in the muscle width of the DOl 
muscle in Him mutants. In wild type embryos the DOl muscles in each hemi-segment 
appears to have a similar thickness, whereas in the Him mutants there is greater variation in 
width; this can be especially apparent in embryos with a DOl duplication.
By observation alone it was difficult to ascertain the nature of the thickness variation. For 
example, whether a dorsal muscle was thick relative to others of the same type in the
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adjacent hemi-segments, or if that muscle was normally sized but the others that are in the 
adjacent hemi-segments are thinner than wild type.
This difficulty is because there is a tendency to judge any variation in thickness of the 
muscles within an embryo rather than between embryos when scoring. Because of this I 
decided to measure the width of the dorsal DOl and D02 muscles in the Him mutants (and 
also in embryos over-expressing Mef2) and compare them to wild type. Measurements were 
taken of the thickness of the muscle at the midline of the hemi-segment at an angle parallel to 
the dorsal ventral axis regardless of the shape or angle of the muscle (described in FIG 
6.5.2).
I measured the thickness of the DOl and D02 muscles in hemi-segments A2, A3, and A4 for 
both sides of 20 embryos for each of the Him mutant lines, Wild Type (Oregon R) and Mef2 
over-expression embryos (UAS Mef2 10T4A x Mef2 Gal4 at 29°C), which meant that for 
each muscle type (DOl or D02) there were 120 separate muscle size measurements per line.
I measured each muscle and kept them scored separately for each hemisegment rather than 
taking an average over the three hemisegments because there is some slight variation 
between the sizes of the wild type muscle in a hemisegment due to variation along the A-P 
axis (Beckett and Baylies, 2009).
Table 6.5.1 shows the average muscle thickness and the range of muscle thicknesses for each 
DOl and D02 muscle in hemi-segments A2, A3 and A4 for wild type, the Him mutants and 
UAS Mef2 (10T4A) driven by Mef2 Gal4 at 29°C.
From this dataset it can be seen that in general Him mutants and UAS Mef2 show a relative 
decrease in average dorsal muscle thickness in comparison to wild type.
This is most noticeable when taking the average muscle thickness per muscle scored 
(counting the muscles in a duplication as two individual muscles). For example, with Him 52,
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Wild Type
A
Him
Him
Him
FIG 6.5.1 Dorsal muscle thickness varies in mutant embryos
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the average measurement size of the DOl muscle in A4 is 20.6pm, whereas the Wild Type 
average for this muscle is 25.5 pm, and in fact for each muscle scored in this line the average 
is lower than the wild type average. All measurements were made on screen and converted 
from mm to pm using a known standard graticule slide where 14mm =10 pm.
When you instead consider the average muscle thickness per hemi-segment scored 
(effectively adding together the thickness of a duplicated/split muscle and treating it as one) 
the average size is brought closer to the wild type size for the DOl muscles, though still 
lower than the wild type average in nearly all cases (in Him 52 DOl A2 the average comes 
above wt 24.3pm vs 23.6pm when considering the duplications as one).
This decrease in thickness is more pronounced for the D02 muscles of the Him mutants and 
UAS Mef2 in comparison to wild type. However to some extent this observation may be 
related to the fact that more duplications occur in the DOl muscles than the D02 muscles 
(Him 52 DOl = 21 vs D02 =3, Him 195 DOl = 6 vs D02 =1 (or 2 if you don’t allow the 
missing D02 to cancel one out), Him 74 DOl = 3 vs D02 =1 and Mef2 10T4A DOl = 6 vs 
D02 =1 ) and that there seems to be a trend between occurrence of a DOl duplication and 
reduction in D02 size in the same segment (see below for more details).
From the measurements of the wild type muscles I got a range of thickness for each muscle 
(DOl or D02) in each hemi-segment (A2-A4) and used this range to decide whether an 
experimental muscle could be described as thick or thin. For example, for wild type DOl in 
A2 the range of muscle thickness measured was 20.7-28.6pm. Consequently, I would define 
a DOl muscle in the A2 hemi-segment as being thin if it had an onscreen measurement of 
28mm (20 pm) or less and as being thick if it has an onscreen measurement of 41mm (29.3 
pm) or more. I treated each muscle separately and only made comparisons between the same 
muscle types taken from the same hemi-segment type. For example a wild type DOl in A3
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would only be compared to a DOl muscle in A3 in experimental embryos, not a DOl muscle 
in A2 or A4. Therefore, each wild type muscle had a separate range to compare against to 
determine if individual muscles in the experimental embryos could be described as thick or 
thin.
Table 6.5.1 contains the muscle size ranges for each of the wild type DOl and D02 muscles 
and from this I was able to go through the complete collected experimental line data and 
assess whether an embryo contained at least one thick or thin dorsal muscle. For this I 
assessed the DOl and D02 size for A2, A3 and A4 of both sides of the embryo and 
compared the recorded size to the wild type range for that muscle as described above. If at 
least one of the muscles was below the wild type range the embryo was scored as Dorsal 
THIN. If at least one of the muscles was above the wild type range the embryo was scored as 
Dorsal THICK. If the embryo had one or more below the range and one or more above the 
range it was scored as Dorsal THICK and THIN and if all the muscles in the embryo fell 
within the wild type range then the embryo was scored as Wild Type. For this dataset only 
non-duplicated muscles were included in the scoring. Table 6.5.2 shows the results of this 
analysis. It was determined that 85% of Him 52 embryos contained at least one thin DO 
muscle compared to wild type and 40% of embryos contained a thick DO compared to wild 
type (Table 6.5.2).
For Him 195 94.7% of embryos contained a thin DO muscle whereas 10.5% contained a 
thick muscle and for UAS Mef2 it was 65% of embryos containing a thin muscle, 25% 
containing a thick muscle. With Him 74 the variation in muscle thickness is greater and less 
marked towards embryos having thinner muscles; 45% of embryos contain a thin muscle and 
65% of embryos contain a muscle that is thicker than wild type (Table 6.5.2).
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To summarise this data so far it can be said that for Him 52, Him 195 and UAS Mef2 there is 
a reduction in dorsal muscle thickness, as seen by a lower average muscle thickness for DOl 
and to an even greater extent, D02 and also a high proportion of embryos that contain a thin 
muscle as it falls below the wild type size range. Him 74 appears to be more similar to Wild 
Type in terms of muscle thickness for DOl, but not so for D02 which, as with the other 
experimental conditions, has a lower muscle thickness average than wild type. Also Him 74 
is the only experimental condition that has a larger proportion of embryos with a thick 
muscle than a thin muscle.
In addition to simply addressing the thickness of the dorsal muscles relative to wild type for 
the different experimental lines, I was also able to gather data on the sizes of the two muscles 
within a duplication event and the effect on dorsal muscle thickness on nearby muscles when 
a duplication occurs. Also, as I made measurements from both sides of 20 embryos, I was 
able to record the frequency of dorsal duplication over 120 hemi-segments rather than 60 
hemi-segments as with the standard muscle scoring dataset.
For Him 52, there were a total of 42 dorsal duplications (21 DOl, 3 D02, 17 DAI and 1 
DA2), for Him 195 a total of 11 (6 DOl, 2 D02 and 3 DAI), for Him 74 a total of 6 (3 DOl, 
1 DOl, 2 DAI) and for UAS Mef2 a total of 8 (6 DOl, 1 D02 and 1 DAI). Duplications in 
DAI and DA2 muscles were noted at the time of recording but no measurements were made 
for these muscles. No dorsal duplications occurred in any of the wild type hemi-segments 
scored. (Table 6.5.3)
Table 6.5.4 gives a breakdown of the muscle sizes in every duplication recorded. It shows the 
thicknesses of the two muscles in a duplication event and their sum thickness and relates this 
to the average muscle size for that muscle and the muscle size range for both that
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experimental line and the wild type condition. In addition it also shows the size data for the 
non-duplicated DO muscle in that segment to assess any affect on the size of that muscle 
when a duplication occurs.
The following data interpretation is based upon the Him 52 line as this contains the largest 
number of duplications.
The majority of dorsal duplications are in the DOl (and DAI) muscles and when a 
duplication occurs, 65% of the time one muscle is larger than the other and 35% of the time 
they are of a similar size. (Where similar in this case is defined as less than 5mm (3.6 pm) 
difference between the two).
In 74% (17/23) of cases the sum thickness of the two duplicated muscles is more than the 
average thickness of a single wild type muscle of the corresponding type. In nearly half of 
these cases (8/17) the sum is greater than the highest measurement in the wild type range for 
that muscle type -  suggesting that if the muscles formed as a result of splitting then the 
original muscle that split was much larger than wild type in the first place.
There may be a correlation between occurrence of a DOl muscle being duplicated and size 
of corresponding D02 muscle in that segment. In more than half the cases (11/20) when a 
DOl duplication occurs the corresponding D02 muscle is smaller than the average for the 
line. In 20% they are the same size as average for the line and the remaining quarter are 
larger than average.
In addition, in such cases where the D02 is smaller than average for the line, the sum muscle 
thickness of the two muscles in a DOl duplications is larger than average. And it correlates 
that the larger the DOl duplication muscle thickness total, the smaller the corresponding 
D02 muscle (In 75% of cases when the DOl total is larger than the maximum of the wild 
type range the corresponding D02 is smaller than the average measurement for the line.) The
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TABLE 6.5.1 : Dorsal muscle measurement table for Him mutants and UAS Mef2 embryos.
DOl
Av.Size
(nm)
Size
Range
(\im)
DOl 
# Dup
Size
Range
(m )
DOl
Av.Size
(nm)
Size
Range
(pm)
DOl 
# Dup
Size
Range
(nm)
DOl
Av.Size
(nm)
Size
Range
(pm)
DOl 
# Dup
Size
Range
(tan)
D02
Av.Size
(nm)
Size
Range
(m )
D02 
# Dup
Size
Range
(pm)
D02
Av.Size
(tun)
Size
Range
(lim)
D02 
# Dup
Size
Range
(lim)
, D02 
Av.Size 
(tun)
Size
Range
(pm)
D02 
# Dup
Size
Range
(pm)
Total 
# DO 
Dup
Line A2 A2 A3 A3 A4 A4 A2 A2 A3 A3 A4 A4
Wild Type 23.5
21-29
0 25.4
19-31
0 25.5
21-31
0 20.5
16-25
0 19.5
14-21
0 18.0
11-22
0 0
Him 52 19.1
7-31
10
(23.9)
21.7
11-32
5
(24.4)
20.6
7-36
6
(23.7)
16.2
7-2.5
0 14.2
7-21
1
(14.6)
13.6
7-32
2
(14.3)
24
Him 195 22.4
11-32
1
(22.9)
21.9
7-29
3
(23.7)
21.9
9-32
2
(23.1)
14.3
7-20
1
(14.0)
14.4
7-19
-1
(14.0)
13.1
7-21
1
(13.4)
8
Him 74 24.0
18-32
1
(24.6)
25.4
(12-33)
1
(26.0)
24.9
(9-33)
1
(25.5)
18.7
(14-26)
1
(19.2)
18.3
(14-22)
-2
(17.4)
16.8
(13-23)
0 4
Mef2 10T4A 
x Mef2 Gal4 
(29°c)
21.4
4-36
1
(21.9)
20.9
15-28
1
(21.4)
21.0
9-37
4
(23.1)
16.0
7-20
0 16.1
10-21
1
(16.5)
15.8
10-24
0 7
K ey:
Muscle scored (e.g DOl or D02) Duplications recorded for this muscle type
Line Segment scored (e.g A2, A3 or A4) In this segment
Avg muscle size (pm) -  taken from all muscles scored (i.e more than 40 
if duplications occurred)
Muscle size range (pm)
No. of muscles duplicated
Avg muscle size (pm) per hemi-segment (divide 
by number hemi-segments not number muscles 
i.e a duplication is effectively added together 
and counted as one muscle)
Measurements made from screen in mm. Embryos viewed at x 20 objective. Frame size set at 512 x 512 pixels. Frame viewed as “Fit into window” -  
size of window expanded to full screen except for start bar.
Using known standard graticule with this measurement method 14mm screen measurement = 0.01mm real size (10pm)
Table 6.5.2 Dorsal muscle thickness measurements -  percentage of embryos showing thick or thin muscles relative to wild type.
Line Dorsal THIN Dorsal THICK Dorsal THICK + THIN Dorsal WT
Him 52 50% (10/20) 5 % (1/20) 35 % (7/20) 10% (2/20)
Him 195 84.2% (16/19) - 10.5% (2/19) 5.3% (1/19)
Him 74 20% (4/20) 40% (8 / 20) 25% (5/20) 15% (3 /20)
UAS Mef2 10T4A 50% (10/20) 10% (2/20) 15% (3/20) 25% (5/20)
For this table the Wild Type (WT) range for each muscle DOl and D02 in A2 A3 and A4 was used as standard (see Wild Type ranges in table 2.4.12). 
If a measured muscle in the line is less than the corresponding range for that type and segment it is defined as THIN, greater than the Wild type range 
and defined as THICK.
An embryo only needs to contain one muscle out of range in any segment on either side to be described as containing a DO thick or thin muscle. If it 
contains a thin and a thick muscle it is described as dorsal THICK + THIN. If it contains all muscles in range it is described as dorsal wt.
Duplications are disregarded for measurements -  eg. only single muscles are included, so if a duplication occurred which consists of a narrow and a 
broad muscle this is not counted as a THIN and THICK muscle for this table.
Table 6.5.3 -  Number of Dorsal Duplications in Him mutant and UAS Mef2 embryos
Line DOl Duplications D02 Duplications DAI Duplications DA2 Duplications Total Dorsal Duplications
Him 52 21 3 17 1 42
Him 195 6 2 3 - 11
Him 74 3 1 2 - 6
UAS Mef2 6 1 1 - 8
Wild Type - - - - 0
For each experiment the number of recorded muscle duplications for the dorsal muscles DOl, D02, DAI and DA2 are presented here. 
Measurements were only made for the DO muscles (see other Tables), no measurements were made for the DA muscles but any duplications in 
these muscles were noted at the time of recording.
Table 6.5.4 Muscle Duplications data -  Muscle sizes when duplication occurs (sizes in mm from original on-screen measurements).
Line Dup’d
Muscle
Type/
Segmt
Muscle
1
Muscle
2
Total Line
Avg
Line
Range
Wild
Type
Avg
Wild
Type
Range
Other
muscle
Size Line
Avg
Line
Range
Wild
Type
Avg
Wild
Type
Range
Him 52 DOl A2 15 25 40 27 10-43 33 29-40 D02 A2 23 23 10-35 29 22-35
Him 52 DOl A2 28 16 44 27 10-43 33 29-40 D02 A2 15 23 10-35 29 22-35
Him 52 DOl A2 20 22 + 10 52 27 10-43 33 29-40 D02 A2 15 23 10-35 29 22-35
Him 52 DOl A2 25 10 35 27 10-43 33 29-40 D02 A2 23 23 10-35 29 22-35
Him 52 DOl A2 21 25 36 27 10-43 33 29-40 D02 A2 22 23 10-35 29 22-35
Him 52 DOl A2 30 10 40 27 10-43 33 29-40 D02 A2 25 23 10-35 29 22-35
Him 52 DOl A2 20 20 40 27 10-43 33 29-40 D02 A2 20 23 10-35 29 22-35
Him 52 DOl A2 17 20 37 27 10-43 33 29-40 D02 A2 24 23 10-35 29 22-35
Him 52 DOl A2 26 15 41 27 10-43 33 29-40 D02 A2 22 23 10-35 29 22-35
Him 52 DOl A3 20 17 37 30 16-45 36 26-43 D02 A3 24 20 10-30 27 20-30
Him 52 DOl A3 17 16 33 30 16-45 36 26-43 D02 A3 20 20 10-30 27 20-30
Him 52 DOl A3 30 13 43 30 16-45 36 26-43 D02 A3 23 20 10-30 27 20-30
Him 52 DOl A3 24 24 48 30 16-45 36 26-43 D02 A3 20 20 10-30 27 20-30
Him 52 DOl A3 22 33 55 30 16-45 36 26-43 D02 A3 14 20 10-30 27 20-30
Him 52 DOl A4 12 21 33 29 10-50 36 29-43 D02 A4 20 19 10-45 25 16-31
Him 52 DOl A4 10 20 30 29 10-50 36 29-43 D02 A4 12+11 19 10-45 25 16-31
Him 52 DOl A4 23 20 43 29 10-50 36 29-43 D02 A4 18 19 10-45 25 16-31
Him 52 DOl A4 30 25 55 29 10-50 36 29-43 D02 A4 15 19 10-45 25 16-31
Him 52 DOl A4 25 20 45 29 10-50 36 29-43 D02 A4 17 19 10-45 25 16-31
Him 52 DOl A4 15 20 35 29 10-50 36 29-43 D02 A4 17 19 10-45 25 16-31
Him 52 D02 A3 15 10 25 20 10-30 27 20-30 DOl A3 35 30 16-45 36 26-43
Him 52 D02 A4 12 11 23 19 10-45 25 16-31 DOl A4 10+20 29 10-50 36 29-43
Him 52 D02 A4 15 10 35 19 10-45 25 16-31 DOl A4 30 29 10-50 36 29-43
Table 6.5.4 CONTINUED Muscle Duplications data -  Muscle sizes when duplication occurs (sizes in mm from on screen measurements).
Line Dup’d 
Muscle 
Type / 
Segmt
Muscle
1
Size
(mm)
Muscle
2
Size
(mm)
Total
mm
Line
Avg
mm
Line
Range
mm
Wild
Type
Avg
mm
Wild
Type
Range
mm
Other
muscle
Size
mm
Line
Avg
mm
Line
Range
mm
Wild
Type
Avg
mm
Wild
Type
Range
mm
Him 195 DOl A2 30 15 45 31 15-45 33 29-40 D02 A2 20 20 10-28 29 22-35
Him 195 DOl A3 25 10 35 31 10-41 36 26-43 D02 A3 25 20 10-26 27 20-30
Him 195 DOl A3 28 12 40 31 10-41 36 26-43 D02 A3 21 20 10-26 27 20-30
Him 195 DOl A3 30 11 41 31 10-41 36 26-43 D02 A3 21 20 10-26 27 20-30
Him 195 DOl A4 24 12 36 31 12-45 36 29-43 D02 A4 15 18 10-30 25 16-31
Him 195 DOl A4 25 20 45 31 12-45 36 29-43 D02 A4 12 18 10-30 25 16-31
Him 195 D02 A2 10 12 22 20 10-28 29 22-35 DOl A2 26 31 15-45 33 29-40
Him 195 D02 A4 13 10 23 18 10-30 25 16-31 DOl A4 34 31 12-45 36 29-43
Him 74 DOl A2 28 29 57 34 25-45 33 29-40 D02 A2 21 26 19-36 29 22-35
Him 74 DOl A3 32 17 49 36 17-46 36 26-43 D02 A3 26 26 19-31 27 20-30
Him 74 DOl A4 13 20 33 35 13-46 36 29-43 D02 A4 21 24 18-32 25 16-31
Him 74 D02 A2 27 22 49 26 19-36 29 22-35 DOl A2 25 34 25-45 33 29-40
10T4A DOl A2 23 5 28 30 5-50 33 29-40 D02 A2 10 22 10-28 29 22-35
10T4A DOl A3 21 21 42 29 21-39 36 26-43 D02 A3 18 23 14-30 27 20-30
10T4A DOl A4 26 21 47 29 13-52 36 29-43 D02 A4 21 22 14-33 25 16-31
10T4A DOl A4 22 24 46 29 13-52 36 29-43 D02 A4 18 22 14-33 25 16-31
10T4A DOl A4 32 13 45 29 13-52 36 29-43 D02 A4 25 22 14-33 25 16-31
10T4A DOl A4 23 15 38 29 13-52 36 29-43 D02 A4 14 22 14-33 25 16-31
10T4A D02 A3 15 25 40 23 14-30 27 20-30 DOl A3 22 29 21-39 36 26-43
Table 6.5.5 Muscle Duplications data -  Muscle sizes when duplication occurs.
The complete dataset for muscle measurement sizes when a duplication occurs. The first data column refers to the muscle type that got duplicated (e.g 
DOl or D02) and which hemi-segment the duplication occurred in (A2-A4). The next two columns show the size of the two muscles in the duplication 
event. Muscle 1 is always the most dorsal of the two muscles. The Total is the combined thickness of Muscle 1 and 2 in the duplication event. The Line 
Average and Line Range are the average muscle thickness and range of muscle thicknesses for this muscle type in this hemi-segment position in the 
experimental line in question. Wild Type Average and Wild Type Range are the average muscle thickness and range of muscle thicknesses for this 
muscle type in this hemi-segment position in Wild Type embryos.
The Other Muscle section refers to the muscle within the hemi-segment that did not undergo the duplication*. For example, with a duplication of DOl 
in A2 the other muscle that the comparison is made against is D02 in A2. If the duplication is in D02 in A2 the other muscle would be DOl in A2 etc. 
The size of the other muscle is in the next column and then data on the average size and size range for that experimental line and the wild type 
condition follows from that.
* If a duplication occurs in the DOl and D02 within the same hemi-segment of an embryo -  (i.e there are 4 DO muscles in the region) then the 
duplication data is included with respect to both duplication and Size of the other muscle is recorded as two numbers.
DOl
Size
(pm)
DOl 
# Dup
DOl
Size
(pm)
DOl 
# Dup
DOl
Size
(pm)
DOl 
# Dup
D02
Size
(pm)
D02 
# Dup
D02
Size
(pm)
D02 
# Dup
D02
Size
(pm)
D02 
# Dup
Total
DO
Dup
Line A2 A2 A3 A3 A4 A4 A2 A2 A3 A3 A4 A4
Wild Type 23.5
21-29
0 25.4
19-31
0 25.5
21-31
0 20.5
16-25
0 19.5
14-21
0 18.0
11-22
0 0
Him 52 19.1
7-31
10
(23.9)
21.7
11-32
5
(24.4)
20.6
7-36
6
(23.7)
16.2
7-2.5
0 14.2
7-21
1
(14.6)
13.6
7-32
2
(14.3)
24
Him 195 22.4
11-32
1
(22.9)
21.9
7-29
3
(23.7)
21.9
9-32
2
(23.1)
14.3
7-20
1
(14.0)
14.4
7-19
-1
(14.0)
13.1
7-21
1
(13.4)
8
Him 74 24.0
18-32
1
(24.6)
25.4
(12-33)
1
(26.0)
24.9
(9-33)
1
(25.5)
18.7
(14-26)
1
(19.2)
18.3
(14-22)
-2
(17.4)
16.8
(13-23)
0 4
Mef2 10T4A 
x Mef2 Gal4 
(29°c)
21.4
4-36
1
(21.9)
20.9
15-28
1
(21.4)
21.0
9-37
4
(23.1)
16.0
7-20
0 16.1
10-21
1
(16.5)
15.8
10-24
0 7
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effect of a DOl duplication causing the corresponding D02 thickness to be decreased may be 
part of the explanation for the greater decrease in average muscle thickness for the D02’s 
when compared to Wild Type than the DOl’s compared to Wild Type (Table 2.4.12). 
However though this effect may be true for lines such as Him 52 which has a large number of 
DOl duplications it would not provide such a significant contribution in conditions that have 
only a relatively small number of DOl duplications such as in Him 74.
The observation that a DOl duplication may cause a reduction in D02 thickness could 
suggest that there are a smaller number of myoblasts available for D02 formation (due to the 
greater demand from the extra DOl muscle / larger DOl muscle that subsequently splits. 
However this hypothesis suggests either a preference for myoblasts to attract to the DOl over 
the D02 or the formation of the DOl before the D02 (also assuming a limited supply of 
fusion competent myoblasts which may unlikely be the case).
6.6 Mef2 over-expression mimics the Him mutant 
phenotype.
Because Him is an established repressor of Mef2 activity, one would expect a Him mutant to 
cause an increase in Mef2 activity (Assuming that any other potential mechanisms of Mef2 
regulation are not able to compensate for the loss of Him -  which because of the mildness of 
the phenotype may be the case). If Mef2 activity is increased in Him mutants, then over­
expression of Mef2 in the embryo may be able to mimic the Him phenotype.
By over-expressing the weaker UAS Mef2 line, UAS Mef2 low (Gunthorpe et al, 1999 -  also 
called UAS Mef2 10T4A) with Mef2 Gal4 I was able to show that this is the case. Somatic 
muscle analysis of the A2-A4 hemisegments in the usual way shows how the same muscle 
are affected in the same way. As with the Him 52 mutant line the phenotype predominantly
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FIG 6.6.1 Somatic muscle phenotype of Him mutants -  Muscle duplication and Muscle Loss
G raphs to sh ow  the p ercen tage of em bryos that contain at least o n e  duplicated (red) or m issing (blue) m u scle  in 
h em isegm en ts  A2-A4 for Him mutant and Mef2 overexpression  lines. The thirty som atic  m u scles of abdom inal h em i-segm en ts  
A2, A3 and A4 w ere scored  for 20  S t17  em bryos for ea ch  experim ental condition. Only on e individual m uscle  in an em bryo (i.e 
o n e  in h em i-segm en ts A2, A3 or A4) n eed  to be duplicated or m issing for that em bryo to be scored  a s  having that d efect in an 
individual m uscle.U A S Mef2 10T4A line used  x Mef2 G al4 at 29°C.
25
Wild Type Him  Mutant
t
FIG 6.6.2 Mef2 gain-of-function and Him loss-of-function 
give the same phenotype
Over-expression of Mef2 mimics the phenotype of the Him mutant. Shown here is 
a duplication of the D01 muscle in UAS Mef2 (A) and Him 52 mutant embryos ( 
C). With the wild type shown for comparison (B).
A schematic in D shows the position of the D01 muscle in the wild type muscle
pattern.
UAS Mef2 10T4A x Mef2 Gal4 at 29°C, Him 52, and Wild Type (Oregon R)
embryos stained with anti p3-tubulin to visualise muscles. Muscle Schemat
Duplicated
Muscle
Him-52 Mutant
(% of total duplicated 
muscles)
UAS Mef2 x Mef2 Gal4
(% of total duplicated 
muscles)
D01 20.5 % 8.3 %
DA1 27.3 % -
LT1 18.2 % 20.8 %
LT2 11.4% 29.2 %
LT3 6.8% 20.8 %
Other
muscles
D03, DA3, VA1, VA3, 
V04
DT1, LT4, VA3
Total No. 
Duplications
44 24
Table 6.6.1 Muscles Duplicated in Him mutant and UAS Mef2
Muscle scored A2-A4 for 20 embryos. UAS Mef2 low driven by Mef2 Gal4 at 29°C.
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involves a duplication of muscles and these muscles are the same subset ; DOl, LT1, LT2 
and LT3. With VA3 also being duplicated as well -  the significance of which is discussed in 
the next chapter.
FIG 6.6.2 shows an example of UAS Mef2 mimicking the Him52 mutant with dorsal DOl 
duplication and Table 6.6.1 shows a break down of the duplicated muscles.
6.7 Muscle duplication or muscle splitting?
When an additional muscle is observed its occurrence might be down to one of two possible 
events; the specification of an additional founder cell for this muscle type early in 
development or the normal formation of a muscle from one founder cell with subsequent 
splitting of the muscle late in development.
It has been well established that the duplication of an individual muscle can occur at the cost 
of the development of another muscle. This stems from a change in fate of one cell within a 
founder cell pair. For example, VA1 and VA2 arise from the same sibling founder cells, with 
one founder specifying VA1 and the other specifying VA2. In an embryo that is mutant for 
the transcription factor Kruppel, two copies of the VA1 muscle form at the expense of the 
VA2 muscle and alternatively embryos over-expressing Kruppel can show a duplication of 
the VA2 muscle with loss of the VA1 (Ruiz-Gomez et al, 1997).
Such examples of muscle fate change seem less likely in the Him mutants studied as there 
does not seem to be any correlation between a muscle that is duplicated and a muscle that is 
lost, and in fact multiple duplications can occur without any muscle loss in that embryo 
(Table 6.5.1-.6.5.5).
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The first thing I needed to do was to determine whether the formation of an extra muscle 
could be described as a genuine duplication and the most obvious way to determine this was 
to look earlier in development before a developed (or developing) muscle would have had 
chance to split and give the impression of a duplication.
By considering the individual muscles that were most frequently duplicated, I was able to 
establish an idea of which founder cell markers would be best to investigate this.
6.8 Kruppel as a marker of the founders
In the Him mutants the most frequently duplicated muscles were DOl, DAI and the LT 
muscles and from the established transcription factors specific to the individual somatic 
muscles (Baylies et al, 1998), I considered Kruppel to be the most appropriate to investigate 
duplication. Kruppel is expressed persistently in DOl, DAI, LT2, LT4, LL1, VL3, V02, 
VA2 and V05 (Ruiz-Gomez et al, 1997) and a comparison of its expression pattern with the 
most frequently duplicated muscles in the Him mutants is shown in FIG 6.7.1.
For founder cell analysis I decided to concentrate on Him 52 as this line has by far the most 
frequent occurrence of muscle duplication (FIG 6.4.4, Table 6.5.3), and consequently any 
founder cell effects early in development are most likely to be seen with this line. In this line 
DOl and DAI are the most frequently duplicated and so I decided to concentrate on the 
founder cells associated with these muscles rather than those associated with the LT muscles. 
This is actually advantageous for a number of reasons; the DOl and DAI muscles are the 
easiest to follow in a Kruppel staining due to their isolated position within the embryo 
(consider how the other Kruppel positive muscles are grouped more closely together (FIG 
6.7.1), which makes scoring the founders more difficult) and also through the combined use 
of an Kruppel ; Eve double staining the DOl and DAI founders can be determined with
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Muscles most duplicated Muscles most duplicated 
in Him mutants in Mef2 over-expression
D01, DA1, LT 1 D01, LT 1/2/3
Kruppel positive 
founder cell derived
D01, DA1, LT2, LT4, 
LL1, V02, V05, VA2
FIG 6.7.1 Kruppel may be an indicator of duplication origin
The most frequently duplicated muscles in Him mutants are D01, DA1 and the LT muscles LT1,2,3. and in UAS Mef2 
embryos they are D01 and the LT muscles .Kruppel is persistently expressed in D01, DA1, LT2, LT4, LL1, VL3, V02, 
VA2 and V 05  (Ruiz-Gomez et al, 1997) and consequently an antibody raised against this transcription factor may be a 
good means of investigating the number of founder cells in the muscles frequently duplicated in Him mutants.
muscle
CO —V
. 1
. .  9 t f  ’
f *- - - - DA1
£ « - - - - - D01
St14 f * \ 11 i t : ,
FIG 6.6.2 Wild Type DA1 and D01 development can be traced with Kruppel antibody
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certainty (Baylies et al, 1998), as has been established in multiple other studies on these 
muscles (Ruiz Gomez and Bate, 1997; Carmena et al, 1997; Park et al, 1998).
FIG 6.7.2 shows how a staining using anti-Kruppel antibody in wild type embryos can be 
used to trace the lineage of the DOl and DAI muscles from the time their founder cells are 
first specified at around S tll. Originally a single founder cell expresses Kruppel and as 
fusion competent myoblasts fuse to this founder they too adopt expression of Kruppel, such 
that the number of Kruppel positive nuclei increase as the muscle develops. At St 11 there are 
two Kruppel positive nuclei, one founder cell for DAI and another for DOl.
6.9 Him Mutants have increased Kruppel positive founder 
cells
To investigate the occurrence of duplication in Him 52 mutants I performed a Kruppel 
staining in embryos that were fixed and stained in parallel with wild type embryos. 
Additionally at this point I also performed this staining in parallel with embryos that were 
over-expressing Him in the Mef2 pattern (UAS Him x Mef2 Gal4 @ 29°C) to investigate any 
effect on over-expressing Him on founder cell formation as it was already established that 
these embryos have a reduction in muscle number, I wanted to see if this could be explained 
by a reduction in founder cell number in a potentially opposite way to the Him 52 mutant 
phenotype. FIG 6.7.3 shows embryos from these experiments.
Though the number of Kruppel positive nuclei in a hemisegment is never completely uniform 
at a single timepoint throughout development (after the single founder cells stage) due to 
fusion competent myoblasts not fusing in synchrony, there is a distinctly greater number of 
Kr positive nuclei in the highlighted hemi-segment of the Him 52 embryo shown here than in
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FIG 6.4.3 Examples of somatic muscle duplication in mutants
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FIG 6.6.3 Him affects Kruppel positive founder cell number
FIG 6.6.3 Him affects Kruppel positive founder cell number
Him 52 mutant (A), Wild type (B) and Him over-expression (C) embryos were stained in parallel with Kruppel antibody to 
highlight Kruppel positive founder cells .
It reveals that Him loss of function conditions (A) cause an increase in founder cell number at St12 when compared to 
Wild type (B), whereas Him gain of function conditions (C) cause a decrease in founder cell number.
At least 15 embryos of the same stage for each line were found and imaged with representative images being shown 
here.
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the other hemi-segments of the embryo; the majority of hemi-segments contain two Kr 
positive nuclei in the Him 52 embryo, whereas in the hemi-segment indicated there are at 
least 5 Kr positive nuclei suggesting a duplication having occurred rather than just fusion 
occurring earlier in this hemi-segment. Compare this to the Wild Type embryo where the 
number of Kr positive nuclei appears fairly uniform across the hemi-segments.
In the Him over-expression embryo there is a clear reduction in founder cell number. There is 
only one Kr positive founder cell in some hemi-segments when there should be two or more 
at this stage. In addition, though the three stainings were performed in parallel the Kr staining 
in the UAS Him embryos appears weaker, which may suggest a general reduction in all Kr 
expression.
These results are significant on a number of levels; it shows that the duplications are genuine 
duplications that occur at the stage of founder cell specification, it gives further insight into 
the action of Him over-expression, and it suggests a role for Him and Mef2 early in 
development.
6.10 Discussion
The role of Him has previously been characterised mainly through its gain of function 
phenotype and is established as a repressor of Mef2 activity (Liotta et al and this study). 
Generation of a mutant deficient for Him through P-element mediated recombination as part 
of my study and the generation of two other targeted mutant lines by homologous 
recombination by the Zhe Han lab enabled the effect of complete loss of Him activity on 
somatic muscle differentiation to be investigated. Detailed analysis of the terminal somatic 
musculature of these mutants reveal that, though in general the musculature forms correctly, 
there were subtle changes to the muscle pattern; a particular subset of muscles are reliably
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duplicated in Him mutant embryos. These were the DOl, DAI, LT1, and LT2 muscles and 
they were seen to be duplicated in all three of the Him mutant lines at various frequencies. 
Whilst the loss of muscles in the terminal somatic musculature may occur for many different 
possible reasons, a duplication of muscle is a phenotype that is seen less frequently and often 
is associated with a role in patterning for a gene that caused the phenotype (Ruiz-Gomez et 
al, 1997). For Him then, any role in patterning would also imply a role for Mef2 on 
patterning and over-expression of Mef2 reveals this is likely to be the case; the Mef2 gain of 
function causes a duplication in these muscles too (and also VA3, see later chapter 7). The 
transcription factor Kruppel seemed a good candidate to investigate these duplications in the 
founder cells for these muscles and an initial analysis of the DOl duplications showed that 
the Him mutant contained additional founder cells that would be associated with a 
duplication for these muscles and alternatively that over-expression of Him resulted in loss of 
these cells and this suggests a role for Mef2 in founder cell patterning that has not been 
established.
The dogma is that Mef2 is not required for initial specification of the founder cells and this 
comes from the observation that certain markers of the founders are still expressed and 
appropriately positioned in Mef2 null mutants. Bour et al, showed this for Eve and Nautilus 
expression (Bour et al, 1995) and Lilly et al showed this for Nautilus, Apterous and S59 /  
Slouch (Lilly et al, 1995). However, neither paper show that all the founders are reliably 
formed and a number of observations have suggested that there may in fact be some role for 
Mef2 in this specification process. For example, a study of neuromuscular junctions that 
involved a detailed analysis of Vestigial and Connectin positive founders revealed that 
numbers of Vestigial positive nuclei are reduced in Mef2 mutant embryos compared to Wild 
Type (Prokop et al, 1996).
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This result with Kruppel expression in Him UAS and mutant embryos suggests that Mef2 
may play some role in the patterning process, though not as the only factor otherwise there 
would be no Kruppel founders at all in Mef2 mutants and this is not the case. In other 
examples of patterning, such as that seen with Numb segregation (Ruiz Gomez et al, 1997) 
only a percentage of founder cells undergo a fate change suggesting other the involvement of 
multiple factors in a pathway.
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Him and Zfhl
7.1 Introduction
Zfhl (Zinc Finger Homeodomain 1) is a transcriptional repressor that is conserved in 
vertebrates and invertebrates. As its name suggests it contains a Zinc Finger domain and a 
homeodomain (Fortini et al, 1991). A number of key papers have identified a role for Zfhl 
in somatic muscle differentiation (Lai et al, 1993; Postigo and Dean, 1997; Postigo et al, 
1999). Mutants for Zfhl are embryonic lethal and show defects in somatic muscle pattern 
formation (Lai et al, 1993) and over-expression of Zfhl through a heat shock construct 
causes inhibition of somatic muscle differentiation (Postigo et al, 1999). Associated with 
this there may be a possible reduction in Mef2 expression in these embryos (Postigo et al, 
1999). However, since this time research involving Zfhl has been directed towards other 
aspects of its function, for example in the pericardial cells of the heart (Liu et al, 2006; Su 
et al, 1999, Johnson et al, 2007; Sellin et al, 2009), the gonadal mesoderm and testes 
(Moore et al, 1998; Broihier et al, 1998; Leatherman and Dinardo, 2008) and the nervous 
system (Layden et al, 2006; Lee and Lundell 2007; Volger and Urban, 2008). Though some 
of these papers do consider the fate of somatic dorsal muscles in conjunction with heart 
pericardial cells (Su et al, 1999; Johnson et al, 2007; Sellin et al, 2009) a general role for 
Zfhl in somatic muscle myogenesis is not addressed.
As outlined, there is an opening in the field to investigate a role for Zfhl in somatic muscle 
differentiation and in addition to this there are a number of parallels between Zfhl and Him 
which make it worthy of investigation in the light of functional overlap between the two 
genes. Currently it is known in the literature tha t:
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- Both Him and Zfhl have repressor activity and have been shown previously to 
either clearly act upon Mef2 (Him - Liotta et al, 2007) or act upon Mef2 with 
some experimental uncertainty (Zfhl - Postigo et al, 1999).
- They have very similar expression patterns in the embryonic mesoderm, from 
the early stages of mesoderm formation through to the end of myogenesis at St 17 
(Fortini et al, 1991 ; Liotta et al, 2007 and Flyexpress).
- Over-expression of either gene causes a severe inhibition to muscle development 
(Liotta et al, 2007; Postigo et al, 1999).
With this in mind, I wanted to make a thorough comparison of the somatic muscle 
phenotypes associated with Him or Zfhl gain of function and loss of function and 
determine if Zfhl was capable of acting as a repressor of Mef2 function and if so, ask if 
there may be any functional redundancy between Him and Z fhl.
7.2 Him and Zfhl have similar expression patterns.
Him and Zflil are expressed in similar patterns in developing muscle, heart and adult 
precursors (FIG 7.1). Earlier in embryogenesis they both show expression in the subdivided 
mesoderm, the precursors of the somatic muscle, precursors of the pharyngeal and the 
precursors of the heart, but at the point of muscle differentiation, around late St 12, both 
transcripts show rapid down-regulation in the cells differentiating into muscle (somatic and 
pharyngeal), whilst remaining expressed in the undifferentiated adult muscle precursors 
(AMPs) and the pericardial cells of the developing heart. In addition to this co-expression
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FIG 7.1 Him and Zfhl have similar expression patterns in 
developing muscle.
Him and Zfhl are both expressed in similar patterns in developing muscle. Earlier in 
embryogenesis they both show strong expression in the mesoderm (arrow), the precursors 
of the somatic muscle and the precursors of the heart, but at the point of muscle 
differentiation, around St12l, both transcripts show rapid down-regulation in the somatic 
muscle, whilst remaining expressed in the undifferentiated adult muscle precursors 
(A .M .P’s) (arrow) and the pericardial cells of the developing heart (arrowhead). In addition 
to this co-expression though, Z fh l is expressed in the nerve cord (blue arrow, out of focus), 
the embryonic brain, the gonads and the pharyngeal muscle, whereas Him is only 
expressed in the pharyngeal.
This co-expression may suggest both genes are expressed in (the same) a muscle cell to 
doubly ensure the appropriate regulation of Mef2; holding back its activity as a 
transcriptional activator until the appropriate time. As Him acts upon the Mef2 protein and 
Zfh l acts upon the Mef2 RNA transcript this may suggest a “belts and braces” mechanism  
of Mef2 repression -  whereby two different convergently evolved mechanisms exist to 
ensure the same result is achieved.
Embryos are wild type Oregon R. In-situ hybridisation perform ed using Him and Z fh l RNA 
probes.
Him RNA in-situ Zfhl RNA in-situ
St12e
Lateral
j m
St12e
Dorsal
St12l
Lateral
St12l
Dorsal
St13
Lateral
I P l W v 'P
St13
Dorsal
FIG 7.1 Him and Zfhl have similar expression patterns in developing 
muscle.
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though, Zfhl is expressed in the nerve cord, the embryonic brain and the gonads (Flybase, 
FlyExpress).
This expression pattern in the developing muscle, whereby the gene is initially expressed in 
cells that are not yet differentiated, is rapidly lost in cells that begin to differentiate in 
muscle, but persists in cells that remain undifferentiated, is consistent with a potential 
repressor of muscle differentiation. Though, Twist, which is considered to be an activator 
in Drosophila development (Baylies and Bate, 1996) also has a pattern similar to this, 
being a marker of the undifferentiated AMPs (Bate et al, 1991).
7.2 Over-expression of Zfhl reduces Mef2 RNA transcript 
levels, whereas over-expression of Him does not.
It was shown previously that Zfhl binds to the regulatory regions of the Mef2 gene and that 
over-expression of Zfhl through a heat shock construct causes a possible reduction in Mef2 
RNA levels (Postigo et al, 1999). This method of gene over-expression is quite crude, in 
that not only can the inducing temperature required for the shock be detrimental to the 
normal development of the embryo, but also there is little control over where the over­
expression occurs and at what level it occurs at. Because of this I wanted to repeat the 
experiment (of testing the effect of Zfhl over-expression on Mef2 RNA levels), but using 
the Gal4 UAS system and at the same time do a direct comparison of over-expression of 
Him on Mef2 RNA levels. FIG 7.2a shows how over-expression of Zfhl in the Mef2 
pattern causes a severe reduction to Mef2 RNA transcript levels in comparison to wild type 
embryos of the same stage. At the driving temperature of 29°C the majority of Mef2 
transcript is lost. The embryos shown are representative of the phenotype and there were 
some Zfhl over-expression embryos where no Mef2 RNA was detected at all (FIG 7.2b).
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UAS Zfhl Wild Type
FIG 7.2b UAS Zfhl can have complete absence of Mef2 RNA transcript
An example of a UAS Zfhl embryo, which causes a loss of all Mef2 RNA transcript. UAS Zfhl 
driven with Mef2 Gal4 at 29°C.
The staining seen in the UAS Zfhl embryo is an artefact of the in-situ hybridisation and does not 
represent Mef2 expression.
St11
St12
St13
St14
FIG 7.2a Zfhl represses Mef2 at the RNA level, whereas Him does not.
Both Zfhl and Him are repressors of Mef2. Zfhl inhibits Mef2 activity at the RNA level. W hen over-exp ressed , Zfhl c a u s e s  a 
se v e r e  reduction in Mef2 transcript level a c r o ss  all s ta g e s  of em b ryogen esis  com pared to wild type. This inhibition can be so  
se v e r e  that no Mef2 transcript is d etected  (FIG 7.2b) Him inhibits Mef2 activity by acting on the Mef2 protein, not the RNA, 
and consequently  the levels of Mef2 transcript in em bryos over-expressing  Him are similar to th o se  s e e n  in wild type em bryos. 
Later s ta g e  Him over-expression  em bryos do sh ow  a slight reduction in Mef2 transcript levels com pared to wild type em bryos  
of the sa m e  sta g e . This m ay b e  due to the e ffects  of reducing M ef2 protein activity at the s ta g e s  w hen M ef2 auto-regulation  
begins.
UAS Zfhl and UAS Him driven by Mef2 Gal4 at 29c. Wild type is Mef2 Gal4 control at 29c. Embryos fixed and in-situ’s 
performed in parallel. Representative embryos of 15 for each stage shown.
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It was established previously that Him represses Mef2 through action upon the Mef2 
protein, not through regulation of the Mef2 transcription or translation (Liotta et al, 2007). 
Consequently, one would expect over-expression of Him to not affect Mef2 RNA levels 
and this is the case (Compare B and C in FIG 7.2a). However, in some embryos it appears 
that Mef2 RNA levels in the later stages are reduced slightly in comparison to wild type 
levels (Compare Stl4 UAS Him embryo with Stl4 Wild Type FIG7.2a, arrow indicates 
developing pharyngeal muscle which is reduced compared to wild type). This may be due 
to the action of Mef2 auto-regulation (Cripps et al, 2004), whereby Mef2 protein acts upon 
its own regulatory region to increase expression of the gene at these stages.
This result shows that Zfhl does indeed reduce Mef2 RNA levels, whereas Him does not, 
and through knowledge from previous publications, shows that Zfhl and Him are both 
capable of inhibiting Mef2 activity but achieve this through alternative mechanisms.
7.3 Over-expression of Him and over-expression of Zfhl gives 
similar somatic muscle phenotypes.
Zfhl and Him can induce very similar somatic muscle defects on comparison of the 
phenotypes associated with their over-expression in the mesoderm.
When driven by Mef2 Gal4 at 29°C both over-expression of UAS Him or over-expression 
of UAS Zfhl causes muscle loss in all embryos tested and they give a similar range and 
average number of muscles missing (A range of 59-72 muscles missing in UAS Him 
embryos (A2-A4) and a range of 47-72 muscles missing in UAS Zfhl embryos. The 
average number of muscles missing is 67.1 and 59.9 for Him and Zfhl respectively) (Table
7.3.1). In addition this over-expression causes embryonic lethality as seen in hatching and 
survival tests (Table 7.3.1).
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Analysis of the individual somatic muscles missing also shows how similar the Him and 
Zfhl over-expression phenotypes are (Table 7.3.2a).
For this analysis at 29°C, all the muscles (A2-A4) of 20 embryos were scored and the table 
shows the percentage of embryos that have an individual muscle type missing. Only one 
individual muscle from the three hemi-segments scored needs to be missing for an embryo 
to be scored as lacking that individual muscle type. As can be seen the majority of muscles 
are missing in the over-expression embryos; 24 out of the 30 muscles are missing in at 
least 80% of embryos for UAS Him at 29°C and 27 of the 30 muscles are missing in at 
least 80% of the embryos for UAS Zfhl at 29°C (Table 7.3.2a).
Because of the severity of the phenotypes I broke down the data further to elucidate which 
individual muscles were the most severely affected and which, though still significantly 
affected, were less so in comparison. I did this in two ways, the first was to further 
categorise the percentage of embryos that show muscle loss; either lost in all embryos 
(100%), in 90-99% of embryos or 80-89% of embryos. And the second was to distinguish 
the individual muscles that were missing almost every time in all three of the hemi- 
segments scored per embryo. For this, I calculated the average number of muscles missing 
(A2-A4) in all the embryos that lacked that muscle type and defined having a muscle 
missing almost every time in every hemi-segment as those that were lost on average 2.8 
times (A2-A4) in an embryo. For example, if a muscle type was lost in every hemi-segment 
in every embryo it would have an average loss of 3 (i.e missing 60 times over the 20 
embryos scored), whereas if it was lost in almost every hemi-segment it would have a 
slightly lower average, e.g for an average of 2.8 then 56 out of a possible 60 muscles would 
be lost over 20 embryos scored. I highlighted the muscles that fell into this category on the 
Table in blue for UAS Him and red for UAS Zfhl.
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Muscle phenotype
UAS Him x Mef2 Gal4
(29°c)
UAS Zfhl x Mef2 Gal4
(29°c)
% embryos with 
muscle missing
100% 100 %
Average No. muscles 
missing per embryo 67.1 59.9
Range of muscles 
missing per embryo 59-72 47-72
Survival assay
Hatching 0% 0%
Survival 0% 0%
Table 7.3.1 -  Muscle phenotypes in embryos over-expressing Him or Zfhl.
Over expression of Him and Zfhl both gives a severe muscle phenotype, with the majority of somatic 
muscles being lost. The severity of the phenotype is similar with both genes, when driven by Mef2 Gal4 at 
29°c.
Cross Muscles Missing in 
100 % Embryos
Muscles Missing in 
90-99 % Embryos
Muscles Missing in 
80-89% Embryos
Muscles Missing in 
50 - 79% Embryos
Muscles Present in 
90 -  100% Embryos
UAS Him
X
Mef2 Gal4 
(29°C)
D02, D03, D05, LL1, 
LT1, LT2, LT3, LT4, 
LOLVL4, VA3, V02, 
V03, V04, V05. V06
DA2, DA3, SBM, 
VL3, VA1, VOl,
D04, VL2, DAI, VT1, VA2, 
DOl, VL1
DTI
UAS Zfhl
X
Mef2 Gal4 
(29°C)
003, D05, LT1, LT2, 
LT3, LT4, LOl, VL4. 
VA1, VA3, VOl, VOS, 
V06
DAI, D04, LL1, 
VL2, VL3, VA2, 
V02, V03, V04
DOl, D02, DA2, 
DA3, VL1
SBM, VT1 DTI
Table 7.3.2a A similar subset of muscles are missing with over-expression of Him or over­
expression ofZfhl at different temperatures.
Cross Muscles Missing in 
100 % Embryos
Muscles Missing in 
90-99 % Embryos
Muscles Missing in 
80-89% Embryos
Muscles Missing in 
50 - 79% Embryos
Muscles Present in 
90 -  100% Embryos
UAS Him
X
Mef2 Gal4 
(21°C)
DAI, DA2. D03, D05, 
LT2, LT3, LT4, LOl, 
VL2, VA1, VA3, VOl, 
V02, V03, V04, V05, 
V06
D04, DA3, SBM, 
VL3, VL4
DOl, LT1, VL1, D02, DTI, LL1, 
VA2
UAS Zfhl
X
Mef2 Gal4 
(21°C)
D03, D04, D05, LL1,
LT2, LT3, LOl, VL3, 
VL4, V03, V04, VOS,
V06
LT4, VA1, VA3, 
V02
DA2, DOl, DAI, DA3, 
LT1, VT1, VL2, 
VA2, VOl
DTI
Table 7.3.2b A similar subset of muscles are missing with over-expression of Him or over 
expression of Zfhl at different temperatures.
Table 7.3.2 A similar subset of muscles are missing with over-expression of Him or over­
expression of Zfhl at different temperatures.
The 30 individual somatic muscles of hemi-segments A2,A3 and A4 (a total of 90 muscles) were scored per embryo. 
Only one individual muscle from the three hemi-segments scored needs to be missing for an embryo to be scored as 
having that individual muscle type missing. Comparisons in the table are made between UAS Him and UAS Zfhl at the 
same temperatures. 20 embryos for each experimental condition were scored at 29°C and 10 embryos for each 
experimental condition were scored at 21 °C. Where a muscle is highlighted as bold and underlined in the table it is 
missing in the same category for both UAS Him and UAS Zfhl at that temperature. A muscle highlighted as just bold is 
in the adjacent category. A muscle that is coloured (blue for UAS Him and red for UAS Zfhl) is missing in that 
percentage of embryos at an average frequency of 2.8 or greater per embryo scored -  i.e that individual muscle was 
missing almost every time in each of the three hemi-segments scored per embryo.
Over-expression of Him or Zfhl in the Mef2 pattern at either 29°C or 21 °C shows a strikingly similar subset of individual 
somatic muscles being missing as shown by the number of muscles missing that fall into the same category for both 
phenotypes. In addition at 29°C and 21 °C, although the phenotype of Him over expression is stronger than that of Zfhl 
over-expression (as shown by the greater number of individual muscles that have an average missing frequency of 2.8 
or greater in hemi-segments A2-A4 and Table 3.3.1) all of the muscles missing at this high frequency in UAS Zfhl at 
29°C (D03, LT1, L01, V05, V06) and 21°C (V05, V06) are missing at the same high frequency in UAS Him at that 
temperature, suggesting that they are a muscle type more susceptible to a decrease in Mef2 activity for both UAS Him 
and UAS Z fh l
Data not shown in table: Him @ 21 °C: VT1 missing 30%. Zfhl @21 °C : D02, VL1 missing 30% . SBM missing 20%
UAS Him
H I M : . ' v
Wild Type
FIG 7.3.1a Over-expression of Him and Zfhl gives similar 
somatic muscle phenotypes
UAS Him and UAS Zfhl both give a similar phenotype of som atic m uscle lo ss  and 
disruption. A large num ber of m u scles  are a b sen t in both UAS Him (B) and UAS  
Zfhl (A) em bryos com pared to Wild Type, C. For exam ple, D 0 3  (arrow), D 0 5  and  
LL1 (blue arrowhead and arrowhead), LT1-4 and L01 (bracket). Similar m u scles  
a lso  remain present with similar d efects , such  a s  DT1 (asterisk), which is 
m isshapen , having parts of the m uscle that are thinner than others (com pare red 
arrows in a single m uscle for both A and B) w h erea s by com parison, wild type DT1 
is a of a consisten t th ickn ess (asterisk in C). A lso VL1 is similarly m isattached in 
both UAS Zfhl and UAS Him em bryos (blue arrow in A -  out of focu s in B and C). 
A sch em atic  of the m u scles  m issing or affected  is show n in D .UAS constructs 
driven by Mef2 Gal4 at 29 °C. All embryos St17 and viewed dorsally. Embryos 
stained with /33-tubulin. Wild type embryo is Oregon R at 29 °C.
LT1-4
Muscle Schematic
FIG 7.3.1b Over-expression of Him and Zfh1 gives similar somatic muscle phenotypes
As shown in Table 7.3.2a and FIG 7.3.1a the phenotypes of UAS Him and UAS Zfh1 in the somatic muscle are very 
similar. This FIG is an extension of 7.3.1b, showing that the somatic muscle phenotype is similar when viewed dorsally 
(A,B), dorso-laterally (D,E), laterally (G,H) and ventro-laterally (J,K). However, notice the striking difference in heart 
formation between the UAS Zfh1 and UAS Him embryos (A,B); the heart is severely disrupted with Zfh1 over­
expression (A), whereas it is similar to wild type in Him over-expression (compare B with C) This is addressed further 
in FIG 7.3.3.
UAS constructs driven by Mef2 Gal4 at 29 °C. All embryos St17. Embryos stained with /33-tubulin. Wild type embryo is 
Oregon R at 29 °C.
UAS Zfh1 UAS Him
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FIG 7.3.1b Over-expression of Him and Zfh1 gives similar somatic muscle phenotypes
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With this in mind we can see that the individual somatic muscles that are lost on over­
expression of Him or Zfhl at 29°C are strikingly similar, with the same muscles being most 
readily lost and the same muscles being most easily retained. For example; D03, D05 
dorsally, LT1, LT2, LT3, LT4 and LOl, laterally and VL4, VA3, V05 and V06 ventrally 
are all lost at least once in the three hemi-segments scored (A2-A4) in 100% of embryos 
(Table 7.3.2a), and of these D03, LT1, LOl, VA3,V05 and V06 are missing in nearly 
every hemi-segment scored for both conditions.
On the other hand muscles such as DTI and VT1 are ones that most frequently remain 
present in both UAS Him and UAS Zfhl embryos (Table 7.3.2a).
These similarities can be seen visually in St 17 embryos stained with p3-tubulin (FIG 
7.3.1a and 7.3.1b). Both the UAS Him and the UAS Zfhl embryos show a phenotype with 
large gaps in the muscle pattern; where particular muscles are consistently lost, such as 
D03, D05, LL1, LT1-4, LOl as shown in the figure and the same muscles being 
consistently present such as DTI and VL1. Those muscles that are present often are not 
wild type in appearance and show the same defects in both Him and Zfhl embryos, for 
example the misattachment of VL1 or the way that DTI is misshapen; being thinner in 
some parts of the muscle than others, whereas a wild type DTI muscle is of a consistent 
thickness (FIG 7.3.1).
When the genes are over-expressed at a lower temperature, a milder phenotype is induced 
for both UAS Him and UAS Zfhl but the similarity of muscles affected still holds true. 
With over-expression of Him or Zfhl in the Mef2 pattern at the lower driving temperature 
of 21°C a number of observations and comparisons can be made. Firstly, the same muscles 
are most readily affected, but at a lower frequency, as you drop the temperature from 29°C 
to 21°C for UAS Him embryos -  showing that although the phenotype associated with 
driving Him at a lower temperature is weaker, and muscles are less frequently lost, the
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individual muscles affected are the same subset of muscles as those lost when Him is 
driven at the higher temperature. For example, over-expression of Him at 29°C gives 13 
individual muscles (D03, D05, LL1, LT1, LT2, LT3, LT4, LOl, VA3, V03, V04, V05, 
V06) that are lost in nearly all hemi-segments of every embryo tested (7.3.2a, columnl), 
whereas over-expression of Him at 21°C gives 9 individual muscles (DA2, D05, LOl, 
VA1, VA3, VOl, V02, V03, V04, V05, V06) that are lost in nearly all hemi-segments 
of every embryo tested (7.3.2b column 1). The same occurs for over-expression of Zfhl at 
the lower temperature, the muscles lost here are the same subset as those lost when Zfhl is 
over-expressed at 29°C, but the loss occurs at a lower frequency. For example, at 29°C 
D03, LT1, LOl, V05 and V06 are lost in nearly all hemi-segment of every embryo scored 
(7.3.2a columnl), whereas at 21°C only V05 and V06 are lost at this high frequency 
(7.3.2b column 1). Importantly from this, it follows that the same subset of muscles are 
missing in UAS Him embryos and UAS Zfhl embryos at 21°C, for example all (with the 
exception of LL1) of the individual muscles that are missing in 90-100% of UAS Zfhl 
embryos at this lower temperature (Table 7.3.2b column 1 and 2) are also missing in 90- 
100% of UAS Him embryos at the same temperature (Table 7.3.2b column 1 and 2). The 
fact that the muscle phenotype is still similar at a lower temperature is reassuring, in that 
not only is it good that the observation still holds true on being repeated but also it stems 
any concerns that the phenotypes may only seem similar at the higher temperature of 29°C 
because the genes were driven so hard, and the phenotype so strong that the majority of 
muscles were lost, and if the majority of muscles are lost it may be harder to accurately 
compare phenotypes.
Despite the definite similarities of somatic muscle phenotypes with Him and Zfhl over­
expression, it should be noted that the UAS Him line tested generally gives a slightly
128
Chapter 7: Him and Zfhl
stronger phenotype than the UAS Zfhl line driven at the same temperature. For example, 
despite the LT muscles LT1-4 being missing in 100% of embryos for both UAS Him and 
UAS Zfhl driven at 29°C, it is only LT1 in UAS Zfhl embryos that is lost in an average of 
2.8 / 3 hemi-segments, whereas LT1, LT2, LT3 and LT4 are lost in an average of 2.8 / 3 
hemi-segments with UAS Him (Table 7.3.2a columnl). This greater frequency of loss in 
UAS Him embryos is reflected in Table 7.3.1, where the range and average of muscles lost, 
though similar to UAS Zfhl is slightly higher in the UAS Him experiments (for example, 
an average number of 67.13 muscles missing in the three hemi-segments scored per 
embryo for UAS Him embryos whereas UAS Zfhl have an average of 59.85 muscles 
missing).
This slight difference in phenotype severity could be due to some variation in the strength 
of the line due to transgene insertion site or it may occur due to a difference in mechanism 
between Him and Zfhl; as Zfhl likely acts upon Mef2 at the level of transcription any 
Mef2 RNA that does manage to become translated would be able to function as normal.
7.4 Differences in the UAS Zfhl and UAS Him muscle 
phenotypes
7.4.1 UAS Zfhl gives unfused myoblasts
Although the same individual muscles are missing in Him and Zfhl over-expression 
embryos, there are two distinct differences in their associated phenotypes. The first is that 
UAS Zfhl embryos have a considerable number of unfused myoblasts present in the 
abdominal wall region. This is especially so in the later, but not final, stages of muscle 
formation (i.e Stl6-early 17, but not late Stl7) -  whereas UAS Him only has a few unfused 
myoblasts present in the abdominal wall at these stages even in both of the over-expression
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UAS Zfhl UAS Him Wild Type
FIG 7.4.1 Over-expression of Zfhl gives unfused myoblasts whereas Him does not
D esp ite  having the sa m e  m u sc le s  m issing, a distinct d ifference b etw een  Zfhl and Him overexp ression  experim ents is that 
there are a large num ber of unfused m yob lasts presen t in the abdom inal wall of UAS Zfhl em b ryos in early S t17  em bryos  
w h erea s  there are none in UAS Him em bryos. Arrow in A, sh o w s an exam p le  of a sin gle  unfused m yoblast for clarity in UAS  
Z fhl em bryo.
Em bryos here are driven by Mef2 Gal4 at 29°C , view ed dorso-laterally and stained with anti p3 tubulin.
UAS Zfhl x Mef2 Gal4 (29°C)
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FIG 7.4.2 Examples of unfused myoblasts in UAS Zfhl 
embryos.
N um erous unfused  m y o b la sts  can  clearly b e  s e e n  in th e  dorsal (A) , lateral (B) and  
ventral (C) reg ion s of em b ry o s  o v e r -ex p ressin g  Z fhl in the M ef2 G al4 pattern at 
29°C . Arrows only point to a  s in g le  e x a m p le  of an un fu sed  m yob last in e a c h  view.
Em bryos are sta in ed  with anti p-tubulin.
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temperatures tested (FIG.7.4.1). Examples of unfused myoblasts in Zfhl over-expression 
embryos can be seen dorsally, laterally and ventrally within the abdominal wall (FIG
7.4.2).
7.4.2 UAS Zfhl affects heart formation
The second difference is perhaps the most striking one, and this is that UAS Zfhl embryos 
have a severe disruption to the development of the heart, inhibiting the expression of p3- 
tubulin and causing loss of the cardioblasts, whereas by comparison, the heart in UAS Him 
embryos appears generally unaffected even when UAS Him is driven strongly at 29°C with 
Mef2 Gal4.
In wild type embryos, four out of the six cardioblasts in each hemi-segment of the heart 
express p3-tubulin (7.4.3 image C). However, when Zfhl is over-expressed in the Mef2 
pattern only the occasional, mis-shapen, apparent P3-tubulin positive cardioblast is present 
(FIG 7.4.3 image A). In contrast to this, over-expression of Him in the Mef2 pattern has 
little effect on heart formation, with, in general, the full four p3-tubulin positive 
cardioblasts being present and correctly shaped and positioned within the linear heart tube 
structure. There are occasional mild defects, such as the loss of one or two p3-tubulin 
cardioblasts, (as seen in this embryo(B) in FIG 7.4.3), a kink in the shape of the heart, or 
extra p3-tubulin cardioblast-like cells outside of the dorsal tube (See FIG 5.2.3).
This observation for Him is consistent with results obtained previously on the role of Mef2 
and of Him on cardioblast differentiation.
In Mef2 null mutants the heart tube forms and the cardioblasts are specified, as shown by 
p3 tubulin expression, but the cells fail to differentiate as markers such as Myosin Heavy 
Chain (Mhc) are not expressed (Lilly et al, 1995; Damm et al, 1999).
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FIG 7.4.3 Over-expression of Him and Zfhl give different phenotypes in the heart
Although UAS Him and UAS Zfhl both give a similar phenotype of som atic  m u scle  lo ss  and disruption their p h en otyp es are 
very different in the heart. p3-tubulin exp ression  in the cardioblasts of the heart in an em bryo over-expressing  Him is similar 
to wild type, with, in general, 4  out of 6 cardioblasts exp ressin g  (33-tubulin in a linear heart a s  exp ected  (com pare bracket in 
B with wild type, C and a lso  Fig 2 .3 .2 ). H ow ever in Zfhl over-expressing  em bryos p3-tubulin exp ression  is severe ly  
disrupted, with only the occasion a l m issh ap en  apparent p3-tubulin positive cardioblast forming (arrows in A).
UAS constructs driven by Mef2 Gal4 at 29 °C. All embryos St17 and viewed dorsally. Embryos stained with /33-tubulin. Wild 
type embryo is Oregon R at 29 °C.
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A similar observation was seen with Him over-expression; p3 tubulin expression in the 
cardioblasts is unaffected, whereas there is a severe disruption to Mhc expression (Liotta, 
PhD thesis 2006). These results suggest that the expression of p3-tubulin in the heart is 
independent of Mef2 and that Zfhl is capable of inhibiting whichever factor is responsible 
for this expression.
7.5 The Stl7 somatic muscle phenotype of Zfhl2 mutants.
After establishing that Him and Zfhl are expressed in the same pattern in the developing 
mesoderm and that their over-expression gives a similar terminal somatic phenotype I 
wanted to make a comparison of the Zfhl and Him mutant phenotypes.
The Zfhl2 mutants were originally established and their phenotype described by Lai et al in 
1993 (Lai et al, 1993). However, the description of the somatic muscle phenotype in this 
paper was quite limited; their analysis of the somatic muscle described how loss of Zfhl 
function results in “various degrees of local errors in cell fate or positioning” and “a wide 
variety of errors in the pattern and a range of severities”, but only mentioned a few specific 
effects on patterning. For this study, I wanted to go into the somatic muscle phenotype of 
Zfhl2 mutants in greater detail in order to further understand the role of Zfhl in somatic 
muscle development, and also enable comparison to other experimental situations where 
Mef2 activity is increased; such as in Him mutants, and Mef2 over-expression embryos.
Analysis of the somatic musculature of hemi-segments A2-A4 of twenty individual 
embryos enabled a more detailed characterisation of which muscles are affected in Zfhl 
mutant embryos. As seen in the Lai et al study, the phenotype of Zfhl2 mutant embryos is 
variable. Embryos can show a predominant gain in muscles, a predominant loss of muscles
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or both gain and loss of muscles. FIG 7.5.1 shows examples of this; where there are 
duplications in the LT muscles in an embryo that shows few other defects (Embryo B - an 
example of an embryo with a predominant gain of muscles). There are also embryos which 
show a predominant loss of muscles (Embryo D), where there are a number of the dorsal 
muscles missing. Embryos F and H are both show gain and loss of individual somatic 
muscles. In embryo H we see reproduction of the main specific phenotype described in the 
Lai et al study; where there is loss of the ventral muscles V04, V05 and V06 to just a 
single VO muscle in this position.
LT muscles were observed to be genuine duplications on the basis that there was no end 
splitting of the muscles, they were distinct, single muscles that could be seen spanning fully 
between attachment points. In addition, all the LT muscles were of a similar size, with a 
height and width that corresponded to both the other LT muscles in a mutant embryo and 
more importantly to wild type LT muscles. This suggests that if each distinct muscle arose 
as a result of splitting during development, then the muscle that split would have been 
twice the thickness of a normal muscle. No such thicker LT muscles or intermediates in a 
splitting process were observed.
Of all of the embryos scored, the majority (75%) have at least one duplication and one 
muscle missing, 15% have muscles missing but no duplications and 10% have duplications 
but no muscles missing (Table 7.5.1); from this scoring the variability of the phenotype can 
be seen. Though 90% of embryos have muscles missing and 85% of embryos have muscles 
duplicated, the frequency of muscle loss in an individual embryo is greater than the 
frequency of muscle gain, for example the average number of muscles missing in an 
embryo is 6.05 and the range of muscles missing in an embryo is 1-24, whereas the average 
number of duplications in an embryo is 2.05 with a range of 1-8 (Table 7.5.2). In addition,
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FIG 7.5.1 -  Zfhl loss of function disrupts muscle pattern
Zfhl mutant embryos can show a phenotype with a predominant gain of muscles, a predominant loss of muscles or a 
combination of both.
Embryo B shows a predominant gain in muscles, with multiple duplications (Compare embryo B, which shows LT 
duplications (asterisks) with Wild Type A). These embryos are often free from many other shape and positional defects. 
Embryo D shows a predominant loss of muscles, with multiple muscles missing (Compare embryo D, which shows loss 
of DA1 (arrow), DA2 (arrowhead) and D02 (asterisk) with Wild Type C). These embryos tend to show other shape and 
positional defects in addition to muscle loss (Compare shape of DA2 (blue arrowhead) and D02 (blue asterisk) in 
hemisegment A3 with Wild Type C).
Embryo F shows both gain and loss of muscle (An LT is duplicated (asterisks) and L01 is lost (arrow) compared to Wild 
Type E). These embryos often show the greatest number of shape and positional defects.
The main phenotype described in the Lai et al study was the apparent reduction of the three ventral-oblique muscles 
(V04, V05, V06) to only one muscle. These VO muscles were the most commonly missing in this studies’ scoring 
analysis (see Table 3.4) and the phenotype is shown in Embryo H (Compare single VO (arrow) to the three in Wild Type 
G). This Zfhl mutant embryo also shows a VA3 duplication (arrowhead) and loss of VA1 (asterisk) and VT1 (blue 
asterisk).
Zfhl mutants were Zfh1-2 /  TM3 ftz LacZ (Lai et al 1999). Homozygous mutants were selected by staining against LacZ. 
Muscles were stained with anti-b3 tubulin (guinea pig). Wild type embryos were Oregon R.
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FIG 7.5.1 -  Zfhl loss of function disrupts muscle pattern
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every embryo scored contains multiple shape defects in individual muscles and a large 
number (60%) of embryos contain attachment defects in some muscles.
Despite the variation in embryos showing either muscle loss or muscle duplication on 
analysis of the individual muscles distinct patterns present; as shown in FIG 7.5.2, certain 
individual muscles are predominantly or solely duplicated (e.g LT1, LT2, LT3 and VA3) 
other muscles, such as D03, LOl, VL1-4 and V04-V06 are only ever missing in the 
embryos scored. There are also other muscles, which appear unaffected (in terms of muscle 
loss or duplication) such as LL1 and V03, and others which have similar percentages of 
embryos with that muscle either lost or duplicated (e.g D02). So despite the fact that on 
first observation the Zfhl mutant phenotype is variable, and that as reported in the Lai et al 
study there are a “wide variety of errors in the pattern and a range of severities”, more 
detailed analysis shows that there is a definite pattern to how individual somatic muscles 
respond to the loss of Zfhl activity, there are muscles which could be described as most 
likely to be duplicated on loss of Zfhl and others that are most likely to be missing on loss 
of Zfhl activity. FIG 7.5.3 shows a summary schematic of the muscles that are 
predominantly or solely duplicated, the muscles that are predominantly or solely missing
and the muscles that appear predominantly unaffected (muscles that are either never
•  * •  * 2missing or duplicated or are only missing in 5% of embryos) in the Zfhl mutant
phenotype. Such an observation may suggest of a role for Zfhl in the control of somatic 
muscle patterning.
In some examples of muscle patterning, a transformation of fates occurs whereby the 
duplication of one muscle happens at the expensive of another one. In this case the two 
muscles arose from an initial progenitor that gave rise to two muscles founders as is the 
case in the formation of the Kruppel positive founders that give rise to the VA1 and VA2
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Muscles
MISSING
Muscles
DUPLICATED
SHAPE
DEFECTS
ATTACHMENT
DEFECTS
% Embryos with 
phenotype
90% 85% 100 % 60%
Average number 
muscles with 
phenotype per 
embryo
6.05 2.06 16.45 3.92
Range 
of muscles with 
phenotype per 
embryo
1- 24 1 - 8 3 - 4 2 1 - 13
TABLE 7.5.2 -  Zfhl loss of function gives a complex muscle pattern phenotype
The thirty somatic muscles of a hemisegment for hemisegments A2-A4 were scored for duplication, loss, shape and 
attachment defects in 20 individual embryos in Zfh1-2 mutants. The percentage of embryos that show at least one example 
of a defect A2-A4 , the average number of muscles of that defect per embryo (A2-A4) and the range of muscles affected (A2- 
A4) for all affected embryos is shown here.
Embryos were stained with (33-tubulin to visual ise muscles.
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FIG 7.5.2 Muscles missing or duplicated in Mutants
Graph showing the percentage of Z fh l2 mutant embryos that show at least one example 
in hemi-segments A2-A4 of muscle loss or muscle duplication for each of the thirty 
individual somatic muscles. Blue represents missing muscles, red represents duplicated 
muscles. Notice that certain individual muscles such as LT1, LT2, LT3 and VA3 are 
predominantly or solely duplicated, others, such as D 03 , L O l, VL1-4 and V 0 4 -V 0 6  are 
only ever missing in the embryos scored. There are also other muscles, which appear 
unaffected (in terms of muscle loss or duplication) and others which have similar 
percentages of embryos with that muscle either lost or duplicated (e.g D02).
DUPLICATED 
Muscles
MISSING
Muscles
UNAFFECTED 
Muscles
LT1, LT2, LT3, VA3 D03, L01, V04, V05, V06 DT1» D05’ LL1 >
SBM, V01, V03,
VT1. VA1, VA2
FIG 7.5.3 Muscles most frequently duplicated, missing or unaffected in the phenotype 
analysis of Z fh l2mutants .
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muscles (Ruiz Gomez et al, 1997). In the Zjhl2 analysis there does not appear to be a 
definite trend whereby one individual muscle is duplicated and others are lost. For 
example, with duplications of the LT muscles, there is not another individual muscle that is 
lost at the same time, and in fact there are embryos where LT duplication occurs without 
the loss of any other somatic muscles (Table 7.5.1). This may not be surprising when one 
considers the origins of the LT muscles; Bourgouin et al, 1992 show that over-expression 
of the transcription factor Apterous , which is a identity gene for these muscles, can cause 
duplication in them, without the expense of other muscles being lost.
The duplication of VA3 may possibly arise at the expensive of other muscles however; in 
every embryo that undergoes a VA3 duplication there is also a loss of the V04 or V06 
muscles (Table 7.5.1). However, recent evidence summarised by Beckett and Baylies, 
2009, suggests that VA3 is paired with an AMP with respect to sibling origin. The pairings 
for V04-5-6, however are not known.
This more detailed analysis of Zfhl mutants allows for a detailed comparison of the Him 
mutant and other experimental situations which result in a possible increase of Mef2 
activity during muscle development.
7.6 Comparison of Zfhl2 mutant phenotype to Him 
mutant and Mef2 over- expression phenotypes.
As described above, certain individual somatic muscles are either lost or duplicated in 
Zfhl2 mutants this was also the case in Him mutants as revealed in their analysis in Chapter 
6. As both Him and Zfhl are repressors of Mef2 activity I wanted to investigate the 
individual muscles affected in Him and Zfhl mutants and see if they were the same. In 
addition, for this comparison I also scored the muscles of the abdominal hemi-segments
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A2-A4 for twenty embryos in the usual way for embryos that over-expressed Mef2 in the 
Mef2 pattern at 29°C. The UAS Mef2 line was the “low strength” line 10T4A as described 
in Gunthorpe at al, 1999.
FIG 7.6.1 shows graphs of the percentage of embryos showing the loss or duplication of an 
individual muscle for each of the thirty muscles in abdominal hemi-segments A2-A4. Mef2 
over-expression, Him loss of function and Zfhl loss of function are all three very distinct 
ways of increasing Mef2 activity in muscle development, yet strikingly there are definite 
similarities in the phenotype for these three different experimental conditions. Most notable 
is the duplication of the LT muscles, which occurs at a relatively high frequency in all of 
the conditions. VA3 is also duplicated in all conditions, but with a much greater frequency 
in Zfhl mutants. Similarly DOl is duplicated in all three conditions but at a much greater 
frequency in the Him mutant.
Examples of the LT duplications for each of the three Mef2 gain-of-function experimental 
conditions are seen in FIG 7.6.2. Here we see two duplications of the LT muscles in each 
of the embryos shown. In all of these embryos there were few other defects to other 
muscles.
Table 7.6.1 shows a more detailed analysis of the muscle duplications in the three 
experimental conditions, and the muscles most frequently duplicated are represented 
diagrammatically in FIG 7.6.3. These data show a definite tendency towards LT 
duplication in experimental conditions that increase Mef2 activity.
Though a similar frequency of duplication occurs in the Zfhl and Him mutants embryos 
(85% of embryos with duplications, an average of 2.06 muscles duplicated per embryo and 
a range of 1-8 duplications per embryo for Zfhl mutants, compared to 95% of embryos 
with duplications, an average of 2.32 muscles duplicated per embryo and a range of 1-7 for 
Him mutants (Table 7.6.2)), a greater number and frequency of muscle loss occurs in Zfhl
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mutants compared to Him mutants (Table 7.6.1 and FIG 7.6.1). Though the muscle most 
frequently lost in Him mutants is also one of the ones most frequently lost in Zfhl mutants 
(V06 -  15% of Him embryos, 40% of Zfhl embryos FIG 7.6.1).
Table 7.6.3 compares aspects of the phenotypes in more detail, for example which muscles 
are lost and which have predominant shape defects and shows that in terms of muscles 
missing there appears to be little similarity between Zfhl mutants and Mef2 over­
expression embryos. And this is true for embryos over-expressing either the low or high 
insertion lines of UAS Mef2 (Table 7.6.2 and FIG 7.6.4).
UAS Mef2 high was driven at 25°C with Mef2 Gal4. The data for this muscle analysis 
came from that performed in the Mef2 dominant negative chapter comparing Mef2 over­
expression to the Mef2-En phenotype (Chapter 3). The somatic muscles of hemi-segments 
A2-A4 of 20 embryos were scored in the usual way.
From this we can see that despite showing a large number of muscles missing and a 
considerable disruption to the muscle phenotype, the strong Mef2 gain-of-function 
condition strikingly still has the same muscle subset being duplicated; with DOl, VA3 and 
the LT muscles being duplicated at a relatively high frequency (FIG 7.6.5). Interestingly 
though, it is only the DOl and VA3 muscles that retain the characteristic of being 
predominantly duplicated; though the LT muscles are duplicated at a frequency similar to 
the other Mef2 gain-of-function conditions (UAS Mef2 (low) over expression, the Him 
mutant and the Zfhl mutant), they are now missing at a similar frequency to duplication 
LT1 or predominantly missing with LT3 and LT4 (LT2 was not observed as missing in this 
analysis) (FIG 7.6.5).
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FIG 7.6.1 Muscles missing or duplicated in Mef2 over-expression, 
Him52 mutant and Zfhl2 mutant embryos.
These graphs show the percentage of embryos showing the loss or duplication of an 
individual muscle for each of the thirty muscles in abdominal hemi-segments A2-A4. Mef2 
over-expression, Him loss of function and Zfhl loss of function are all three very distinct 
ways of increasing Mef2 activity in muscle development.
Strikingly there are definite similarities in the phenotype for these three different experimental 
conditions. Most notable is the duplication of the LT muscles. VA3 is also duplicated in all 
conditions, but with a much greater frequency in Zfhl mutants. Similarly D01 is duplicated in 
all three conditions but at a much greater frequency in the Him mutant.
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FIG 7.6.1 Muscles missing or duplicated in Mef2 over-expression, 
Him52mutant and Z fh l2mutant embryos.
Duplicated Muscles in Him mutant, UAS Mef2 and Zfhl mutant
Duplicated
Muscle
Him-52 Mutant
(% of total duplicated 
muscles)
UAS Mef2 x Mef2 Gal4
(% of total duplicated 
muscles)
Zfh1-2 Mutant
(% of total duplicated 
muscles)
D01 20.5 % 8.3 % 2.9 %
DA1 27.3 % - 2.9 %
LT1 18.2% 20.8 % 22.9 %
LT2 11.4% 29.2 % 14.3 %
LT3 6.8% 20.8 % 22.9 %
VA3 4.5 % 8.3 % 22.9 %
Other
muscles
D03, DA3, 
VA1, V04
DT1, LT4 D02, DA2, 
DA3, LT4
Total No. 
Duplications
44 24 35
Table 7.6.1 -  Increasing Mef2 activity leads to muscle duplication in the same individual 
somatic muscles
Wild Type
C
\   /
UAS Mef2
D
\ /
FIG 7.6.2 An increase in 
Mef2 activity can lead to an 
increase in muscle number
Increasing Mef2 activity leads to significant 
duplications in specific somatic muscles. 
This phenotype was observed with three 
different genetic routes : over-expression of 
the full length Mef2 protein using Mef2 
Gal4, loss of function of Him, which 
represses Mef2 at the protein level, and 
loss of function of Z fh l which represses 
Mef2 at the RNA level.
Shown here are duplications in the lateral 
muscles, L1-L3. There are five LT muscles 
in an individual hemi-segment in the UAS 
Mef2 (B), Him mutant (C) and Z fh l mutant 
(D) embryos instead of the usual wild type 
number of three (A).
Lines u se d : Him-52, Zfh1-2 and UAS Mef2 
low 10T4A. UAS experiment performed at 
29°c. Wild type was OR.
Him Mutant Zfhl Mutant
Main muscles duplicated Main muscles duplicated 
in Him mutants in UAS Mef2
Main muscles duplicated 
in Zfh1 mutant
D01, DA1, LT1/2/3 D01, LT1/2/3, VA3 LT1/2/3, VA3
FIG 7.6.3 Most frequently duplicated muscles in Him mutant, Mef2 over-expression and 
Zfh1 mutant embryos.
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7.7 Zfhl and Him double mutants.
As Him and Zfhl both act to repress Mef2 and are expressed in the same pattern in the 
developing mesoderm I wanted to test if there is functional redundancy between the two 
proteins. One could easily imagine that in order to achieve most effective regulation of 
Mef2, there may be a failsafe system in place to regulate Mef2 activity by two different 
mechanisms.
Because of this I generated fly stocks which were double mutant for both Him and Zfhl 
(see Materials and Methods for crossing scheme) and was then able to test the somatic 
muscle phenotype of these embryos using the usual analysis method (scoring of each of the 
30 individual muscles in hemi-segments A2-A4 for 20 different embryos).
For analysis of the double mutants, embryos were first stained with anti-LacZ antibody to 
select against the TM3 ftz LacZ balancer chromosome and ensure that chosen embryos 
were homozygous for Zfhl (there was no need to make such a selection for Him as the 
mutant alleles are homozygous viable) and then muscles were stained using anti-(33 tubulin 
antibody.
Analysis of the somatic muscles of Him52 ; Zfhl2 double mutants reveals that the phenotype 
is distinct from the phenotypes of either Him alone or Zfhl alone. There is disruption to 
the muscle pattern, but this is not necessarily more severe than each of the individual 
phenotypes, in fact it appears to be a combination of aspects of the two phenotypes. The 
predominant affect is a duplication of the VA3 muscle and loss of the V04-V06 muscles; 
duplication of VA3 occurs in 70% of the embryos scored, loss of V04 occurs in 70% of 
embryos scored and loss of V06 occurs in 55% of the embryos scored (loss of V05 is less 
frequent at 15%). There was no occurrence of VA3 deletion or V04-6 duplication. (FIG 
7.7.1).
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O N LY
%
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muscles
DUPLICATED
O N LY
%
Embryos 
with muscles 
MISSING  
A ND  
DUPLICATED
UAS Mef2 
(Nguyen) 
X
Mef2 Gal4
100% 8.8 1-18 60% 1.55 1-2 45% 0% 55%
UAS Mef2 
(10T4A) 
X
Mef2 Gal4
65% 1.69 1-3 70% 1.71 1-3 25% 30% 40%
Z f h l - 2 
Mutant
90% 6.05 1-24 85% 2.06 1-8 15% 10% 75%
Him-52
Mutant
55% 1.27 1-3 95% 2.32 1-7 0% 40% 55%
Table 7.6.2 -  Muscles Missing or Duplicated in Mef2 gain-of function muscle phenotypes
Muscles 
Missing 
in > 50 % 
Embryos
Muscles 
Missing 
in 25-49% 
Embryos
Muscles 
Missing 
in 10-24% 
Embryos
Shape 
Defects 
in >75% 
Embryos
Shape 
Defects 
in 50-74% 
Embryos
Muscles 
Duplicated 
in >20% 
Embryos
UAS Mef2 High 
(Nguyen) x 
Mef2 Gal4 
(25°c)
DTI,
LT4,
VA1
DAI, D02, DA2,
LL1, LT1, LT2,
LT3, LOl,
VL4, V04,
V06
DA3, D05, 
SBM, VL1, 
VL3, VA2, 
V03
DOl, LT1,
LT3, LT4, 
VA3
UAS Mef2 Low 
(10T4A) x 
Mefi Gal4 
(29°c)
D04 DA3, V04 VA3 D03, VT1, 
VA1, V04
DOl, DTI, 
LT1, LT2,
LT3, VA3
Zflil-2
Mutant
V04 D03, LOl, 
VL4, V05,
V06
DAI, DA2,
D04, LT1,
LT3, LT4, 
VL1, VL2,
VL3, V02
VT1, VA1, 
VA2, VA3, 
V04, V06
LT1, LT2,
LT3, VA3
Him-52
Mutant
V06 DOl, DAI, 
LT1, LT2,
Table 7.6.3 -  Muscle phenotype comparison of Mef2 over-expression, Zfhl loss of function 
and Him loss of function
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FIG 7.6.5 Muscles missing or duplicated in Mef2 over-expression, 
Him52 mutant and Z fh l 2mutant embryos.
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j
As with the Zfhl single mutants, there may be a correlation between duplication of VA3 
and loss of V04/6; There are 14 embryos that contain a duplication of VA3 and of these 12 
also have either V04 and/or V06 missing (85.7%) -  in fact 11 of the 14 have loss of V04 
and 9 of the 14 have loss of V06 (with the majority therefore having loss of both V04 and 
V06). Despite this there are occasions where a VA3 duplication occurs without loss of 
V04-6 and where V04 or V06 are lost without gain of VA3 (Table 7.7.1).
FIG 7.7.2 shows examples of these duplications and deletions occurring. There is distinct 
duplication of the VA3 muscle and this can occur more than once in an individual hemi- 
segment as well as multiple times within an embryo. Note though that in a hemi-segment it 
does not follow that one gain of VA3 gives one loss of V04 or V06, for example in the 
figure in A2 there is a duplication of VA3, but V04-6 are present, in A3 there is a 
duplication of VA3 but all three of V04-6 are missing and in A4 there are two duplications 
of VA3 but all three V04-6 are present.
Comparison to the muscles affected in Him52 and Zfhl2 single mutants shows that the 
double mutant has a combination of each of the phenotypic characteristics, though it is 
more similar to the Zfhl2 phenotype dorsally (DO 1,2, DAI,2) and ventrally (VA3, V04-6) 
(FIG 7.7.3). Unlike the Zfhl2 single mutant (and like the Him52 single mutant) the double 
mutant has relatively few cases of muscle deletion in the majority of muscles (with the 
distinct exception of V04-V06) -  for example compare the frequency of loss of D03, 
LOl, and VL1-4 in the double mutant to the Zfhl2 single mutant. In addition the double 
mutant has considerably fewer dorsal duplications than the Him52 mutant in the DOl and 
DAI muscles (20% of embryos have DOl duplications in the double mutant, 45% have 
DOl duplications in the Him52 single mutant and 10% of embryos have DAI duplications 
in the double mutant, whereas 35% of embryos have DAI duplications in the Him52 single 
mutant FIG 7.7.3). Possibly the most striking difference between the Him52 ; Zfhl2 double
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FIG 7.7.1 Muscles missing or duplicated in 
Double Mutants
Graph show ing the p e r c en ta g e  o f Him52 ; Z fh l2 d ou b le  m utant em b ryos that sh o w  at 
least on e  exam p le in h e m i-se g m e n ts  A 2-A 4 o f m u sc le  lo s s  or m u sc le  duplication for ea ch  
of the thirty individual so m a tic  m u sc le s . B lue r ep resen ts  m issin g  m u sc le s , red rep resen ts  
duplicated m u scles. N otice that certain individual m u sc le s  su ch  a s  VA3 so le ly  duplicated, 
w hereas others, su ch  a s  V 0 4 - V 0 6  are only e v e r  m issin g  in th e  em b ryos scored . There  
are a lso  other m u scles , w hich a p p ea r  unaffected  (in term s of m u sc le  lo ss  or duplication) 
and others which h ave sim ilar p e r c e n ta g e s  of em b ry o s with that m u sc le  either lost or 
duplicated (e.g  D 0 2 ).
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ONLY
%
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with muscles 
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AND 
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UAS Mef2 
(Nguyen) 
X
Mef2 Gal4
100% 8.8 1-18 60% 1.55 1-2 45% 0% 55%
UAS Mef2 
(10T4A) 
X
Mef2 Gal4
65% 1.69 1-3 70% 1.71 1-3 25% 30% 40%
Zfhl - 2
Mutant
90% 6.05 1-24 85% 2.06 1-8 15% 10% 75%
Him-52
Mutant
55% 1.27 1-3 95% 2.32 1-7 0% 40% 55%
Him-52; 
Z fh l - 2
Double
Mutant
85% 3.7 1-9 90% 2.4 1-7 0% 5% 85%
Table 7.7.2 -  Muscles Missing or Duplicated in Mef2 gain-of function muscle phenotypes
A ) Wild Type
A2 A3 A4
B) Him52 ; Z fh l2double mutant
’. ' 4 M k i A j k
A2 A3 A4
C) Muscle schematic
|  Duplicated 
|  Missing
*  * * *
FIG 7.7.2 -  Him52; Z fh l2double mutants muscle phenotype
Examples of duplication and deletion of muscles in the Him52 ; Z fh l2 double mutant muscle phenotype. The VA3 muscle is 
frequently duplicated; there should only be one copy of the muscle per hemi-segment (see asterisks in wild type A and muscle 
schematic of a single hemi-segment in C) but can be seen here duplicated once in the A2, once in the A3 and twice in the A4 
hemi-segments of this Him52 ; Z fh l2 double mutant embryo (asterisks in B). In addition the ventral V04-6 muscles are 
frequently missing; in wild type embryos there is one of each of these muscles per hemi-segment (indicated by arrows in A and 
shown in the muscle schematic C), however this mutant embryo has all three missing in hemi-segment A3 (arrows in B). The 
V 04  or V 06  muscles are often missing in embryos that have a VA3 duplication (see data Table 7.7.2). This particular mutant 
embryo also contains a duplication of LT1 and LT2 in A3 (arrowheads, out of focus), but it should be noted that duplications of 
these muscles in the double mutant is considerably less frequent than duplication of the VA3 muscle.
Wild type embryos are Oregon R. Double mutants were first selected by staining against Ftz LacZ to ensure homozygosity o f 
the Z fh l mutant allele. Muscles were stained with anti 133-tubulin antibody. A ll experiments performed at 25°C.
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mutant and the two single mutants (and also UAS Mef2 FIG 7.6.1) is the reduction of 
duplications in the LT muscles; in the double mutant LT1 is only duplicated in 5% of 
embryos, LT2 in 10% of embryos and LT3 is not duplicated, whereas in the Him52 single 
mutant LT1 is duplicated in 35% of embryos, LT2 in 20% and LT3 in 10%, similarly the 
Zfhl2 single mutant LT1 is duplicated in 35% of embryos, LT2 in 20% and LT3 in 35% 
(FIG 7.7.3) (for UAS Mef2 low LT1 is duplicated in 20% of embryos, LT2 in 25% and 
LT3 in 25%). Despite this, it appears that the frequency of duplication has not changed 
when comparing the Him52 mutant to the Him52; Z fh l2 double mutant, but the muscles that 
get duplicated has shifted — to become predominantly VA3 in the double mutant. For 
example the % of embryos showing a duplication, the average number of duplications and 
the range of duplications per embryo are very similar for the Him52 mutant and the Him52\ 
Zfhl double mutant (95% of embryos, 2.3 muscles per embryo and 1-7 muscles per 
embryo for Him and 90% of embryos, 2.4 muscles per embryo and 1-7 muscles per 
embryo for the Him ; Zfhl double mutant) (Table 7.7.1), but instead of the duplications 
occurring predominantly in DOl, DAI,  LT1 and LT2 as in the Him mutant, they occur 
predominantly in VA3 (and DOl) in the Him52; Z fh l2 double mutant (FIG 7.7.3).
In addition to the duplication of VA3 and deletion of V04/V06 another frequently 
occurring aspect to the Him52\ Z fh l2 double mutant phenotype is the occurrence of stray 
muscular structures which cross the ventral midline of around of 75% of embryos. These 
thin structures completely cross the midline and are quite deep within the embryo being 
situated just ventrally to the visceral muscle as opposed to closer to the surface as with the 
regular somatic muscles. Focussing on the microscope shows that they are not folds of the
gut but are individual structures. FIG 7.7.4 shows an example of these stray muscles. They
2^ 2 * are not seen in wild type embryos, Him single mutants or Zfhl single mutants.
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FIG 7.7.3 Comparison of muscles missing or duplicated in 
mutant, Z fh l2mutant and Him 52; double mutant embryos.
Him52; Zfh 12double mutant
FIG 7.7.4 -  Him52 ; Z fh l2double mutants muscle phenotype
In H im 52; Zfh12 double mutant embryos there are frequently what appears to be stray muscles spanning the ventral mid-line of 
the embryo. They appear as thin muscular structures that completely cross the midline. They are fairly deep within the embryo, 
beneath the visceral muscle, and are not folds of the gut but individual structures. They appear in around 75% of the mutant 
embryos scored.
Embryos are viewed ventrally. Muscles were visualised using anti /53-tubulin antibody. Him52 ; Zfh12 homozygous double 
mutants were selected by first staining against the presence o f Ftz LacZ balancer. Wild type embryos are Oregon R. 
Experiment performed at 25°C.
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7.8 General Discussion; Mef2, Him and Zfhl.
In this chapter I have confirmed that Zfhl is able to repress Mef2 at the RNA level and 
over-expression of Zfhl or Him in the Mef2 pattern causes a severe reduction in somatic 
muscle formation. Detailed analysis of the individual somatic muscles affected shows that 
Him and Zfhl have the same effect on terminal somatic muscle differentiation and that the 
somatic muscles can be divided up into types that are more easily lost and those that are 
most frequently present; an observation that has been shown previously in this work with 
other experimental conditions that cause a reduction in Mef2 activity, such as the Mef2 
dominant negative, Mef2 RNAi and Mef2 alleles (Chapter 3).
As discussed previously, this reinforced the idea that individual somatic muscles, or the 
muscle founders and identity genes that define them, have different requirements for Mef2 
activity. With muscles that are lost most frequently being the ones that require the most 
Mef2 for their correct formation; a reduction in only a small amount of Mef2 activity 
results in their failure to form.
Conversely the muscles that appear unaffected under conditions of that reduce Mef2 
activity, have a very low requirement for Mef2 activity as even in conditions of severe 
Mef2 activity reduction these muscles still form. One wouldn’t expect these muscles to be 
Mef2-independent however, as they do not develop in complete absence of Mef2 such as 
seen in the Mef2 null (Bour et al, 1995; Lilly et al, 1995), and in fact one could interpret 
this low level of Mef2 activity required for their formation as a possible measure of the 
muscles’ importance to the final musculature.
For example, though all the somatic muscles are similar with respect to their physiological 
characteristics (Bate and Rushton, 1993), they clearly have very distinct shapes and 
positions within the embryo. When one considers the structure of some of the individual 
low and high Mef2 requirement muscles there does seem to be some structural similarities
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that emerges. High Mef2 requirement muscles such as D03, D04, V04 and V06 are all 
very similar in shape and size; being long and thin and extending diagonally across the 
embryo in a dorso-anterior to ventro-posterior direction.
Low Mef2 requirement muscles, however, such as DTI, VT1 and VT1 and VA2 are 
broader, bulky muscles that extend in an anterior to posterior direction.
From this one can wonder whether there is any advantage in these muscles having a Low 
Mef2 requirement. Are the muscles in this second subset more integral to the structure or 
function of the musculature? Would loss of muscles from the first subset be more easily 
tolerated by the larvae? Or from a more basic body building plan are the Mef2 low 
requirement muscles needed to be laid down earlier to as a basis to build up the other 
muscles in the structure.
So from this we could say that Mef2 requirement could either be due to the importance or 
the timing of formation of a muscle. Studies which delete single muscles in the musculature 
by either specific Gal4 targeted deletion or founder cell ablation may be a means of 
assessing the importance of a muscle in the larval life.
Though this provides insight into the requirements of Mef2 for individual muscles it is the 
Mef2-gain of function experiments that provide a novel insight into a role for Mef2 in 
patterning.
The observation that a distinct subset of muscles is reliably duplicated under conditions of 
Mef2 gain of function has never been described before. It suggests that Mef2 plays a role in 
their normal specification and that tight regulation of Mef2 must be maintained to ensure 
that additional muscles are not made. Thus though it has been established that Mef2 
mutants can specify a number of founder markers (Bour et al, 1995; Lilly et al 1995), my
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results suggest that there is Mef2 input into at least a subset of the founders and that this 
subset are the founders that define the DOl, DAI, LT1, LT2 and VA3 muscles.
An explanation for this at the founder cell level may be that Mef2 targets the activation of 
the specific identity gene responsible for this muscle fate. For example with the DO 
muscles it may be that Mef2 plays a role in the regulation of Kruppel; as shown in my work 
previously (Chapter 6) Him mutants and Him over-expression affects the number of 
Kruppel positive founder cells and it already known that Kruppel mutants and over­
expression can cause the duplication or gain of this muscle (Ruiz Gomez et al, 1997), in 
addition Kr alongside a number of the other muscle identity genes has been identified as a 
potential Mef2 target (Sandmann et al, 2006).
In a similar vein the identity gene Apterous may be a Mef2 target suitable for investigation 
of the LT muscle duplications. Ap is expressed in LT1-4 and its over-expression causes LT 
duplication, whereas its loss-of-function causes LT loss (Bourgouin et al, 1992) and like Kr 
it appears as a potential Mef2 target (Sandmann et al, 2006). .
The idea of Mef2 playing a role in the fate of the founders may shed some light on the 
other observations made in Mef2 gain and loss of function conditions in my thesis. For 
example the identity gene S59 / Slouch is expressed in the DTI, VA2 and VT1 muscles 
(Knirr et al, 1999) and these three muscles are all consistently found in the subset most 
resistant to reductions in Mef2 activity. One may easily imagine a scenario where such 
“Low Mef2 Requirement Muscles” like DTI, VA2 and VT1 might be regulated by a “Low 
Mef2 Requirement Gene”. Slouch has already been identified as having Mef2 bind to sites 
near its gene locus, implicating it as a potential Mef2 target (Sandmann et al, 2006), if it 
could be shown that Slouch was such a low requirement gene in a similar way to other
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established Mef2 targets (Elgar et al, 2008) then one would be able to build upon a model 
for Mef2’s action within muscle development. However, the model would not be as simple 
as “Low Mef2 Requirement Gene” gives “Low Mef2 Requirement Muscle”, as despite 
Slouch being a potential Mef2 target, it is well established that Slouch expression in 
founder cells occurs in Mef2 mutants (Lilly et al, 1995) so other factors must play a role in 
the initial specification. Also for muscle that express a combination of identity genes a 
simple model like this for Mef2 activity would not suffice.
This model for the formation of founder to muscle would have Mef2 at the head of a 
program of muscle specific transcriptional pathways; the formation of a specific muscle 
would be conducted by the identity gene that Mef2 activates within the original founder 
and the aspects of fusion and guidance would be co-ordinated by other as yet identified 
transcription factors (though one such factor could be mesol8E for guidance -  see next 
chapter). These specific muscle identity genes would require certain levels of Mef2 activity 
to be expressed or regulated. To ensure appropriate levels of Mef2 activity are established 
to activate these identity genes, specific repressors that act upon Mef2 at the transcriptional 
level (Zfhl) and the protein level (Him) would be in place and, once the expression of the 
repressors is established a fine tuning of Mef2 activity can be achieved through Mef2 auto­
regulation and the activation of its own repressor, Him.
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mesol8E
8.1 Introduction
Originally it was thought that Mef2 acted at the later stages of myogenesis; as it was shown 
to directly regulate the expression of a number of key structural components of the 
differentiated musculature (e.g Tropomyosin (Lin et al, 1996) and Paramyosin 
(Arrendondo et al, 2000) and the Mef2-binding site was identified in nearly all known 
skeletal muscle genes (reviewed in Black and Olson, 1998). However, a study in 
Drosophila by Dr.Taylor, showed that Mef2 also acted early on in the differentiation 
program, regulating the expression of a previously uncharacterised gene, mesol8E (Taylor, 
2000).
This study initially involved a subtractive hybridisation screen looking for genes with an 
early mesodermal expression pattern after subtractive hybridisation of cDNA isolated from 
Twist mutants and Wild Type embryos. From this, mesol8E was identified as a Twist 
dependent gene whose expression pattern closely resembled that of Mef2 (Shown in 
FIG8.1.1 and Taylor, 2000).
mesol8E is expressed in the developing mesoderm and in the precursors of the somatic, 
visceral and cardiac muscle and subsequently it is expressed in the somatic muscle, visceral 
muscle and the cardioblasts of the heart in an expression pattern that resembles that of Mef2 
throughout myogenesis (Taylor et al, 1995; Taylor, 2000) An RNA in-situ hybridisation 
profile for mesol8E is shown in FIG 8.1.1 (Images taken from Taylor, 2000 Fig.3).
In his study, Dr.Taylor identified a nuclear localisation sequence in mesol8E which 
suggests it to be putative nuclear protein. He also revealed a role for Mef2 in the regulation 
of mesol8E; an RNA in-situ using mesol8E  probe in mef2 mutants shows that mesol8E 
expression is reduced in the visceral muscle precursors (from Stl 1) and the somatic muscle
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FIG 8.1 meso18Ewild type RNA in-situ hybridisation pattern
These images are taken from Taylor, 2000 FIG5 and highlight expression in the mesodermal crossbridges o f 
(St11 arrowhead), somatic primordia (St12 arrow), visceral primordia (St12 arrowhead), heart (St13 arrowhead), developing 
somatic muscle (St13 arrow), somatic muscle (St15 arrow), pharyngeal muscle (St16 arrow) and cardioblast s(St16 
arrowhead).
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precursors (from St 12) and ectopic expression of Mef2 using a Da-Gal4 driver results in 
ectopic expression of mesol8E in that pattern (Taylor, 2000).
Despite this role of Mef2 in mesol8E  expression, there are also aspects to the expression of 
mesol8E that are independent of Mef2. Mef2 is expressed in the cardioblasts, the 
contractile cells of the heart, but despite being necessary for the expression of some 
terminal muscle markers such as Mhc in these cells, Mef2 is not needed for the formation 
of the heart tube structure itself, or the expression of other muscle markers such as fi3- 
tubulin in cardioblasts, as shown by studies of Mef2 null mutants (Bour et al, 1995; Lilly et 
al, 1995; Damm et al, 1998).
The expression of mesol8E  in the cardioblast cells of the heart in a Mef2 null mutant 
background is unaffected, suggesting that, in the heart, mesol8E has a Mef2 independent 
aspect to its expression, possibly in a similar way to p3-tubulin. (Taylor, 2000; Damm et 
al, 1998). In addition, the expression of mesol8E in the somatic and visceral mesoderm is 
only reduced in Mef2 mutants, it is not lost entirely in a Mef2 null mutant background. 
Recent advances in whole genome microarray technology have allowed potential Mef2 
targets to be identified in large scale analyses. mesol8E  has been identified as a potential 
Mef2 target on three microarrays (Junion et al, 2005; Sandman et al, 2006; Elgar et al 
2008) again suggesting the importance of Mef2 in mesol8E regulation. The Junion et al 
study also went to on to show that the expression of a GFP reporter construct containing 
the upstream regulatory region of mesol8E is reduced (but not lost entirely) in a Mef2 
mutant background.
However, it should be stressed that none of this work outlined above shows that Mef2 
directly activates mesol8E.
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Despite knowing the expression pattern of mesol8E and that Twist and Mef2 play a role 
the expression of this putative nuclear protein, little else is known about the structure and 
function of the gene and any role it may have in muscle development.
Consequently as part of my PhD I wanted further investigate the regulation of the gene 
expression and explore the role of mesol8E through bioinformatics, gene over-expression 
and loss of function studies.
8.2 Expression Regulation
As outlined above there are both Mef2 dependent and Mef2 independent aspects to 
mesol8E expression. I wanted to investigate the expression regulation of mesol8E to 
determine whether Mef2 can be shown to activate mesol8E  directly and also to attain any 
insight into the Mef2 independent aspect of mesol8E expression, which may suggest 
potential players involved in an alternative pathway to Mef2 action in muscle 
differentiation.
To investigate the expression regulation of mesol8E  I designed GFP reporter constructs 
corresponding to the non-coding regions around the gene. In a large number of genes the 
regions immediately upstream are the source of regulation and thus are the most obvious 
place to begin an investigation into transcriptional regulation. Because of this I 
concentrated my analysis of mesol8E regulation on the region corresponding to all of the 
non-coding DNA immediately upstream of mesol8E and up to the start the next gene, 
CGI 2531, and also the mesol8E gene itself. I then divided up these regions and selected 
fragments for analysis upon the basis of phylogenetic footprinting. This process makes use 
of the complete genomic sequences established for a number of distantly-related species 
and through alignment and comparison of equivalent DNA regions across these species
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regions can be identified that are evolutionary conserved. Any conservation in regions of 
non-coding DNA, (where there is a greater degree of tolerated mutation and sequence 
variation than coding DNA), suggests that this site may be of particular importance, and as 
such is often indicative of the sites of key transcription factor binding sites involved in the 
regulation of the gene (for review see Zhang and Gerstein, 2003).
FIG 8.2.1 shows a phylogenetic footprint generated by the Vista tools program (Frazer et 
al, 2004) for the mesol8E region. Each alignment shows the sequence comparison of a 
particular Drosophila species to Drosophila melanogaster. The species that are more 
closely related to D. melanogaster are shown at the top of the diagram and these show the 
greatest degree of sequence conservation. The species that are farther removed in 
evolutionary terms to D.melanogaster, such as D.virilis and D.mojavensis show 
considerably less sequence similarity (Russo et al, 1995), but it is the peaks of conservation 
in the non-coding DNA that do remain across evolutionary time that are of potential 
significance (Zhang and Gerstein, 2003; Dickmeis and Fuller, 2005).
In addition to this I also searched the potential mesol8E regulatory region for Mef2 
binding sites using the established consensus sequence YTAWWWWTAR (Andres et al, 
1995) and found five.
8.2.1 Design of GFP Reporter constructs
FIG 8.2.2a shows how I divided the mesol8E region into reporter constructs. Note how the 
orientation of the region differs from the orientation of the phylogenetic footprint figure; 
the reporter construct map depicts the region with the gene of interest in the conventional 
5’ to 3’ orientation, whereas the same region is depicted in the opposite way in the 
phylogenetic footprint, because Vista orientates the comparisons in the direction that the D. 
melanogaster genome was sequenced.
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FIG 8.2.1 Phylogenetic conservation footprint for the meso18E regulatory region
Vista tools genome comparison (Frazer et al, 2004) of aligned genomic sequences for different Drosophila species. Red 
peaks correspond to regions of conservation in non-coding sequence. Dark blue represents exons of the meso18E Gene and 
turquiose represents Untranslated Regions of the meso18E gene. Each row represents a different species alignment relative 
to the meso18E region of Drosophila melanogaster. The species lower down the graph are more distantly related to D. 
melanogaster, (Russo et al, 1995), suggesting that any conservation in the non-coding region in these alignments may have a 
greater functional significance (Zhang and Gerstein, 2003).
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FIG 8.2.2a Reporter construct analysis for the regulatory region
I divided the upstream  region of m e so 1 8 E  into different regions for the generation  of G FP reporter con stru cts for 
transcriptional regulation a n a ly sis  of the m e so 1 8 E  g e n e . I b a sed  the division upon the identified p ea k s  of phylogenetically  
co n serv ed  reg ion s identified by s p e c ie s  s e q u e n c e  alignm ent (FIG 4 .1 .2 )  In addition I a lso  sea rch ed  the region for potential 
M ef2 s ite s  using the s e q u e n c e  binding motif YTAVWVWWTAR. R eporters A, B and C lie upstream  of the m e so 1 8 E  g e n e .  
R eporter D lies in the first intron of the g e n e , but sh o w s  s o m e  d e g r e e  of phylogen etic  con servation . S e q u e n c e  an a lysis  
sh o w s  that all o f the M ef2 s ite s  included in the con stru cts lie within regions that are phylogenetica lly  co n serv ed .
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The regions of phylogenetic conservation are highlighted as orange lines positions of the 
Mef2 sites are shown in the figure as blue triangles. Note how the Mef2 sites fall into the 
regions of conservation even though the regions of conservation can be relatively small (for 
example, conservation in the most proximal region upstream of mesol8E (within Construct 
C on FIG) is only 183bp in length, whereas the whole intergenic region between mesol8E 
and CGI2531 is approximately 6.5Kb), suggesting the relative importance of Mef2 in 
mesol8E direct regulation.
The regions were divided on the basis of the phylogenetic footprinting, reporter sizes that 
would be favourable towards generation of PCR fragments (i.e not greater than 2-3Kb) and 
that fell conveniently with internal restriction sites which could be used to fuse the 
fragments together subsequently if necessary and ensure that adjacent constructs end or 
start at the same point without overlap. In addition to the region directly upstream of 
mesol8E, I also chose to generate a reporter construct corresponding to the first intron of 
mesol8E, due to the sequence conservation peak corresponding to this region (FIG 8.2.2). 
The first intron of a gene is also well established as having responsibility for the regulation 
of a genes expression, for example, Mef2 was found to bound a significant proportion of 
sites in the first intron of genes in the Sandmann et al 2006 study.
FIG 8.2.2b shows how these constructs were designed. The Primer sequence for these 
constructs is given below and the method of construct generation can be found in the 
Materials and Methods.
Primers:
Underlined shows restriction site.
Construct A -  1848bp :
18E-A fwd:SphI GCATGCCAAGAATAAGAATCCACC Tm = 61.0°C
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18E-A rev :BglII AG AT CTTCG ACTGG AT A AA A T CGGT C Tm = 61.6°C
Construct B - 1759bp :
18E-B fwdiBglll AGATCTGAAAGATTGAAAGATACAAGCAG 
Tm = 61.0°C
18E-B rev:EcoRI GGAATTCGTATTAACAAAGTAATATCCAAGG 
Tm = 61.0°C
Construct C -  1155bp :
18E-C Fwd (EcoRJ) - GAATTCATTATACCCGCCTGTTGG Tm61.1°C 
18E-C Rev (BamHI) - GGATCCCGTTGCCGATACTAAC Tm = 62.1°C 
Construct D -  771 bo :
18E-C Fwd (Bglll) -  AGATCTCAGGACGGCGGACTAC Tm = 63.9°C 
18E-C Rev (BamHI) - GGATCCTTTGTGACACTTAACGTCTAG Tm = 63.5°C
During my PhD I successfully generated reporter constructs and subsequent transgenic 
lines for the 1155bp region immediately upstream of the start site of mesol8E and the 
771 bp region covering the first intron of the gene; mesol8E C GFP pStinger and mesol8E 
D GFP pHStinger respectively. (The difference between pStinger and pHStinger is that 
pHStinger contains a TATAA box, whereas pStinger doesn’t. For reporter fragments that 
contain an endogenous TATAA box such as those immediately upstream of a gene start 
site, as in the 18E C fragment, the pStinger vector is used (Barolo et al, 2000)).
At least three transgenic lines were tested for each o f these reporter constructs and 
representative lines are shown in the figures.
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FIG 8.2.2b Generation of the reporter constructs for the regulatory region
I used  two internal restriction sites, Eco RV and Hind III, (purple on diagram) that w ere unique to the region and 
com patible with the pStinger GFP or pH Stinger GFP vectors used . Primers w ere d esign ed  that overlapped th e se  sites  
appropriately and introduced unique restriction s ite s  at the end of the PCR fragm ent (Black on diagram) that allowed for 
cloning into the vectors in an appropriate orientation that would a lso  allow for su b seq u en t joining up of the fragm ents a s  
required. On cloning, PCR fragm ents could then be cut with EcoRV and Hindlll a s  n ecessa ry  so  that reporter constu cts A, 
B and C would have no overlapping se q u e n c e  a s  individual constructs (Blue on diagram). T h ese  fragm ents could then  
also  be easily  cloned together to generate the larger reporter constructs AB, BC and ABC (Green on diagram) if analysis  
of A, B, and C required it. A s reporter D is a stand alone construct, the PCR fragm ent could be cloned directly into pH 
Stinger and used  directly a s  a GFP reporter.
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8.2.2 mesol8E C GFP pStinger Reporter expression
FIG 8.2.3 shows the expression pattern for mesol8E C GFP, the proximal region to the 
transcription start site, which contains a conserved Mef2 site within its sequence. The 
pattern resembles that of wild type mesol8E as seen in the RNA in-situ against the 
mesol8E gene (FIG 8.1.1). Early uniform mesodermal expression is seen, which continues 
as the mesoderm develops and then becomes segmentally repeated at around St 10, shortly 
after it also gets expressed in the somatic, pharyngeal, visceral and heart precursors. 
Somatic expression continues to be seen from the precursors at St 10 right through all the 
subsequent stages and into St 17, when the somatic muscle has fully formed. At the same 
time as this we see expression in the pharyngeal muscle, from the precursors seen at St 10 
right through to St 17, and also the visceral muscle (which can be seen out of focus 
throughout the stages St 12-17 in this figure, and also when brought into focus in FIG 
8.2.3b).
Heart expression is like the wild type pattern; detectable in the cardioblasts from St 10 up 
until the later stages of embryogenesis though the levels of expression are quite weak by 
St 17. This expression pattern suggests that the mesol8E C GFP reporter may be a minimal 
promoter region, giving sufficient expression to represent the wild type mesol8E 
expression pattern.
8.2.3 mesol8E D GFP pStinger Reporter expression
The expression of mesol8E D GFP, which corresponds to the first intron of mesol8E, 
shows a very distinctive profile, being expressed specifically in small clusters of large cells 
in the abdominal hemisegments A1-A7 (FIG 8.2.4).
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FIG 8.2.3a meso18E C GFP Reporter construct expression pattern mimics wild type 
meso18E
m eso18E C GFP : St14 (dor)
/
FIG 8.2.3b Examples of meso18E C GFP Reporter construct expression in the 
visceral muscle
The expression pattern of the meso18E C reporter fragment mimics (FIG 8.2.3a) mimic that of wild type meso18E 
expression (see in-situ FIG 8.1). Embryos are shown from St9-St17 and are representative. The line shown was one of 
three others tested, all that show the same pattern. GFP reporter construct pattern visualised using anti-GFP antibody.
FIG8.2.3b shows visceral expression in at St14 (arrow) and St15 (arrowhead) in this line
m eso18E C GFP . St15
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The staining of the cells is initially seen at St 11 and continues through to St 17. The large 
cells are in clusters of around 2-9 cells, which varies from embryo to embryo and hemi- 
segment to hemi-segment, but have an average of around 6 cells. The image in FIG 8.2.4 
shows a representative St 15 embryo for the reporter expression.
Initial description of similar cells in the Hartenstein Atlas of Drosophila Development 
(Hartenstein, 1993 and www.sdbonline.org/fly/atlas/OOatlas.htm) suggested that these may 
be the oenocytes. Subsequent personal communication with Alex Gould, NIMR and Adi 
Salzberg, Technion, Israel and comparison to the Drifter LacZ pattern and Spalt 
localisation, which are both markers of the oenocytes (Elstob et al, 2001) reinforced this. 
The oenocytes are secretory cells derived from the peripheral nervous system (Gould et al 
2001 review) which may have a role in regulation of the transition between developmental 
stages in Drosophila development (i.e moults and pupation) (Thummel, 2001) and in the 
final size of a fly (Columbani et al, 2005) through their secretion of the ecdysteroid 
hormone Ecdysone (Kozlova and Thummel, 2003). In addition these cells have recently 
been identified as having an essential role in lipid metabolism, where they function as 
hepatocyte cells giving them a role similar to the liver (Gutierrez et al, 2006).
Though there are links between the ecdysone pathway and Mef2 that may be of 
significance, (for example it has been shown that ecdysone steroid hormone induces 
transcription of Mef2 in the adult Drosophila myoblasts (Lovato et al, 2005)), I decided to 
concentrate my studies on the immediate investigation of mesol8E in muscle 
differentiation.
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FIG 8.2.4 meso18E D GFP reporter construct expresses specifically in the oenocytes
Chapter 8: mesol8E
8.2.4 Site Directed Mutagenesis to the Mef2 site in the mesol8E 
C GFP reporter reveals mesol8E to be a direct target of MeC.
As the expression of the mesol8E C GFP pStinger reporter is representative of the wild 
type pattern mesol8E pattern (FIG 8.2.3) and that this wild type pattern itself is 
reminiscent of the Mef2 pattern in its later stages of embryogenesis I wanted to investigate 
the significance of the conserved Mef2 transcription factor binding site within the region.
It has already been shown that Mef2 plays a role in the regulation of mesol8E expression 
(Taylor, 2000; Junion et al, 2005) but it has never been established if this regulation is 
through the direct action of Mef2 on the meso!8E promoter, or indirect, through the 
interaction or upstream action upon some other regulatory gene.
Deletion of the binding site in reporter constructs via Site Directed Mutagenesis (SDM) is 
the classic way of determining whether a gene is a direct target for a specific transcription 
factor, and this has been used as a means of determining a number of direct targets for 
Mef2 in the past. For example, Tropomyosin (Lin et al, 1996), 03-tubulin (Damm et al, 
1998) , Paramyosin (Arrendondo et al, 2000), Act57B (Kelly et al, 2002) and Mef2 itself 
(Cripps et al, 2004) were all established as direct Mef2 targets in this way.
The sequence of the Mef2 site in the mesol8E C region is CTATTTTTAG, which fits to 
the Mef2 site consensus of YTAWWWWTAR (Andres et al, 1995), where Y = C or T, W 
= A or T and R = A or G and is the exact same sequence of another Mef2 site previously 
established as essential for the expression of the Mef2 target, Act57B (Kelly et al, 2002).
It has been previously established that an A to C change in the third base of the consensus 
sequence, is sufficient to abolish Mef2 protein binding to the transcription factor binding 
site (Serjesi and Olson, 1991), though more recently more changes were introduced in the
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central region of the site also, changing the A/Ts (W) to C/Gs, sometimes through the 
introduction of a CG rich restriction site such as SacII (CGGCGG) (Cripps et al, 2004) or 
Not I (GCGGCCGC) (Kelly et al, 2002). For site-directed mutagenesis to the Mef2 site in 
the mesol8E C region of the GFP reporter I decided to introduce a SacII site changing the 
site from CTATTTTTAG to CCCGCCGTAG, which should completely destroy the 
binding activity of the site. As the Mef2 site is identical to the key Mef2 site in Act57B I 
did consider introducing a Notl site into the sequence, as was done for that study (Kelly et 
al 2002), but on further investigation, the potential for forming hairpin loops, dimers and 
bulge loops in the primers at key PCR extension temperatures was considerable 
(GeneRunner program) and I decided to use SacII instead which seemed less potentially 
problematic. I also checked that what would be the new sequence in the region of the site 
would not inadvertently introduce any new transcription factor binding sites using the 
Patch program (gene-regulation.com).
I then successfully generated, sequenced and confirmed this construct (see Materials and 
Methods) and named it mesol8E C AMef2 SDM.
Subsequently it was injected by Jun Han in the lab, and she established transgenic lines that 
were recently investigated by her. On investigation of these multiple lines, she showed that 
the reporter gave a complete absence of GFP expression, showing that Mef2 is responsible 
for the pattern generated by this construct and revealing mesol8E to be a direct target of 
Mef2.
8.3 Structure of the mesol8E gene.
Little was known at the beginning of my PhD about the mesol8E protein. It was 
established that the protein is 553 amino acids in length and is described as a putative 
nuclear protein due to the presence of a bipartite nuclear localisation sequence (NLS) at
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residues 86-102 and analysis by the PSORT program (Taylor, 2000). In addition, at this 
time Blast protein database searches revealed little in the way of significant similarity to 
other proteins and found no functional protein domains which may suggest any role for the 
protein (Taylor, 2000).
In the last ten years there have been considerable advances in bioinformatic technologies 
and expansion in protein and nucleotide databases as more sequencing occurs. 
Consequently, it was an appropriate time for me to revisit the analysis of mesol8E to 
search for homology, protein domains and protein structure as a way of elucidating more 
about the protein and possibly from this, a suggestion of its function.
8.3.1 mesol8E homology searches
A Blast search of the mesol8E amino acid sequence against the non-redundant protein 
database at Swiss Prot (www.ch.embnet.org) reveals that the mesol8E protein is highly 
conserved among the Drosophila species, but outside of this genus has no proteins that 
show significant homology to the complete protein (FIG 8.3.1). However, the Blast search 
does repeatedly bring up a lower level of similarity to one specific region of around 80 
amino acids long at the N terminal end of the mesol8E protein and that on closer 
inspection of the sequence alignments reveals that it is the same residues that keep 
occurring across a range of various proteins from different species. This suggests that the 
region could correspond to a conserved protein domain and that the residues that keep 
reoccurring in the alignment are key residues for the function of the protein domain.
The proteins that show homology to this region are all nuclear and seem to have some 
degree of transcription factor activity; for example, the p400 SWI / SNF related protein in 
humans, the Domino protein highlighted in mouse, humans and also Drosophila in this
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FIG 8.3.1 meso18E is conserved among the species and contains an
evolutionally conserved myb-like domain
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search, and GT2 and GT3a, plant transcription factors found in Arabidopsis. The residue 
sequence that is recurring in the alignment is :
HW++V++V+NSR++KQCNRYEN+
8.3.2 mesol8E protein domain searches
I used the ProSite protein database (www.expasy.ch) to search for potential domains within 
the mesol8E amino acid sequence. This identified a Myb-like domain at residues 18-86 
with a low level confidence and a bipartite nuclear localization sequence at residues 86- 
102. The location of the Myb-like domain corresponds to the same region that shows the 
degree of homology to the various nuclear factors in the Blast search. Myb-like domains 
consist of a trihelix structure which follows a helix, helix-tum-helix pattern. They are part 
of the Myb family of domains, which itself is a distinct branch of the well established 
Helix-Tum-Helix (HTH) superfamily of protein domains. The HTH domain was the first 
established DNA binding motif (Pabo and Sauer, 1992) and is found in proteins from 
bacteria to man. It has been established that the second helix of the HTH domain is the 
helix that binds to the major groove of DNA and confers specificity in the DNA binding 
interaction; it is called the recognition helix. Variation in the recognition helix allows for 
the domain to bind to different DNA sequences and so allow variation in binding properties 
in different HTH proteins. The first helix in a HTH protein plays a role in the stability of 
the binding in the interaction.
The Myb family is a distinct branch of the HTH family; the domain contains an additional 
helix and as such has a helix, helix-tum-helix structure. As with the regular HTH domains, 
it is the second helix of the helix-tum-helix section that confers DNA binding specificity 
and is the recognition helix, (i.e in the Myb domain, the third helix is the recognition helix).
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The Myb domain is named after the first proteins that were discovered to contain this tri­
helix structure; the viral and cellular Myb proteins (Peters et al, 1987; Biedenkapp et al, 
1988). Myb-type domains are DNA binding, and proteins containing them have been 
shown to function as transcription factors in a number of diverse roles from cell growth, 
differentiation and apoptosis (Oh and Reddy, 1999), to regulation of the cell cycle (Hirai 
and Sherr, 1996) and the maintenance of telomeres (Broccoli et al, 1997). The Myb domain 
itself is around 50 amino acids in length and is frequently found in a series of tandem 
repeats of the domain; for example in the c-Myb protein itself there are three adjacent 
repeats of the tri-helical Myb domain; R l, R2 and R3 (Gabrielson et al, 1991), though of 
these only R2 and R3 are essential for Myb function (Saikumar et al, 1990; Ogata et al, 
1994). In other Myb containing proteins only two tandem Myb domains are found; R2 and 
R3, and in fact there is a distinct class of Myb related proteins found in plants called the 
R2R3 class which have this specific make up (Oh and Reddy, 1999; Jin and Martin, 1999). 
There are also members of the Myb family which only contain one copy of the Myb 
domain within the protein (effectively R3 only containing proteins) (Oh and Reddy, 1999). 
mesol8E only contains one Myb-like domain and this is discussed later in this section. 
Other members of the Myb domain family are the SANT domain and the Myb-like domain; 
like the Myb domain they consist of a helix, helix-tum-helix structure and are both similar 
to the Myb domain in terms of sequence and structure.
Unlike the Myb domain the SANT domain has protein binding properties as opposed to 
DNA binding properties, and this difference is thought to be down to variation in specific 
amino acid residues in the recognition helix of the domain; the SANT domains tend to 
contain a number of bulky aromatic and acidic residues whereas the Myb domain shows a 
greater number of positively charged residues making binding with the negatively charged 
backbone of the DNA more favourable (Aasland et al, 1996; Martin and Paz-Ares, 1997).
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The SANT domain takes it name from a number of nuclear receptor co-repressors that were 
found to contain it (Switching Defective Protein (Swi3), Adaptor 2 (Ada2), Nuclear 
Receptor Co-Repressor (N-CoR) and Transcription Factor (TF)IIIB) (Aasland et al, 1996). 
SANT domain-containing proteins tend to show chromatin remodeling properties (Aasland 
et al, 1996) or an ability to bind to histone tails (Boyer et al, 2004).
Myb-like domains contain structural and sequence similarity to the Myb and SANT 
domains but vary sufficiently in specific residues in the helices to make them distinct from 
these domains. This category is in some ways quite varied as it appears that any domain 
that appears similar to, but distinct from, the Myb domain is described as Myb-like. With 
time it may be that they get a more distinct categorization however.
Myb-like domains have been shown to have either DNA binding or protein binding 
properties. A lot of recently identified Myb-like domains appear as single domains (as 
opposed to the tandem repeats such as with the R l, R2, R3 of c-Myb) and are longer than 
the Myb or SANT domains, typically being around 80 amino acids in length as opposed to 
around 50; as such they are sometimes described as extended Myb domains (Mohrmann et 
al, 2002; Barg et al, 2005; Zimmerman et al, 2007). The Myb-type domain can be further 
categorized into different subgroups, for example the Myb-like domain in mes2 is 
described as a MADF domain (Myb / SANT like domain in Adfl, the first protein it was 
described in (England et al, 1990; England et al, 1992)).
The ProSite database generates a Sequence Logo for each established protein domain and 
this Sequence Logo is a means of showing the key conserved residues in a protein domain. 
It does this by assigning a weight to a particular residue based upon the frequency of its 
occurrence in alignments of numerous proteins containing the domain. The taller the height 
of a residue in the Logo the more highly conserved it is, and so, one expects, the more
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functionally important it is. The Sequence Logo to the Myb-like domain is shown in FIG 
8.3.2 A) and a comparison of the mesol8E amino acid sequence to this is shown in B). 
Though mesol8E does not give a complete match, a high proportion of the key residues 
that defines a Myb-like domain are present in this region of mesol8E. Conserved residues 
in the mesol8E sequence are highlighted in bold in the corresponding colour to the key 
residue in the Myb-like domain Sequence Logo. The Tryptophan residue (W) at position 29 
of the Sequence Logo is not conserved and this is part of the reason that mesol8E does not 
score highly as a typical Myb-like domain. Tryptophan residues have been established as 
key residues in the Myb domain as their hydrophobic properties form a scaffold which 
maintains the conformation of the Myb type helix (Saikumar et al, 1990). In C) of the 
figure, the residues that were conserved and kept occurring in the Blast results are shown. 
These Blast conserved residues are underlined in the full mesol8E sequence to the region 
in B). A residue that is underlined and highlighted in bold therefore is conserved across 
species (Blast) and shown to be key in the Myb-like domain (Sequence Logo); there are a 
number of residues like this, especially in the more 3’ region of the mesol8E sequence in 
this region (KQC NR YEN), suggesting that this part of the domain may be of particular 
importance, which is what one would expect as this region would correspond to the third 
helix (the recognition helix) of the Myb-like tri-helix.
A feature of the ProSite database is that it allows you to search all of the proteins that it 
classes as Myb-like domain containing, the database shows 1,818 proteins containing a 
myb-like domain from species as diverse as bacteria to man and reassuringly proteins such 
as Domino, ISI SWI and GT2 that were identified in Blast homology searches also feature 
in this list.
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FIG 8.3.4a Graphical representation of domains present in mesol8E and mes2
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FIG 8.3.4b Sequence alignment of identified MADF (Myb-like Adfl) Domain of mesol8E and mes2 with Adfl.
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From this ProSite list, a number of Drosophila proteins that are classed as Myb-like 
containing feature. Among these are the transcription factor Zeste and the recently 
identified mesodermal factor mes2. There have been recent publications on each of these 
genes which characterises their Myb-like domains and which stresses the general similarity 
but not complete conservation to the Myb-like domain (Mohrmann et al, 2002; 
Zimmermann et al, 2006). From this I was able to make direct comparisons of the mesol8E 
Myb-like domain to the data in these papers. FIG 8.3.3 shows a comparison of the 
mesol8E region to the Myb and SANT domain alignments for the Zeste study. In this 
comparison a residue in the mesol8E sequence is highlighted in a colour if its position and 
type corresponds to those in the Myb/ SANT alignment. Residues with a hash beneath them 
are key consensus residues. Comparison of how the mesol8E sequence lines up with the 
Myb/ SANT alignment compared to the Zeste alignment shows that mesol8E also has the 
key residues of the Myb and SANT domain conserved in terms of either specific residue or 
type of residue. The fact that there is variation between mesol8E and Zeste in terms of 
other residues that align with the Myb/ SANT domain alignment is likely to be a reflection 
of variation in DNA binding properties (assuming that, like Zeste, mesol8E has DNA 
binding properties of course). It also worth noticing that unlike zeste mesol8E does not 
contain a proline or glycine residue which separates the second and third helix of the 
domain, which may confer a difference in the way the region turns between the two helices, 
but the presence of such a residue is not essential to the Myb/SANT domain as a number of 
other proteins in the alignment also do not contain these (e.g the R1 repeat of drosophila 
myb, hTRFl, hRAPl and mmNCoRA).
Similarly to mesol8E mes2 is a mesodermal protein that was originally identified in a 
screen looking for factors affected in Twist mutants (Furlong et al, 2001). In the subsequent
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mes2 study, the Myb-like domain is presented as a MADF domain (Zimmermann et al, 
2006). The MADF domain was first described in Drosophila Adfl (England et al, 1992) 
and its name derives from Myb/SANT like in Adfl (and should not be confused with the 
MADS domain present in Mef2 as described previously). The MADF domain is DNA 
binding and examples there are a number of MADF domain containing proteins found in 
Drosophila, including Adfl (England et al, 1992), Dorsal interacting protein, Dip3 
(Bhaskar and Courey, 2002), Stonewall (Clark and McKearin, 1996) and mes2 
(Zimmermann et al, 2006). All of these have DNA binding ability, transactivational activity 
and have a single Myb-like MADF domain at the N terminal end. Analysis of the protein 
sequence of the mesodermally expressed mes2 by Zimmermann et al was performed using 
the Conserved Domain Database (CDD) (Marchler-Bauer and Bryant, 2004). Analysis of 
the mesol8E sequence with this program detects a MADF domain in the N terminus of the 
protein FIG 4.2.4a and a comparison of this with the mes2 alignment is shown in FIG 
4.2.4b. The alignments are made using the sequence of the Drosophila Adfl protein, which 
is the defining sequence for the MADF domain in this program.
Note that although the alignment of mesol8E with Adfl shows less similarity than mes2 
does (an e-value of 0.11 as opposed to 3e-21), there is still significant conservation, 
especially in residues that have already been established to be key defining parts of the 
helices of Myb-like domains (Hulo et al, 2007).
In addition to this sequence analysis which suggests mesol8E consists of a tri-helix Myb 
related domain I also performed a prediction of potential protein structure through 
sequence analysis using the JPRED program (Cole et al, 2008). This also predicts a trihelix 
structure with high confidence within the region corresponding to the MADF domain 
predicted by CDD (amino acids 34-109) (or alternatively the Myb-like domain predicted by 
Prosite (amino acids 18-86). And additionally as one might expect, the residues that are
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conserved in alignment fall specifically within these predicted helix regions (FIG 8.3.5a, 
FIG 8.3.5b and FIG8.3.5c).
From this structural analysis and the alignments with the Prosite Myb-like sequence logo, 
the Zeste Myb-like comparison and the MADF comparison it can be seen that by sequence 
analysis mesol8E contains a tri-helical protein domain at its N-terminal end which 
certainly lies within the Myb family and whose similarity but not complete conservation 
with established Myb-like and MADF domains suggests it may have similar transcriptional 
activity to these.
From this data I designed UAS constructs to investigate the functional significance of this 
domain in the context of over-expression using the Gal4 UAS system.
8.4 mesol8E UAS constructs
FIG 8.4.1 shows a graphic representation of the mesol8E over-expression constructs 
designed to investigate the role of the protein and the significance of domains within it. The 
full length over-expression construct was previously designed and generated in the lab by 
Dr.Taylor, it over-expresses the full 553 amino acids of the mesol8E protein. The other 
constructs were designed based upon the protein sequence analysis above to investigate the 
significance of the Myb-like / MADF domain at the N terminus and also the predicted 
bipartite NLS and a Serine rich region at amino acids 165-191. I designed a construct 
which takes a considerable truncation to the C terminus. It consists of the first 125 amino 
acids of the protein and contains the Myb-like region (18-86), the predicted NLS (86-102) 
and continues further to ensure that these domains are completely included in the protein 
and also to include some amino acids which had some weak conservation homology based 
on Blasted sequence.
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FIG 8.3.5a Summary of mesol8E protein analysis with respect to predicted MADF 
domain.
mesol8E amino acid sequence 1-553 (Flybase)
Blue tex t: Region predicted as MADF domain - amino acids 34-109 (e value 0.11) (CDD) 
Red tex t: Conserved residues within the predicted MADF domain from Adfl alignment 
Underlined : Predicted Helix structures (JPRED)
MDTKNP P PVT S S YHHQRAPRT PE S Y FNVPE SVALLN I'VKSERIQSAFQSN 
RKNHASVWEMVAEVLNRFSARKRTAKQCCNRYENLKKIYTQLKKNPERHV 
RRNWPYMFLFKEIEEQRGECWGSNGKRLALITKNHNELSYYQRRRQAAEL 
GVLLNKDNLTPHQHSLLQSLSQSQSQSHSHAHSTDSSQSGSKLDRFLPNH 
FVEAQLSEVAGPVGGSASGVSGMSAGGFDENPLQMQMVQAAAAAAAVAAH 
KRHELQMASVGGVQMTPEDDDEDEPQRPAFKNHLHVLGHGHGLGLGHAPM 
DDSGEAPDFEKDCNGALNMHHQNNNHNENHISMKSEPLSEGEFNPDDIQL 
MQTNYN GAQNYY S PGMDANILHPDVIVDTDILSDCS S S TTLKKKRKMS TS 
TDGDSTNYELIEYLKRREKRDEELLKRMDAREDRLMNLLERTWAIETLA 
VKRALTFPVNPTKENAPATARPLSPPPPEAQFAAPPATQEQPTSPERNGI 
ATGRSGT IPVANQDAAIEVPDDGDSGDDVQVKDKLAKLTPKAGGDERTDG 
RQT
FIG 8.3.5b Summary of mesol8E protein analysis with respect to predicted Myb-like 
domain and ProSite Logo conservation.
mesol8E amino acid sequence 1-553 (Flybase)
Blue tex t: Predicted Myb-like region (aminoacids 18-86) (Prosite)
Red tex t: Conserved residues in Myb-like domain as identified in ProSite Logo 
comparison (Prosite)
Underlined : Predicted Helix structures (JPRED)
MDTKNPPPVTSSYHHQRAPRTPESYFNVPESVALLNI VKSERIQSAFQSN 
RKNHASVWEMVAEVLNRFSARP.RTAKQCCNRYENLKKIYTQLKKNPERHV 
RRNWPYMFLFKE I EEQRGECWGSNGKRLAL I TKNHNELS YYQRRRQAAEL 
GVLLNKDNLTPHQHSLLQSLSQSQSQSHSHAHSTDSSQSGSKLDRFLPNH 
FVEAQLSEVAGPVGGSASGVSGMSAGGFDENPLQMQMVQAAAAAAAVAAH 
KRHELQMASVGGVQMTPEDDDEDEPQRPAFKNHLHVLGHGHGLGLGHAPM 
DDS GE AP D FE KDCN GALNMHHQNNNHNENHISMKS E PL S E GE FNPDDIQL 
MQTNYNGAQNYYS PGMDANI LHPDVI VDTDI LS DCS S S T TLKKKRKMS T S 
TDGDSTNYELIEYLKRREKRDEELLKRMDAREDRLMNLLERTWAIETLA 
VKRALTFPVNPTKENAPATARPLSPPPPEAQFAAPPATQEQPTSPERNGI 
ATGRSGT IPVANQDAAIEVPDDGDSGDDVQVKDKLAKLTPKAGGDERTDG 
RQT
FIG 8.3.5c Summary of mesol8E protein analysis with respect to predicted Myb-like 
domain and conserved BLAST residues.
mesol8E amino acid sequence 1-553 (Flybase)
Blue tex t: Predicted Myb-like region (aminoacids 18-86) (Prosite)
Red tex t: Conserved residues across species as identified in BLAST search (Expasy) 
Highlighted dark blue : Predicted Helix structures (JPRED)
Predicted B ipartite NLS KIYTOLKKNPERHVRR (Prosite)
domain NLS
1. UAS meso18E 1-553 full length
domain ISILS
H I
Myb-like 
domain NLS
2. UAS meso18E truncation 1-125 
(myb-like domain and NLS only)
3. UAS meso18E truncation 1-197 
(myb-like domain, NLS and serine rich region)
Myb-like 
domain NLS
4. UAS meso18E 1-553 Myb-like SDM 
(myb-like domain Site Directed Mutagenesis)
FIG 8.4.1 Planned UAS constructs for analysis of meso18E function
To investigate the role of meso18E I designed UAS constructs that could be over-expressed using the Gal4 system. The 
diagram shows a graphic representation of these (not to scale). Full length meso18E protein is 553 amino acids and should 
show any phenotype associated with gain-of-function of the gene. Based on my analysis of the protein sequence (Chapter 
4.2) I also designed constructs which might provide insight into the role of the identified Myb-like / MADF domain at the N 
terminus of the protein. Through identification of the key conserved residues within this region I also designed a construct to 
target the deletion of these residues specifically via site directed mutagenesis in the predicted recognition helix of the 
domain. All proteins are shown with the N terminus at the left.
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I also designed a construct which would change key residues within the Myb-like domain. I 
wanted to make that made the most potentially significant changes within the domain, so 
consequently chose to mutate residues that were within the third predicted helix, the 
recognition helix, and that were conserved within the alignment comparison to the Myb- 
like domain protein logo and conserved in the Blast homology alignments. There were 
physical constraints in the design of the construct regarding the number of residues that 
could be mutated, due to the number of base pair changes that the site directed mutagenesis 
kit could tolerate (Stratagene). To maximize the number of amino acid residues that could 
be mutated I aimed to make single base changes in a codon that would result in the change 
of the specified amino acid. For maximal disruption to the helix I tried to introduce Proline 
or Glycine residues. The change made in the third helix were as follows :
RTAKQCCNRYENLKKIYTQL to RTAKPGCNGPEGPKKIYTQL 
RTAKQCCNRYENLKKIYTQL MADF conserved residues in the 3rd helix 
RTAKQCCNRYENLKKIYTQL Myb-like conserved residues in the 3rd helix 
RTAKQCCNRYENLKKI YTQL BLAST identified residues in the 3rd helix
For comparison, the residues identified as key or conserved in the MADF analysis, the 
Myb-like analysis and the BLAST search of the 3rd helix of mesol8E are highlighted in 
red.
The third construct I designed was an extension of the truncated protein which extends to 
197 amino acids rather than 125. The purpose of this was to include a Serine rich region of 
the protein.
Of the four constructs described here, only full length mesol8E was analysed as part of my 
thesis. The mesol8E 1-125 truncation was made, injected and fly lines established but not
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B
FIG 8.5.1 Over-expression of full length in the mesoderm causes a
severe disruption to muscle pattern
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investigated at the time of writing and the mesol8 1-197 truncation and Myb-like domain 
SDM constructs were not completed. Description of the construct design can be found in 
the materials and methods.
8.5 mesol8E gain-of-function analysis.
Three independent, homozygous viable lines carrying the UAS mesol8E 1-553 full length 
transgene were generated previously in the lab by Dr. Taylor and I investigated their effect 
on muscle development through overexpression with various Gal4 lines.
Because of the similarity in expression pattern of mesol8E to Mef2 (Taylor et al, 1995; 
Taylor, 2000 and section 8.1), I chose to use the Mef2 Gal4 driver to initially investigate a 
role for mesol8E in muscle development. Mef2 Gal4 also has the advantage of being a 
particularly strong mesodermal driver.
8.5.1 Over-expression of mesol8E has a severe effect on muscle 
development.
FIG 8.5.1 shows an example of how over-expression of mesol8E in the Mef2 pattern 
causes a severe disruption to the muscle pattern of St 17 embryos. The order of the somatic 
musculature is lost and there are a high proportion of muscles appearing misattached and 
particularly spindly and misshapen in comparison to wild type. In addition there are a 
number of muscles that appear to be missing completely, for example in the representative 
embryo shown in FIG 8.5.1, the LT1-4 muscle are missing in the majority of hemi- 
segments, leaving large gaps in the muscle pattern.
The UAS m esol8E line used in this figure was mesol8E 20T2. The three established lines 
were called mesol8E 20T2, mesol8E 29T1 and mesol8E 29T24 and each of them was 
investigated as part of the analysis of meso 18E gain-of-function.
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FIG 8.5.1 Over-expression of full length m eso18E  in the mesoderm causes a 
severe disruption to muscle pattern
The regular somatic muscle pattern seen in Wild Type embryos (B) is severely disrupted when full length meso18E is 
over-expressed in the mesoderm (A). The embryo here had the UAS meso18E 20T2 line driven in the Mef2 pattern at 
29°C and shows a representative phenotype of all those seen. 
There is a severe loss of organisation to the musculature with a high proportion of muscles appearing misattached and 
especially spindly and misshapen in comparison to Wild Type. For example this is particularly noticeable in the ventral 
region where the VL1-4 and V01-3 muscles are situated (arrow). 
In addition there are also subsets of muscles that appear to be completely missing in each of the hemi-segments within 
the meso18E over-expression embryo, for example absence of the LT1-4 muscles causes distinctive gaps in the 
muscle pattern of the embryo (compare asterisk region in A with Wild type B). 
The embryos are St17, viewed laterally and stained with anti-|33 tubulin antibody to visualise muscles.
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All of the lines give a similar effect upon muscle development, disrupting the shape and 
attachment of a large proportion of muscles and also causing muscle loss. However, there 
is variation in strength between the transgenic lines, which is not unusual and probably due 
to differences in insertion position. mesol8E 20T2 is the strongest line whereas mesol8E 
29T1 and mesol8E 29T24 are of a more comparable level. This is reflected by the extent of 
muscle loss in embryos that were scored for presence, absence, shape and attachment 
defects in A2-A4 of ten individual embryos; FIG 8.5.2 shows how the average number of 
muscles lost in hemi-segments A2-A4 is distinctly higher in the mesol8E 20T2 line (58.8) 
than the mesol8E 29T1 and mesol8E 29T24 lines (12.4 and 10.9 respectively) when the 
lines are driven by Mef2 Gal4 at 29°C. In a similar manner the range of muscles affected 
in any one embryo (A2-A4) is also higher in the mesol8E 20T2 than the other lines, (45-74 
muscles missing as opposed to 4-19 missing for mesol8E 29T1 and 1-24 missing in 
mesol8E 29T24 embryos).
Despite the differences in strength, the lines show clear similarities in their phenotype in 
the way over-expression of mesol8E effects the derivatives of the mesoderm, with the 
29T1 and 29T24 lines showing milder phenotypes as opposed to different phenotypes to 
the 20T2 line. This can be seen in the tables showing the data for the analysis of somatic 
muscle phenotype of the three lines (TABLE 8.5.1a and 8.5.1b) and seen in the 
representative embryos shown in FIG 8.5.3.
Over-expression of meso!8E causes a strong phenotype in all of the mesoderm derivatives 
it is expressed in. As shown in FIG 8.5.1 over-expression of mesol8E causes a severe 
derangement to the somatic muscles. In addition, the gut is frequently severely misshapen 
in mesol8E 20T2 over-expression embryos; it fails to constrict and instead forms a 
rounded bloated structure, which consequently appears to affect the shape of the embryo 
itself, deforming it where the gut blisters out and also causing the somatic musculature in
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Muscle phenotype
UAS 18E (20T2)
X
Mef2 Gal4 
(29°C)
UAS18E (29T1)
X
Mef2 Gal4 
(29°C)
UAS 18E (29T24)
X
Mef2 Gal4 
(29°C)
% embryos with 
muscle missing 100 % 100% 100 %
Average No. 
muscles missing per 
embryo 58.8 12.4 10.9
Range of muscles 
missing per embryo 45-74 4-19 1 -24
Table 8.5.2 - Muscle missing phenotype of meso18E over-expression lines
The thirty individual somatic muscles per hemisegment scored A2-A4 for 15 individual embryos for each meso18E 
overexpression line. The average number of muscles A2-A4 missing per embryo is shown and the range of muscles 
missing A2-A4 for the embryos scored for that experimental condition are shown. There is a total possible muscles 
missing of 90 (30 per hemisegment) for each embryo tested. All three UAS meso18E lines driven by Mef2 Gal4 at 
29°C.
Muscles 
Missing 
in > 50 % 
Embryos
Muscles 
Missing 
in 2 5 - 4 9 %  
Embryos
Muscles 
Missing 
in 10-24% 
Embryos
Muscle 
Duplication 
in 1 0 - 3 0 %  
Embryos
Shape 
Defects 
in > 70 % 
Embryos
Shape 
Defects 
in 50 -69 % 
Embryos
UAS 18E (20T2) 
X
Mef2 Gal4 
(29°C)
All others 
(see Table 
4.4.3b)
DTI LL1, D05 DA3, D05,
DTI, LL1,
VT1, VL1, 
VL2, VL3, 
VL4, VA1
SBM, VOl, 
V02
UAS 18E (29T1)
X
Mef2 Gal4 
(29°C)
D03, D04, 
LT1, LT4, 
LOl, VT1, 
VA3, V04, 
V06
LT2, LT3, 
SBM
DAI, D02,
DA2, DA3,
D05, LL1,
VL2, VL3,
VA1, VA2,
VOl, V02, 
V05
DOl, LT1, 
VA3
D04, DA3,
LL1, LT1,
LT2, LT3,
VT1, VA1,
VA2, VA3,
V04, V05, 
V 06
DA2, D03,
D05, LT4, 
SBM
UAS 18E (29T24) 
X
Mef2 Gal4 
(29°C)
DA2, LT3, 
LT4, VL2, 
VL3, V04
D03, D04, 
D05, LT2, 
LOl, VA3, 
VOl, V05, 
V06
DAI, DA3, 
DTI, LT1, 
SBM, VT1, 
VL1, VL4, 
VA1, V02 
V03
DOl, DAI, 
V04, V06
D02, D03, 
D04, DA3, 
LT2, LT3, 
VT1, VA1, 
VA3, V04, 
V05, V06
DOl, DAI, 
DA2, LT1, 
LT4, LOl, 
VA2
Table 8.5.1a Individual muscle phenotype analysis of meso18E over-expression lines
Cross Muscles Missing in 
100 % Embryos
Muscles Missing in 
90-99 % Embryos
Muscles Missing in 
80-89% Embryos
Muscles Missing in 
70 - 79% Embryos
Muscles Missing in 
10 -  30% Embryos
UAS 18E 
(20T2)
X
Mef2 Gal4 
(29°C)
D03, LT1, LT2, 
LT3, LT4, LOl, 
VA2, VA3, V03, 
V04, V05, V06
D04, VL3, V02, SBM, VL1, VL2, 
VOl
DA3, VT1, VL4 D05, DTI, LL1,
Table 8.5.1b - Meso18E 20T2 over-expression muscle phenotype analysis
Wild Type meso18E 20T2
meso18E 29T24 meso18E 29T1
FIG 8.5.3 There is some variation in strength, but not type of muscle phenotype when 
over-expression of the three full length meso18E transgenic lines are compared.
meso18E20T2, meso18E 29T24 and meso18E 29T1 driven by Mef2 Gal4 at 29°C all give a muscle phenotype which 
shows disruption to the muscle pattern with predominantly muscles being missing or misattached (see Table 8.5.1 for 
details). The images shown here are representative of the strength of phenotype observed, with meso18E 20T2 being 
Muscles stained with anti (33-tubulin.
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the region it extends into to be misshapen (FIG 8.5.4a). This gut phenotype is also seen in 
the weaker mesol8E lines at a lower frequency. An example of this gut structure in 
mesol8E 29T1 over-expression embryos is shown in FIG 8.5.4b.
Another striking aspect to the mesol8E gain-of-function phenotype is the failure of a 
proper heart structure to form. This is particularly profound in the mesol8E 20T2 over­
expression embryos where there can be a complete absence of a heart structure except for a 
few remaining clumps of misshapen cardioblast cells (FIG 8.5.5). Slightly milder 
phenotypes also occur with mesol8E 20T2, whereby only partial sections of tubular heart 
form or their appears to a large number of misshapen cardioblasts either side of the dorsal 
midline where the heart should be but no dorsal tube forms, as if the cells were unable to 
find their position or maintain their integrity (FIG 8.5.5). This embryo that shows no dorsal 
tube also shows defects in the shape and pattern of the cells within pharyngeal muscle, 
though the general shape of the muscle itself remains distinguishable (FIG 8.5.5). With the 
lower strength over-expression lines, a milder heart phenotype occurs; the heart tube forms, 
but their can be kinks within it or incorrect numbers of p3-tubulin positive cardioblasts in 
the heart pattern (FIG 8.5.6).
In addition to somatic muscles appearing misguiding and misshapen in the body wall of the 
embryo (FIG 8.5.1 and 8.5.3), they can also stray across into the ventral midline as shown 
in FIG 8.5.7.
A small proportion of embryos examined from the staining show a very distinctive 
phenotype where they appear to have differentiated somatic musculature resembling that of 
Stl7 (albeit with shape defects), but the shape of the embryo more closely resembles a Stl2 
embryo with respect to germ band retraction (FIG 8.5.8). The embryo shown here used the 
meso!8E 29T1 line, it was not seen with the mesol8E 20T2 line in the embryos examined.
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FIG 8.5.4a The gut fails to restrict in meso18E over-expression embryos, which results in a 
bloated phenotype
In the majority of embryos strongly over-expressing meso18E there is a failure of the gut to constrict properly and instead 
it forms a rounded blister like structure which bloats the embryo causing the shape of the embryo itself to become 
deformed and also the somatic muscles and heart to not form in this area or be severely misshapen.
The embryos here are St17 and viewed dorso-laterally. In the meso18E over-expression embryo, B, the focus is on the 
visceral muscle and shows the mishapen rounded gut in comparison to the tubular constricted gut of Wild Type in A. 
Shifting focus at this position shows that the somatic muscles are especially affected where the abdomen distends, with 
muscles missing or seemingly stretched to the shape of the rounded gut where the somatic muscles are present 
(compare D with wild type C).
Line used meso18E 20T2, driven by Mef2 Gal4 at 29°C, stained with anti p3-tubulin.
meso18E 20T2 meso18E 29T1
Dorsal view 
(Visceral focus)
Dorsal view
(Somatic / Cardiac focus)
FIG 8.5.4b The gut fails to restrict in both meso18E high and low strength over-expression 
embryos.
FIG 8.5.5 Strong over-expression of meso18E causes loss of heart structure
Over-expression of meso18E causes a severe heart phenotype, which can result in almost complete loss of the 
heart.
Embryo B shows only a few cardioblasts, which are misshapen and in a small isolated clump (arrow in B).
In embryo C there is som e tubular structure that forms, but this is only a partial section of heart, in which the 
cardioblasts are also misshapen (bracket in C). This heart section is also mis-positioned within the embryo compared 
to wild type, having strayed away from the dorsal midline (marked by an arrowhead in the full embryo image of C).
Embryo D shows a no heart structure at all in the dorsal midline, but has a large number of severely disorganised 
cardioblast-like cells either side of the midline (arrow in D). The general shape of the pharyngeal in this embryo wild 
type but the shape of the cells and their pattern seem s disorganised (arrowhead, D).
All embryos are St17, aligned dorsally and stained with 03-tubulin antibody. UAS meso18E line used is 20T2 and 
was driven by Mef2 Gal4 at 29 °C. Wild type embryos are OR.
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FIG 8.5.5 Strong over-expression of meso18E causes loss of heart structure
FIG 8.5.6 Milder over-expression of meso18E disrupts heart pattern
When meso18E is over-expressed with the weaker UAS insertion lines (29T24 or 29T1) the heart phenotype is less 
severe than that seen with 20T2 which can result in loss of heart structure.
Instead with these lines the heart forms, but shows structural or pattern defects. Embryo B shows a linear heart, 
consisting of two rows of cardioblasts, but that has defects in cardioblast pattern.
The wild type heart consists of two rows of cardioblasts which have a repeating pattern of four out of six p3-tubulin 
positive cardioblasts per hemisegment (see A). With meso18E overexpression the pattern is disrupted, with a group of 
two in one row (arrows in B) and a group of nine in another row (bracket in B).
Embryo C shows a stronger phenotype consisting of sections of cells being missing (arrow, C) and circular clumps of 
misshapen cardioblasts (arrowhead, C) -  a phenotype which was also seen with the stronger UAS meso18E line (FIG 
4.4.3 -  B)
Embryo D shows a group of misshapen and disorganised cardioblasts (arrow, D) and a kink in the tubular structure of 
the heart (line D).
All embryos are St17, aligned dorsally and stained with /33-tubulin antibody. UAS meso18E lines used were 29T24 and 
29T1 and were driven by Mef2 Gal4 at 29 °C. Wild type embryos are OR.
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FIG 8.5.6 Milder over-expression of meso18E disrupts heart pattern
Wild Type UAS meso18E
FIG 8.5.7 Over-expression of meso18E causes muscles to stray across the ventral midline
Embryos overexpressing meso18E show a severe disruption to muscle pattern with some muscles straying across the ventral 
midline as seen in the image above. Compare the ventrally viewed embryo B, where spindly muscles can be seen spanning the 
midline (arrow B) to wild type A). No muscles do this in the wild type condition (arrow A). More examples of muscles crossing 
the midline in this way can be seen in FIG 8.5.10
All embryos are St17, aligned ventrally and stained with /33-tubulin antibody. UAS meso18E lines used is 20T2 and was driven 
by Mef2 Gal4 at 29 °C. Wild type embryos are Oregon R.
UAS meso18E Wild Type
St12
St17
St17
FIG 8.5.8 Over-expression of meso18E can cause severe 
developmental defects in some embryos
In a small percentage of meso18E (20T2) over-expression embryos a phenotype is seen 
where the embryo has the appearance o f a St12 embryo, with the germ band not yet 
retracted (arrow) but the m usculature of a St17 embryo where distinct individual muscles 
have formed.
This phenotype could occur as a result o f premature muscle differentiation or delayed 
germ band retraction.
UAS meso18E
FIG 8.5.9 Over-expression of meso18E with Twist Gal4 also severely disrupts muscle pattern
FIG 8.5.10 Examples of muscles crossing the ventral midline in 
meso18E overexpression embryos.
A proportion of em bryos (approx 30%) overexpressing m eso18E show m uscles that 
span either partially or completely the ventral midline. T hese m uscles are  also 
m isshapen and thin. The line used in all of these  im ages is m eso18E 20T2 and w as 
driven by Twi ; Twi Gal4 at 25°C. The m uscles were visualised by staining with anti p3- 
tubulin antibody. All embryos St17 and viewed ventrally. Wild type is Oregon R.
Wild Type
UAS meso18E X Twi : Twi Gal4
FIG 8.5.10 Examples of muscles crossing the ventral midline in meso18E 
over-expression embryos
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Over-expression of mesol8E slightly earlier in muscle development also causes a very 
severe disruption to muscle development. Driving the lines in the Twist pattern (with T w i; 
Twi Gal4) can cause muscle loss, and severe shape and attachment defects in somatic 
musculature, disruption to the formation of the heart, failure of the gut to restrict (not 
shown) and muscles to stray into the ventral midline (FIG 8.5.9); these muscles can 
occasionally completely span the ventral midline (FIG 8.5.10). The line shown here is the 
stronger mesol8E 20T2 UAS line and was driven with Twi; Twi Gal4 at 25°C. The 
mesol8E 29T1 and 29T24 also gave a similar phenotype (not shown) in a manner 
resembling that seen when the lines were driven by Mef2 Gal4 (FIG 8.5.3).
8.6 mesol8E loss-of-function.
After the discovery that mesol8E gain-of-function gives a severe muscle phenotype in all 
the tissues it is normally expressed in (somatic : muscle loss, missattachment and 
misguidance, cardiac : complete loss of heart structure or cardioblast pattern, visceral : 
failure of gut to constrict, forming rounded bloated shape which can effect embryo shape, 
and pharyngeal : muscle cell shape and pattern) I wanted to investigate any potential 
phenotype associated with loss-of-function of mesol8E in the embryo.
Investigation of the genomic region around mesol8E (Flybase) showed that the region was 
rich in transposable element insertion stocks. FIG 8.6.1 shows a GBrowse map of the 18E 
region on the X chromosome which the mesol8E gene lies in and highlights all the 
transposable element stocks available in the region. Analysis of the orientation and 
structure of the transposable elements revealed two which were appropriately aligned and 
positioned to enable the targeted deletion of mesol8E alone through the technique of 
transposable element mediated recombination
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FIG 8.6.1 meso18E gene region and transposable element insertions
The Flybase GBrowse data for the region of the meso18E gene showing the pBac RB e02398 exelixis element and 
pRS3 UM-8195-3 DrosDel elements that can be used together to make a deficieny specific to meso18E.
(FlyBase)
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Crossing schemes have been developed for generating an FRT mediated deletion between 
two P-elements generated in the Drosdel collection at Cambridge (Ryder et al, 2001) or 
between two P-elements from the Exelixis collection at Harvard (Parks et al, 2001) which 
result in convenient analysis of the event occurring by tracing a w+ marker. However, 
although tracing the event can be more difficult, it is possible to use a combination of a 
Drosdel and an Exelixis element provided the FRT sites are oriented in the same direction 
for a flip event between them to occur. This is what I did for the targeted deletion of 
mesol8E. There is a DrosDel RS3 element, UM-8195-3, which is situated 59bp upstream 
from the start o f mesol8E and the Exelixis RB element, e02398, situated in the third intron 
of mesol8E (FIG 8.6.1 and 8.6.2). A Flippase induced trans-recombination event via the 
FRT sites o f the elements results in a deletion (and duplication) of the 5220bp’s of 
endogenous DNA situated between them. Deletion of region corresponds to the first three 
exons and the first two introns of the mesol8E gene, this means that a deletion removes the 
first 447 amino acids of the gene, which corresponds to approximately 80% of the gene 
(447/553), before even considering that a new start codon needs to be found in the remain 
coding sequence. As established in section 8.3, a deletion of the first 447 amino acids 
means that the predicted Myb-like domain would also be removed in the recombination 
event.
Based upon the crossing scheme for two DrosDel elements (Ryder et al, 2001) and the 
crossing scheme for two Exelixis elements (Parks et al, 2001), I designed a crossing 
scheme that would allow use of one of each the elements for the mesol8E situation.
Because of the nature of the element and design of the DrosDel system, the RS3 element 
must be first “flipped out” to reduce its number of FRT sites from two to one making it 
compatible for recombination with another FRT containing element in the same 
orientation. The consequence of this is that an additional heat shock step is required and the
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FIG 8.6.2 meso18E FRT element map
Graphic representation of the meso18E gene and the transposableelements in the region that can be used to 
generate a deletion of the gene. The RS element is UM-8195-3 (DrosDel) and the pBacRB element is e02398 
(Exelixis).
On recombination between the FRT sites within elements 5220bp’s of Endogenous DNA will be removed from 
the region that they span. This corresponds to the majority of the meso18E gene including the predicted myb-like 
domain towards the N terminus of the protein.
Around 1/5th of the gene will remain at the 3’ end.
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RS3 element loses its w+ marker gene, becoming a RS3r w- element at the same position 
in the genome. The e023898 RB element contains a w+ element is capable of FRT 
mediated recombination with another FRT containing element immediately, provided the 
Flippase enzyme is present. Thus, at the start of the recombination cross you begin with 
two separate P-element stocks, the white eyed UM-8195-3 RS3r w- element and the red 
eyed e02398 w+ RB element. For recombination to occur the individual X chromosomes 
containing these separate elements must be brought together in the presence of a copy of a 
heat-shock inducible Flippase enzyme which can act upon the FRT sites of the elements 
and induce a recombination event in trans between the two chromosomes. (As the elements 
are on the X chromosome for this recombination, an autosomal copy (on the II) of the 
Flippase enzyme was introduced). If recombination is successful there are two possible 
outcomes for the endogenous DNA between the two FRT sites of the elements, a deletion 
of the region or a duplication of the region. This event is outlined in FIG 8.6.4. As shown 
in the figure, the chromosome that gains the w+ gene from the RB element after the 
recombination event is dictated by the position of the eye colour gene in relation to the 
interacting FRT sites. Because of this, the deletion chromosome gains the w+ gene and so 
flies containing a deletion chromosome will be red eyed and the duplication chromosome 
does not get the w+ gene (or the w- gene) but as the genetic background for the cross stock 
is w - , flies that contain the duplication chromosome will be white eyed.
However in order to distinguish the deletion chromosome containing progeny with progeny 
that simply contain an unrecombined e02398 w+ element, PCR is needed. In the same way 
PCR is needed to distinguish progeny that contain a duplication chromosome with a 
progeny that contain an unrecombined RS3r element. Primers were designed in pairs that 
consisted of one primer that would bind to the end of an element and the other being 
specific to the endogenous DNA adjacent to it as outlined in FIG 8.6.4. As the figure
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FIG 8.6.3 FRT element mediated trans recombination of the meso18E gene region
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FIG 8.6.4 PCR confirmation of 
successful deletion and 
duplication recombination events
S W1118; TM6B / MKRS, hsFLP 86E ; 3iso x $ w1118 p{FRT, w+} RB ; 2iso ; 3iso
$ w1118 p{FRT, w +} RB; MKRS, hsFLP 86E ; 3iso
x $v w1118 p{FRT, w-} RSr ; 2iso ; 3iso
'Heat
?v w1118 p{ FRT, w- }RSr Iw1118 p{FRT, w+}RB ; MKRS, hsFLP 86E ; 3iso
x FM7h iso ; 2iso ; 3iso
$v w1118 p{FRT, w-}RSr — p{ FRT, w+}RB / FM7i iso ; 2iso ; 3iso
x S FM7i iso ; 2iso ; 3iso
Screen progeny b y  PCR to
confirm recombination
event
w1118, p{FRT,w-}RSr—p{FRT,w+} RB ;iso ;iso
FIG 8.6.5 FRT element mediated trans-recombination of the gene region
Chapter 8: mesol8E
indicates only certain combinations of primer pairs will give a PCR product depending 
upon the chromosomal make up.
The RS3r element will only give PCR products to primer pairs A and B. The RB element 
will only give products to primer pairs C and D. If a deletion event occurs only A and D 
will now give a product whereas if a deletion event occurred PCR to the genomic DNA of 
the progeny will only give a product from primer pairs B and C. Genomic screening by 
PCR of the emerging progeny after they have emerged from the recombination inducing 
heat shock cross (and you have allowed them to mate to pass on their genes) and looking 
for these changes in conjunction with the progeny having the appropriate eye colour as 
outlined above was how I isolated two deletion alleles and one duplication allele for the 
mesol8E region. (As for every successful recombination event there is a deletion and a 
duplication event, clearly I missed a successful duplication in my screening process).
The crossing scheme for this recombination is shown in FIG 8.6.5. The deletion alleles 
were named mesol8E del-6 and mesol8E del-8 after the progeny flies that they originated 
from and the duplication allele was named mesol 8E Dup-11.
8.7 Preliminary analysis of the mesol8E deletion and 
duplication alleles.
Each of the alleles is homozygous lethal and consequently have to be kept over FM7 
balancer chromosomes. I have established separate stocks which put these alleles over the 
following balancer chromosomes :
1) FM7c, ftz lacZ 2) FM7c, actinGFP 3) FM7c, twi Gal4, UAS GFP and 4) FM7c dfd 
YFP
but still need to confirm an absence of mesol8E RNA in homozygous embryos of the 
deletion lines.
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Experiment Embryo
Hatching
Survival to adult 
fly
Wild Type 99% 87%
mesol8E Del-6 100% 4%
mesol8E Del-8 100% 5%
mesol8E Dup-11 96% 8%
mesol 8E RNAi x 
Dicer I I ; Mef2 Gal4 
(29°c)
92% 0%
female male
embfyo
prepupa
2nd Instar larva
3rd instar larva
FIG 8.7.1 meso18E  mutant phenotype analysis
Hatching and survival data for the established deletion and duplication lines for the m esol 8E recombination. The 
data suggests that the mutants are lethal with only a small number of escapers surviving to adulthood. These that 
survive are infertile and die within a day of eclosing. The majority of the mutants die at the pupal stage for both 
the deletion and duplication lines.
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All three of the lines themselves are homozygous lethal. Hatching and survival tests using 
the actin GFP lines as balancers to test for homozyosity reveal that the majority of flies for 
both the deletion and the duplication lines die at the late larval / pupal stages. Pupae are 
considerably smaller than wild type. There are occasional adult escapers and these are 
small, weak, non-fertile, unable to fly and die within one day of eclosion (FIG 8.7.1).
8.8 Summary
Following on from Dr. Taylors original investigation I have found the following in my 
characterisation o f mesol 8E;
It is a putative nuclear factor that contains a conserved helix-helix-tum-helix Myb-like 
domain at its N terminus.
That it is a direct target of Me£2; a 1Kb region upstream of the gene is capable of 
recapitulating mesol8E expression, and a Mef2 site located in a region of phylogenetically 
conserved non-coding DNA within this region is essential for this expression, as revealed 
by Site Directed Mutagenesis to the binding site of a GFP reporter construct. 
Over-expression o f mesol8E causes a severe disruption to the formation of the somatic 
musculature, heart and visceral muscle. A predominant phenotype of misguided muscles in 
the abdominal wall is seen as well a number of muscles than can stray across the ventral 
midline and others that can cross the dorsal midline. In addition overexpression in the heart 
causes a severe disruption to the formation of the vessel as seen with loss of b3 tubulin 
expressing cardioblasts.
That a distinct subset o f muscles are seen to be missing in mesol8E over-expression 
embryos that are different to the high mef2 requirement subset as seen in Mef2 loss of 
function conditions.
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In addition I have generated and confirmed by PCR two deletion alleles and one 
duplication allele for mesol8E  that were made by P-element mediated recombination.
All of these alleles are lethal at the pupal stage; the flies are smaller than wild type and fail 
to get out of their pupal case.
In addition to these new mutant alleles, I have also generated a UAS mesol8E 1-125 
overexpression construct for which transgenic lines have recently been generated.
8.9 Discussion
As a potential transcription factor that is directly activated early in myogenesis by Mef2 
mesol8E is a good candidate for a role as a Mef2 effector; a factor which would 
subsequently activate its own cohort of genes to help regulate a specific process.
The phenotype associated with mesol8E over-expression suggests that this could be as an 
effector of the muscle guidance program. If this was the case one might expect evidence of 
regulation by mesol 8E or genetic interaction of mesol 8E with factors already known to be 
players in this process, be this at the level of signalling between the tendons and myotube 
or in defining the midline with genes such as roundabout.
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Concluding Remarks and Models for Mef2 action.
The aim of this study was to gain insight on the role of Me£2 in muscle development. I did 
this through changing Mef2 activity levels throughout the embryo by a variety of distinct 
methods and then carefully characterising the terminal somatic muscle phenotype and 
investigating any trends.
From the observations this study has presented I feel that two models can be made which 
provide an explanation for the role of Mef2 in the patterning of the somatic musculature. 
The first comes from the observation that, unlike previously thought, there is a role for 
Mef2 in the specification of founder cells — though only a specific subset of founders. The 
model, outlined below (and expanded from observations by Park et al, 1998), provides an 
explanation placing the actions Mef2 and Him in the fate specification of the affected 
subset of founder cells.
The second model is the idea that individual somatic muscles have a specific requirement 
for Mef2 for their correct formation and that this requirement may be dictated by the 
identity genes that the muscle derives from. Though this second aspect can be an 
explanation for a role for Mef2 in founder cell specification, it is also an explanation for the 
correct formation of muscles whose founders appear to have formed independently of Mef2.
9.1 The specification of particular founder cells
I identified a possible role for Mef2 in the specification of the founder cells that specify the 
DOl, LT1, LT2, LT3 and VA3 muscles.
Experiments looking at the Kruppel positive founders for the DOl/DAI muscle show that 
these founder cells can undergo an increase in number under conditions of increased Mef2
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activity and that this manifests as a duplication in the corresponding muscle in the terminal 
St 17 phenotype. The sibling for this DOl founder is a pericardial cell. The two cells derive 
from a progenitor that is initially positive for Mef2, but on division and distribution of the 
asymmetric determinant Numb, the cells adopt two different fates; the cell that acquires 
Numb maintains Mef2 expression and becomes a DOl founder (that will subsequently 
differentiate into the DO 1 muscle), whereas the cell that does not acquire numb loses Mef2 
expression and becomes an eve positive pericardial cell of the heart (Park et al, 1998).
In FIG 9.1.1,1 add to this model by suggesting that it is Him that is responsible for this loss 
of Mef2 expression and that this action is mediated by Notch maintaining expression of 
Him. The other muscles such as the VA3, which is derived from a muscle / non-muscle 
sibling pair (VA3 founder and AMP -  Beckett and Baylies, 2009) can also be explained in 
this way. Such a model would provide an explanation for the maintenance of Him 
expression observed in the AMPs and pericardial cells (Chapter 4) and is supported by a 
number of factors such as over-expression of Him causing increased pericardial cell 
number (Liotta, PhD thesis 2006), the presence of numerous SuH sites in the Him 
regulatory region (Chapter 4.3 and Rebeiz et al, 2002) and the observation that Him 
appears as a potential Notch target on a recent microarray (Krejci and Bray, 2007).
As can be seen from FIG 9.1.1, the distribution of the factors provides an explanation for 
both an increase in these muscle numbers seen in Him mutants or Mef2 overexpression and 
also an explanation for decrease in muscle number in Him overexpression or Mef2 mutant 
backgrounds. FIG 9.1.2 shows fates adopted in various experimental conditions and an 
explanation for these fates according to the model. From this it is clear that a number of 
further investigations are required in order to validate the model. One of the key 
experiments would be to show that when a muscle duplication occurs (in Him mutants or
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FIG 9.1.1 A model for the role of Mef2 in asymmetric founder division
Experiment
Wild Type 
Him mutant
UAS Mef2 
x Mef2 G
UAS Him
x Mef2 G
Mef2 mutant
Numb Mutant
UAS Numb 
xTwi;24B Gal4
Notch mutant
Comments
Numb inhibits Notch, Him o ff and Mef2 active : DA1 fate. In 
sibling, no numb means Notch active, Him expression maintained 
and Mef2 repressed -  non Muscle EPC fate.
No Him in EPC sibling to inactivate Mef2 -  therefore muscle fate 
adopted. This would be at the expense o f the sibling pericardial 
cell forming.
Additional Mef2 in the EPC sibling may be able to compete with 
wild type Him -  causing DA1 fate. Additional Mef2 in the DA1 
sibling has no effect on fate.
Cell fate outcome Seen?
O
Y
Y
Check EPC loss
Y
Check EPC loss
Ectopic Him in the DA1 sibling -  Mef2 repressed: DA1 lost, EPC 
fate adopted. Additional Him in the EPC sibling has no effect.
No Mef2 in the DA1 sibling to induce the muscle fate - :  DA1 lost, 
EPC fate adopted. Him in the EPC sibling not required as no Mef2.
No Numb in DA1 sibling to inactivate Notch -  therefore Him 
expression remains and Mef2 repressed: non-muscle, EPC fate 
adopted.
Numb in both siblings -  therefore Notch repressed in both, Him 
off in both, Mef2 active in both -  both adopt DA1 muscle fate.
Him expression not maintained in the EPC sibling as Notch not 
present to activate. Thus the DA1 fate is adopted as Mef2 is not 
repressed in the EPC sibling
Y
epc) Check gain of EPC
Y
Check gain of EPC
Y
Parks. Carmena. 
Ruiz Gomez
Y
,Parks-Twi;24B Gal4 
/Carmena-Twi Gal4
Y
Parks.
FIG 9.1.2 Cell fate outcome for Mef2 founder cell specification model
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UAS Mef2 experiments) a pericardial cell is lost (or AMP is lost, if that is the sibling cell 
of the pair such as with VA3). The most suitable way to achieve this would be by double 
florescent labelling for Eve and Kruppel as this would be able to show distinctly each DOl, 
DAI and eve positive pericardial cell in an experimental condition. Conversely, when a 
muscle is lost it would be good to show that a pericardial cell is gained. Additionally if it 
could be shown that overexpression of Mef2 was able to rescue the Numb mutant 
phenotype and Him overexpression was able to rescue the Notch mutant phenotype, this 
would both reinforce the validity of the model and help place factors in the correct position 
in the pathway.
It should also be noted that despite the plausibility of this model other explanations exist 
for a possible muscle duplication at this stage; for example if there is a division of the 
founder cell before myoblast recruitment this could explain the formation of two muscles 
of the same fate forming in the same area as is seen. The main difference between this and 
the model is that the sibling cell of the precursor should develop normally in this situation.
9.2 The Role of Mef2 activity requirement for general 
muscle patterning
The other model I propose is based upon the fact that certain muscles have a specific 
requirement for Mef2 activity; with High Mef2 Requirement Muscles being easily lost and 
Low Mef2 Requirement Muscles remaining present under conditions of decreased Mef2 
activity. Analysis of the individual muscles that fall into these categories in conjunction 
with the expression patterns of known identity genes allows for a model that proposes the 
identity genes in turn have various requirements for Mef2 activity. The fact that the identity
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FIG 9.2 A model for the role of Mef2 activity requirement for general muscle 
patterning
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genes are potential Mef2 targets has only recently been established (Sandmann et al, 2006) 
and supports the potential for such a hypothesis.
As it is already known that Mef2 is not required for the initial expression of many of the 
identity genes, I propose that this is a role for more the maintenance of identity gene 
expression in order to co-ordinate differentiation of the founder. A model for this is shown 
in FIG 9.2, where two examples of High and Low Mef2 requirement muscles are shown for 
which exist specific identity genes which have the same expression pattern. At the head of 
the cascade the regulation of Mef2 activity is tightly controlled via input from Him and 
Zfhl and through autoregulation and a new role of activation of its repressors for fine 
tuning.
One would expect other intermediate requirement patterns to occur as a result of possible 
responses to identity gene combinations, the analysis of which would be more complex. 
However, through further analysis of the role of Mef2 in founder cell specification and 
investigation into its role in the tightly controlled regulation of identity genes a more 
detailed picture can be built up that gives an understanding of the process of muscle 
differentiation and how Mef2 orchestrates this process.
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